data_2l1s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l1s _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.23 -26.2 67.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.16 0.584 . . . . 0.0 111.163 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -23.02 65.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.634 1.574 . . . . 0.0 113.837 171.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -101.36 4.5 41.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.996 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.89 111.28 21.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 121.017 1.735 . . . . 0.0 109.497 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 11' ' ' LYS . 4.0 mp -81.92 -165.51 1.01 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.412 1.577 . . . . 0.0 106.841 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 10' ' ' LEU . 13.5 ptmt -134.3 -13.96 2.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.725 -2.034 . . . . 0.0 113.236 164.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 178.49 159.09 0.53 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.882 0.765 . . . . 0.0 110.502 -163.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -167.33 -175.54 2.94 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.659 1.584 . . . . 0.0 109.159 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -128.49 135.49 49.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 157.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.54 161.98 33.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 158.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 20.65 11.96 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 163.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 62.29 29.45 17.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.331 1.853 . . . . 0.0 112.586 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -129.96 122.51 28.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.611 2.364 . . . . 0.0 107.626 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.58 147.0 30.96 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -147.21 158.49 43.97 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.811 0.844 . . . . 0.0 110.292 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.16 173.44 11.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.964 1.306 . . . . 0.0 109.0 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.64 108.22 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.77 2.37 39.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.598 -1.668 . . . . 0.0 114.822 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -178.06 1.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.481 1.64 . . . . 0.0 108.135 161.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.18 146.99 48.33 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.667 -1.27 . . . . 0.0 107.581 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.6 m -79.09 162.1 65.68 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.84 162.26 39.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.797 2.331 . . . . 0.0 111.077 162.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -16.3 44.15 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.437 1.095 . . . . 0.0 112.153 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtt -60.06 -17.24 38.0 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 124.874 1.27 . . . . 0.0 112.158 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -119.95 1.72 10.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.6 -26.22 57.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.461 1.028 . . . . 0.0 110.269 167.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -57.99 144.4 75.5 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.66 -4.24 14.23 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 112.724 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.04 -14.95 18.9 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.795 2.038 . . . . 0.0 114.005 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.6 -5.09 8.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.253 1.421 . . . . 0.0 112.237 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.27 106.74 2.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.906 2.082 . . . . 0.0 110.15 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.57 83.62 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -63.72 -16.92 62.36 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.273 -0.892 . . . . 0.0 111.115 167.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -90.11 70.77 7.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.148 2.179 . . . . 0.0 108.022 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -111.92 -19.45 12.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -72.17 -35.99 69.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.767 1.167 . . . . 0.0 111.483 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -78.13 38.1 0.27 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.552 0.615 . . . . 0.0 110.034 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -146.39 166.1 27.36 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 127.271 2.228 . . . . 0.0 106.611 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.38 -16.47 62.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.167 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.85 148.71 75.55 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 0.0 112.265 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -74.1 157.85 46.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.086 2.524 . . . . 0.0 112.757 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.65 142.58 96.13 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.607 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.37 162.89 39.2 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.058 2.505 . . . . 0.0 112.189 -171.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.54 160.57 29.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.95 50.72 1.42 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.453 1.501 . . . . 0.0 113.266 -161.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.53 38.9 0.02 OUTLIER Glycine 0 CA--C 1.528 0.9 0 C-N-CA 127.37 2.414 . . . . 0.0 109.835 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.9 p -148.37 172.17 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.645 1.223 . . . . 0.0 110.577 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -145.58 156.41 43.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.173 0.511 . . . . 0.0 111.956 169.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -73.33 141.41 47.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.983 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.27 131.95 35.12 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.141 2.177 . . . . 0.0 106.256 -169.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.16 100.34 11.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.48 -155.66 0.07 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 108.309 169.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.98 60.99 0.53 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 127.355 2.407 . . . . 0.0 113.89 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.4 66.13 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.381 0.591 . . . . 0.0 113.329 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -134.87 154.74 51.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.61 115.54 30.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.73 149.33 7.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.8 tp -100.92 126.08 47.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.03 135.79 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 C-N-CA 123.81 0.844 . . . . 0.0 110.056 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 133.77 52.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 108.617 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.15 -2.27 23.91 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.808 -1.183 . . . . 0.0 112.044 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -127.15 13.2 7.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.68 1.592 . . . . 0.0 109.534 -170.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -164.38 -48.24 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.401 1.08 . . . . 0.0 109.814 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 33.95 66.48 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 126.753 2.12 . . . . 0.0 112.18 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 143.01 32.7 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 160.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.0 86.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.3 mm? -63.62 -49.67 72.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.207 1.003 . . . . 0.0 110.117 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -146.21 161.05 41.1 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.689 1.596 . . . . 0.0 108.762 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.6 t -144.2 131.58 17.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.257 1.823 . . . . 0.0 107.592 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.038 1.335 . . . . 0.0 108.626 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.53 160.32 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.965 0.506 . . . . 0.0 109.831 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.31 71.06 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.482 -1.177 . . . . 0.0 113.778 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.32 -20.72 65.74 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.813 1.806 . . . . 0.0 112.86 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.7 tt -59.11 -20.18 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.203 1.001 . . . . 0.0 112.198 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.58 -35.34 72.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.871 1.268 . . . . 0.0 111.958 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.43 -17.89 29.49 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.867 0.758 . . . . 0.0 111.068 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -61.99 152.06 33.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 108.558 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 127.859 2.464 . . . . 0.0 105.598 -170.625 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 pt . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.89 -26.21 68.5 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.2 0.6 . . . . 0.0 112.52 -168.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -58.62 -30.33 67.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.36 1.064 . . . . 0.0 112.515 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.32 -3.97 49.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.416 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.65 89.58 2.24 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.921 1.237 . . . . 0.0 110.849 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.53 133.99 43.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 107.207 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -87.0 -20.19 27.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.971 0.805 . . . . 0.0 111.911 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -154.17 161.3 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.947 1.699 . . . . 0.0 108.789 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.92 175.34 13.69 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.959 1.704 . . . . 0.0 108.664 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 m -130.6 121.58 25.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.47 153.91 51.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 58.08 29.25 17.54 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.245 1.021 . . . . 0.0 111.427 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 58.69 14.81 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.435 1.894 . . . . 0.0 113.325 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -115.03 126.81 55.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.21 149.29 25.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -146.19 152.69 39.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.603 0.761 . . . . 0.0 110.015 -172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -134.94 165.48 25.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.004 1.321 . . . . 0.0 108.209 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.22 115.48 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.3 59.1 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.752 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -176.25 1.15 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.72 1.76 . . . . 0.0 107.943 153.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.79 159.89 28.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.52 1.928 . . . . 0.0 109.537 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.86 158.09 32.44 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.055 -1.028 . . . . 0.0 110.98 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.13 160.39 47.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.648 2.232 . . . . 0.0 110.949 164.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.76 -13.21 41.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -23.13 10.59 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.272 1.829 . . . . 0.0 112.351 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.55 -20.12 9.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.713 0.633 . . . . 0.0 111.88 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.4 -23.67 62.79 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.516 -0.74 . . . . 0.0 111.435 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -57.3 143.19 74.21 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.041 0.936 . . . . 0.0 108.73 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.65 -4.18 11.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.558 3.505 . . . . 0.0 113.395 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.23 -33.83 74.13 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.244 1.817 . . . . 0.0 113.198 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -114.41 4.97 15.5 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.01 94.87 0.11 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.994 2.117 . . . . 0.0 110.141 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.38 74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 123.929 1.823 . . . . 0.0 107.456 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -59.15 -37.43 77.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.023 160.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -78.33 80.09 4.75 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.215 1.406 . . . . 0.0 111.689 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -83.52 -37.94 22.39 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.955 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -46.41 -51.09 15.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.241 1.016 . . . . 0.0 112.901 -169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -79.53 12.83 2.29 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 112.529 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -118.93 162.34 18.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 161.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.21 -6.48 23.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.354 1.062 . . . . 0.0 112.859 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.42 159.65 57.51 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.885 1.674 . . . . 0.0 112.143 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.03 175.02 11.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.017 3.144 . . . . 0.0 109.884 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.37 158.96 25.76 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.884 0.874 . . . . 0.0 110.502 166.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.3 168.1 23.23 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.476 2.118 . . . . 0.0 110.537 165.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -78.2 161.22 27.48 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 163.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.32 112.56 4.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.516 0.726 . . . . 0.0 109.801 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.11 23.68 31.6 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.159 0.436 . . . . 0.0 112.404 -176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.3 p -135.55 167.65 20.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 117.891 0.846 . . . . 0.0 109.276 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -150.99 157.58 43.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.437 0.637 . . . . 0.0 110.427 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -82.86 149.15 27.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.6 p -140.08 155.51 47.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.138 0.575 . . . . 0.0 109.907 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -97.15 85.41 3.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.03 98.81 8.7 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.722 1.609 . . . . 0.0 107.275 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.85 80.43 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.147 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.95 2.6 59.41 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.545 1.673 . . . . 0.0 112.253 -170.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -113.75 148.52 36.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.099 1.45 . . . . 0.0 107.931 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -95.82 108.85 21.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.11 130.25 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.84 118.14 31.04 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.154 1.382 . . . . 0.0 108.198 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.48 140.41 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.861 0.864 . . . . 0.0 109.823 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.69 136.32 54.14 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -13.06 60.43 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.467 -0.771 . . . . 0.0 112.503 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -132.25 19.44 4.43 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.62 1.968 . . . . 0.0 109.53 -162.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -170.13 -40.01 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.889 1.276 . . . . 0.0 110.078 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.59 26.72 74.19 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.517 -1.157 . . . . 0.0 112.938 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -59.03 141.12 54.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.9 mt -79.24 85.03 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.83 -49.31 68.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.341 0.657 . . . . 0.0 110.258 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -152.09 160.52 43.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.505 1.922 . . . . 0.0 107.344 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.97 147.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.1 153.19 50.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 159.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -61.01 155.02 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.911 0.885 . . . . 0.0 109.574 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.91 64.51 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.465 1.031 . . . . 0.0 113.1 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -50.23 -31.97 15.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.489 1.115 . . . . 0.0 112.776 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -59.81 -19.69 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.549 1.14 . . . . 0.0 112.745 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.1 -28.22 67.66 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.444 1.02 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.11 -0.46 33.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.789 0.836 . . . . 0.0 111.892 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -62.73 171.53 2.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.196 1.398 . . . . 0.0 110.621 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.15 -165.554 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -63.21 -28.93 70.38 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.613 1.965 . . . . 0.0 111.374 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -61.28 -28.98 69.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.742 0.817 . . . . 0.0 112.271 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -98.05 -2.22 40.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.275 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.03 86.87 0.55 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.343 0.974 . . . . 0.0 109.633 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.17 145.73 54.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -102.86 -16.0 16.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.125 0.42 . . . . 0.0 112.011 170.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.54 164.25 38.56 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.63 175.63 13.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.692 1.597 . . . . 0.0 108.067 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -131.53 125.44 32.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.48 156.19 48.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.81 29.7 12.38 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.314 -0.866 . . . . 0.0 112.937 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 53.85 22.77 3.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.1 2.16 . . . . 0.0 112.5 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.1 m -120.29 128.05 52.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.441 2.296 . . . . 0.0 105.775 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -84.09 150.8 25.32 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.069 0.948 . . . . 0.0 110.062 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -151.7 141.31 21.74 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 124.798 1.239 . . . . 0.0 110.211 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -124.4 167.18 14.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.42 1.488 . . . . 0.0 109.856 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.59 113.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.6 -4.51 32.72 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.092 -1.394 . . . . 0.0 113.458 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.18 -171.34 1.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.002 1.401 . . . . 0.0 107.968 166.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 149.48 50.43 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.172 -1.58 . . . . 0.0 109.382 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.6 158.14 43.22 Favored Pre-proline 0 N--CA 1.468 0.447 0 C-N-CA 124.15 0.98 . . . . 0.0 111.016 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.2 164.26 33.33 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.328 2.685 . . . . 0.0 111.619 165.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -16.11 44.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 112.703 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.2 mmt -53.64 -30.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.45 1.1 . . . . 0.0 111.884 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -102.94 -2.5 27.6 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.21 -23.59 24.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.097 0.862 . . . . 0.0 110.935 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.72 144.1 85.86 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 -4.62 9.88 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.554 3.503 . . . . 0.0 113.343 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.45 -16.85 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.25 2.22 . . . . 0.0 113.207 172.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -121.26 -1.84 9.66 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.59 1.086 . . . . 0.0 110.932 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.9 97.24 4.53 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.729 1.612 . . . . 0.0 112.502 -163.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -81.47 82.6 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 107.756 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.87 -30.92 69.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.647 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.98 36.38 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.436 1.894 . . . . 0.0 113.734 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -56.67 -34.47 67.38 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.398 -1.439 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.91 -39.35 93.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.584 1.554 . . . . 0.0 113.07 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -24.86 42.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.406 1.003 . . . . 0.0 110.647 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -80.05 -177.44 6.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.649 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.87 -19.66 40.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.467 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.93 144.67 76.4 Favored Pre-proline 0 CA--C 1.537 0.469 0 O-C-N 121.017 -1.052 . . . . 0.0 111.156 -161.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.95 164.48 27.13 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.75 2.967 . . . . 0.0 113.596 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.22 97.11 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.575 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.2 172.39 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.204 2.603 . . . . 0.0 110.608 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.48 167.73 19.8 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.851 -1.156 . . . . 0.0 109.294 168.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 34.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 115.397 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.9 33.17 0.06 OUTLIER Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.301 1.905 . . . . 0.0 110.303 173.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.0 p -144.24 166.12 25.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.121 0.961 . . . . 0.0 110.768 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -155.75 156.25 34.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.269 0.557 . . . . 0.0 111.315 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.32 143.93 31.86 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.347 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 p -138.67 179.52 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.306 1.842 . . . . 0.0 110.07 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -107.7 145.6 33.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.65 1.58 . . . . 0.0 107.822 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.9 147.21 29.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 166.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.81 -4.83 0.01 OUTLIER Glycine 0 CA--C 1.55 2.22 0 N-CA-C 117.589 1.796 . . . . 0.0 117.589 170.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.31 -10.75 19.77 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 121.144 2.472 . . . . 0.0 113.778 -167.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -103.0 173.13 6.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.548 2.739 . . . . 0.0 110.224 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -112.38 134.87 53.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.08 1.352 . . . . 0.0 109.261 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.72 154.06 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 119.69 1.132 . . . . 0.0 110.968 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.11 120.1 39.39 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.287 1.035 . . . . 0.0 109.031 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.3 pt -127.77 150.13 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.726 1.21 . . . . 0.0 109.483 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.13 140.69 39.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.032 0.833 . . . . 0.0 109.505 172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -14.73 61.78 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.407 1.083 . . . . 0.0 112.45 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -119.54 2.58 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.739 1.615 . . . . 0.0 111.1 -162.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -163.37 -45.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.982 0.913 . . . . 0.0 109.035 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.55 21.65 53.24 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.1 0.857 . . . . 0.0 112.497 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 130.33 43.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.22 95.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.792 1.637 . . . . 0.0 106.766 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 mt -80.09 -52.97 7.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.888 0.875 . . . . 0.0 109.574 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -144.59 160.5 41.05 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.779 0.832 . . . . 0.0 109.625 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.6 t -134.13 142.35 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -134.99 137.71 43.28 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 162.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -60.38 149.12 34.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.69 -15.12 32.27 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.948 1.737 . . . . 0.0 113.261 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.92 -30.29 61.41 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.393 1.597 . . . . 0.0 112.135 171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.81 -1.72 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.012 0.925 . . . . 0.0 111.745 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -60.05 -43.1 95.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.32 -1.487 . . . . 0.0 111.511 164.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -88.02 -17.64 30.74 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -64.59 160.98 18.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.915 1.286 . . . . 0.0 109.404 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.698 1.199 . . . . 0.0 107.836 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.47 -34.61 69.2 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.931 1.692 . . . . 0.0 112.38 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -58.64 -28.97 66.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.541 0.737 . . . . 0.0 112.585 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -98.02 -2.51 40.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.834 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.93 87.13 1.31 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.279 0.945 . . . . 0.0 109.031 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.25 166.6 23.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -124.96 -25.11 3.93 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.265 0.626 . . . . 0.0 112.553 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 157.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.806 1.242 . . . . 0.0 107.933 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.5 177.04 11.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -131.24 129.29 41.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 163.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.79 149.27 46.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.98 34.15 24.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.199 1.0 . . . . 0.0 111.452 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 59.83 35.69 21.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.8 1.64 . . . . 0.0 112.01 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -136.98 121.05 17.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.832 1.653 . . . . 0.0 107.35 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -79.59 150.23 31.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.695 0.798 . . . . 0.0 109.017 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -150.05 159.36 44.47 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.41 1.484 . . . . 0.0 110.595 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -145.6 165.42 28.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.392 1.877 . . . . 0.0 108.781 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.93 120.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.38 3.9 84.0 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 117.454 -1.748 . . . . 0.0 113.559 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.21 178.41 2.34 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.017 1.908 . . . . 0.0 108.68 156.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.71 142.89 50.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.608 1.163 . . . . 0.0 109.073 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.32 163.77 35.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.171 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.98 154.22 63.0 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.458 2.772 . . . . 0.0 112.653 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.61 54.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.582 1.553 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.411 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -55.45 -22.6 21.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.588 1.155 . . . . 0.0 113.019 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 13.8 m-85 -113.9 -10.3 12.96 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.865 0.728 . . . . 0.0 112.906 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.23 -30.33 68.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.191 0.451 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -65.49 144.11 98.86 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.543 0.737 . . . . 0.0 109.716 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.05 -4.85 9.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.246 3.297 . . . . 0.0 115.449 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -54.97 -33.96 62.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.898 1.279 . . . . 0.0 112.086 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -103.21 -8.56 20.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.964 0.802 . . . . 0.0 112.086 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.73 100.36 0.91 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.769 2.827 . . . . 0.0 111.952 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.93 85.58 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.764 1.226 . . . . 0.0 108.694 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -67.48 -10.86 55.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.356 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -95.44 89.51 5.45 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.72 1.208 . . . . 0.0 107.914 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -132.19 -25.71 1.97 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.924 -1.036 . . . . 0.0 113.557 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.21 -36.33 79.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.277 1.399 . . . . 0.0 111.613 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -82.82 8.52 12.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.624 0.77 . . . . 0.0 111.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -123.18 165.7 16.45 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.586 -1.322 . . . . 0.0 108.96 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.74 -22.63 56.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 -169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.58 156.41 17.13 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 125.211 1.404 . . . . 0.0 110.498 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.61 172.57 13.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.303 1.335 . . . . 0.0 110.774 168.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.5 165.51 2.16 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.491 164.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -67.97 171.46 12.36 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 120.97 1.113 . . . . 0.0 109.825 160.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.92 161.46 21.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 158.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.49 112.55 3.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.7 7.99 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.581 1.086 . . . . 0.0 111.907 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -149.42 169.02 21.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.889 1.845 . . . . 0.0 111.89 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -149.03 163.91 36.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.623 0.769 . . . . 0.0 110.354 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.95 141.95 28.29 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.279 0.631 . . . . 0.0 109.631 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -128.51 172.16 11.42 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -103.35 111.59 24.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 110.343 173.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 ttm -129.89 118.0 21.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.823 1.649 . . . . 0.0 109.869 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 -11.27 4.08 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.922 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.07 -7.17 19.2 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.538 1.669 . . . . 0.0 112.319 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -109.85 172.94 6.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.657 1.583 . . . . 0.0 110.302 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.38 117.92 35.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 108.545 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.0 145.84 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 66.9 tp -101.19 126.68 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.01 142.57 43.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.967 0.907 . . . . 0.0 110.239 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.44 131.26 44.99 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.423 0.689 . . . . 0.0 109.594 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.98 5.8 6.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.934 1.349 . . . . 0.0 113.503 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -127.7 1.22 6.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.895 2.478 . . . . 0.0 110.938 -171.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -166.87 -60.11 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.309 0.644 . . . . 0.0 109.36 -164.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 24.92 9.89 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 124.761 1.172 . . . . 0.0 113.931 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -60.48 129.11 39.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.548 2.174 . . . . 0.0 109.319 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 86.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 129.229 3.012 . . . . 0.0 106.067 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.69 -44.63 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -145.64 161.31 40.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.457 0.703 . . . . 0.0 109.331 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.68 137.99 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -126.84 142.42 51.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 157.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.49 151.14 24.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.72 -22.78 27.0 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.744 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.5 -29.6 25.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.048 1.424 . . . . 0.0 112.506 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.77 -9.09 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.025 0.93 . . . . 0.0 112.613 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.17 -50.79 44.44 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 120.424 -1.422 . . . . 0.0 110.546 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -80.15 -16.27 55.27 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.759 0.824 . . . . 0.0 111.921 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -55.36 124.9 18.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.736 2.414 . . . . 0.0 107.447 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 O-C-N 121.922 -0.486 . . . . 0.0 111.351 -162.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -27.66 65.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.835 0.289 . . . . 0.0 111.756 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -61.59 -23.02 65.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.625 0.77 . . . . 0.0 112.674 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -102.44 -8.26 21.26 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.77 0.828 . . . . 0.0 110.905 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.11 92.13 4.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.22 162.84 27.05 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -112.66 -23.22 10.33 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.181 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -158.76 160.94 36.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.592 1.557 . . . . 0.0 109.032 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -157.18 -177.29 6.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.749 2.019 . . . . 0.0 108.808 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -135.93 114.94 12.24 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.76 152.42 45.4 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.274 1.6 p30 50.99 27.47 3.25 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 61.67 14.67 6.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.072 2.549 . . . . 0.0 112.732 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.9 m -98.23 124.29 42.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.527 2.331 . . . . 0.0 105.935 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.33 143.99 48.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -142.18 143.29 32.88 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 109.481 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -127.7 170.34 12.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.48 113.62 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.64 -2.08 42.28 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.431 -1.76 . . . . 0.0 114.386 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.36 -171.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.085 1.943 . . . . 0.0 108.684 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.08 143.46 51.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.533 -1.354 . . . . 0.0 108.803 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.91 162.96 71.9 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.597 -0.689 . . . . 0.0 110.297 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.41 161.9 42.98 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.484 2.789 . . . . 0.0 110.779 159.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.38 44.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mmt -54.21 -20.09 6.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.198 1.799 . . . . 0.0 111.991 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -122.84 -8.77 8.37 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.063 0.945 . . . . 0.0 112.995 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.78 -18.08 56.82 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.901 0.88 . . . . 0.0 111.435 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -60.74 144.48 89.56 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.33 -4.35 14.79 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.195 3.263 . . . . 0.0 115.332 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -51.13 -30.85 17.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.724 2.01 . . . . 0.0 114.927 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.45 2.97 14.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.148 0.979 . . . . 0.0 110.975 -167.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -66.42 129.29 39.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.196 1.798 . . . . 0.0 110.858 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -106.82 90.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 108.268 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -22.93 63.0 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.686 -0.634 . . . . 0.0 111.285 163.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.12 30.67 0.58 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.808 1.243 . . . . 0.0 111.87 -166.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -75.35 -29.93 60.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.647 1.579 . . . . 0.0 115.167 -167.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -67.93 -38.16 82.54 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.864 1.666 . . . . 0.0 112.629 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -61.86 -11.24 11.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.978 0.911 . . . . 0.0 112.357 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.34 157.78 16.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -70.61 2.35 4.16 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.565 -0.709 . . . . 0.0 112.184 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.41 148.16 85.67 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 120.896 -1.127 . . . . 0.0 110.367 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.63 165.24 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.464 2.109 . . . . 0.0 111.798 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 149.63 89.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.834 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.37 171.15 14.55 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.298 2.665 . . . . 0.0 111.506 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.49 168.98 18.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.808 1.289 . . . . 0.0 109.398 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.55 38.88 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.219 2.608 . . . . 0.0 113.986 -167.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.97 37.71 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.239 1.876 . . . . 0.0 110.461 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.4 p -148.62 166.95 26.78 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.654 -0.91 . . . . 0.0 109.816 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -146.73 152.29 38.58 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.837 0.827 . . . . 0.0 111.054 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.47 144.81 46.1 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -133.62 162.65 31.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 109.868 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.23 65.87 0.74 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.944 0.898 . . . . 0.0 110.942 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 102.7 6.87 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.8 75.17 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.464 164.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.3 -5.6 33.77 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.118 1.459 . . . . 0.0 112.734 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -113.64 162.67 15.95 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.374 1.47 . . . . 0.0 107.325 -172.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.45 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 45.3 m-85 -109.77 111.23 22.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.04 132.48 69.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 tp -92.59 117.05 29.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.864 0.866 . . . . 0.0 108.697 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.4 pt -116.25 142.31 30.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.843 0.857 . . . . 0.0 109.499 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 143.03 51.4 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.58 9.74 5.69 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.683 0.793 . . . . 0.0 112.023 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -147.64 16.78 1.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.904 1.681 . . . . 0.0 110.525 -163.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -171.48 -45.37 0.02 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 126.536 1.934 . . . . 0.0 108.286 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 26.18 50.07 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.624 -1.098 . . . . 0.0 112.22 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.36 138.49 58.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -79.0 84.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.593 1.957 . . . . 0.0 106.176 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.12 -44.47 84.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.806 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -152.14 158.73 43.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.693 1.197 . . . . 0.0 108.894 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -135.52 143.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -135.87 145.72 46.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.084 1.353 . . . . 0.0 107.572 161.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.72 155.99 36.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.639 0.654 . . . . 0.0 111.86 172.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -58.08 -25.05 56.23 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 124.619 1.104 . . . . 0.0 114.132 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.38 -27.49 36.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.887 1.344 . . . . 0.0 113.116 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.9 -20.2 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.941 0.896 . . . . 0.0 112.504 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.7 -44.92 96.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.656 0.782 . . . . 0.0 109.725 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.15 -17.14 38.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.752 0.821 . . . . 0.0 111.478 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -58.2 147.24 31.0 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 128.075 2.55 . . . . 0.0 109.552 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 . . . . . 0 C--O 1.248 1.022 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 172.124 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -34.1 72.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 111.746 -168.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -55.96 -33.85 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.486 1.115 . . . . 0.0 112.144 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.05 -4.71 56.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.648 -1.168 . . . . 0.0 110.784 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.81 90.98 0.81 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.731 1.605 . . . . 0.0 110.506 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.12 128.02 32.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.03 -16.57 37.79 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 0.986 . . . . 0.0 112.817 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.68 164.59 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -155.0 174.96 14.43 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 107.393 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -133.26 128.03 34.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.83 137.03 24.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 44.59 62.42 2.05 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 110.003 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.263 1.7 p90 44.96 31.61 0.72 Allowed 'General case' 0 C--O 1.232 0.174 1 C-N-CA 132.004 4.122 . . . . 0.0 113.013 174.914 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 m -131.84 124.86 30.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -80.73 157.04 25.97 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -152.91 156.09 38.26 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.354 1.062 . . . . 0.0 110.26 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -140.2 167.67 21.61 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.929 1.692 . . . . 0.0 109.431 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.14 108.84 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.08 -7.02 21.52 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.326 -1.819 . . . . 0.0 114.162 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -174.8 1.49 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.771 1.786 . . . . 0.0 110.263 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.04 150.69 42.76 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.443 -1.411 . . . . 0.0 109.044 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.91 159.84 39.35 Favored Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 161.2 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.545 2.163 . . . . 0.0 111.557 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.58 -10.58 19.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.639 0.776 . . . . 0.0 112.748 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.88 -26.13 65.63 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.803 0.841 . . . . 0.0 111.549 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -107.83 -10.25 15.6 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.9 -24.79 55.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.675 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -55.95 145.25 54.67 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.004 0.921 . . . . 0.0 109.943 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.87 -9.74 22.43 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 124.722 3.615 . . . . 0.0 112.17 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -56.04 -27.8 54.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.432 1.493 . . . . 0.0 113.504 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -117.02 2.52 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.806 0.842 . . . . 0.0 111.191 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -59.73 104.66 0.3 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 128.28 2.632 . . . . 0.0 111.301 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mm -77.03 79.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -39.65 73.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.931 169.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -88.82 66.06 7.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.311 1.044 . . . . 0.0 110.119 -174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -65.31 -50.25 66.37 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.047 -0.408 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.03 96.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.953 0.501 . . . . 0.0 111.985 -158.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.69 -25.8 60.8 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.527 1.131 . . . . 0.0 113.265 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.86 27.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.835 -1.165 . . . . 0.0 111.321 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m120 68.01 -3.67 1.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.988 2.115 . . . . 0.0 112.252 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.66 163.84 42.42 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.533 1.933 . . . . 0.0 111.847 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.46 175.23 11.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.446 2.764 . . . . 0.0 112.541 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 164.35 19.63 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 111.765 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -72.52 -169.66 0.5 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.047 2.498 . . . . 0.0 111.117 162.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.58 -172.34 2.48 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 158.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 104.05 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.803 169.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.28 -12.48 54.71 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.583 1.087 . . . . 0.0 114.587 169.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.2 p -73.41 168.52 19.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.822 1.311 . . . . 0.0 109.23 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -158.72 151.56 22.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.615 -0.678 . . . . 0.0 109.654 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -81.88 143.57 31.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -133.7 162.1 32.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.527 0.731 . . . . 0.0 110.644 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -96.32 96.95 9.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.989 1.316 . . . . 0.0 108.259 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.93 96.6 6.15 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.233 1.813 . . . . 0.0 106.848 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.13 79.61 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.904 -1.498 . . . . 0.0 113.824 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.94 6.92 64.82 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.614 1.707 . . . . 0.0 112.373 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.31 147.14 31.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.403 1.602 . . . . 0.0 107.712 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.427 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 37.4 m-85 -96.94 114.29 25.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.08 131.92 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.45 112.76 24.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.02 143.57 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.193 0.997 . . . . 0.0 110.2 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.06 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -59.61 -18.57 42.42 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -115.85 12.35 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 126.295 1.838 . . . . 0.0 110.215 -161.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.94 -51.62 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.801 -1.187 . . . . 0.0 109.385 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.52 29.69 35.39 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 126.013 1.768 . . . . 0.0 112.594 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 138.32 58.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.379 1.09 . . . . 0.0 108.978 176.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.6 mt -79.7 84.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.66 -45.67 78.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.542 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -153.33 163.26 40.23 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.798 2.039 . . . . 0.0 107.633 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.7 t -137.13 151.53 27.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.21 157.97 42.96 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 156.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -63.63 156.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.392 0.677 . . . . 0.0 109.266 168.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -63.62 -22.36 65.9 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 124.764 1.173 . . . . 0.0 113.601 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.72 -17.39 34.37 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.62 1.21 . . . . 0.0 113.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.02 -26.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.973 0.909 . . . . 0.0 112.465 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -65.91 -12.04 51.68 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.675 -0.64 . . . . 0.0 111.544 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.43 18.44 12.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.57 -173.47 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 108.273 163.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.814 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.46 -32.38 68.69 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.984 0.811 . . . . 0.0 112.886 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -58.66 -27.25 64.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.803 0.841 . . . . 0.0 112.893 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -97.91 -1.65 42.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.956 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.18 90.22 5.48 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.199 1.363 . . . . 0.0 109.663 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.91 128.89 34.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -83.82 -17.87 39.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.264 0.484 . . . . 0.0 112.3 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.28 165.7 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.719 2.408 . . . . 0.0 107.236 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.11 179.61 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.715 1.206 . . . . 0.0 108.308 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -130.44 136.6 49.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.89 43.95 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 164.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.15 38.11 26.68 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.139 0.971 . . . . 0.0 111.666 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 60.02 14.31 4.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.443 1.897 . . . . 0.0 113.757 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.4 m -119.19 126.97 52.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.171 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -87.07 149.17 24.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -145.6 155.97 43.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.017 0.927 . . . . 0.0 110.798 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -139.61 164.0 31.07 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.405 1.482 . . . . 0.0 109.145 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.76 115.87 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 164.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.33 -0.09 55.81 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 117.676 -1.625 . . . . 0.0 114.811 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.89 -178.28 3.18 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.324 1.562 . . . . 0.0 109.851 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.39 152.25 41.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.952 1.701 . . . . 0.0 110.44 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.43 158.76 31.14 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 121.401 -0.812 . . . . 0.0 112.22 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.62 158.0 59.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.799 2.333 . . . . 0.0 111.774 165.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -14.43 62.89 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.501 1.12 . . . . 0.0 113.487 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.8 ptp -56.08 -22.7 29.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.894 0.878 . . . . 0.0 112.935 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.68 -10.63 14.07 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.4 -20.13 55.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.883 0.873 . . . . 0.0 111.299 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -64.03 152.5 87.43 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.246 1.418 . . . . 0.0 110.463 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.19 -7.77 16.58 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.127 2.551 . . . . 0.0 114.262 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.56 -18.97 55.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.13 0.972 . . . . 0.0 113.276 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -122.45 -5.36 8.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 112.496 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 106.9 1.51 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.7 1.6 . . . . 0.0 112.186 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mm -79.01 78.77 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 O-C-N 120.832 -1.167 . . . . 0.0 107.966 -176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -61.76 -28.75 69.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.008 -1.057 . . . . 0.0 112.664 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -93.2 65.32 3.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.804 1.242 . . . . 0.0 109.698 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -82.9 -44.36 15.47 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -30.81 69.08 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.724 0.693 . . . . 0.0 111.024 -170.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -78.8 17.24 0.74 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.377 1.471 . . . . 0.0 113.308 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -129.56 22.89 5.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.286 1.403 . . . . 0.0 113.28 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 57.4 8.09 0.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.414 1.886 . . . . 0.0 114.035 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.59 165.25 23.5 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.689 -1.257 . . . . 0.0 110.956 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.18 170.14 20.64 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.617 3.545 . . . . 0.0 111.641 168.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.78 165.49 2.4 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 127.21 2.204 . . . . 0.0 112.292 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.54 -164.65 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.764 2.976 . . . . 0.0 111.235 160.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.66 -169.84 1.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 158.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.51 105.75 13.82 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.46 -1.4 . . . . 0.0 110.594 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.93 44.43 7.69 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 p -140.28 166.78 23.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -152.86 145.6 24.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.904 0.859 . . . . 0.0 110.512 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -72.84 147.48 45.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.82 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -139.4 170.28 16.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.746 2.818 . . . . 0.0 108.332 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -116.62 78.66 1.22 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.575 0.625 . . . . 0.0 112.18 -172.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 97.86 11.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.727 2.011 . . . . 0.0 109.611 -172.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.86 11.4 63.03 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.354 -0.841 . . . . 0.0 114.623 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.8 -15.73 37.29 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.198 0.999 . . . . 0.0 112.054 -170.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -89.08 138.4 31.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.633 1.217 . . . . 0.0 108.303 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.7 112.47 18.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.93 125.22 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 tp -89.87 111.78 22.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.44 150.34 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 123.057 0.543 . . . . 0.0 110.211 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.65 139.29 43.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.511 0.724 . . . . 0.0 109.433 169.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.53 -17.41 64.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.422 0.629 . . . . 0.0 110.86 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 p -100.26 -5.19 27.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.163 2.185 . . . . 0.0 112.716 -161.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -174.79 -44.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 109.003 -157.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.42 28.4 61.75 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.362 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.32 132.47 53.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.814 1.307 . . . . 0.0 108.347 163.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.34 86.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 128.666 2.786 . . . . 0.0 105.512 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.97 -46.78 83.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -152.63 163.7 39.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.018 1.327 . . . . 0.0 109.653 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.63 145.15 26.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.06 157.79 45.91 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.806 1.643 . . . . 0.0 107.143 164.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.2 157.51 34.43 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -28.63 62.96 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.271 2.367 . . . . 0.0 113.142 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -62.96 -20.3 65.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.024 0.93 . . . . 0.0 112.514 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.45 -21.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 111.889 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.53 -7.44 10.22 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 112.781 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -119.47 -0.97 10.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.005 1.322 . . . . 0.0 111.911 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -74.43 165.58 24.95 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.344 1.858 . . . . 0.0 109.488 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 129.328 3.051 . . . . 0.0 106.117 -178.038 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.91 -22.64 64.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 118.065 0.393 . . . . 0.0 110.879 -169.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.71 -26.18 68.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.509 1.124 . . . . 0.0 113.015 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -99.5 0.34 42.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.72 1.208 . . . . 0.0 111.641 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.49 101.19 0.95 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.92 151.08 25.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -101.28 -12.56 18.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.527 0.731 . . . . 0.0 111.81 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -177.05 156.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -155.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -172.15 -179.1 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 109.232 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -125.95 135.32 51.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.06 137.82 46.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.71 34.38 23.73 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.337 1.065 . . . . 0.0 110.751 168.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 59.34 14.79 3.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.835 2.454 . . . . 0.0 114.376 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -103.08 134.54 46.34 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.489 1.516 . . . . 0.0 107.267 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -90.25 141.88 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.347 1.859 . . . . 0.0 109.161 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -146.45 155.62 42.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.047 0.385 . . . . 0.0 111.71 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -145.31 167.58 22.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.734 1.214 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.0 mm -58.86 117.31 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.17 -11.84 55.36 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.003 -1.443 . . . . 0.0 114.323 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.53 -178.44 4.1 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.79 1.795 . . . . 0.0 107.164 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.78 148.09 43.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 119.349 -2.094 . . . . 0.0 108.951 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.38 163.4 66.42 Favored Pre-proline 0 CA--C 1.538 0.5 0 O-C-N 121.581 -0.699 . . . . 0.0 110.396 170.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.14 160.91 39.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.286 2.657 . . . . 0.0 111.378 160.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -23.5 67.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.571 1.148 . . . . 0.0 113.132 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.513 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 6.7 ptm -53.78 -20.93 6.34 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.823 1.249 . . . . 0.0 113.594 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.513 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 8.6 m-85 -117.55 -8.15 11.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.646 1.178 . . . . 0.0 112.557 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -79.03 -25.8 43.22 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.594 1.558 . . . . 0.0 110.873 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 t -62.35 144.79 94.88 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.69 -9.57 21.37 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.649 2.233 . . . . 0.0 114.463 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -55.55 -36.51 66.87 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.062 0.945 . . . . 0.0 110.968 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.78 -11.12 16.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.767 0.827 . . . . 0.0 111.052 -173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -61.07 111.04 1.54 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.944 1.698 . . . . 0.0 109.956 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.6 mt -87.99 90.63 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -73.43 -28.52 62.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.572 164.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.23 68.95 9.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.356 0.98 . . . . 0.0 109.137 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -69.92 -57.26 5.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -44.83 -47.76 11.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.44 1.496 . . . . 0.0 114.839 -159.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -63.31 -21.64 66.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -75.22 -165.34 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.26 2.62 31.78 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.845 -1.159 . . . . 0.0 111.431 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.04 156.15 81.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 121.325 -0.86 . . . . 0.0 112.204 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.05 171.48 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.678 3.585 . . . . 0.0 111.061 161.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.02 158.36 26.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 112.484 173.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.99 158.92 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.356 2.037 . . . . 0.0 111.01 167.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.06 149.1 42.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.72 101.27 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.435 0.694 . . . . 0.0 110.504 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.49 12.98 10.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.621 -1.1 . . . . 0.0 113.378 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.7 p -132.4 176.08 8.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.136 1.468 . . . . 0.0 111.06 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -149.49 154.37 38.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.132 0.973 . . . . 0.0 110.474 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -72.77 156.05 39.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.971 0.509 . . . . 0.0 109.865 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -147.46 167.97 23.08 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.48 106.16 16.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.297 1.839 . . . . 0.0 108.342 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 86.7 mmm -81.56 -154.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.193 1.797 . . . . 0.0 109.693 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.03 58.51 0.55 Allowed Glycine 0 C--N 1.338 0.679 0 C-N-CA 129.607 3.48 . . . . 0.0 111.701 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.23 56.8 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 125.676 1.608 . . . . 0.0 113.992 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -130.96 158.66 39.65 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.073 1.436 . . . . 0.0 108.87 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -102.95 125.79 49.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 108.694 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.71 151.02 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.648 -0.657 . . . . 0.0 109.412 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.7 tp -103.46 127.99 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 pt -131.67 131.91 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 125.429 1.492 . . . . 0.0 110.538 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.78 134.52 57.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -8.6 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.086 -1.009 . . . . 0.0 111.377 172.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 t -134.05 12.01 3.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.928 2.091 . . . . 0.0 109.494 -158.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -171.91 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 0.0 111.425 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.1 37.95 24.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.481 1.515 . . . . 0.0 113.01 -165.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 145.63 40.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 159.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.2 mt -81.78 91.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -61.31 -56.92 15.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.35 163.09 35.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.468 1.507 . . . . 0.0 110.395 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.1 t -137.18 136.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.326 1.851 . . . . 0.0 107.304 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.59 142.99 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.153 0.981 . . . . 0.0 108.357 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.41 146.19 54.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.59 -20.96 40.67 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.446 1.022 . . . . 0.0 112.798 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -49.65 -30.94 9.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.509 1.124 . . . . 0.0 112.42 171.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -58.36 -25.49 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.72 1.208 . . . . 0.0 112.574 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.31 -35.28 76.92 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.565 0.62 . . . . 0.0 110.657 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.73 2.37 51.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.708 0.803 . . . . 0.0 113.048 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.443 ' CD2' ' H ' ' A' ' 83' ' ' ARG . 19.0 t60 -84.15 -174.66 5.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.341 0.656 . . . . 0.0 110.116 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.443 ' H ' ' CD2' ' A' ' 82' ' ' HIS . 4.3 ptm180 . . . . . 0 C--O 1.248 0.987 0 C-N-CA 127.073 2.149 . . . . 0.0 109.207 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.4 pt . . . . . 0 C--O 1.224 -0.274 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.59 -24.83 65.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.101 1.76 . . . . 0.0 113.049 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.27 -34.86 77.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.289 0.636 . . . . 0.0 112.293 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -90.49 -3.84 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.099 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.39 0.78 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.432 1.014 . . . . 0.0 108.723 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.6 164.01 14.93 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -124.99 -20.06 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.46 1.504 . . . . 0.0 111.351 -172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -159.17 163.04 36.4 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.772 2.029 . . . . 0.0 107.505 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -163.71 175.56 10.43 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 110.148 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 m -127.74 112.68 15.06 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.47 158.48 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 25.39 12.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.264 0.938 . . . . 0.0 111.978 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 58.43 16.62 4.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.429 1.891 . . . . 0.0 113.133 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.7 m -117.8 125.9 51.43 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.661 1.984 . . . . 0.0 105.961 -171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -80.5 149.01 30.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -147.9 157.31 43.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.038 1.335 . . . . 0.0 109.495 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.68 167.67 21.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.318 1.447 . . . . 0.0 108.566 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.35 119.3 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.19 -13.35 40.44 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 117.782 -1.566 . . . . 0.0 114.014 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.86 -171.17 1.02 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 119.592 1.696 . . . . 0.0 107.879 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 142.56 50.49 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 118.379 -2.701 . . . . 0.0 109.981 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.36 156.56 73.63 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 121.547 -0.721 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.38 156.6 61.37 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.408 2.072 . . . . 0.0 110.564 165.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -17.25 52.3 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.1 mmt -51.8 -27.44 12.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.533 1.533 . . . . 0.0 113.231 173.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.5 -7.31 15.18 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mt -79.23 -23.75 43.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.584 1.154 . . . . 0.0 112.071 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -56.17 149.25 37.07 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.45 1.1 . . . . 0.0 110.262 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.77 -8.59 15.98 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.433 2.756 . . . . 0.0 113.18 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.02 -29.29 70.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.831 2.052 . . . . 0.0 111.861 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.38 1.22 9.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.671 1.188 . . . . 0.0 111.668 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 91.28 0.15 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.624 2.77 . . . . 0.0 108.915 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.78 112.61 5.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -88.55 -31.49 18.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 117.392 -1.29 . . . . 0.0 111.053 167.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.07 88.18 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.963 1.256 . . . . 0.0 110.655 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -104.15 -33.84 8.59 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.555 0.742 . . . . 0.0 111.972 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.76 -28.24 69.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.131 0.878 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -83.43 29.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.776 1.231 . . . . 0.0 110.754 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -141.49 169.14 18.16 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.862 2.465 . . . . 0.0 107.364 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.6 -13.91 62.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.737 1.215 . . . . 0.0 111.987 166.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.74 157.2 80.52 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.303 -0.873 . . . . 0.0 111.764 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -71.01 169.36 20.69 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.947 3.098 . . . . 0.0 111.253 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 149.72 77.14 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.72 166.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.96 169.54 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.108 2.539 . . . . 0.0 110.502 168.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -77.67 167.74 21.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.895 0.878 . . . . 0.0 108.666 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.03 42.24 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 114.426 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.65 56.12 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -159.91 171.78 18.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.305 0.642 . . . . 0.0 111.175 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -145.92 156.92 43.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.439 0.563 . . . . 0.0 110.95 167.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -80.94 153.17 27.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -136.53 168.81 18.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.397 1.079 . . . . 0.0 110.729 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -106.03 84.94 2.12 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.376 1.471 . . . . 0.0 107.646 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.3 mtp -94.85 102.06 13.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.131 0.972 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.33 6.29 86.28 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.663 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.27 4.1 53.59 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.068 1.434 . . . . 0.0 112.007 -167.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -115.09 143.71 44.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.412 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 53.8 m-85 -93.88 113.38 25.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.49 143.25 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -172.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 tp -102.6 122.9 45.32 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.1 pt -124.68 149.06 28.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.007 0.923 . . . . 0.0 109.872 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.65 136.75 41.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.08 -25.16 65.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.655 0.741 . . . . 0.0 112.388 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 t -123.12 27.13 7.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.152 1.781 . . . . 0.0 110.147 -161.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -173.96 -36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.783 1.633 . . . . 0.0 110.552 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.32 21.46 77.66 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.079 1.323 . . . . 0.0 113.894 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 136.18 57.85 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.543 1.137 . . . . 0.0 108.59 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.48 87.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.2 mt -70.67 -49.24 49.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.167 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -152.52 157.94 41.83 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 109.695 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -140.67 130.17 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.626 1.97 . . . . 0.0 107.087 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -129.43 148.19 51.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.631 1.173 . . . . 0.0 108.73 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.64 157.81 35.4 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.817 -0.552 . . . . 0.0 111.241 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.412 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -61.73 -27.2 67.92 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-O 118.454 -1.192 . . . . 0.0 113.975 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -55.88 -27.62 52.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.961 1.381 . . . . 0.0 112.738 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.67 -26.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.579 1.152 . . . . 0.0 112.324 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -62.79 -30.34 71.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.375 0.534 . . . . 0.0 111.24 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -99.17 4.38 46.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.03 0.932 . . . . 0.0 111.627 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -69.7 -178.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.273 1.829 . . . . 0.0 110.039 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 . . . . . 0 C--O 1.245 0.855 0 O-C-N 120.77 -1.206 . . . . 0.0 111.122 -166.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.13 -22.99 67.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.011 0.924 . . . . 0.0 112.727 -170.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -60.4 -30.69 69.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.057 0.943 . . . . 0.0 112.693 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.52 -3.49 46.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.156 0.983 . . . . 0.0 110.688 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.88 82.24 7.6 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 109.365 -168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.96 151.27 46.74 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -16.24 15.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.071 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -156.66 157.62 35.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.067 1.347 . . . . 0.0 109.652 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -158.77 177.28 11.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.094 1.758 . . . . 0.0 109.286 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -126.13 128.75 47.81 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.08 44.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.45 38.04 4.96 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.948 1.356 . . . . 0.0 112.243 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 60.74 34.51 19.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.929 2.091 . . . . 0.0 112.953 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 m -142.33 131.85 23.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.594 1.557 . . . . 0.0 107.163 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.9 147.74 36.85 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.49 144.2 39.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.864 1.265 . . . . 0.0 108.48 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.04 174.46 7.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.05 122.66 18.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.81 -1.54 55.41 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.342 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.93 -171.38 2.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.098 1.449 . . . . 0.0 108.678 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.29 127.31 25.9 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.325 -1.484 . . . . 0.0 110.894 -169.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.8 m -70.03 158.32 87.65 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 123.22 0.608 . . . . 0.0 111.492 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.52 159.96 51.1 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.187 1.925 . . . . 0.0 111.023 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.09 -15.89 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.325 0.65 . . . . 0.0 112.54 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -25.97 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 112.097 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -116.43 -9.49 11.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.72 1.208 . . . . 0.0 113.24 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.01 -18.41 37.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.525 0.73 . . . . 0.0 111.32 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 t -53.01 150.81 9.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.212 0.605 . . . . 0.0 109.408 166.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.96 -4.39 15.04 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.866 2.378 . . . . 0.0 113.842 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -57.3 -23.93 51.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 113.246 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -121.57 10.13 10.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.746 1.157 . . . . 0.0 113.199 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.23 106.39 0.61 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.686 2.394 . . . . 0.0 112.371 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.4 mm -73.91 79.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.312 1.045 . . . . 0.0 108.724 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.54 -32.44 73.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.353 -0.842 . . . . 0.0 110.8 166.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -76.65 34.34 0.14 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.843 1.257 . . . . 0.0 114.017 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -75.64 -32.83 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -65.04 -32.34 74.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.43 1.468 . . . . 0.0 110.547 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.61 27.24 0.86 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.686 0.794 . . . . 0.0 111.737 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -132.05 165.53 23.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.02 1.728 . . . . 0.0 107.614 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.81 -19.87 60.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.44 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.61 151.56 61.11 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.371 1.069 . . . . 0.0 110.331 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.43 164.47 32.55 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.693 1.596 . . . . 0.0 110.359 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.6 157.64 36.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.411 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.59 162.1 32.64 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.324 1.35 . . . . 0.0 110.083 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -70.74 167.54 18.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 162.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.65 61.25 1.79 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 113.252 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.31 41.28 0.04 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.159 1.837 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.3 p -151.04 169.91 20.67 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.841 -0.799 . . . . 0.0 110.728 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -147.01 157.21 43.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.101 0.961 . . . . 0.0 110.184 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -98.56 137.3 37.42 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.283 0.633 . . . . 0.0 109.421 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -137.58 159.11 42.88 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.642 -0.661 . . . . 0.0 110.015 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -99.92 61.27 1.11 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.83 0.824 . . . . 0.0 112.391 -167.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 102.89 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.985 2.114 . . . . 0.0 109.82 -164.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.33 14.12 59.19 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.335 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.29 -1.52 37.53 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.851 1.825 . . . . 0.0 112.965 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -114.84 161.47 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.74 1.77 . . . . 0.0 107.909 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 65.7 m-85 -105.05 113.84 27.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.16 135.08 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -92.27 110.88 22.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.655 1.182 . . . . 0.0 108.543 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.55 142.32 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.706 1.202 . . . . 0.0 108.683 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.77 143.7 54.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.82 -12.66 61.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -140.34 24.1 2.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.274 1.43 . . . . 0.0 109.176 -159.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -165.78 -44.42 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.469 1.508 . . . . 0.0 109.166 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.39 25.03 71.57 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.292 0.949 . . . . 0.0 113.306 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 133.39 55.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 167.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.73 88.69 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.049 2.139 . . . . 0.0 106.515 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -45.95 66.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.287 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -152.17 160.9 43.3 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 109.673 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.2 141.72 40.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.172 1.789 . . . . 0.0 106.42 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -139.14 140.25 37.84 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.267 1.827 . . . . 0.0 106.378 165.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.98 155.84 35.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.431 1.014 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -51.49 -31.06 28.13 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.642 1.591 . . . . 0.0 112.789 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.56 -33.68 6.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.489 1.916 . . . . 0.0 112.551 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 tt -69.4 -12.09 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.534 1.134 . . . . 0.0 112.025 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -67.07 -34.93 78.72 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.845 -1.159 . . . . 0.0 111.182 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -91.32 -17.62 25.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.651 0.78 . . . . 0.0 111.329 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.11 141.64 55.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 128.27 2.628 . . . . 0.0 108.838 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 169.596 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -53.53 -29.95 39.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.623 1.569 . . . . 0.0 112.651 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.2 -21.02 66.41 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -107.89 4.04 24.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.927 1.291 . . . . 0.0 110.766 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.63 94.51 1.01 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.12 163.64 24.36 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -121.79 -19.09 6.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.004 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.6 164.64 24.05 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.406 1.882 . . . . 0.0 107.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -168.59 -176.64 2.85 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.292 1.837 . . . . 0.0 109.084 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -135.67 133.45 38.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.106 0.962 . . . . 0.0 108.716 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.69 35.41 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.047 0.939 . . . . 0.0 109.409 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.2 39.81 20.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.924 1.29 . . . . 0.0 109.968 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.42 15.5 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.442 2.697 . . . . 0.0 114.855 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 m -114.21 131.82 56.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.419 1.488 . . . . 0.0 107.425 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.85 155.74 23.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.73 0.695 . . . . 0.0 109.373 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -149.26 153.66 37.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.408 1.483 . . . . 0.0 110.485 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -136.64 165.98 24.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.1 1.36 . . . . 0.0 107.365 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.7 mm -59.81 125.84 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 168.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.35 44.02 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.677 -1.624 . . . . 0.0 114.162 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.52 -175.89 0.91 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.213 1.506 . . . . 0.0 109.62 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 131.74 45.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 119.92 -1.737 . . . . 0.0 110.27 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.84 164.1 63.15 Favored Pre-proline 0 N--CA 1.467 0.397 0 C-N-CA 126.052 1.741 . . . . 0.0 111.984 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 74.1 Cg_endo -74.09 158.5 45.52 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.497 2.798 . . . . 0.0 112.234 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.43 68.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.042 1.337 . . . . 0.0 111.797 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -66.8 -33.44 75.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.358 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.41 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 25.5 m-85 -87.04 -4.3 59.15 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 118.261 -1.375 . . . . 0.0 114.146 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.37 -21.39 62.88 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.148 0.886 . . . . 0.0 110.95 168.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -69.62 148.7 96.89 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 121.899 -0.5 . . . . 0.0 111.035 -172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.5 -14.87 42.02 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.053 3.169 . . . . 0.0 111.809 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.48 -30.16 60.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.439 1.896 . . . . 0.0 112.563 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -112.62 -8.28 13.82 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.211 1.404 . . . . 0.0 111.833 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -80.77 118.22 22.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.808 1.643 . . . . 0.0 111.28 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.01 92.78 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 -21.09 63.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 111.63 169.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.57 40.12 0.29 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.621 1.168 . . . . 0.0 112.95 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -53.52 -41.45 66.38 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.279 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -61.71 -27.57 68.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.996 1.726 . . . . 0.0 114.68 -167.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -84.99 -14.86 46.13 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.461 1.482 . . . . 0.0 112.746 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 -83.74 172.11 12.54 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 166.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -109.78 8.15 24.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.325 -0.86 . . . . 0.0 111.491 -158.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.72 166.97 10.08 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 129.28 3.032 . . . . 0.0 112.613 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.07 175.5 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 121.387 1.391 . . . . 0.0 111.6 153.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 164.18 2.2 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.796 1.238 . . . . 0.0 111.238 166.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.63 167.93 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.278 1.319 . . . . 0.0 110.459 160.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -81.03 170.49 16.16 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.42 -0.8 . . . . 0.0 109.788 160.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.75 108.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.372 1.469 . . . . 0.0 110.909 167.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.64 29.78 51.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.764 174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.6 p -130.77 171.36 13.21 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.475 1.138 . . . . 0.0 110.365 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -151.26 164.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.386 0.613 . . . . 0.0 111.445 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -106.32 121.34 44.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.293 1.037 . . . . 0.0 110.129 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.4 p -109.0 -179.97 4.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.303 1.441 . . . . 0.0 110.139 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -131.2 80.85 1.96 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.824 1.193 . . . . 0.0 111.323 -172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtp -99.18 105.5 17.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.593 1.557 . . . . 0.0 111.325 -168.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.09 15.31 62.73 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 118.711 -1.049 . . . . 0.0 113.787 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.58 8.6 59.49 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.105 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.75 127.91 54.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.228 1.514 . . . . 0.0 106.917 172.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.437 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 73.3 m-85 -85.29 121.2 27.68 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.3 145.46 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 118.847 0.748 . . . . 0.0 109.785 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.53 126.67 50.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.09 135.33 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 138.89 57.87 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.412 -0.805 . . . . 0.0 109.012 170.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.94 -13.94 60.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.6 0.714 . . . . 0.0 110.726 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 p -109.04 -6.24 15.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.097 1.359 . . . . 0.0 111.011 -161.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.43 -37.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.701 1.201 . . . . 0.0 109.684 -160.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.26 41.0 96.6 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 125.753 1.644 . . . . 0.0 111.888 -172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -65.69 133.99 52.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.13 93.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' H ' HD21 ' A' ' 72' ' ' LEU . 1.4 mm? -65.26 -53.04 50.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -147.91 167.48 24.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 111.584 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -142.55 141.18 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 127.448 2.299 . . . . 0.0 105.706 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -136.48 151.62 49.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.986 1.714 . . . . 0.0 108.019 167.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.59 153.32 40.26 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -62.88 -19.09 60.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 126.074 1.797 . . . . 0.0 113.0 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -57.02 -25.17 58.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.699 1.249 . . . . 0.0 111.405 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.27 -23.8 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.718 -0.613 . . . . 0.0 111.618 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -66.27 -13.05 59.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.856 1.207 . . . . 0.0 112.629 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -100.42 -4.94 27.95 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.417 -0.802 . . . . 0.0 110.251 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -77.53 69.89 3.84 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.419 2.287 . . . . 0.0 110.101 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.395 2.678 . . . . 0.0 117.144 158.044 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.1 pt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.84 -32.72 70.93 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 112.429 -168.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -56.13 -29.52 60.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.449 1.499 . . . . 0.0 113.618 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.99 -1.45 42.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.9 96.18 0.57 Allowed 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.748 1.158 . . . . 0.0 108.246 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.62 140.38 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -84.57 -20.34 31.64 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 122.304 -0.247 . . . . 0.0 110.932 168.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -157.61 162.73 38.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.037 1.335 . . . . 0.0 108.927 -168.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.27 177.32 11.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.377 1.071 . . . . 0.0 108.651 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -126.92 132.52 50.86 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.64 153.91 46.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 27.01 15.76 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.379 0.991 . . . . 0.0 112.692 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 57.64 14.64 2.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.062 -172.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.2 m -111.52 137.2 49.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 128.271 2.628 . . . . 0.0 105.791 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.04 154.15 18.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -149.7 153.4 36.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.254 0.621 . . . . 0.0 109.953 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -143.28 169.06 18.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.648 0.779 . . . . 0.0 109.045 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.16 93.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.87 5.46 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-O 117.809 -1.551 . . . . 0.0 114.174 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.92 176.04 1.78 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.469 1.634 . . . . 0.0 108.384 166.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.71 138.5 44.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -82.19 157.81 67.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.2 158.01 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 110.653 166.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.74 43.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.39 1.076 . . . . 0.0 112.479 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtm -51.92 -35.94 47.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.062 1.345 . . . . 0.0 111.824 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -97.24 -7.44 32.26 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.93 -18.97 61.34 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.665 0.666 . . . . 0.0 110.158 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.4 p -55.29 158.08 5.79 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.03 1.332 . . . . 0.0 111.497 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.37 -12.24 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.981 2.454 . . . . 0.0 113.032 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.87 -21.85 66.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.554 1.141 . . . . 0.0 112.408 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -115.51 13.36 16.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.932 1.693 . . . . 0.0 111.243 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -89.48 82.38 6.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.864 2.066 . . . . 0.0 111.218 -162.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.5 71.29 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.491 1.516 . . . . 0.0 110.905 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -68.6 -23.09 64.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.197 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -74.1 94.36 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 170.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -125.4 -27.05 3.5 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.812 -1.18 . . . . 0.0 113.641 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -51.42 -44.1 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.721 0.691 . . . . 0.0 109.177 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 -24.2 8.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.825 2.45 . . . . 0.0 115.453 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -116.07 177.06 4.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.478 1.511 . . . . 0.0 108.32 -170.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -9.58 59.66 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.07 -0.394 . . . . 0.0 111.022 -172.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.22 144.94 98.35 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 123.364 0.666 . . . . 0.0 109.816 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.11 159.86 24.62 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.796 2.331 . . . . 0.0 108.959 166.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.42 147.42 68.59 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.841 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -63.62 158.15 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.427 1.418 . . . . 0.0 108.767 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -72.52 156.41 39.05 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.48 65.06 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.533 1.533 . . . . 0.0 112.362 -164.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 25.57 0.05 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 128.004 2.716 . . . . 0.0 110.94 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.0 p -143.84 167.49 22.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.163 1.481 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -146.55 152.35 38.81 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.024 0.53 . . . . 0.0 111.726 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -92.06 128.43 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -131.8 155.44 47.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.297 0.639 . . . . 0.0 111.035 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 11.5 t80 -91.11 119.76 31.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.465 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtt -141.57 110.43 6.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.558 1.072 . . . . 0.0 111.266 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 1.98 33.85 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.106 0.86 . . . . 0.0 113.499 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.99 -18.15 19.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.824 1.678 . . . . 0.0 111.833 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -82.97 162.83 21.35 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.707 1.203 . . . . 0.0 109.5 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.463 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 34.3 m-85 -109.87 118.11 35.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.478 1.511 . . . . 0.0 107.6 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.72 131.45 62.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -168.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -89.0 111.02 21.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -106.96 147.88 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.614 1.166 . . . . 0.0 108.09 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 141.75 52.15 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.3 -10.73 60.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.669 0.747 . . . . 0.0 112.543 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -124.05 -5.77 7.87 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.263 2.225 . . . . 0.0 111.299 -161.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -152.92 -32.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.36 1.464 . . . . 0.0 109.461 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.1 16.16 80.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 124.101 0.858 . . . . 0.0 113.138 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 131.63 49.86 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.596 -0.943 . . . . 0.0 108.567 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.26 94.58 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.62 -52.56 14.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.867 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -150.15 162.53 40.26 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.116 1.366 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -139.58 136.45 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -133.89 143.52 48.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.37 1.068 . . . . 0.0 108.171 168.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.99 144.1 57.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -55.39 -22.78 32.01 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.337 1.446 . . . . 0.0 114.135 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.86 -20.46 57.27 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.182 1.491 . . . . 0.0 113.585 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.27 -16.8 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 112.169 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.59 -49.38 69.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.862 -1.149 . . . . 0.0 110.056 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -82.52 -17.74 43.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.24 0.616 . . . . 0.0 111.707 -168.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.12 124.09 10.8 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 130.308 3.443 . . . . 0.0 108.747 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.016 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 C--O 1.226 -0.135 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.61 -15.58 63.57 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.88 0.472 . . . . 0.0 111.811 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.9 -21.95 66.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.297 1.439 . . . . 0.0 112.586 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.65 0.73 31.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.808 1.243 . . . . 0.0 111.722 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 106.77 12.07 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.987 1.267 . . . . 0.0 109.574 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -72.41 -162.12 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HE2' ' OE1' ' A' ' 12' ' ' GLU . 15.4 ptmt -134.92 -16.62 1.94 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 119.956 -1.715 . . . . 0.0 109.968 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.437 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.6 pt-20 -165.29 170.64 14.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -162.47 172.57 15.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.683 0.793 . . . . 0.0 109.501 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.11 141.3 45.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 159.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.25 142.74 32.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 160.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.64 31.14 12.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 170.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 70.15 13.72 7.72 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.451 2.701 . . . . 0.0 114.042 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.9 m -105.46 133.03 50.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 107.845 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.65 149.32 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.125 1.77 . . . . 0.0 110.25 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -157.12 146.9 20.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.887 0.875 . . . . 0.0 111.039 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -140.44 167.61 21.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.799 0.84 . . . . 0.0 110.475 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 mm -61.19 101.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.46 -10.97 9.77 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 117.577 -1.68 . . . . 0.0 116.16 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.58 -174.76 1.8 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 121.005 2.403 . . . . 0.0 109.45 171.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.09 139.6 53.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.648 -1.282 . . . . 0.0 108.872 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.21 159.36 82.56 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 121.338 -0.851 . . . . 0.0 109.266 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.16 155.95 42.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.712 2.275 . . . . 0.0 111.137 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -11.48 32.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.15 -33.73 71.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 109.581 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -102.21 -8.3 21.43 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.21 -27.06 65.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.2 -0.428 . . . . 0.0 109.98 167.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.3 p -64.42 144.45 98.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 117.837 0.29 . . . . 0.0 111.725 -168.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.39 -6.0 18.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.08 1.853 . . . . 0.0 111.871 -171.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.01 -38.36 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.095 2.158 . . . . 0.0 111.719 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -106.97 7.02 29.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.261 1.425 . . . . 0.0 111.702 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -90.92 107.84 19.46 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.296 1.839 . . . . 0.0 110.633 -171.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.56 66.83 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.468 1.507 . . . . 0.0 110.211 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -54.23 -26.48 28.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.755 1.222 . . . . 0.0 112.133 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -72.84 90.34 1.43 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.834 1.654 . . . . 0.0 108.743 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -114.46 -28.84 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.379 1.445 . . . . 0.0 113.285 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.17 -38.84 77.43 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.773 1.229 . . . . 0.0 111.765 -168.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -119.28 44.7 2.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.807 1.243 . . . . 0.0 109.069 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -124.05 29.11 6.55 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.766 0.826 . . . . 0.0 112.4 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 m120 52.7 27.05 4.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.015 1.326 . . . . 0.0 111.853 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.9 mt -127.93 159.02 68.79 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 120.424 1.465 . . . . 0.0 110.448 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.32 173.47 13.78 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.025 2.483 . . . . 0.0 111.73 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.79 151.55 97.09 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.176 0.99 . . . . 0.0 110.947 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.31 164.89 34.27 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.559 3.506 . . . . 0.0 111.41 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.66 167.56 14.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.865 0.84 . . . . 0.0 109.186 163.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.65 51.82 0.28 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.586 2.355 . . . . 0.0 115.15 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.79 43.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 126.275 1.893 . . . . 0.0 109.156 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.2 p -154.73 168.38 27.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.469 1.135 . . . . 0.0 111.584 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -155.53 156.09 34.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.205 1.003 . . . . 0.0 109.962 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -80.57 141.31 35.19 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.277 1.031 . . . . 0.0 108.699 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -130.99 158.61 39.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.475 1.11 . . . . 0.0 108.692 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -96.02 109.24 21.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.478 1.111 . . . . 0.0 108.592 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.87 112.86 13.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.943 1.297 . . . . 0.0 110.827 -170.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.57 -1.13 15.43 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.292 -175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.67 -12.52 25.26 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 120.066 1.933 . . . . 0.0 113.341 -164.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.76 163.01 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 118.642 1.221 . . . . 0.0 109.482 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -101.17 111.52 23.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.863 1.665 . . . . 0.0 108.376 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.49 135.9 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.396 -0.815 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 tp -89.11 113.3 24.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.563 1.545 . . . . 0.0 110.1 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.28 142.28 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.598 1.159 . . . . 0.0 109.159 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 137.13 41.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.903 0.881 . . . . 0.0 109.408 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.06 1.85 4.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.944 0.898 . . . . 0.0 113.018 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 t -143.3 9.12 1.63 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.241 1.416 . . . . 0.0 110.775 -168.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -155.64 -42.65 0.08 Allowed 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.568 -1.332 . . . . 0.0 108.528 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 16.62 71.55 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.742 0.687 . . . . 0.0 111.461 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 139.72 58.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.35 1.075 . . . . 0.0 109.043 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.4 mt -81.43 79.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.629 1.571 . . . . 0.0 107.523 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.54 -47.14 76.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -149.86 162.67 39.85 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.186 1.794 . . . . 0.0 108.878 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -140.62 136.93 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -137.27 144.83 42.9 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.994 1.718 . . . . 0.0 107.289 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -70.57 159.42 34.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.83 0.741 . . . . 0.0 111.612 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.25 -28.71 72.69 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.04 0.829 . . . . 0.0 111.902 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.18 -21.51 33.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 112.455 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.5 tt -61.88 -30.73 49.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.156 0.889 . . . . 0.0 111.469 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -66.57 -12.45 57.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 111.774 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.78 -8.01 20.14 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.488 1.115 . . . . 0.0 112.192 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -54.16 170.95 0.12 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.926 2.091 . . . . 0.0 110.046 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -173.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 C--O 1.226 -0.165 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -56.89 -19.51 18.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.139 2.176 . . . . 0.0 112.179 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.76 -33.93 77.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 0.0 112.576 170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -95.07 0.63 54.58 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.088 1.355 . . . . 0.0 111.81 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 87.4 1.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.927 0.891 . . . . 0.0 109.386 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.77 158.98 35.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -105.51 -13.3 15.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.112 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.82 160.76 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.717 1.607 . . . . 0.0 109.039 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -159.66 175.38 13.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.697 1.599 . . . . 0.0 108.869 168.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -117.38 143.67 45.74 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.07 153.77 34.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 166.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.07 24.13 13.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.165 0.893 . . . . 0.0 111.752 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 56.64 17.23 2.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.066 2.146 . . . . 0.0 113.54 -170.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -108.33 128.75 55.03 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.57 1.948 . . . . 0.0 106.787 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -82.55 149.27 27.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.596 1.559 . . . . 0.0 110.092 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -152.49 153.91 34.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.827 0.851 . . . . 0.0 111.052 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -139.62 165.17 27.97 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.422 1.089 . . . . 0.0 108.837 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.63 112.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.77 -9.81 34.71 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.288 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.44 -175.93 2.11 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 119.494 1.647 . . . . 0.0 107.142 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.09 161.33 21.17 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 119.046 -2.284 . . . . 0.0 108.243 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -90.81 163.11 31.27 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 109.883 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.86 155.63 61.96 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.645 2.23 . . . . 0.0 110.97 158.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -17.91 60.48 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.862 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 mmt -49.89 -22.17 1.41 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.907 2.083 . . . . 0.0 113.454 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -116.8 -10.16 11.1 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.374 0.988 . . . . 0.0 112.699 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.56 -31.68 65.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.157 0.889 . . . . 0.0 110.945 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 t -50.94 144.67 13.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.071 1.348 . . . . 0.0 109.263 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.12 -11.32 31.79 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.011 2.474 . . . . 0.0 112.711 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.17 -18.85 11.27 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 112.97 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -118.93 -1.44 11.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 112.358 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -70.37 99.51 1.59 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.724 1.61 . . . . 0.0 110.659 -168.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 mt -81.39 83.84 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -62.52 -23.32 66.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.477 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -83.67 104.89 14.15 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.539 1.063 . . . . 0.0 111.014 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.43 -25.92 2.6 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 117.652 -1.166 . . . . 0.0 114.112 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -33.92 73.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.959 1.254 . . . . 0.0 112.193 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.7 26.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.818 1.247 . . . . 0.0 111.327 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -141.32 163.76 32.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.571 1.149 . . . . 0.0 108.448 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -64.74 -28.54 69.65 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.752 0.821 . . . . 0.0 112.449 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.65 153.76 7.58 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 124.476 1.11 . . . . 0.0 112.255 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.19 177.43 8.87 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.904 2.403 . . . . 0.0 111.209 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.57 164.46 7.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.338 1.455 . . . . 0.0 111.429 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -67.52 178.2 3.4 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.619 2.212 . . . . 0.0 109.266 157.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB2' ' HG ' ' A' ' 52' ' ' SER . 21.6 m-20 -85.38 179.11 7.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 162.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.91 37.4 0.24 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.263 1.425 . . . . 0.0 114.72 -166.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 43.83 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.049 1.785 . . . . 0.0 109.757 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.446 ' HG ' ' HB2' ' A' ' 49' ' ' ASP . 3.3 p -147.05 172.41 13.79 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.58 -1.541 . . . . 0.0 109.604 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -145.56 149.33 34.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.774 0.321 . . . . 0.0 111.636 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.46 142.88 38.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -134.16 170.44 15.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.591 1.156 . . . . 0.0 109.94 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.468 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 25.8 t80 -106.55 104.22 13.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.418 1.087 . . . . 0.0 108.666 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.68 102.11 9.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.734 1.614 . . . . 0.0 109.149 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.98 3.14 50.63 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.992 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 111.23 -1.33 28.2 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.464 1.132 . . . . 0.0 113.04 -169.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -120.48 140.0 52.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.651 1.58 . . . . 0.0 107.673 -167.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.1 120.39 28.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.65 144.4 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 tp -102.11 125.18 48.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.2 pt -130.03 135.18 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.885 0.874 . . . . 0.0 111.942 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -60.12 129.7 43.03 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.421 0.688 . . . . 0.0 111.348 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.94 15.73 0.84 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.743 1.217 . . . . 0.0 112.633 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 65' ' ' THR . 15.2 t -143.13 4.93 1.46 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.151 2.58 . . . . 0.0 111.642 -171.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -168.69 -50.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.9 1.28 . . . . 0.0 108.876 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.43 41.7 29.63 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.439 1.971 . . . . 0.0 111.17 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -61.11 153.75 24.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 159.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.0 mt -87.61 89.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 -47.98 69.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 110.484 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -144.59 158.95 43.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.91 0.884 . . . . 0.0 110.679 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.87 130.89 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.988 2.115 . . . . 0.0 106.062 166.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -125.58 142.33 51.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 160.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -63.7 151.53 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.357 0.526 . . . . 0.0 110.039 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.84 -18.77 47.73 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.575 1.083 . . . . 0.0 113.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.37 -27.73 38.43 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.437 1.119 . . . . 0.0 111.907 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -63.33 -20.57 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 112.735 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.18 -50.68 72.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.362 0.983 . . . . 0.0 109.978 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.66 -15.51 58.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.878 1.671 . . . . 0.0 112.274 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -85.27 88.27 7.47 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -174.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 127.267 2.227 . . . . 0.0 112.575 178.613 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.15 -30.87 71.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.895 0.478 . . . . 0.0 111.449 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -64.0 -20.68 66.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.388 1.875 . . . . 0.0 112.802 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -105.34 2.2 28.62 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.202 1.401 . . . . 0.0 111.25 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.61 96.22 1.53 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.48 157.24 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -129.71 0.46 4.9 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.357 1.063 . . . . 0.0 111.528 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -173.04 161.01 4.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.929 2.891 . . . . 0.0 106.457 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -169.51 177.48 4.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.235 1.414 . . . . 0.0 109.329 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -132.52 140.58 48.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 165.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.8 41.87 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 165.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t0 54.14 27.02 7.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 61.24 29.06 18.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.52 1.928 . . . . 0.0 111.704 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 m -125.8 135.83 52.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -110.16 150.29 28.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 109.476 -171.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -148.67 146.37 28.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.565 -160.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -144.28 167.07 23.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.668 1.587 . . . . 0.0 108.266 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 mm -69.81 118.23 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.89 -11.0 57.46 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.866 -1.519 . . . . 0.0 113.71 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.14 -179.85 2.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.804 1.802 . . . . 0.0 107.363 166.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.58 157.31 31.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 119.306 -2.121 . . . . 0.0 107.617 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.96 165.23 38.18 Favored Pre-proline 0 C--O 1.238 0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 111.444 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.18 158.56 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.18 2.586 . . . . 0.0 111.42 163.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.8 67.52 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.02 0.928 . . . . 0.0 112.025 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.417 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 18.9 ptp -54.8 -20.44 8.58 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 126.104 1.762 . . . . 0.0 114.273 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 10.8 m-85 -110.2 3.73 20.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.34 -23.0 35.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 111.508 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 t -66.65 145.53 98.95 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.197 0.999 . . . . 0.0 110.89 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.96 -6.71 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.531 3.487 . . . . 0.0 114.351 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -51.63 -42.44 62.02 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.44 1.096 . . . . 0.0 110.971 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.21 -12.15 19.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.521 0.728 . . . . 0.0 112.216 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -60.76 99.95 0.1 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.878 2.471 . . . . 0.0 112.211 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -78.18 79.31 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.123 1.769 . . . . 0.0 106.4 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -62.73 -29.24 70.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.6 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -76.05 76.59 2.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 111.639 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -98.54 -19.19 17.76 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.588 -0.695 . . . . 0.0 111.405 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -0.87 13.5 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.571 -1.331 . . . . 0.0 112.976 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.47 12.45 6.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.838 1.655 . . . . 0.0 111.775 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -120.86 173.58 7.14 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 120.842 -1.161 . . . . 0.0 107.953 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.03 -12.66 49.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.044 0.537 . . . . 0.0 112.079 -170.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.44 152.64 95.42 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.996 1.318 . . . . 0.0 109.904 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.46 167.14 19.52 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.245 2.63 . . . . 0.0 111.628 170.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.21 144.3 97.46 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.893 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.04 173.37 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.243 2.629 . . . . 0.0 110.847 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.66 175.64 9.99 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.005 0.922 . . . . 0.0 110.096 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.76 99.66 0.12 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.589 1.556 . . . . 0.0 111.422 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.3 49.36 20.84 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.169 -0.957 . . . . 0.0 111.058 -175.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -132.02 171.09 14.04 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 159.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.4 154.41 34.41 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.013 0.435 . . . . 0.0 111.113 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -75.62 143.51 42.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.523 175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -129.75 172.8 11.27 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.268 1.427 . . . . 0.0 109.02 168.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 114.47 28.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.465 ' CG ' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -89.41 -154.33 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.328 0.967 . . . . 0.0 110.016 175.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 57' ' ' MET . . . -46.55 7.63 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 1 C-N-CA 132.65 4.929 . . . . 0.0 117.862 170.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 57' ' ' MET . . . 138.37 -19.5 3.21 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 127.193 2.33 . . . . 0.0 110.883 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -92.5 162.9 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.346 1.458 . . . . 0.0 110.55 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.24 125.84 52.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.374 1.469 . . . . 0.0 107.496 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.53 156.37 41.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.0 tp -117.62 125.33 50.56 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.72 136.55 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 124.397 1.079 . . . . 0.0 110.851 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.61 135.45 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.744 0.818 . . . . 0.0 109.644 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -6.25 8.94 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.818 -0.551 . . . . 0.0 112.221 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -135.85 12.68 3.4 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.673 1.589 . . . . 0.0 110.145 -158.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -170.95 -31.4 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 125.887 1.675 . . . . 0.0 109.822 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.43 35.65 21.83 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.271 1.415 . . . . 0.0 111.661 -165.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.86 152.61 42.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 170.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.7 mt -86.97 86.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' H ' HD21 ' A' ' 72' ' ' LEU . 1.7 mm? -64.4 -51.76 61.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -149.8 161.88 41.38 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 109.364 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.13 142.35 40.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -132.49 152.14 51.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 161.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.49 160.8 28.41 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.877 -0.514 . . . . 0.0 111.02 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -22.19 71.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 124.451 1.024 . . . . 0.0 113.037 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -59.87 -18.57 45.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 112.296 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.33 -19.73 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 112.946 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -72.3 -35.06 68.56 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.512 1.051 . . . . 0.0 111.746 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -76.74 -16.42 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.775 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.622 ' CD2' ' H ' ' A' ' 83' ' ' ARG . 15.0 t60 -72.77 174.53 7.54 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.075 0.941 . . . . 0.0 110.378 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.622 ' H ' ' CD2' ' A' ' 82' ' ' HIS . 11.7 ptm180 . . . . . 0 C--O 1.246 0.916 0 C-N-CA 126.359 1.864 . . . . 0.0 110.518 -161.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.92 -25.88 58.26 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.865 1.666 . . . . 0.0 113.166 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -65.75 -27.17 68.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.81 0.43 57.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.321 1.049 . . . . 0.0 110.507 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.56 90.96 2.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.851 1.26 . . . . 0.0 111.628 -167.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.8 129.37 34.49 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.402 1.081 . . . . 0.0 108.303 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -92.01 -15.95 27.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.095 0.862 . . . . 0.0 112.393 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.83 166.4 29.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.312 1.445 . . . . 0.0 107.625 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -156.72 176.8 12.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.047 0.939 . . . . 0.0 108.881 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -129.89 129.82 44.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.34 142.43 32.48 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 44.34 51.77 7.51 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.02 1.328 . . . . 0.0 109.961 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.299 2.6 p90 48.24 24.19 0.65 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.014 3.326 . . . . 0.0 114.601 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.6 m -115.48 138.0 51.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.669 1.988 . . . . 0.0 107.407 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -89.78 150.71 22.15 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.019 0.928 . . . . 0.0 109.33 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -149.86 154.03 37.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.116 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -135.43 160.82 37.25 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.981 0.912 . . . . 0.0 108.644 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.27 113.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 -13.26 25.24 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.496 -1.724 . . . . 0.0 114.066 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.8 -172.38 1.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.078 1.939 . . . . 0.0 109.602 169.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.84 148.8 49.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.543 1.537 . . . . 0.0 108.966 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.67 154.55 45.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.681 -0.675 . . . . 0.0 110.234 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.28 165.63 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.929 2.419 . . . . 0.0 112.021 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -8.93 32.99 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.884 0.874 . . . . 0.0 112.708 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -22.81 60.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.801 1.64 . . . . 0.0 110.838 170.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -110.66 -23.67 10.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.872 0.869 . . . . 0.0 113.153 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -76.97 -18.02 58.5 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.304 0.502 . . . . 0.0 111.456 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 t -54.06 147.98 23.45 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.346 1.858 . . . . 0.0 110.508 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.38 -11.37 31.2 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.71 -9.72 15.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.764 1.625 . . . . 0.0 113.761 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -132.12 0.19 3.78 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.527 1.058 . . . . 0.0 112.591 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.26 136.9 57.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.645 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -118.71 88.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.696 1.599 . . . . 0.0 108.672 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.41 -14.23 62.79 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.702 -0.624 . . . . 0.0 111.839 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.16 43.12 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.053 1.341 . . . . 0.0 110.516 -162.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -70.6 -15.49 62.75 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.97 -25.58 67.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.397 0.999 . . . . 0.0 111.74 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.09 39.36 0.76 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 119.564 1.075 . . . . 0.0 111.712 -171.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 174.15 156.56 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 130.11 3.364 . . . . 0.0 106.684 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -81.82 0.75 37.98 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.734 . . . . 0.0 111.621 -174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.22 151.87 16.97 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 119.261 0.937 . . . . 0.0 111.179 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.79 168.42 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.077 1.851 . . . . 0.0 110.481 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.52 158.18 11.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.282 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.9 162.51 37.5 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.734 1.623 . . . . 0.0 110.232 167.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -70.73 162.66 28.69 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 162.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 109.25 1.96 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.926 -1.109 . . . . 0.0 110.92 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.58 33.98 17.65 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.339 0.518 . . . . 0.0 111.895 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.3 p -130.69 171.12 13.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.018 0.927 . . . . 0.0 108.869 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -143.77 153.26 42.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -94.48 133.78 37.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.372 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -134.64 160.25 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.07 114.89 26.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -152.89 0.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.972 1.309 . . . . 0.0 108.417 171.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.81 52.87 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 130.233 3.778 . . . . 0.0 115.3 166.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.97 3.49 89.13 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 117.818 0.809 . . . . 0.0 113.756 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -121.49 166.63 13.87 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.966 1.307 . . . . 0.0 107.566 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -108.6 120.65 43.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.07 155.63 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -111.33 118.87 37.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.9 145.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.366 1.867 . . . . 0.0 109.145 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.02 141.18 56.29 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 120.053 1.297 . . . . 0.0 107.69 166.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -73.18 -6.88 48.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.87 0.843 . . . . 0.0 112.368 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 t -136.07 23.24 3.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.434 1.894 . . . . 0.0 110.288 -163.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -172.92 -38.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.94 1.696 . . . . 0.0 109.2 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.63 25.97 68.65 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 125.14 1.352 . . . . 0.0 113.216 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.99 143.87 57.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.565 1.146 . . . . 0.0 108.972 174.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.97 91.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.991 1.716 . . . . 0.0 107.501 -169.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.5 mt -79.38 -48.3 14.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.631 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -146.27 163.03 36.76 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.467 1.507 . . . . 0.0 108.043 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.0 t -140.58 142.83 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.72 148.96 51.48 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 161.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.25 158.72 16.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.072 0.949 . . . . 0.0 112.44 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.3 -24.52 55.74 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 126.15 1.834 . . . . 0.0 115.083 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -63.84 -21.13 66.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 120.141 1.97 . . . . 0.0 112.694 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.48 0.67 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 121.271 -0.893 . . . . 0.0 111.564 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -66.29 -41.62 89.54 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.397 -1.439 . . . . 0.0 110.952 162.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -131.48 16.71 4.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.475 1.11 . . . . 0.0 112.848 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.5 133.44 29.94 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.894 2.077 . . . . 0.0 107.961 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.567 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 121.124 0.488 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.74 -16.62 64.37 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.476 1.11 . . . . 0.0 112.798 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -57.94 -24.73 59.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.672 1.589 . . . . 0.0 112.457 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.98 -1.27 34.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 0.0 111.98 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.77 104.07 10.1 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.862 0.755 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.14 125.57 29.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -65.84 -30.15 70.72 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.519 -1.363 . . . . 0.0 110.422 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.78 153.85 28.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.69 176.26 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.058 1.343 . . . . 0.0 108.554 171.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.3 m -126.74 139.07 53.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.45 151.11 37.69 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.33 35.18 13.19 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.875 0.87 . . . . 0.0 111.871 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 58.54 37.94 25.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.906 2.482 . . . . 0.0 112.691 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -138.12 133.19 33.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.998 1.719 . . . . 0.0 107.506 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.28 154.42 21.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.546 0.738 . . . . 0.0 109.688 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -147.5 154.28 40.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.079 1.752 . . . . 0.0 110.435 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -145.81 165.21 29.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.231 1.412 . . . . 0.0 109.364 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -66.7 100.65 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.87 -1.92 19.69 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.042 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -79.51 -174.44 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.266 1.033 . . . . 0.0 108.679 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 164.81 20.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.712 1.605 . . . . 0.0 109.606 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.97 163.89 16.25 Favored Pre-proline 0 N--CA 1.47 0.534 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.11 155.54 47.29 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.756 1.637 . . . . 0.0 110.221 162.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.78 -16.39 57.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp -56.25 -18.19 9.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.018 1.727 . . . . 0.0 112.508 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -116.35 -11.35 11.23 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.29 1.036 . . . . 0.0 113.268 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.5 -13.96 59.21 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-N 118.744 0.702 . . . . 0.0 110.61 171.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -64.88 145.04 99.05 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.163 -0.961 . . . . 0.0 108.44 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.1 -3.8 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.178 2.585 . . . . 0.0 114.209 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.02 -12.67 1.54 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.884 -1.135 . . . . 0.0 113.334 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -127.02 3.12 6.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.803 1.241 . . . . 0.0 112.042 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 116.84 5.71 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.429 2.691 . . . . 0.0 111.4 -170.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.76 122.14 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.813 1.645 . . . . 0.0 107.85 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -131.94 -5.14 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.82 34.57 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.445 1.93 . . . . 0.0 112.312 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.02 -29.25 70.15 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 120.737 -1.227 . . . . 0.0 110.916 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -56.88 -13.3 2.51 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.322 1.449 . . . . 0.0 113.712 172.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.15 1.77 7.89 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.722 1.609 . . . . 0.0 113.341 -173.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 -118.0 161.17 20.24 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.842 1.657 . . . . 0.0 109.493 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.01 58.63 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.151 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.61 155.41 73.55 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.013 1.325 . . . . 0.0 109.472 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.99 164.72 34.79 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.441 2.761 . . . . 0.0 113.095 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.29 84.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.045 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.46 -59.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.594 0.891 . . . . 0.0 113.263 -166.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 176.61 -162.3 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 131.527 3.931 . . . . 0.0 105.681 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.08 2.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.178 2.191 . . . . 0.0 112.388 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.32 47.32 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 p -142.02 165.76 26.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.154 0.981 . . . . 0.0 110.883 168.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -137.49 157.49 46.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.889 0.476 . . . . 0.0 110.195 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -84.53 151.68 24.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p -138.73 176.89 8.31 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.689 1.596 . . . . 0.0 109.119 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 8.0 t80 -116.85 104.4 11.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.616 1.167 . . . . 0.0 108.661 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.92 98.67 7.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.396 1.878 . . . . 0.0 108.176 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.31 11.22 64.1 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.444 1.02 . . . . 0.0 113.904 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 109.63 -12.42 32.8 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.973 1.386 . . . . 0.0 113.311 -172.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -94.51 120.17 34.33 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.468 2.307 . . . . 0.0 107.202 -171.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.465 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 30.7 m-85 -64.55 114.5 4.41 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.369 -0.832 . . . . 0.0 108.887 162.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.97 154.88 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -109.32 130.47 55.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.513 1.125 . . . . 0.0 109.864 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.6 pt -131.5 142.36 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.804 1.241 . . . . 0.0 110.061 -173.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 138.82 53.0 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.902 0.774 . . . . 0.0 109.772 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.51 -14.89 62.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.88 0.872 . . . . 0.0 112.113 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -128.59 1.37 5.55 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.115 1.766 . . . . 0.0 110.484 -167.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.16 -35.38 0.24 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.989 -1.069 . . . . 0.0 111.907 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.44 20.43 79.38 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.759 0.695 . . . . 0.0 113.228 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 132.99 55.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.26 92.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 127.568 2.347 . . . . 0.0 105.781 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.35 -54.07 16.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -151.16 170.69 18.83 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.743 0.817 . . . . 0.0 109.681 -170.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.2 p -143.23 140.78 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 1 C-N-CA 132.07 4.148 . . . . 0.0 105.113 171.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -142.79 112.37 6.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.412 -1.28 . . . . 0.0 108.262 160.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -49.19 146.73 3.44 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.904 1.229 . . . . 0.0 113.117 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -44.53 -26.15 0.98 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.732 -1.594 . . . . 0.0 116.175 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -49.67 -30.79 9.69 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.875 1.837 . . . . 0.0 112.686 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.06 -22.57 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.947 0.899 . . . . 0.0 112.379 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.16 -30.62 71.73 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 111.305 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -93.21 8.45 40.18 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.471 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -72.96 172.38 11.06 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.242 0.544 . . . . 0.0 110.594 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.325 0.65 . . . . 0.0 110.426 179.699 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 -20.43 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.437 0.562 . . . . 0.0 112.019 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -52.82 -26.51 14.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.007 2.123 . . . . 0.0 113.797 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -96.58 0.65 50.34 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.51 1.524 . . . . 0.0 112.31 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.65 118.43 22.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.406 1.457 . . . . 0.0 108.581 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.4 -167.97 1.91 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 123.872 1.796 . . . . 0.0 106.753 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 -19.76 6.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.167 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -170.79 170.59 6.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -159.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -170.47 -178.38 2.68 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.862 1.665 . . . . 0.0 109.37 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -125.47 137.96 53.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 164.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.2 43.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 164.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.55 30.17 16.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.099 0.952 . . . . 0.0 112.06 176.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 58.35 25.22 12.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.672 1.189 . . . . 0.0 111.796 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 m -127.29 128.86 46.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.023 2.529 . . . . 0.0 106.768 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.88 152.96 29.35 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.831 0.853 . . . . 0.0 109.468 174.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -146.28 158.1 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.415 1.086 . . . . 0.0 110.024 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -139.73 164.44 29.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.135 1.774 . . . . 0.0 109.174 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.91 117.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 166.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -5.78 56.1 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.169 -1.351 . . . . 0.0 113.892 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.55 -177.11 3.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.082 1.941 . . . . 0.0 107.484 165.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 157.09 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.257 -1.527 . . . . 0.0 108.524 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.16 162.45 34.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.906 0.775 . . . . 0.0 109.452 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.99 162.46 34.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.0 2.467 . . . . 0.0 111.633 163.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -17.08 24.92 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.581 1.153 . . . . 0.0 112.998 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.18 -21.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.057 1.343 . . . . 0.0 112.44 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.95 -6.59 10.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.882 0.873 . . . . 0.0 112.774 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.81 -33.62 72.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.946 1.248 . . . . 0.0 109.873 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.2 t -49.35 144.3 8.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.644 1.578 . . . . 0.0 109.286 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.785 1.657 . . . . 0.0 113.015 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -54.69 -29.18 52.21 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -116.44 4.22 13.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.688 1.195 . . . . 0.0 111.204 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -80.85 118.07 22.04 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.446 2.299 . . . . 0.0 109.389 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.46 76.88 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -61.54 -30.44 70.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.366 -0.834 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.82 104.77 1.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -127.08 -15.03 5.38 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.813 -1.179 . . . . 0.0 113.795 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -30.72 32.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.047 1.294 . . . . 0.0 112.092 -177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -89.03 44.16 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.064 0.847 . . . . 0.0 108.805 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -146.7 -170.28 3.48 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.214 2.206 . . . . 0.0 106.503 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.85 -15.76 24.74 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.654 0.782 . . . . 0.0 111.607 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.96 150.77 96.22 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.05 169.35 20.75 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.609 1.54 . . . . 0.0 109.14 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 146.58 79.34 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.8 169.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.99 -167.43 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.518 3.479 . . . . 0.0 111.266 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 165.39 11.74 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 165.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.87 46.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.431 1.493 . . . . 0.0 113.026 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.59 23.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.957 2.218 . . . . 0.0 111.686 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 p -140.06 165.12 28.21 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.19 -1.183 . . . . 0.0 111.162 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -147.12 156.26 42.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.201 0.6 . . . . 0.0 111.203 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -77.97 134.41 37.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.304 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -127.47 165.7 19.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.926 1.29 . . . . 0.0 109.429 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.11 105.65 15.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.249 1.419 . . . . 0.0 108.392 177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 97.4 mmm -78.53 -154.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.452 1.501 . . . . 0.0 108.934 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.21 64.94 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 128.909 3.147 . . . . 0.0 111.895 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.61 14.67 79.54 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.448 -1.751 . . . . 0.0 114.569 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.23 159.05 43.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.846 1.823 . . . . 0.0 108.863 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.06 137.23 35.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.19 158.6 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 121.523 -0.736 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.69 114.3 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.447 1.099 . . . . 0.0 109.066 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.47 144.99 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.102 0.961 . . . . 0.0 110.047 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' THR . 1.3 p -73.07 137.83 45.52 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -77.8 10.63 2.62 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.682 1.23 . . . . 0.0 113.26 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' THR . 4.5 t -139.44 7.68 2.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.749 2.02 . . . . 0.0 110.827 -167.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -167.14 -49.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.937 1.295 . . . . 0.0 109.059 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.45 19.55 17.98 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.174 1.369 . . . . 0.0 112.563 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 131.11 45.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.618 -0.931 . . . . 0.0 110.283 -173.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.76 91.95 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.507 1.523 . . . . 0.0 107.778 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.27 -42.66 25.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.418 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -149.15 155.28 40.43 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.183 0.993 . . . . 0.0 108.531 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.64 125.79 31.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -126.74 119.11 26.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 107.652 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.12 145.0 27.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.485 1.514 . . . . 0.0 111.702 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -7.26 40.02 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.196 -1.565 . . . . 0.0 114.521 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.3 -22.42 62.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.312 1.556 . . . . 0.0 111.049 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 -30.0 45.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-N 120.317 1.417 . . . . 0.0 111.126 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -53.05 -35.93 60.05 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.015 1.326 . . . . 0.0 111.316 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -87.22 20.79 2.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.802 0.841 . . . . 0.0 111.586 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -117.0 49.68 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.992 1.317 . . . . 0.0 111.805 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 115.815 -2.04 . . . . 0.0 108.828 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 CA--C 1.522 -0.102 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.82 -20.6 65.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.735 0.814 . . . . 0.0 111.029 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -65.15 -18.9 65.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.423 1.889 . . . . 0.0 113.969 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -102.69 2.95 36.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.329 1.052 . . . . 0.0 110.975 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 97.4 1.58 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.837 1.199 . . . . 0.0 109.141 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.8 143.31 46.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.0 -12.58 44.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.653 0.206 . . . . 0.0 110.713 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 177.87 164.93 0.67 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.165 2.186 . . . . 0.0 108.19 -164.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -168.56 -175.09 2.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.55 1.54 . . . . 0.0 109.589 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.88 47.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.83 152.95 38.51 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 162.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.83 30.19 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.289 1.043 . . . . 0.0 112.679 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 56.43 14.74 1.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.583 1.953 . . . . 0.0 113.122 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 m -100.12 117.22 33.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.729 2.012 . . . . 0.0 105.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.99 37.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.8 0.84 . . . . 0.0 109.81 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -148.1 154.01 39.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 110.956 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -146.65 161.86 39.66 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.577 1.551 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.91 122.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.65 7.95 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.014 -1.992 . . . . 0.0 113.867 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.06 -170.32 0.45 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 120.02 1.91 . . . . 0.0 109.871 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.02 160.72 32.82 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.676 1.99 . . . . 0.0 108.74 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.7 m -107.71 163.74 16.31 Favored Pre-proline 0 N--CA 1.476 0.872 0 O-C-N 120.576 -1.327 . . . . 0.0 112.671 -174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 41.8 Cg_endo -72.33 163.39 38.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.492 2.795 . . . . 0.0 114.198 169.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.79 66.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 112.23 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.62 -21.92 54.98 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 119.033 0.833 . . . . 0.0 111.044 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 22.5 m-85 -109.32 11.09 25.43 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.58 -23.22 19.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.904 . . . . 0.0 111.952 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 t -69.44 147.81 97.0 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.598 0.759 . . . . 0.0 111.107 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.39 -4.62 9.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.609 3.539 . . . . 0.0 113.768 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.57 -22.83 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.16 1.784 . . . . 0.0 113.325 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -121.49 -6.12 9.26 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.636 1.175 . . . . 0.0 111.507 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.79 123.59 20.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.97 1.308 . . . . 0.0 111.047 -172.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -104.27 96.01 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.99 -37.41 87.03 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.567 -0.708 . . . . 0.0 110.36 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -89.02 109.06 19.95 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.191 0.996 . . . . 0.0 109.352 -167.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . 0.273 23.0 p-90 -112.83 -47.21 3.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 116.782 -1.58 . . . . 0.0 114.992 -170.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.71 -37.67 76.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.221 1.828 . . . . 0.0 111.11 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -55.7 -36.2 66.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.078 0.551 . . . . 0.0 111.932 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -88.97 24.14 2.17 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.095 -1.003 . . . . 0.0 111.397 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.31 6.32 5.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.292 2.637 . . . . 0.0 112.706 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.65 156.06 35.76 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 120.856 -1.152 . . . . 0.0 112.696 -159.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 166.82 25.9 Favored 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.581 4.187 . . . . 0.0 111.277 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.48 153.23 51.08 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.824 1.25 . . . . 0.0 110.478 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -65.46 170.37 11.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.159 1.906 . . . . 0.0 110.364 165.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.76 160.31 32.83 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 103.38 0.56 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.134 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.89 32.59 4.05 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.765 1.65 . . . . 0.0 111.057 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.8 p -150.58 173.6 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.613 -1.522 . . . . 0.0 110.239 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -156.09 158.81 38.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.722 0.772 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.97 144.1 37.05 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.801 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -131.93 172.26 12.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.09 1.356 . . . . 0.0 108.87 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.91 122.05 46.4 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.9 mmt -90.07 -162.71 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.119 1.367 . . . . 0.0 108.09 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.42 -12.02 5.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 127.32 2.39 . . . . 0.0 116.426 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.19 4.93 0.02 OUTLIER Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.888 1.709 . . . . 0.0 112.713 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -129.54 152.26 49.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 110.408 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.81 130.03 44.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.721 1.208 . . . . 0.0 108.602 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.61 155.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.43 115.81 24.22 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.662 1.585 . . . . 0.0 109.116 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.45 142.06 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.2 1.0 . . . . 0.0 109.396 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 143.62 50.66 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 122.753 0.421 . . . . 0.0 110.473 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -66.52 -18.38 65.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 t -120.25 -9.37 9.54 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.26 1.824 . . . . 0.0 110.83 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -144.92 -45.96 0.23 Allowed 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.38 1.072 . . . . 0.0 108.89 -165.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 22.4 66.62 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.663 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 131.61 51.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.539 1.17 . . . . 0.0 108.375 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.08 91.12 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 126.678 1.991 . . . . 0.0 105.881 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.36 -55.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.36 148.8 28.57 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.674 0.67 . . . . 0.0 109.568 -169.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -128.89 137.21 57.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -131.14 147.94 52.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.16 155.79 39.28 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.717 -0.615 . . . . 0.0 110.232 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.31 -11.55 59.41 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.796 1.188 . . . . 0.0 112.607 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.1 -32.96 56.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.763 1.625 . . . . 0.0 111.823 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.51 -23.33 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.422 0.555 . . . . 0.0 112.117 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -63.07 -30.32 71.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.562 -0.712 . . . . 0.0 111.65 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -77.46 -25.74 50.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.459 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -65.06 142.95 58.23 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.283 1.033 . . . . 0.0 109.05 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 . . . . . 0 C--O 1.251 1.15 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.51 -27.86 62.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.426 1.09 . . . . 0.0 112.103 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -53.09 -34.46 56.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.033 1.333 . . . . 0.0 113.067 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.81 -6.82 58.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.886 0.874 . . . . 0.0 111.729 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 101.23 3.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.768 1.167 . . . . 0.0 109.13 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.79 129.15 37.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -64.35 -28.6 69.81 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 120.049 -1.657 . . . . 0.0 110.106 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.81 158.99 39.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.354 0.662 . . . . 0.0 110.145 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CD1' ' CE ' ' A' ' 57' ' ' MET . 54.9 p90 -160.04 -177.99 6.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.984 1.314 . . . . 0.0 110.877 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -133.88 139.21 46.05 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.922 1.289 . . . . 0.0 108.172 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.33 31.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.958 0.903 . . . . 0.0 109.778 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.54 41.25 4.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.951 1.7 . . . . 0.0 112.26 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 59.62 49.14 8.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.529 1.932 . . . . 0.0 111.066 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 m -152.73 144.77 23.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.882 1.673 . . . . 0.0 108.652 168.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.95 147.93 25.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.332 2.253 . . . . 0.0 110.01 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.03 160.25 41.68 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.914 1.686 . . . . 0.0 111.863 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -141.97 169.14 18.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.871 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm -58.85 121.87 7.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 5.87 70.32 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.866 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.66 -172.81 3.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.731 1.766 . . . . 0.0 108.976 160.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.47 139.99 53.24 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 109.001 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.88 160.23 78.83 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.18 166.64 26.2 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.434 2.089 . . . . 0.0 110.261 161.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.0 -23.51 33.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.879 1.272 . . . . 0.0 112.141 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.8 mtp -55.88 -16.84 5.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.248 1.819 . . . . 0.0 113.694 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -118.92 -1.56 10.98 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -24.2 43.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.241 0.928 . . . . 0.0 110.372 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.38 154.22 23.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 127.17 2.188 . . . . 0.0 113.618 -174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -67.64 -5.43 14.22 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.434 4.089 . . . . 0.0 113.928 171.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -58.92 -63.89 1.14 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.605 1.162 . . . . 0.0 108.867 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -87.15 2.91 48.42 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.626 1.57 . . . . 0.0 112.709 -168.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.08 132.53 53.77 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.892 2.077 . . . . 0.0 110.314 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mm -119.06 80.04 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.529 1.131 . . . . 0.0 108.246 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -52.73 -29.05 24.85 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.017 -1.052 . . . . 0.0 112.099 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 0.45 17.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.705 1.202 . . . . 0.0 113.794 -165.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -59.66 -3.21 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -166.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -40.33 71.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 122.391 2.36 . . . . 0.0 112.908 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -137.54 55.86 1.78 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 110.337 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -137.48 34.88 2.48 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.607 1.163 . . . . 0.0 110.459 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.449 HD22 ' CA ' ' A' ' 83' ' ' ARG . 9.5 m120 75.32 -36.56 0.31 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 129.074 2.95 . . . . 0.0 113.714 172.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.83 149.99 61.66 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 126.212 1.805 . . . . 0.0 110.8 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.02 165.24 33.2 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.591 2.194 . . . . 0.0 111.78 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.76 97.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 165.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.47 172.76 12.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.563 2.176 . . . . 0.0 111.303 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 161.34 27.13 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 107.85 0.63 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.934 1.293 . . . . 0.0 110.569 175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.74 9.06 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.456 1.503 . . . . 0.0 112.414 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.5 p -146.63 166.38 26.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.816 1.308 . . . . 0.0 110.958 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -156.04 157.23 35.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.755 0.822 . . . . 0.0 111.259 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.06 130.73 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 p -124.84 154.94 40.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 105.8 11.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.582 ' CE ' HD21 ' A' ' 60' ' ' ASN . 8.2 ptm -77.4 -154.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.97 62.55 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 1 C-N-CA 131.672 4.463 . . . . 0.0 112.89 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.64 6.75 88.91 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 126.309 1.909 . . . . 0.0 114.457 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.582 HD21 ' CE ' ' A' ' 57' ' ' MET . 14.3 m-80 -125.03 164.76 19.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.57 1.548 . . . . 0.0 106.828 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -95.74 131.71 41.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 m -119.43 149.23 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 120.159 1.345 . . . . 0.0 109.238 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.38 119.3 32.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.66 146.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.852 1.261 . . . . 0.0 108.455 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.449 ' HG1' ' CG ' ' A' ' 68' ' ' GLU . 0.8 OUTLIER -78.64 152.48 31.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.06 0.391 . . . . 0.0 111.515 177.073 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -34.81 78.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.442 165.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -86.97 -7.87 57.75 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.061 -1.024 . . . . 0.0 111.822 -171.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.449 ' CG ' ' HG1' ' A' ' 65' ' ' THR . 14.4 pt-20 -155.14 -35.55 0.09 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 172.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.5 49.58 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.813 -172.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 132.03 51.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.967 0.883 . . . . 0.0 108.95 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.88 82.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 129.174 2.989 . . . . 0.0 106.807 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.89 -50.08 58.36 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -145.27 168.09 21.28 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.898 1.279 . . . . 0.0 108.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.1 p -133.94 149.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 C-N-CA 133.786 4.835 . . . . 0.0 105.222 167.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -140.05 130.63 25.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 151.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.34 146.43 9.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.662 0.664 . . . . 0.0 109.526 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.7 -26.82 11.2 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.519 -1.156 . . . . 0.0 113.206 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -54.74 -24.93 24.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.115 1.766 . . . . 0.0 112.161 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -55.98 -33.05 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.062 0.846 . . . . 0.0 110.996 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -61.43 -13.46 20.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.429 1.891 . . . . 0.0 112.433 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.16 -8.62 15.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.199 0.909 . . . . 0.0 112.977 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -81.0 34.7 0.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.395 1.878 . . . . 0.0 110.978 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CA ' HD22 ' A' ' 44' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 C-N-CA 125.98 1.712 . . . . 0.0 111.641 -156.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.44 153.52 43.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 162.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.88 58.4 1.6 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.86 -107.57 0.59 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.46 -18.64 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.42 -167.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.23 -26.2 67.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.16 0.584 . . . . 0.0 111.163 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -23.02 65.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.634 1.574 . . . . 0.0 113.837 171.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -101.36 4.5 41.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.996 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.89 111.28 21.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 121.017 1.735 . . . . 0.0 109.497 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 11' ' ' LYS . 4.0 mp -81.92 -165.51 1.01 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.412 1.577 . . . . 0.0 106.841 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 10' ' ' LEU . 13.5 ptmt -134.3 -13.96 2.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.725 -2.034 . . . . 0.0 113.236 164.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 178.49 159.09 0.53 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.882 0.765 . . . . 0.0 110.502 -163.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -167.33 -175.54 2.94 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.659 1.584 . . . . 0.0 109.159 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -128.49 135.49 49.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 157.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.54 161.98 33.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 158.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 20.65 11.96 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 163.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 62.29 29.45 17.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.331 1.853 . . . . 0.0 112.586 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -129.96 122.51 28.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.611 2.364 . . . . 0.0 107.626 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.58 147.0 30.96 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -147.21 158.49 43.97 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.811 0.844 . . . . 0.0 110.292 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.16 173.44 11.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.964 1.306 . . . . 0.0 109.0 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.64 108.22 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.77 2.37 39.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.598 -1.668 . . . . 0.0 114.822 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -178.06 1.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.481 1.64 . . . . 0.0 108.135 161.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.18 146.99 48.33 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.667 -1.27 . . . . 0.0 107.581 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.6 m -79.09 162.1 65.68 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.84 162.26 39.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.797 2.331 . . . . 0.0 111.077 162.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -16.3 44.15 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.437 1.095 . . . . 0.0 112.153 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtt -60.06 -17.24 38.0 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 124.874 1.27 . . . . 0.0 112.158 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -119.95 1.72 10.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.6 -26.22 57.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.461 1.028 . . . . 0.0 110.269 167.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -57.99 144.4 75.5 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.66 -4.24 14.23 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 112.724 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.04 -14.95 18.9 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.795 2.038 . . . . 0.0 114.005 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.6 -5.09 8.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.253 1.421 . . . . 0.0 112.237 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.27 106.74 2.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.906 2.082 . . . . 0.0 110.15 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.57 83.62 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -63.72 -16.92 62.36 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.273 -0.892 . . . . 0.0 111.115 167.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -90.11 70.77 7.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.148 2.179 . . . . 0.0 108.022 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -111.92 -19.45 12.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -72.17 -35.99 69.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.767 1.167 . . . . 0.0 111.483 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -78.13 38.1 0.27 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.552 0.615 . . . . 0.0 110.034 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -146.39 166.1 27.36 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 127.271 2.228 . . . . 0.0 106.611 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.38 -16.47 62.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.167 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.85 148.71 75.55 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 0.0 112.265 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -74.1 157.85 46.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.086 2.524 . . . . 0.0 112.757 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.65 142.58 96.13 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.607 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.37 162.89 39.2 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.058 2.505 . . . . 0.0 112.189 -171.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.54 160.57 29.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.95 50.72 1.42 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.453 1.501 . . . . 0.0 113.266 -161.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.53 38.9 0.02 OUTLIER Glycine 0 CA--C 1.528 0.9 0 C-N-CA 127.37 2.414 . . . . 0.0 109.835 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.9 p -148.37 172.17 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.645 1.223 . . . . 0.0 110.577 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -145.58 156.41 43.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.173 0.511 . . . . 0.0 111.956 169.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -73.33 141.41 47.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.983 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.27 131.95 35.12 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.141 2.177 . . . . 0.0 106.256 -169.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.16 100.34 11.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.48 -155.66 0.07 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 108.309 169.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.98 60.99 0.53 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 127.355 2.407 . . . . 0.0 113.89 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.4 66.13 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.381 0.591 . . . . 0.0 113.329 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -134.87 154.74 51.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.61 115.54 30.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.73 149.33 7.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.8 tp -100.92 126.08 47.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.03 135.79 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 C-N-CA 123.81 0.844 . . . . 0.0 110.056 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 133.77 52.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 108.617 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.15 -2.27 23.91 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.808 -1.183 . . . . 0.0 112.044 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -127.15 13.2 7.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.68 1.592 . . . . 0.0 109.534 -170.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -164.38 -48.24 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.401 1.08 . . . . 0.0 109.814 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 33.95 66.48 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 126.753 2.12 . . . . 0.0 112.18 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 143.01 32.7 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 160.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.0 86.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.3 mm? -63.62 -49.67 72.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.207 1.003 . . . . 0.0 110.117 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -146.21 161.05 41.1 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.689 1.596 . . . . 0.0 108.762 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.6 t -144.2 131.58 17.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.257 1.823 . . . . 0.0 107.592 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.038 1.335 . . . . 0.0 108.626 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.53 160.32 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.965 0.506 . . . . 0.0 109.831 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.31 71.06 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.482 -1.177 . . . . 0.0 113.778 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.32 -20.72 65.74 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.813 1.806 . . . . 0.0 112.86 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.7 tt -59.11 -20.18 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.203 1.001 . . . . 0.0 112.198 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.58 -35.34 72.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.871 1.268 . . . . 0.0 111.958 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.43 -17.89 29.49 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.867 0.758 . . . . 0.0 111.068 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -61.99 152.06 33.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 108.558 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 127.859 2.464 . . . . 0.0 105.598 -170.625 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.95 -169.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.24 1.416 . . . . 0.0 111.893 -167.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.23 61.46 1.3 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.62 -172.27 33.33 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 pt -65.11 -16.39 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 113.893 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.89 -26.21 68.5 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.2 0.6 . . . . 0.0 112.52 -168.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -58.62 -30.33 67.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.36 1.064 . . . . 0.0 112.515 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.32 -3.97 49.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.416 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.65 89.58 2.24 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.921 1.237 . . . . 0.0 110.849 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.53 133.99 43.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 107.207 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -87.0 -20.19 27.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.971 0.805 . . . . 0.0 111.911 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -154.17 161.3 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.947 1.699 . . . . 0.0 108.789 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.92 175.34 13.69 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.959 1.704 . . . . 0.0 108.664 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 m -130.6 121.58 25.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.47 153.91 51.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 58.08 29.25 17.54 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.245 1.021 . . . . 0.0 111.427 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 58.69 14.81 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.435 1.894 . . . . 0.0 113.325 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -115.03 126.81 55.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.21 149.29 25.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -146.19 152.69 39.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.603 0.761 . . . . 0.0 110.015 -172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -134.94 165.48 25.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.004 1.321 . . . . 0.0 108.209 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.22 115.48 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.3 59.1 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.752 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -176.25 1.15 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.72 1.76 . . . . 0.0 107.943 153.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.79 159.89 28.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.52 1.928 . . . . 0.0 109.537 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.86 158.09 32.44 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.055 -1.028 . . . . 0.0 110.98 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.13 160.39 47.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.648 2.232 . . . . 0.0 110.949 164.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.76 -13.21 41.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -23.13 10.59 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.272 1.829 . . . . 0.0 112.351 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.55 -20.12 9.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.713 0.633 . . . . 0.0 111.88 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.4 -23.67 62.79 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.516 -0.74 . . . . 0.0 111.435 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -57.3 143.19 74.21 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.041 0.936 . . . . 0.0 108.73 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.65 -4.18 11.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.558 3.505 . . . . 0.0 113.395 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.23 -33.83 74.13 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.244 1.817 . . . . 0.0 113.198 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -114.41 4.97 15.5 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.01 94.87 0.11 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.994 2.117 . . . . 0.0 110.141 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.38 74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 123.929 1.823 . . . . 0.0 107.456 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -59.15 -37.43 77.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.023 160.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -78.33 80.09 4.75 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.215 1.406 . . . . 0.0 111.689 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -83.52 -37.94 22.39 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.955 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -46.41 -51.09 15.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.241 1.016 . . . . 0.0 112.901 -169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -79.53 12.83 2.29 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 112.529 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -118.93 162.34 18.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 161.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.21 -6.48 23.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.354 1.062 . . . . 0.0 112.859 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.42 159.65 57.51 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.885 1.674 . . . . 0.0 112.143 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.03 175.02 11.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.017 3.144 . . . . 0.0 109.884 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.37 158.96 25.76 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.884 0.874 . . . . 0.0 110.502 166.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.3 168.1 23.23 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.476 2.118 . . . . 0.0 110.537 165.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -78.2 161.22 27.48 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 163.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.32 112.56 4.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.516 0.726 . . . . 0.0 109.801 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.11 23.68 31.6 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.159 0.436 . . . . 0.0 112.404 -176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.3 p -135.55 167.65 20.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 117.891 0.846 . . . . 0.0 109.276 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -150.99 157.58 43.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.437 0.637 . . . . 0.0 110.427 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -82.86 149.15 27.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.6 p -140.08 155.51 47.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.138 0.575 . . . . 0.0 109.907 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -97.15 85.41 3.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.03 98.81 8.7 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.722 1.609 . . . . 0.0 107.275 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.85 80.43 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.147 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.95 2.6 59.41 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.545 1.673 . . . . 0.0 112.253 -170.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -113.75 148.52 36.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.099 1.45 . . . . 0.0 107.931 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -95.82 108.85 21.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.11 130.25 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.84 118.14 31.04 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.154 1.382 . . . . 0.0 108.198 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.48 140.41 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.861 0.864 . . . . 0.0 109.823 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.69 136.32 54.14 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -13.06 60.43 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.467 -0.771 . . . . 0.0 112.503 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -132.25 19.44 4.43 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.62 1.968 . . . . 0.0 109.53 -162.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -170.13 -40.01 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.889 1.276 . . . . 0.0 110.078 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.59 26.72 74.19 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.517 -1.157 . . . . 0.0 112.938 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -59.03 141.12 54.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.9 mt -79.24 85.03 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.83 -49.31 68.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.341 0.657 . . . . 0.0 110.258 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -152.09 160.52 43.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.505 1.922 . . . . 0.0 107.344 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.97 147.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.1 153.19 50.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 159.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -61.01 155.02 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.911 0.885 . . . . 0.0 109.574 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.91 64.51 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.465 1.031 . . . . 0.0 113.1 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -50.23 -31.97 15.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.489 1.115 . . . . 0.0 112.776 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -59.81 -19.69 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.549 1.14 . . . . 0.0 112.745 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.1 -28.22 67.66 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.444 1.02 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.11 -0.46 33.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.789 0.836 . . . . 0.0 111.892 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -62.73 171.53 2.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.196 1.398 . . . . 0.0 110.621 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.15 -165.554 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.43 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.95 165.3 13.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.876 2.07 . . . . 0.0 106.866 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.83 89.76 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 166.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.84 -169.47 21.65 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 160.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 pt -74.46 -10.26 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -63.21 -28.93 70.38 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.613 1.965 . . . . 0.0 111.374 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -61.28 -28.98 69.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.742 0.817 . . . . 0.0 112.271 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -98.05 -2.22 40.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.275 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.03 86.87 0.55 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.343 0.974 . . . . 0.0 109.633 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.17 145.73 54.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -102.86 -16.0 16.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.125 0.42 . . . . 0.0 112.011 170.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.54 164.25 38.56 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.63 175.63 13.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.692 1.597 . . . . 0.0 108.067 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -131.53 125.44 32.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.48 156.19 48.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.81 29.7 12.38 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.314 -0.866 . . . . 0.0 112.937 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 53.85 22.77 3.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.1 2.16 . . . . 0.0 112.5 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.1 m -120.29 128.05 52.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.441 2.296 . . . . 0.0 105.775 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -84.09 150.8 25.32 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.069 0.948 . . . . 0.0 110.062 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -151.7 141.31 21.74 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 124.798 1.239 . . . . 0.0 110.211 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -124.4 167.18 14.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.42 1.488 . . . . 0.0 109.856 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.59 113.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.6 -4.51 32.72 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.092 -1.394 . . . . 0.0 113.458 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.18 -171.34 1.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.002 1.401 . . . . 0.0 107.968 166.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 149.48 50.43 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.172 -1.58 . . . . 0.0 109.382 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.6 158.14 43.22 Favored Pre-proline 0 N--CA 1.468 0.447 0 C-N-CA 124.15 0.98 . . . . 0.0 111.016 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.2 164.26 33.33 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.328 2.685 . . . . 0.0 111.619 165.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -16.11 44.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 112.703 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.2 mmt -53.64 -30.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.45 1.1 . . . . 0.0 111.884 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -102.94 -2.5 27.6 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.21 -23.59 24.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.097 0.862 . . . . 0.0 110.935 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.72 144.1 85.86 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 -4.62 9.88 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.554 3.503 . . . . 0.0 113.343 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.45 -16.85 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.25 2.22 . . . . 0.0 113.207 172.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -121.26 -1.84 9.66 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.59 1.086 . . . . 0.0 110.932 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.9 97.24 4.53 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.729 1.612 . . . . 0.0 112.502 -163.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -81.47 82.6 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 107.756 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.87 -30.92 69.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.647 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.98 36.38 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.436 1.894 . . . . 0.0 113.734 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -56.67 -34.47 67.38 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.398 -1.439 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.91 -39.35 93.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.584 1.554 . . . . 0.0 113.07 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -24.86 42.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.406 1.003 . . . . 0.0 110.647 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -80.05 -177.44 6.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.649 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.87 -19.66 40.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.467 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.93 144.67 76.4 Favored Pre-proline 0 CA--C 1.537 0.469 0 O-C-N 121.017 -1.052 . . . . 0.0 111.156 -161.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.95 164.48 27.13 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.75 2.967 . . . . 0.0 113.596 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.22 97.11 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.575 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.2 172.39 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.204 2.603 . . . . 0.0 110.608 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.48 167.73 19.8 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.851 -1.156 . . . . 0.0 109.294 168.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 34.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 115.397 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.9 33.17 0.06 OUTLIER Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.301 1.905 . . . . 0.0 110.303 173.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.0 p -144.24 166.12 25.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.121 0.961 . . . . 0.0 110.768 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -155.75 156.25 34.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.269 0.557 . . . . 0.0 111.315 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.32 143.93 31.86 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.347 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 p -138.67 179.52 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.306 1.842 . . . . 0.0 110.07 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -107.7 145.6 33.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.65 1.58 . . . . 0.0 107.822 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.9 147.21 29.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 166.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.81 -4.83 0.01 OUTLIER Glycine 0 CA--C 1.55 2.22 0 N-CA-C 117.589 1.796 . . . . 0.0 117.589 170.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.31 -10.75 19.77 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 121.144 2.472 . . . . 0.0 113.778 -167.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -103.0 173.13 6.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.548 2.739 . . . . 0.0 110.224 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -112.38 134.87 53.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.08 1.352 . . . . 0.0 109.261 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.72 154.06 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 119.69 1.132 . . . . 0.0 110.968 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.11 120.1 39.39 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.287 1.035 . . . . 0.0 109.031 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.3 pt -127.77 150.13 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.726 1.21 . . . . 0.0 109.483 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.13 140.69 39.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.032 0.833 . . . . 0.0 109.505 172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -14.73 61.78 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.407 1.083 . . . . 0.0 112.45 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -119.54 2.58 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.739 1.615 . . . . 0.0 111.1 -162.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -163.37 -45.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.982 0.913 . . . . 0.0 109.035 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.55 21.65 53.24 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.1 0.857 . . . . 0.0 112.497 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 130.33 43.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.22 95.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.792 1.637 . . . . 0.0 106.766 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 mt -80.09 -52.97 7.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.888 0.875 . . . . 0.0 109.574 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -144.59 160.5 41.05 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.779 0.832 . . . . 0.0 109.625 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.6 t -134.13 142.35 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -134.99 137.71 43.28 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 162.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -60.38 149.12 34.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.69 -15.12 32.27 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.948 1.737 . . . . 0.0 113.261 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.92 -30.29 61.41 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.393 1.597 . . . . 0.0 112.135 171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.81 -1.72 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.012 0.925 . . . . 0.0 111.745 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -60.05 -43.1 95.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.32 -1.487 . . . . 0.0 111.511 164.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -88.02 -17.64 30.74 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -64.59 160.98 18.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.915 1.286 . . . . 0.0 109.404 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.698 1.199 . . . . 0.0 107.836 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.78 -176.7 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.075 1.35 . . . . 0.0 111.088 -154.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.38 56.79 7.39 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.332 1.053 . . . . 0.0 111.693 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.77 -172.59 49.02 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 159.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 pt -67.58 -11.18 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 124.831 1.252 . . . . 0.0 112.904 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.47 -34.61 69.2 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.931 1.692 . . . . 0.0 112.38 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -58.64 -28.97 66.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.541 0.737 . . . . 0.0 112.585 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -98.02 -2.51 40.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.834 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.93 87.13 1.31 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.279 0.945 . . . . 0.0 109.031 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.25 166.6 23.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -124.96 -25.11 3.93 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.265 0.626 . . . . 0.0 112.553 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 157.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.806 1.242 . . . . 0.0 107.933 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.5 177.04 11.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -131.24 129.29 41.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 163.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.79 149.27 46.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.98 34.15 24.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.199 1.0 . . . . 0.0 111.452 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 59.83 35.69 21.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.8 1.64 . . . . 0.0 112.01 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -136.98 121.05 17.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.832 1.653 . . . . 0.0 107.35 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -79.59 150.23 31.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.695 0.798 . . . . 0.0 109.017 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -150.05 159.36 44.47 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.41 1.484 . . . . 0.0 110.595 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -145.6 165.42 28.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.392 1.877 . . . . 0.0 108.781 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.93 120.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.38 3.9 84.0 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 117.454 -1.748 . . . . 0.0 113.559 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.21 178.41 2.34 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.017 1.908 . . . . 0.0 108.68 156.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.71 142.89 50.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.608 1.163 . . . . 0.0 109.073 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.32 163.77 35.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.171 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.98 154.22 63.0 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.458 2.772 . . . . 0.0 112.653 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.61 54.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.582 1.553 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.411 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -55.45 -22.6 21.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.588 1.155 . . . . 0.0 113.019 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 13.8 m-85 -113.9 -10.3 12.96 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.865 0.728 . . . . 0.0 112.906 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.23 -30.33 68.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.191 0.451 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -65.49 144.11 98.86 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.543 0.737 . . . . 0.0 109.716 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.05 -4.85 9.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.246 3.297 . . . . 0.0 115.449 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -54.97 -33.96 62.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.898 1.279 . . . . 0.0 112.086 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -103.21 -8.56 20.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.964 0.802 . . . . 0.0 112.086 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.73 100.36 0.91 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.769 2.827 . . . . 0.0 111.952 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.93 85.58 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.764 1.226 . . . . 0.0 108.694 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -67.48 -10.86 55.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.356 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -95.44 89.51 5.45 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.72 1.208 . . . . 0.0 107.914 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -132.19 -25.71 1.97 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.924 -1.036 . . . . 0.0 113.557 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.21 -36.33 79.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.277 1.399 . . . . 0.0 111.613 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -82.82 8.52 12.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.624 0.77 . . . . 0.0 111.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -123.18 165.7 16.45 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.586 -1.322 . . . . 0.0 108.96 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.74 -22.63 56.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 -169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.58 156.41 17.13 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 125.211 1.404 . . . . 0.0 110.498 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.61 172.57 13.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.303 1.335 . . . . 0.0 110.774 168.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.5 165.51 2.16 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.491 164.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -67.97 171.46 12.36 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 120.97 1.113 . . . . 0.0 109.825 160.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.92 161.46 21.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 158.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.49 112.55 3.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.7 7.99 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.581 1.086 . . . . 0.0 111.907 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -149.42 169.02 21.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.889 1.845 . . . . 0.0 111.89 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -149.03 163.91 36.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.623 0.769 . . . . 0.0 110.354 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.95 141.95 28.29 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.279 0.631 . . . . 0.0 109.631 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -128.51 172.16 11.42 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -103.35 111.59 24.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 110.343 173.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 ttm -129.89 118.0 21.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.823 1.649 . . . . 0.0 109.869 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 -11.27 4.08 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.922 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.07 -7.17 19.2 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.538 1.669 . . . . 0.0 112.319 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -109.85 172.94 6.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.657 1.583 . . . . 0.0 110.302 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.38 117.92 35.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 108.545 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.0 145.84 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 66.9 tp -101.19 126.68 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.01 142.57 43.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.967 0.907 . . . . 0.0 110.239 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.44 131.26 44.99 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.423 0.689 . . . . 0.0 109.594 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.98 5.8 6.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.934 1.349 . . . . 0.0 113.503 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -127.7 1.22 6.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.895 2.478 . . . . 0.0 110.938 -171.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -166.87 -60.11 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.309 0.644 . . . . 0.0 109.36 -164.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 24.92 9.89 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 124.761 1.172 . . . . 0.0 113.931 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -60.48 129.11 39.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.548 2.174 . . . . 0.0 109.319 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 86.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 129.229 3.012 . . . . 0.0 106.067 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.69 -44.63 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -145.64 161.31 40.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.457 0.703 . . . . 0.0 109.331 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.68 137.99 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -126.84 142.42 51.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 157.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.49 151.14 24.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.72 -22.78 27.0 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.744 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.5 -29.6 25.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.048 1.424 . . . . 0.0 112.506 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.77 -9.09 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.025 0.93 . . . . 0.0 112.613 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.17 -50.79 44.44 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 120.424 -1.422 . . . . 0.0 110.546 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -80.15 -16.27 55.27 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.759 0.824 . . . . 0.0 111.921 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -55.36 124.9 18.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.736 2.414 . . . . 0.0 107.447 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 O-C-N 121.922 -0.486 . . . . 0.0 111.351 -162.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.08 63.77 1.47 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.377 1.871 . . . . 0.0 107.31 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.62 33.63 4.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.331 1.452 . . . . 0.0 109.951 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.67 -152.7 6.29 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt -54.41 -20.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.728 2.011 . . . . 0.0 114.506 -163.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -27.66 65.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.835 0.289 . . . . 0.0 111.756 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -61.59 -23.02 65.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.625 0.77 . . . . 0.0 112.674 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -102.44 -8.26 21.26 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.77 0.828 . . . . 0.0 110.905 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.11 92.13 4.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.22 162.84 27.05 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -112.66 -23.22 10.33 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.181 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -158.76 160.94 36.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.592 1.557 . . . . 0.0 109.032 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -157.18 -177.29 6.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.749 2.019 . . . . 0.0 108.808 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -135.93 114.94 12.24 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.76 152.42 45.4 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.274 1.6 p30 50.99 27.47 3.25 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 61.67 14.67 6.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.072 2.549 . . . . 0.0 112.732 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.9 m -98.23 124.29 42.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.527 2.331 . . . . 0.0 105.935 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.33 143.99 48.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -142.18 143.29 32.88 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 109.481 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -127.7 170.34 12.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.48 113.62 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.64 -2.08 42.28 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.431 -1.76 . . . . 0.0 114.386 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.36 -171.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.085 1.943 . . . . 0.0 108.684 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.08 143.46 51.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.533 -1.354 . . . . 0.0 108.803 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.91 162.96 71.9 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.597 -0.689 . . . . 0.0 110.297 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.41 161.9 42.98 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.484 2.789 . . . . 0.0 110.779 159.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.38 44.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mmt -54.21 -20.09 6.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.198 1.799 . . . . 0.0 111.991 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -122.84 -8.77 8.37 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.063 0.945 . . . . 0.0 112.995 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.78 -18.08 56.82 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.901 0.88 . . . . 0.0 111.435 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -60.74 144.48 89.56 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.33 -4.35 14.79 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.195 3.263 . . . . 0.0 115.332 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -51.13 -30.85 17.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.724 2.01 . . . . 0.0 114.927 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.45 2.97 14.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.148 0.979 . . . . 0.0 110.975 -167.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -66.42 129.29 39.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.196 1.798 . . . . 0.0 110.858 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -106.82 90.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 108.268 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -22.93 63.0 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.686 -0.634 . . . . 0.0 111.285 163.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.12 30.67 0.58 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.808 1.243 . . . . 0.0 111.87 -166.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -75.35 -29.93 60.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.647 1.579 . . . . 0.0 115.167 -167.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -67.93 -38.16 82.54 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.864 1.666 . . . . 0.0 112.629 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -61.86 -11.24 11.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.978 0.911 . . . . 0.0 112.357 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.34 157.78 16.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -70.61 2.35 4.16 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.565 -0.709 . . . . 0.0 112.184 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.41 148.16 85.67 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 120.896 -1.127 . . . . 0.0 110.367 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.63 165.24 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.464 2.109 . . . . 0.0 111.798 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 149.63 89.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.834 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.37 171.15 14.55 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.298 2.665 . . . . 0.0 111.506 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.49 168.98 18.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.808 1.289 . . . . 0.0 109.398 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.55 38.88 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.219 2.608 . . . . 0.0 113.986 -167.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.97 37.71 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.239 1.876 . . . . 0.0 110.461 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.4 p -148.62 166.95 26.78 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.654 -0.91 . . . . 0.0 109.816 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -146.73 152.29 38.58 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.837 0.827 . . . . 0.0 111.054 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.47 144.81 46.1 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -133.62 162.65 31.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 109.868 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.23 65.87 0.74 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.944 0.898 . . . . 0.0 110.942 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 102.7 6.87 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.8 75.17 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.464 164.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.3 -5.6 33.77 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.118 1.459 . . . . 0.0 112.734 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -113.64 162.67 15.95 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.374 1.47 . . . . 0.0 107.325 -172.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.45 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 45.3 m-85 -109.77 111.23 22.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.04 132.48 69.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 tp -92.59 117.05 29.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.864 0.866 . . . . 0.0 108.697 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.4 pt -116.25 142.31 30.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.843 0.857 . . . . 0.0 109.499 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 143.03 51.4 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.58 9.74 5.69 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.683 0.793 . . . . 0.0 112.023 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -147.64 16.78 1.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.904 1.681 . . . . 0.0 110.525 -163.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -171.48 -45.37 0.02 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 126.536 1.934 . . . . 0.0 108.286 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 26.18 50.07 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.624 -1.098 . . . . 0.0 112.22 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.36 138.49 58.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -79.0 84.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.593 1.957 . . . . 0.0 106.176 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.12 -44.47 84.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.806 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -152.14 158.73 43.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.693 1.197 . . . . 0.0 108.894 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -135.52 143.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -135.87 145.72 46.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.084 1.353 . . . . 0.0 107.572 161.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.72 155.99 36.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.639 0.654 . . . . 0.0 111.86 172.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -58.08 -25.05 56.23 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 124.619 1.104 . . . . 0.0 114.132 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.38 -27.49 36.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.887 1.344 . . . . 0.0 113.116 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.9 -20.2 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.941 0.896 . . . . 0.0 112.504 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.7 -44.92 96.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.656 0.782 . . . . 0.0 109.725 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.15 -17.14 38.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.752 0.821 . . . . 0.0 111.478 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -58.2 147.24 31.0 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 128.075 2.55 . . . . 0.0 109.552 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 . . . . . 0 C--O 1.248 1.022 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 172.124 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.77 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.78 -176.06 4.11 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.968 1.384 . . . . 0.0 109.614 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.97 3.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.673 1.989 . . . . 0.0 112.387 -167.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.16 -155.82 7.31 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.332 1.92 . . . . 0.0 109.703 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 pt -78.39 -10.97 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -34.1 72.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 111.746 -168.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -55.96 -33.85 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.486 1.115 . . . . 0.0 112.144 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.05 -4.71 56.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.648 -1.168 . . . . 0.0 110.784 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.81 90.98 0.81 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.731 1.605 . . . . 0.0 110.506 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.12 128.02 32.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.03 -16.57 37.79 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 0.986 . . . . 0.0 112.817 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.68 164.59 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -155.0 174.96 14.43 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 107.393 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -133.26 128.03 34.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.83 137.03 24.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 44.59 62.42 2.05 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 110.003 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.263 1.7 p90 44.96 31.61 0.72 Allowed 'General case' 0 C--O 1.232 0.174 1 C-N-CA 132.004 4.122 . . . . 0.0 113.013 174.914 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 m -131.84 124.86 30.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -80.73 157.04 25.97 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -152.91 156.09 38.26 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.354 1.062 . . . . 0.0 110.26 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -140.2 167.67 21.61 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.929 1.692 . . . . 0.0 109.431 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.14 108.84 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.08 -7.02 21.52 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.326 -1.819 . . . . 0.0 114.162 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -174.8 1.49 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.771 1.786 . . . . 0.0 110.263 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.04 150.69 42.76 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.443 -1.411 . . . . 0.0 109.044 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.91 159.84 39.35 Favored Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 161.2 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.545 2.163 . . . . 0.0 111.557 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.58 -10.58 19.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.639 0.776 . . . . 0.0 112.748 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.88 -26.13 65.63 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.803 0.841 . . . . 0.0 111.549 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -107.83 -10.25 15.6 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.9 -24.79 55.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.675 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -55.95 145.25 54.67 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.004 0.921 . . . . 0.0 109.943 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.87 -9.74 22.43 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 124.722 3.615 . . . . 0.0 112.17 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -56.04 -27.8 54.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.432 1.493 . . . . 0.0 113.504 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -117.02 2.52 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.806 0.842 . . . . 0.0 111.191 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -59.73 104.66 0.3 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 128.28 2.632 . . . . 0.0 111.301 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mm -77.03 79.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -39.65 73.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.931 169.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -88.82 66.06 7.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.311 1.044 . . . . 0.0 110.119 -174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -65.31 -50.25 66.37 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.047 -0.408 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.03 96.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.953 0.501 . . . . 0.0 111.985 -158.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.69 -25.8 60.8 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.527 1.131 . . . . 0.0 113.265 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.86 27.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.835 -1.165 . . . . 0.0 111.321 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m120 68.01 -3.67 1.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.988 2.115 . . . . 0.0 112.252 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.66 163.84 42.42 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.533 1.933 . . . . 0.0 111.847 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.46 175.23 11.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.446 2.764 . . . . 0.0 112.541 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 164.35 19.63 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 111.765 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -72.52 -169.66 0.5 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.047 2.498 . . . . 0.0 111.117 162.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.58 -172.34 2.48 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 158.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 104.05 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.803 169.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.28 -12.48 54.71 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.583 1.087 . . . . 0.0 114.587 169.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.2 p -73.41 168.52 19.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.822 1.311 . . . . 0.0 109.23 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -158.72 151.56 22.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.615 -0.678 . . . . 0.0 109.654 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -81.88 143.57 31.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -133.7 162.1 32.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.527 0.731 . . . . 0.0 110.644 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -96.32 96.95 9.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.989 1.316 . . . . 0.0 108.259 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.93 96.6 6.15 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.233 1.813 . . . . 0.0 106.848 -174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.13 79.61 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.904 -1.498 . . . . 0.0 113.824 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.94 6.92 64.82 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.614 1.707 . . . . 0.0 112.373 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.31 147.14 31.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.403 1.602 . . . . 0.0 107.712 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.427 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 37.4 m-85 -96.94 114.29 25.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.08 131.92 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.45 112.76 24.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.02 143.57 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.193 0.997 . . . . 0.0 110.2 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.06 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -59.61 -18.57 42.42 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -115.85 12.35 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 126.295 1.838 . . . . 0.0 110.215 -161.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.94 -51.62 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.801 -1.187 . . . . 0.0 109.385 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.52 29.69 35.39 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 126.013 1.768 . . . . 0.0 112.594 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 138.32 58.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.379 1.09 . . . . 0.0 108.978 176.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.6 mt -79.7 84.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.66 -45.67 78.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.542 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -153.33 163.26 40.23 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.798 2.039 . . . . 0.0 107.633 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.7 t -137.13 151.53 27.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.21 157.97 42.96 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 156.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -63.63 156.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.392 0.677 . . . . 0.0 109.266 168.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -63.62 -22.36 65.9 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 124.764 1.173 . . . . 0.0 113.601 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.72 -17.39 34.37 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.62 1.21 . . . . 0.0 113.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.02 -26.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.973 0.909 . . . . 0.0 112.465 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -65.91 -12.04 51.68 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.675 -0.64 . . . . 0.0 111.544 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.43 18.44 12.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.57 -173.47 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 108.273 163.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.814 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.552 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.67 35.08 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 120.064 1.932 . . . . 0.0 108.664 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.03 -0.69 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.68 -142.55 12.35 Favored Glycine 0 N--CA 1.461 0.333 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 pt -93.64 -12.02 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.46 -32.38 68.69 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.984 0.811 . . . . 0.0 112.886 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -58.66 -27.25 64.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.803 0.841 . . . . 0.0 112.893 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -97.91 -1.65 42.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.956 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.18 90.22 5.48 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.199 1.363 . . . . 0.0 109.663 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.91 128.89 34.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -83.82 -17.87 39.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.264 0.484 . . . . 0.0 112.3 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.28 165.7 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.719 2.408 . . . . 0.0 107.236 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.11 179.61 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.715 1.206 . . . . 0.0 108.308 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -130.44 136.6 49.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.89 43.95 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 164.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.15 38.11 26.68 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.139 0.971 . . . . 0.0 111.666 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 60.02 14.31 4.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.443 1.897 . . . . 0.0 113.757 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.4 m -119.19 126.97 52.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.171 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -87.07 149.17 24.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -145.6 155.97 43.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.017 0.927 . . . . 0.0 110.798 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -139.61 164.0 31.07 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.405 1.482 . . . . 0.0 109.145 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.76 115.87 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 164.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.33 -0.09 55.81 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 117.676 -1.625 . . . . 0.0 114.811 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.89 -178.28 3.18 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.324 1.562 . . . . 0.0 109.851 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.39 152.25 41.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.952 1.701 . . . . 0.0 110.44 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.43 158.76 31.14 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 121.401 -0.812 . . . . 0.0 112.22 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.62 158.0 59.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.799 2.333 . . . . 0.0 111.774 165.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -14.43 62.89 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.501 1.12 . . . . 0.0 113.487 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.8 ptp -56.08 -22.7 29.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.894 0.878 . . . . 0.0 112.935 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.68 -10.63 14.07 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.4 -20.13 55.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.883 0.873 . . . . 0.0 111.299 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -64.03 152.5 87.43 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.246 1.418 . . . . 0.0 110.463 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.19 -7.77 16.58 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.127 2.551 . . . . 0.0 114.262 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.56 -18.97 55.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.13 0.972 . . . . 0.0 113.276 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -122.45 -5.36 8.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 112.496 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 106.9 1.51 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.7 1.6 . . . . 0.0 112.186 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mm -79.01 78.77 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 O-C-N 120.832 -1.167 . . . . 0.0 107.966 -176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -61.76 -28.75 69.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.008 -1.057 . . . . 0.0 112.664 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -93.2 65.32 3.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.804 1.242 . . . . 0.0 109.698 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -82.9 -44.36 15.47 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -30.81 69.08 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.724 0.693 . . . . 0.0 111.024 -170.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -78.8 17.24 0.74 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.377 1.471 . . . . 0.0 113.308 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -129.56 22.89 5.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.286 1.403 . . . . 0.0 113.28 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 57.4 8.09 0.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.414 1.886 . . . . 0.0 114.035 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.59 165.25 23.5 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.689 -1.257 . . . . 0.0 110.956 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.18 170.14 20.64 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.617 3.545 . . . . 0.0 111.641 168.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.78 165.49 2.4 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 127.21 2.204 . . . . 0.0 112.292 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.54 -164.65 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.764 2.976 . . . . 0.0 111.235 160.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.66 -169.84 1.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 158.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.51 105.75 13.82 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.46 -1.4 . . . . 0.0 110.594 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.93 44.43 7.69 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 p -140.28 166.78 23.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -152.86 145.6 24.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.904 0.859 . . . . 0.0 110.512 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -72.84 147.48 45.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.82 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -139.4 170.28 16.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.746 2.818 . . . . 0.0 108.332 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -116.62 78.66 1.22 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.575 0.625 . . . . 0.0 112.18 -172.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 97.86 11.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.727 2.011 . . . . 0.0 109.611 -172.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.86 11.4 63.03 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.354 -0.841 . . . . 0.0 114.623 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.8 -15.73 37.29 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.198 0.999 . . . . 0.0 112.054 -170.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -89.08 138.4 31.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.633 1.217 . . . . 0.0 108.303 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.7 112.47 18.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.93 125.22 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 tp -89.87 111.78 22.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.44 150.34 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 123.057 0.543 . . . . 0.0 110.211 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.65 139.29 43.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.511 0.724 . . . . 0.0 109.433 169.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.53 -17.41 64.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.422 0.629 . . . . 0.0 110.86 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 p -100.26 -5.19 27.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.163 2.185 . . . . 0.0 112.716 -161.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -174.79 -44.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 109.003 -157.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.42 28.4 61.75 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.362 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.32 132.47 53.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.814 1.307 . . . . 0.0 108.347 163.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.34 86.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 128.666 2.786 . . . . 0.0 105.512 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.97 -46.78 83.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -152.63 163.7 39.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.018 1.327 . . . . 0.0 109.653 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.63 145.15 26.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.06 157.79 45.91 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.806 1.643 . . . . 0.0 107.143 164.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.2 157.51 34.43 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -28.63 62.96 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.271 2.367 . . . . 0.0 113.142 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -62.96 -20.3 65.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.024 0.93 . . . . 0.0 112.514 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.45 -21.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 111.889 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.53 -7.44 10.22 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 112.781 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -119.47 -0.97 10.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.005 1.322 . . . . 0.0 111.911 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -74.43 165.58 24.95 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.344 1.858 . . . . 0.0 109.488 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 129.328 3.051 . . . . 0.0 106.117 -178.038 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 CA-C-O 118.709 -1.05 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.52 28.15 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.284 2.634 . . . . 0.0 117.703 156.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.79 77.25 2.09 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.336 0.971 . . . . 0.0 110.373 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.93 -111.84 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 106.593 -2.603 . . . . 0.0 106.593 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 pt -121.3 -19.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.91 -22.64 64.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 118.065 0.393 . . . . 0.0 110.879 -169.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.71 -26.18 68.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.509 1.124 . . . . 0.0 113.015 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -99.5 0.34 42.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.72 1.208 . . . . 0.0 111.641 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.49 101.19 0.95 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.92 151.08 25.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -101.28 -12.56 18.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.527 0.731 . . . . 0.0 111.81 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -177.05 156.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -155.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -172.15 -179.1 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 109.232 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -125.95 135.32 51.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.06 137.82 46.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.71 34.38 23.73 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.337 1.065 . . . . 0.0 110.751 168.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 59.34 14.79 3.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.835 2.454 . . . . 0.0 114.376 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -103.08 134.54 46.34 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.489 1.516 . . . . 0.0 107.267 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -90.25 141.88 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.347 1.859 . . . . 0.0 109.161 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -146.45 155.62 42.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.047 0.385 . . . . 0.0 111.71 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -145.31 167.58 22.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.734 1.214 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.0 mm -58.86 117.31 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.17 -11.84 55.36 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.003 -1.443 . . . . 0.0 114.323 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.53 -178.44 4.1 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.79 1.795 . . . . 0.0 107.164 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.78 148.09 43.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 119.349 -2.094 . . . . 0.0 108.951 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.38 163.4 66.42 Favored Pre-proline 0 CA--C 1.538 0.5 0 O-C-N 121.581 -0.699 . . . . 0.0 110.396 170.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.14 160.91 39.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.286 2.657 . . . . 0.0 111.378 160.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -23.5 67.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.571 1.148 . . . . 0.0 113.132 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.513 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 6.7 ptm -53.78 -20.93 6.34 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.823 1.249 . . . . 0.0 113.594 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.513 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 8.6 m-85 -117.55 -8.15 11.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.646 1.178 . . . . 0.0 112.557 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -79.03 -25.8 43.22 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.594 1.558 . . . . 0.0 110.873 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 t -62.35 144.79 94.88 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.69 -9.57 21.37 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.649 2.233 . . . . 0.0 114.463 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -55.55 -36.51 66.87 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.062 0.945 . . . . 0.0 110.968 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.78 -11.12 16.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.767 0.827 . . . . 0.0 111.052 -173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -61.07 111.04 1.54 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.944 1.698 . . . . 0.0 109.956 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.6 mt -87.99 90.63 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -73.43 -28.52 62.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.572 164.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.23 68.95 9.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.356 0.98 . . . . 0.0 109.137 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -69.92 -57.26 5.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -44.83 -47.76 11.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.44 1.496 . . . . 0.0 114.839 -159.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -63.31 -21.64 66.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -75.22 -165.34 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.26 2.62 31.78 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.845 -1.159 . . . . 0.0 111.431 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.04 156.15 81.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 121.325 -0.86 . . . . 0.0 112.204 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.05 171.48 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.678 3.585 . . . . 0.0 111.061 161.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.02 158.36 26.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 112.484 173.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.99 158.92 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.356 2.037 . . . . 0.0 111.01 167.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.06 149.1 42.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.72 101.27 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.435 0.694 . . . . 0.0 110.504 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.49 12.98 10.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.621 -1.1 . . . . 0.0 113.378 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.7 p -132.4 176.08 8.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.136 1.468 . . . . 0.0 111.06 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -149.49 154.37 38.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.132 0.973 . . . . 0.0 110.474 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -72.77 156.05 39.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.971 0.509 . . . . 0.0 109.865 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -147.46 167.97 23.08 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.48 106.16 16.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.297 1.839 . . . . 0.0 108.342 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 86.7 mmm -81.56 -154.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.193 1.797 . . . . 0.0 109.693 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.03 58.51 0.55 Allowed Glycine 0 C--N 1.338 0.679 0 C-N-CA 129.607 3.48 . . . . 0.0 111.701 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.23 56.8 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 125.676 1.608 . . . . 0.0 113.992 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -130.96 158.66 39.65 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.073 1.436 . . . . 0.0 108.87 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -102.95 125.79 49.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 108.694 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.71 151.02 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.648 -0.657 . . . . 0.0 109.412 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.7 tp -103.46 127.99 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 pt -131.67 131.91 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 125.429 1.492 . . . . 0.0 110.538 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.78 134.52 57.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -8.6 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.086 -1.009 . . . . 0.0 111.377 172.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 t -134.05 12.01 3.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.928 2.091 . . . . 0.0 109.494 -158.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -171.91 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 0.0 111.425 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.1 37.95 24.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.481 1.515 . . . . 0.0 113.01 -165.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 145.63 40.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 159.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.2 mt -81.78 91.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -61.31 -56.92 15.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.35 163.09 35.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.468 1.507 . . . . 0.0 110.395 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.1 t -137.18 136.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.326 1.851 . . . . 0.0 107.304 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.59 142.99 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.153 0.981 . . . . 0.0 108.357 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.41 146.19 54.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.59 -20.96 40.67 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.446 1.022 . . . . 0.0 112.798 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -49.65 -30.94 9.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.509 1.124 . . . . 0.0 112.42 171.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -58.36 -25.49 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.72 1.208 . . . . 0.0 112.574 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.31 -35.28 76.92 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.565 0.62 . . . . 0.0 110.657 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.73 2.37 51.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.708 0.803 . . . . 0.0 113.048 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.443 ' CD2' ' H ' ' A' ' 83' ' ' ARG . 19.0 t60 -84.15 -174.66 5.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.341 0.656 . . . . 0.0 110.116 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.443 ' H ' ' CD2' ' A' ' 82' ' ' HIS . 4.3 ptm180 . . . . . 0 C--O 1.248 0.987 0 C-N-CA 127.073 2.149 . . . . 0.0 109.207 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.91 160.76 42.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.412 1.106 . . . . 0.0 108.96 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.09 24.98 1.78 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.118 0.967 . . . . 0.0 110.289 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.86 -170.01 21.67 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 125.51 1.529 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.4 pt -62.35 -18.71 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.318 1.047 . . . . 0.0 113.478 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.59 -24.83 65.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.101 1.76 . . . . 0.0 113.049 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.27 -34.86 77.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.289 0.636 . . . . 0.0 112.293 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -90.49 -3.84 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.099 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.39 0.78 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.432 1.014 . . . . 0.0 108.723 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.6 164.01 14.93 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -124.99 -20.06 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.46 1.504 . . . . 0.0 111.351 -172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -159.17 163.04 36.4 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.772 2.029 . . . . 0.0 107.505 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -163.71 175.56 10.43 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 110.148 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 m -127.74 112.68 15.06 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.47 158.48 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 25.39 12.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.264 0.938 . . . . 0.0 111.978 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 58.43 16.62 4.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.429 1.891 . . . . 0.0 113.133 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.7 m -117.8 125.9 51.43 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.661 1.984 . . . . 0.0 105.961 -171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -80.5 149.01 30.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -147.9 157.31 43.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.038 1.335 . . . . 0.0 109.495 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.68 167.67 21.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.318 1.447 . . . . 0.0 108.566 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.35 119.3 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.19 -13.35 40.44 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 117.782 -1.566 . . . . 0.0 114.014 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.86 -171.17 1.02 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 119.592 1.696 . . . . 0.0 107.879 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 142.56 50.49 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 118.379 -2.701 . . . . 0.0 109.981 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.36 156.56 73.63 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 121.547 -0.721 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.38 156.6 61.37 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.408 2.072 . . . . 0.0 110.564 165.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -17.25 52.3 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.1 mmt -51.8 -27.44 12.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.533 1.533 . . . . 0.0 113.231 173.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.5 -7.31 15.18 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mt -79.23 -23.75 43.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.584 1.154 . . . . 0.0 112.071 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -56.17 149.25 37.07 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.45 1.1 . . . . 0.0 110.262 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.77 -8.59 15.98 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.433 2.756 . . . . 0.0 113.18 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.02 -29.29 70.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.831 2.052 . . . . 0.0 111.861 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.38 1.22 9.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.671 1.188 . . . . 0.0 111.668 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 91.28 0.15 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.624 2.77 . . . . 0.0 108.915 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.78 112.61 5.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -88.55 -31.49 18.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 117.392 -1.29 . . . . 0.0 111.053 167.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.07 88.18 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.963 1.256 . . . . 0.0 110.655 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -104.15 -33.84 8.59 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.555 0.742 . . . . 0.0 111.972 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.76 -28.24 69.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.131 0.878 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -83.43 29.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.776 1.231 . . . . 0.0 110.754 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -141.49 169.14 18.16 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.862 2.465 . . . . 0.0 107.364 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.6 -13.91 62.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.737 1.215 . . . . 0.0 111.987 166.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.74 157.2 80.52 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.303 -0.873 . . . . 0.0 111.764 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -71.01 169.36 20.69 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.947 3.098 . . . . 0.0 111.253 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 149.72 77.14 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.72 166.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.96 169.54 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.108 2.539 . . . . 0.0 110.502 168.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -77.67 167.74 21.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.895 0.878 . . . . 0.0 108.666 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.03 42.24 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 114.426 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.65 56.12 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -159.91 171.78 18.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.305 0.642 . . . . 0.0 111.175 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -145.92 156.92 43.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.439 0.563 . . . . 0.0 110.95 167.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -80.94 153.17 27.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -136.53 168.81 18.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.397 1.079 . . . . 0.0 110.729 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -106.03 84.94 2.12 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.376 1.471 . . . . 0.0 107.646 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.3 mtp -94.85 102.06 13.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.131 0.972 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.33 6.29 86.28 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.663 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.27 4.1 53.59 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.068 1.434 . . . . 0.0 112.007 -167.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -115.09 143.71 44.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.412 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 53.8 m-85 -93.88 113.38 25.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.49 143.25 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -172.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 tp -102.6 122.9 45.32 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.1 pt -124.68 149.06 28.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.007 0.923 . . . . 0.0 109.872 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.65 136.75 41.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.08 -25.16 65.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.655 0.741 . . . . 0.0 112.388 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 t -123.12 27.13 7.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.152 1.781 . . . . 0.0 110.147 -161.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -173.96 -36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.783 1.633 . . . . 0.0 110.552 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.32 21.46 77.66 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.079 1.323 . . . . 0.0 113.894 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 136.18 57.85 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.543 1.137 . . . . 0.0 108.59 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.48 87.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.2 mt -70.67 -49.24 49.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.167 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -152.52 157.94 41.83 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 109.695 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -140.67 130.17 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.626 1.97 . . . . 0.0 107.087 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -129.43 148.19 51.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.631 1.173 . . . . 0.0 108.73 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.64 157.81 35.4 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.817 -0.552 . . . . 0.0 111.241 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.412 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -61.73 -27.2 67.92 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-O 118.454 -1.192 . . . . 0.0 113.975 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -55.88 -27.62 52.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.961 1.381 . . . . 0.0 112.738 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.67 -26.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.579 1.152 . . . . 0.0 112.324 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -62.79 -30.34 71.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.375 0.534 . . . . 0.0 111.24 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -99.17 4.38 46.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.03 0.932 . . . . 0.0 111.627 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -69.7 -178.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.273 1.829 . . . . 0.0 110.039 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 . . . . . 0 C--O 1.245 0.855 0 O-C-N 120.77 -1.206 . . . . 0.0 111.122 -166.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.324 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.63 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.825 2.05 . . . . 0.0 111.219 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.94 -6.08 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.581 1.553 . . . . 0.0 110.699 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.49 -168.53 44.38 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 164.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.79 -16.49 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 124.428 1.091 . . . . 0.0 112.968 -168.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.13 -22.99 67.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.011 0.924 . . . . 0.0 112.727 -170.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -60.4 -30.69 69.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.057 0.943 . . . . 0.0 112.693 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.52 -3.49 46.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.156 0.983 . . . . 0.0 110.688 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.88 82.24 7.6 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 109.365 -168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.96 151.27 46.74 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -16.24 15.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.071 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -156.66 157.62 35.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.067 1.347 . . . . 0.0 109.652 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -158.77 177.28 11.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.094 1.758 . . . . 0.0 109.286 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -126.13 128.75 47.81 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.08 44.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.45 38.04 4.96 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.948 1.356 . . . . 0.0 112.243 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 60.74 34.51 19.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.929 2.091 . . . . 0.0 112.953 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 m -142.33 131.85 23.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.594 1.557 . . . . 0.0 107.163 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.9 147.74 36.85 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.49 144.2 39.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.864 1.265 . . . . 0.0 108.48 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.04 174.46 7.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.05 122.66 18.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.81 -1.54 55.41 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.342 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.93 -171.38 2.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.098 1.449 . . . . 0.0 108.678 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.29 127.31 25.9 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.325 -1.484 . . . . 0.0 110.894 -169.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.8 m -70.03 158.32 87.65 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 123.22 0.608 . . . . 0.0 111.492 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.52 159.96 51.1 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.187 1.925 . . . . 0.0 111.023 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.09 -15.89 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.325 0.65 . . . . 0.0 112.54 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -25.97 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 112.097 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -116.43 -9.49 11.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.72 1.208 . . . . 0.0 113.24 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.01 -18.41 37.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.525 0.73 . . . . 0.0 111.32 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 t -53.01 150.81 9.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.212 0.605 . . . . 0.0 109.408 166.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.96 -4.39 15.04 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.866 2.378 . . . . 0.0 113.842 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -57.3 -23.93 51.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 113.246 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -121.57 10.13 10.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.746 1.157 . . . . 0.0 113.199 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.23 106.39 0.61 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.686 2.394 . . . . 0.0 112.371 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.4 mm -73.91 79.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.312 1.045 . . . . 0.0 108.724 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.54 -32.44 73.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.353 -0.842 . . . . 0.0 110.8 166.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -76.65 34.34 0.14 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.843 1.257 . . . . 0.0 114.017 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -75.64 -32.83 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -65.04 -32.34 74.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.43 1.468 . . . . 0.0 110.547 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.61 27.24 0.86 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.686 0.794 . . . . 0.0 111.737 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -132.05 165.53 23.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.02 1.728 . . . . 0.0 107.614 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.81 -19.87 60.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.44 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.61 151.56 61.11 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.371 1.069 . . . . 0.0 110.331 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.43 164.47 32.55 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.693 1.596 . . . . 0.0 110.359 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.6 157.64 36.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.411 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.59 162.1 32.64 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.324 1.35 . . . . 0.0 110.083 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -70.74 167.54 18.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 162.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.65 61.25 1.79 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 113.252 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.31 41.28 0.04 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.159 1.837 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.3 p -151.04 169.91 20.67 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.841 -0.799 . . . . 0.0 110.728 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -147.01 157.21 43.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.101 0.961 . . . . 0.0 110.184 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -98.56 137.3 37.42 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.283 0.633 . . . . 0.0 109.421 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -137.58 159.11 42.88 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.642 -0.661 . . . . 0.0 110.015 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -99.92 61.27 1.11 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.83 0.824 . . . . 0.0 112.391 -167.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 102.89 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.985 2.114 . . . . 0.0 109.82 -164.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.33 14.12 59.19 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.335 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.29 -1.52 37.53 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.851 1.825 . . . . 0.0 112.965 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -114.84 161.47 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.74 1.77 . . . . 0.0 107.909 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 65.7 m-85 -105.05 113.84 27.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.16 135.08 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -92.27 110.88 22.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.655 1.182 . . . . 0.0 108.543 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.55 142.32 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.706 1.202 . . . . 0.0 108.683 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.77 143.7 54.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.82 -12.66 61.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -140.34 24.1 2.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.274 1.43 . . . . 0.0 109.176 -159.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -165.78 -44.42 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.469 1.508 . . . . 0.0 109.166 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.39 25.03 71.57 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.292 0.949 . . . . 0.0 113.306 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 133.39 55.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 167.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.73 88.69 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.049 2.139 . . . . 0.0 106.515 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -45.95 66.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.287 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -152.17 160.9 43.3 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 109.673 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.2 141.72 40.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.172 1.789 . . . . 0.0 106.42 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -139.14 140.25 37.84 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.267 1.827 . . . . 0.0 106.378 165.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.98 155.84 35.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.431 1.014 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -51.49 -31.06 28.13 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.642 1.591 . . . . 0.0 112.789 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.56 -33.68 6.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.489 1.916 . . . . 0.0 112.551 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 tt -69.4 -12.09 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.534 1.134 . . . . 0.0 112.025 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -67.07 -34.93 78.72 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.845 -1.159 . . . . 0.0 111.182 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -91.32 -17.62 25.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.651 0.78 . . . . 0.0 111.329 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.11 141.64 55.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 128.27 2.628 . . . . 0.0 108.838 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 169.596 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.1 141.16 56.26 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 155.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.31 49.8 0.83 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.235 1.414 . . . . 0.0 110.435 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.84 -168.87 23.38 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 pt -59.68 -16.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -165.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -53.53 -29.95 39.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.623 1.569 . . . . 0.0 112.651 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.2 -21.02 66.41 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -107.89 4.04 24.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.927 1.291 . . . . 0.0 110.766 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.63 94.51 1.01 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.12 163.64 24.36 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -121.79 -19.09 6.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.004 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.6 164.64 24.05 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.406 1.882 . . . . 0.0 107.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -168.59 -176.64 2.85 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.292 1.837 . . . . 0.0 109.084 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -135.67 133.45 38.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.106 0.962 . . . . 0.0 108.716 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.69 35.41 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.047 0.939 . . . . 0.0 109.409 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.2 39.81 20.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.924 1.29 . . . . 0.0 109.968 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.42 15.5 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.442 2.697 . . . . 0.0 114.855 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 m -114.21 131.82 56.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.419 1.488 . . . . 0.0 107.425 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.85 155.74 23.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.73 0.695 . . . . 0.0 109.373 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -149.26 153.66 37.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.408 1.483 . . . . 0.0 110.485 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -136.64 165.98 24.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.1 1.36 . . . . 0.0 107.365 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.7 mm -59.81 125.84 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 168.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.35 44.02 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.677 -1.624 . . . . 0.0 114.162 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.52 -175.89 0.91 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.213 1.506 . . . . 0.0 109.62 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 131.74 45.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 119.92 -1.737 . . . . 0.0 110.27 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.84 164.1 63.15 Favored Pre-proline 0 N--CA 1.467 0.397 0 C-N-CA 126.052 1.741 . . . . 0.0 111.984 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 74.1 Cg_endo -74.09 158.5 45.52 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.497 2.798 . . . . 0.0 112.234 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.43 68.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.042 1.337 . . . . 0.0 111.797 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -66.8 -33.44 75.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.358 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.41 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 25.5 m-85 -87.04 -4.3 59.15 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 118.261 -1.375 . . . . 0.0 114.146 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.37 -21.39 62.88 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.148 0.886 . . . . 0.0 110.95 168.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -69.62 148.7 96.89 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 121.899 -0.5 . . . . 0.0 111.035 -172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.5 -14.87 42.02 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.053 3.169 . . . . 0.0 111.809 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.48 -30.16 60.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.439 1.896 . . . . 0.0 112.563 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -112.62 -8.28 13.82 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.211 1.404 . . . . 0.0 111.833 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -80.77 118.22 22.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.808 1.643 . . . . 0.0 111.28 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.01 92.78 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 -21.09 63.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 111.63 169.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.57 40.12 0.29 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.621 1.168 . . . . 0.0 112.95 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -53.52 -41.45 66.38 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.279 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -61.71 -27.57 68.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.996 1.726 . . . . 0.0 114.68 -167.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -84.99 -14.86 46.13 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.461 1.482 . . . . 0.0 112.746 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 -83.74 172.11 12.54 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 166.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -109.78 8.15 24.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.325 -0.86 . . . . 0.0 111.491 -158.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.72 166.97 10.08 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 129.28 3.032 . . . . 0.0 112.613 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.07 175.5 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 121.387 1.391 . . . . 0.0 111.6 153.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 164.18 2.2 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.796 1.238 . . . . 0.0 111.238 166.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.63 167.93 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.278 1.319 . . . . 0.0 110.459 160.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -81.03 170.49 16.16 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.42 -0.8 . . . . 0.0 109.788 160.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.75 108.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.372 1.469 . . . . 0.0 110.909 167.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.64 29.78 51.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.764 174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.6 p -130.77 171.36 13.21 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.475 1.138 . . . . 0.0 110.365 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -151.26 164.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.386 0.613 . . . . 0.0 111.445 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -106.32 121.34 44.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.293 1.037 . . . . 0.0 110.129 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.4 p -109.0 -179.97 4.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.303 1.441 . . . . 0.0 110.139 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -131.2 80.85 1.96 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.824 1.193 . . . . 0.0 111.323 -172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtp -99.18 105.5 17.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.593 1.557 . . . . 0.0 111.325 -168.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.09 15.31 62.73 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 118.711 -1.049 . . . . 0.0 113.787 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.58 8.6 59.49 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.105 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.75 127.91 54.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.228 1.514 . . . . 0.0 106.917 172.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.437 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 73.3 m-85 -85.29 121.2 27.68 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.3 145.46 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 118.847 0.748 . . . . 0.0 109.785 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.53 126.67 50.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 pt -131.09 135.33 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 138.89 57.87 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.412 -0.805 . . . . 0.0 109.012 170.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.94 -13.94 60.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.6 0.714 . . . . 0.0 110.726 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 p -109.04 -6.24 15.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.097 1.359 . . . . 0.0 111.011 -161.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.43 -37.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.701 1.201 . . . . 0.0 109.684 -160.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.26 41.0 96.6 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 125.753 1.644 . . . . 0.0 111.888 -172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -65.69 133.99 52.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.13 93.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' H ' HD21 ' A' ' 72' ' ' LEU . 1.4 mm? -65.26 -53.04 50.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -147.91 167.48 24.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 111.584 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -142.55 141.18 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 127.448 2.299 . . . . 0.0 105.706 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -136.48 151.62 49.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.986 1.714 . . . . 0.0 108.019 167.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.59 153.32 40.26 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -62.88 -19.09 60.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 126.074 1.797 . . . . 0.0 113.0 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -57.02 -25.17 58.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.699 1.249 . . . . 0.0 111.405 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.27 -23.8 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.718 -0.613 . . . . 0.0 111.618 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -66.27 -13.05 59.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.856 1.207 . . . . 0.0 112.629 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -100.42 -4.94 27.95 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.417 -0.802 . . . . 0.0 110.251 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -77.53 69.89 3.84 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.419 2.287 . . . . 0.0 110.101 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.395 2.678 . . . . 0.0 117.144 158.044 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.443 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 152.71 19.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.711 0.805 . . . . 0.0 110.43 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.13 88.59 1.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.279 166.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.09 36.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 154.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.1 pt -68.51 -11.92 15.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 125.208 1.403 . . . . 0.0 113.268 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.84 -32.72 70.93 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 112.429 -168.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -56.13 -29.52 60.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.449 1.499 . . . . 0.0 113.618 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.99 -1.45 42.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.9 96.18 0.57 Allowed 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.748 1.158 . . . . 0.0 108.246 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.62 140.38 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -84.57 -20.34 31.64 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 122.304 -0.247 . . . . 0.0 110.932 168.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -157.61 162.73 38.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.037 1.335 . . . . 0.0 108.927 -168.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.27 177.32 11.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.377 1.071 . . . . 0.0 108.651 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -126.92 132.52 50.86 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.64 153.91 46.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 27.01 15.76 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.379 0.991 . . . . 0.0 112.692 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 57.64 14.64 2.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.062 -172.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.2 m -111.52 137.2 49.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 128.271 2.628 . . . . 0.0 105.791 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.04 154.15 18.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -149.7 153.4 36.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.254 0.621 . . . . 0.0 109.953 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -143.28 169.06 18.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.648 0.779 . . . . 0.0 109.045 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.16 93.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.87 5.46 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-O 117.809 -1.551 . . . . 0.0 114.174 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.92 176.04 1.78 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.469 1.634 . . . . 0.0 108.384 166.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.71 138.5 44.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -82.19 157.81 67.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.2 158.01 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 110.653 166.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.74 43.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.39 1.076 . . . . 0.0 112.479 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtm -51.92 -35.94 47.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.062 1.345 . . . . 0.0 111.824 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -97.24 -7.44 32.26 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.93 -18.97 61.34 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.665 0.666 . . . . 0.0 110.158 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.4 p -55.29 158.08 5.79 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.03 1.332 . . . . 0.0 111.497 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.37 -12.24 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.981 2.454 . . . . 0.0 113.032 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.87 -21.85 66.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.554 1.141 . . . . 0.0 112.408 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -115.51 13.36 16.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.932 1.693 . . . . 0.0 111.243 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -89.48 82.38 6.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.864 2.066 . . . . 0.0 111.218 -162.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.5 71.29 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.491 1.516 . . . . 0.0 110.905 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -68.6 -23.09 64.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.197 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -74.1 94.36 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 170.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -125.4 -27.05 3.5 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.812 -1.18 . . . . 0.0 113.641 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -51.42 -44.1 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.721 0.691 . . . . 0.0 109.177 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 -24.2 8.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.825 2.45 . . . . 0.0 115.453 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -116.07 177.06 4.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.478 1.511 . . . . 0.0 108.32 -170.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -9.58 59.66 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.07 -0.394 . . . . 0.0 111.022 -172.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.22 144.94 98.35 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 123.364 0.666 . . . . 0.0 109.816 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.11 159.86 24.62 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.796 2.331 . . . . 0.0 108.959 166.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.42 147.42 68.59 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.841 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -63.62 158.15 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.427 1.418 . . . . 0.0 108.767 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -72.52 156.41 39.05 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.48 65.06 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.533 1.533 . . . . 0.0 112.362 -164.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 25.57 0.05 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 128.004 2.716 . . . . 0.0 110.94 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.0 p -143.84 167.49 22.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.163 1.481 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -146.55 152.35 38.81 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.024 0.53 . . . . 0.0 111.726 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -92.06 128.43 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -131.8 155.44 47.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.297 0.639 . . . . 0.0 111.035 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 11.5 t80 -91.11 119.76 31.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.465 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtt -141.57 110.43 6.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.558 1.072 . . . . 0.0 111.266 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 1.98 33.85 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.106 0.86 . . . . 0.0 113.499 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.99 -18.15 19.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.824 1.678 . . . . 0.0 111.833 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -82.97 162.83 21.35 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.707 1.203 . . . . 0.0 109.5 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.463 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 34.3 m-85 -109.87 118.11 35.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.478 1.511 . . . . 0.0 107.6 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.72 131.45 62.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -168.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -89.0 111.02 21.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -106.96 147.88 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.614 1.166 . . . . 0.0 108.09 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 141.75 52.15 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.3 -10.73 60.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.669 0.747 . . . . 0.0 112.543 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -124.05 -5.77 7.87 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.263 2.225 . . . . 0.0 111.299 -161.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -152.92 -32.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.36 1.464 . . . . 0.0 109.461 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.1 16.16 80.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 124.101 0.858 . . . . 0.0 113.138 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.41 131.63 49.86 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.596 -0.943 . . . . 0.0 108.567 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.26 94.58 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.62 -52.56 14.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.867 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -150.15 162.53 40.26 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.116 1.366 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -139.58 136.45 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -133.89 143.52 48.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.37 1.068 . . . . 0.0 108.171 168.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.99 144.1 57.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -55.39 -22.78 32.01 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.337 1.446 . . . . 0.0 114.135 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.86 -20.46 57.27 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.182 1.491 . . . . 0.0 113.585 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.27 -16.8 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 112.169 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.59 -49.38 69.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.862 -1.149 . . . . 0.0 110.056 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -82.52 -17.74 43.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.24 0.616 . . . . 0.0 111.707 -168.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.12 124.09 10.8 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 130.308 3.443 . . . . 0.0 108.747 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.016 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.45 -1.75 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.13 169.36 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.104 1.452 . . . . 0.0 108.201 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.16 12.93 1.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.03 -105.44 3.0 Favored Glycine 0 C--O 1.219 -0.791 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.3 pt -117.93 -20.4 5.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.653 -0.91 . . . . 0.0 111.787 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.61 -15.58 63.57 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.88 0.472 . . . . 0.0 111.811 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.9 -21.95 66.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.297 1.439 . . . . 0.0 112.586 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.65 0.73 31.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.808 1.243 . . . . 0.0 111.722 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 106.77 12.07 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.987 1.267 . . . . 0.0 109.574 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -72.41 -162.12 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HE2' ' OE1' ' A' ' 12' ' ' GLU . 15.4 ptmt -134.92 -16.62 1.94 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 119.956 -1.715 . . . . 0.0 109.968 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.437 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.6 pt-20 -165.29 170.64 14.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -162.47 172.57 15.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.683 0.793 . . . . 0.0 109.501 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.11 141.3 45.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 159.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.25 142.74 32.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 160.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.64 31.14 12.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 170.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 70.15 13.72 7.72 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.451 2.701 . . . . 0.0 114.042 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.9 m -105.46 133.03 50.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 107.845 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.65 149.32 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.125 1.77 . . . . 0.0 110.25 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -157.12 146.9 20.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.887 0.875 . . . . 0.0 111.039 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -140.44 167.61 21.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.799 0.84 . . . . 0.0 110.475 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 mm -61.19 101.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.46 -10.97 9.77 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 117.577 -1.68 . . . . 0.0 116.16 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -73.58 -174.76 1.8 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 121.005 2.403 . . . . 0.0 109.45 171.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.09 139.6 53.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.648 -1.282 . . . . 0.0 108.872 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.21 159.36 82.56 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 121.338 -0.851 . . . . 0.0 109.266 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.16 155.95 42.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.712 2.275 . . . . 0.0 111.137 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -11.48 32.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.15 -33.73 71.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 109.581 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -102.21 -8.3 21.43 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.21 -27.06 65.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.2 -0.428 . . . . 0.0 109.98 167.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.3 p -64.42 144.45 98.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 117.837 0.29 . . . . 0.0 111.725 -168.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.39 -6.0 18.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.08 1.853 . . . . 0.0 111.871 -171.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.01 -38.36 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.095 2.158 . . . . 0.0 111.719 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -106.97 7.02 29.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.261 1.425 . . . . 0.0 111.702 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -90.92 107.84 19.46 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.296 1.839 . . . . 0.0 110.633 -171.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.56 66.83 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.468 1.507 . . . . 0.0 110.211 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -54.23 -26.48 28.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.755 1.222 . . . . 0.0 112.133 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -72.84 90.34 1.43 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.834 1.654 . . . . 0.0 108.743 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -114.46 -28.84 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.379 1.445 . . . . 0.0 113.285 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.17 -38.84 77.43 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.773 1.229 . . . . 0.0 111.765 -168.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -119.28 44.7 2.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.807 1.243 . . . . 0.0 109.069 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -124.05 29.11 6.55 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.766 0.826 . . . . 0.0 112.4 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 m120 52.7 27.05 4.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.015 1.326 . . . . 0.0 111.853 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.9 mt -127.93 159.02 68.79 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 120.424 1.465 . . . . 0.0 110.448 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.32 173.47 13.78 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.025 2.483 . . . . 0.0 111.73 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.79 151.55 97.09 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.176 0.99 . . . . 0.0 110.947 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.31 164.89 34.27 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.559 3.506 . . . . 0.0 111.41 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.66 167.56 14.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.865 0.84 . . . . 0.0 109.186 163.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.65 51.82 0.28 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.586 2.355 . . . . 0.0 115.15 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.79 43.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 126.275 1.893 . . . . 0.0 109.156 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.2 p -154.73 168.38 27.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.469 1.135 . . . . 0.0 111.584 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -155.53 156.09 34.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.205 1.003 . . . . 0.0 109.962 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -80.57 141.31 35.19 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.277 1.031 . . . . 0.0 108.699 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -130.99 158.61 39.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.475 1.11 . . . . 0.0 108.692 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -96.02 109.24 21.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.478 1.111 . . . . 0.0 108.592 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.87 112.86 13.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.943 1.297 . . . . 0.0 110.827 -170.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.57 -1.13 15.43 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.292 -175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.67 -12.52 25.26 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 120.066 1.933 . . . . 0.0 113.341 -164.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.76 163.01 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 118.642 1.221 . . . . 0.0 109.482 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -101.17 111.52 23.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.863 1.665 . . . . 0.0 108.376 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.49 135.9 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.396 -0.815 . . . . 0.0 109.964 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 tp -89.11 113.3 24.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.563 1.545 . . . . 0.0 110.1 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.28 142.28 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.598 1.159 . . . . 0.0 109.159 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 137.13 41.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.903 0.881 . . . . 0.0 109.408 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.06 1.85 4.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.944 0.898 . . . . 0.0 113.018 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 t -143.3 9.12 1.63 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.241 1.416 . . . . 0.0 110.775 -168.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -155.64 -42.65 0.08 Allowed 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.568 -1.332 . . . . 0.0 108.528 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 16.62 71.55 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.742 0.687 . . . . 0.0 111.461 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 139.72 58.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.35 1.075 . . . . 0.0 109.043 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.4 mt -81.43 79.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.629 1.571 . . . . 0.0 107.523 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.54 -47.14 76.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -149.86 162.67 39.85 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.186 1.794 . . . . 0.0 108.878 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -140.62 136.93 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -137.27 144.83 42.9 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.994 1.718 . . . . 0.0 107.289 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -70.57 159.42 34.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.83 0.741 . . . . 0.0 111.612 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.25 -28.71 72.69 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.04 0.829 . . . . 0.0 111.902 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.18 -21.51 33.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 112.455 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.5 tt -61.88 -30.73 49.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.156 0.889 . . . . 0.0 111.469 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -66.57 -12.45 57.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 111.774 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.78 -8.01 20.14 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.488 1.115 . . . . 0.0 112.192 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -54.16 170.95 0.12 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.926 2.091 . . . . 0.0 110.046 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -173.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.026 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.69 32.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.397 2.679 . . . . 0.0 116.436 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.02 51.62 2.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 111.724 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.81 10.18 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -53.56 -25.98 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -56.89 -19.51 18.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.139 2.176 . . . . 0.0 112.179 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.76 -33.93 77.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 0.0 112.576 170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -95.07 0.63 54.58 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.088 1.355 . . . . 0.0 111.81 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 87.4 1.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.927 0.891 . . . . 0.0 109.386 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.77 158.98 35.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -105.51 -13.3 15.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.112 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.82 160.76 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.717 1.607 . . . . 0.0 109.039 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -159.66 175.38 13.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.697 1.599 . . . . 0.0 108.869 168.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -117.38 143.67 45.74 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.07 153.77 34.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 166.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.07 24.13 13.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.165 0.893 . . . . 0.0 111.752 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 56.64 17.23 2.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.066 2.146 . . . . 0.0 113.54 -170.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -108.33 128.75 55.03 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.57 1.948 . . . . 0.0 106.787 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -82.55 149.27 27.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.596 1.559 . . . . 0.0 110.092 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -152.49 153.91 34.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.827 0.851 . . . . 0.0 111.052 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -139.62 165.17 27.97 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.422 1.089 . . . . 0.0 108.837 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.63 112.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.77 -9.81 34.71 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.288 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.44 -175.93 2.11 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 119.494 1.647 . . . . 0.0 107.142 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.09 161.33 21.17 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 119.046 -2.284 . . . . 0.0 108.243 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -90.81 163.11 31.27 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 109.883 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.86 155.63 61.96 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.645 2.23 . . . . 0.0 110.97 158.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -17.91 60.48 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.862 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 mmt -49.89 -22.17 1.41 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.907 2.083 . . . . 0.0 113.454 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -116.8 -10.16 11.1 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.374 0.988 . . . . 0.0 112.699 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.56 -31.68 65.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.157 0.889 . . . . 0.0 110.945 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 t -50.94 144.67 13.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.071 1.348 . . . . 0.0 109.263 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.12 -11.32 31.79 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.011 2.474 . . . . 0.0 112.711 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.17 -18.85 11.27 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 112.97 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -118.93 -1.44 11.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 112.358 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -70.37 99.51 1.59 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.724 1.61 . . . . 0.0 110.659 -168.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 mt -81.39 83.84 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -62.52 -23.32 66.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.477 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -83.67 104.89 14.15 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.539 1.063 . . . . 0.0 111.014 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.43 -25.92 2.6 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 117.652 -1.166 . . . . 0.0 114.112 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -33.92 73.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.959 1.254 . . . . 0.0 112.193 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.7 26.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.818 1.247 . . . . 0.0 111.327 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -141.32 163.76 32.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.571 1.149 . . . . 0.0 108.448 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -64.74 -28.54 69.65 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.752 0.821 . . . . 0.0 112.449 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.65 153.76 7.58 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 124.476 1.11 . . . . 0.0 112.255 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.19 177.43 8.87 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.904 2.403 . . . . 0.0 111.209 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.57 164.46 7.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.338 1.455 . . . . 0.0 111.429 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -67.52 178.2 3.4 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.619 2.212 . . . . 0.0 109.266 157.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB2' ' HG ' ' A' ' 52' ' ' SER . 21.6 m-20 -85.38 179.11 7.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 162.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.91 37.4 0.24 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.263 1.425 . . . . 0.0 114.72 -166.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 43.83 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.049 1.785 . . . . 0.0 109.757 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.446 ' HG ' ' HB2' ' A' ' 49' ' ' ASP . 3.3 p -147.05 172.41 13.79 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.58 -1.541 . . . . 0.0 109.604 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -145.56 149.33 34.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.774 0.321 . . . . 0.0 111.636 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.46 142.88 38.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -134.16 170.44 15.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.591 1.156 . . . . 0.0 109.94 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.468 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 25.8 t80 -106.55 104.22 13.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.418 1.087 . . . . 0.0 108.666 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.68 102.11 9.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.734 1.614 . . . . 0.0 109.149 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.98 3.14 50.63 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.992 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 111.23 -1.33 28.2 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.464 1.132 . . . . 0.0 113.04 -169.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -120.48 140.0 52.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.651 1.58 . . . . 0.0 107.673 -167.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.1 120.39 28.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.65 144.4 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 tp -102.11 125.18 48.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.2 pt -130.03 135.18 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.885 0.874 . . . . 0.0 111.942 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -60.12 129.7 43.03 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.421 0.688 . . . . 0.0 111.348 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.94 15.73 0.84 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.743 1.217 . . . . 0.0 112.633 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 65' ' ' THR . 15.2 t -143.13 4.93 1.46 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.151 2.58 . . . . 0.0 111.642 -171.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -168.69 -50.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.9 1.28 . . . . 0.0 108.876 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.43 41.7 29.63 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.439 1.971 . . . . 0.0 111.17 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -61.11 153.75 24.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 159.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.0 mt -87.61 89.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 -47.98 69.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 110.484 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -144.59 158.95 43.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.91 0.884 . . . . 0.0 110.679 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.87 130.89 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.988 2.115 . . . . 0.0 106.062 166.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -125.58 142.33 51.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 160.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -63.7 151.53 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.357 0.526 . . . . 0.0 110.039 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.84 -18.77 47.73 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.575 1.083 . . . . 0.0 113.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.37 -27.73 38.43 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.437 1.119 . . . . 0.0 111.907 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -63.33 -20.57 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 112.735 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.18 -50.68 72.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.362 0.983 . . . . 0.0 109.978 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.66 -15.51 58.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.878 1.671 . . . . 0.0 112.274 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -85.27 88.27 7.47 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -174.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 127.267 2.227 . . . . 0.0 112.575 178.613 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.04 168.5 15.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.89 1.676 . . . . 0.0 107.312 164.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.29 73.73 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.24 -105.58 0.23 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 pt -120.72 -17.27 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.15 -30.87 71.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.895 0.478 . . . . 0.0 111.449 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -64.0 -20.68 66.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.388 1.875 . . . . 0.0 112.802 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -105.34 2.2 28.62 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.202 1.401 . . . . 0.0 111.25 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.61 96.22 1.53 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.48 157.24 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -129.71 0.46 4.9 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.357 1.063 . . . . 0.0 111.528 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -173.04 161.01 4.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.929 2.891 . . . . 0.0 106.457 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -169.51 177.48 4.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.235 1.414 . . . . 0.0 109.329 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -132.52 140.58 48.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 165.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.8 41.87 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 165.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t0 54.14 27.02 7.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 61.24 29.06 18.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.52 1.928 . . . . 0.0 111.704 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 m -125.8 135.83 52.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -110.16 150.29 28.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 109.476 -171.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -148.67 146.37 28.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.565 -160.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -144.28 167.07 23.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.668 1.587 . . . . 0.0 108.266 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 mm -69.81 118.23 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.89 -11.0 57.46 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.866 -1.519 . . . . 0.0 113.71 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.14 -179.85 2.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.804 1.802 . . . . 0.0 107.363 166.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.58 157.31 31.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 119.306 -2.121 . . . . 0.0 107.617 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.96 165.23 38.18 Favored Pre-proline 0 C--O 1.238 0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 111.444 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.18 158.56 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.18 2.586 . . . . 0.0 111.42 163.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.8 67.52 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.02 0.928 . . . . 0.0 112.025 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.417 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 18.9 ptp -54.8 -20.44 8.58 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 126.104 1.762 . . . . 0.0 114.273 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 10.8 m-85 -110.2 3.73 20.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.34 -23.0 35.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 111.508 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 t -66.65 145.53 98.95 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.197 0.999 . . . . 0.0 110.89 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.96 -6.71 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.531 3.487 . . . . 0.0 114.351 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -51.63 -42.44 62.02 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.44 1.096 . . . . 0.0 110.971 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.21 -12.15 19.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.521 0.728 . . . . 0.0 112.216 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -60.76 99.95 0.1 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.878 2.471 . . . . 0.0 112.211 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -78.18 79.31 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.123 1.769 . . . . 0.0 106.4 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -62.73 -29.24 70.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.6 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -76.05 76.59 2.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 111.639 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -98.54 -19.19 17.76 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.588 -0.695 . . . . 0.0 111.405 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -0.87 13.5 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.571 -1.331 . . . . 0.0 112.976 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.47 12.45 6.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.838 1.655 . . . . 0.0 111.775 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -120.86 173.58 7.14 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 120.842 -1.161 . . . . 0.0 107.953 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.03 -12.66 49.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.044 0.537 . . . . 0.0 112.079 -170.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.44 152.64 95.42 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.996 1.318 . . . . 0.0 109.904 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.46 167.14 19.52 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.245 2.63 . . . . 0.0 111.628 170.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.21 144.3 97.46 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.893 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.04 173.37 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.243 2.629 . . . . 0.0 110.847 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.66 175.64 9.99 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.005 0.922 . . . . 0.0 110.096 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.76 99.66 0.12 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.589 1.556 . . . . 0.0 111.422 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.3 49.36 20.84 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.169 -0.957 . . . . 0.0 111.058 -175.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -132.02 171.09 14.04 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 159.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.4 154.41 34.41 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.013 0.435 . . . . 0.0 111.113 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -75.62 143.51 42.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.523 175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -129.75 172.8 11.27 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.268 1.427 . . . . 0.0 109.02 168.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 114.47 28.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.465 ' CG ' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -89.41 -154.33 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.328 0.967 . . . . 0.0 110.016 175.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 57' ' ' MET . . . -46.55 7.63 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 1 C-N-CA 132.65 4.929 . . . . 0.0 117.862 170.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 57' ' ' MET . . . 138.37 -19.5 3.21 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 127.193 2.33 . . . . 0.0 110.883 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -92.5 162.9 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.346 1.458 . . . . 0.0 110.55 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.24 125.84 52.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.374 1.469 . . . . 0.0 107.496 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 m -129.53 156.37 41.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.0 tp -117.62 125.33 50.56 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.72 136.55 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 124.397 1.079 . . . . 0.0 110.851 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.61 135.45 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.744 0.818 . . . . 0.0 109.644 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -6.25 8.94 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.818 -0.551 . . . . 0.0 112.221 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -135.85 12.68 3.4 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.673 1.589 . . . . 0.0 110.145 -158.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -170.95 -31.4 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 125.887 1.675 . . . . 0.0 109.822 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.43 35.65 21.83 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.271 1.415 . . . . 0.0 111.661 -165.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.86 152.61 42.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 170.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.7 mt -86.97 86.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' H ' HD21 ' A' ' 72' ' ' LEU . 1.7 mm? -64.4 -51.76 61.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -149.8 161.88 41.38 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 109.364 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.13 142.35 40.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -132.49 152.14 51.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 161.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.49 160.8 28.41 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.877 -0.514 . . . . 0.0 111.02 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -22.19 71.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 124.451 1.024 . . . . 0.0 113.037 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -59.87 -18.57 45.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 112.296 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.33 -19.73 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 112.946 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -72.3 -35.06 68.56 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.512 1.051 . . . . 0.0 111.746 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -76.74 -16.42 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.775 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.622 ' CD2' ' H ' ' A' ' 83' ' ' ARG . 15.0 t60 -72.77 174.53 7.54 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.075 0.941 . . . . 0.0 110.378 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.622 ' H ' ' CD2' ' A' ' 82' ' ' HIS . 11.7 ptm180 . . . . . 0 C--O 1.246 0.916 0 C-N-CA 126.359 1.864 . . . . 0.0 110.518 -161.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.98 -162.97 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.137 0.975 . . . . 0.0 109.74 -152.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.57 0.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.165 2.186 . . . . 0.0 116.189 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.83 -160.37 32.92 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 164.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 pt -62.66 -20.25 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -165.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.92 -25.88 58.26 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.865 1.666 . . . . 0.0 113.166 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -65.75 -27.17 68.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.81 0.43 57.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.321 1.049 . . . . 0.0 110.507 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.56 90.96 2.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.851 1.26 . . . . 0.0 111.628 -167.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.8 129.37 34.49 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.402 1.081 . . . . 0.0 108.303 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -92.01 -15.95 27.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.095 0.862 . . . . 0.0 112.393 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.83 166.4 29.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.312 1.445 . . . . 0.0 107.625 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -156.72 176.8 12.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.047 0.939 . . . . 0.0 108.881 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -129.89 129.82 44.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.34 142.43 32.48 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 44.34 51.77 7.51 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.02 1.328 . . . . 0.0 109.961 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.299 2.6 p90 48.24 24.19 0.65 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.014 3.326 . . . . 0.0 114.601 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.6 m -115.48 138.0 51.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.669 1.988 . . . . 0.0 107.407 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -89.78 150.71 22.15 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.019 0.928 . . . . 0.0 109.33 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -149.86 154.03 37.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.116 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -135.43 160.82 37.25 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.981 0.912 . . . . 0.0 108.644 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.27 113.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 -13.26 25.24 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.496 -1.724 . . . . 0.0 114.066 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.8 -172.38 1.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.078 1.939 . . . . 0.0 109.602 169.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.84 148.8 49.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.543 1.537 . . . . 0.0 108.966 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.67 154.55 45.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.681 -0.675 . . . . 0.0 110.234 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.28 165.63 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.929 2.419 . . . . 0.0 112.021 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -8.93 32.99 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.884 0.874 . . . . 0.0 112.708 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -22.81 60.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.801 1.64 . . . . 0.0 110.838 170.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -110.66 -23.67 10.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.872 0.869 . . . . 0.0 113.153 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 mt -76.97 -18.02 58.5 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.304 0.502 . . . . 0.0 111.456 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 t -54.06 147.98 23.45 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.346 1.858 . . . . 0.0 110.508 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.38 -11.37 31.2 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.71 -9.72 15.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.764 1.625 . . . . 0.0 113.761 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -132.12 0.19 3.78 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.527 1.058 . . . . 0.0 112.591 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.26 136.9 57.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.645 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -118.71 88.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.696 1.599 . . . . 0.0 108.672 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.41 -14.23 62.79 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.702 -0.624 . . . . 0.0 111.839 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.16 43.12 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.053 1.341 . . . . 0.0 110.516 -162.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -70.6 -15.49 62.75 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.97 -25.58 67.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.397 0.999 . . . . 0.0 111.74 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.09 39.36 0.76 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 119.564 1.075 . . . . 0.0 111.712 -171.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 174.15 156.56 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 130.11 3.364 . . . . 0.0 106.684 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -81.82 0.75 37.98 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.734 . . . . 0.0 111.621 -174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.22 151.87 16.97 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 119.261 0.937 . . . . 0.0 111.179 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.79 168.42 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.077 1.851 . . . . 0.0 110.481 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.52 158.18 11.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.282 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.9 162.51 37.5 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.734 1.623 . . . . 0.0 110.232 167.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -70.73 162.66 28.69 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 162.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 109.25 1.96 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.926 -1.109 . . . . 0.0 110.92 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.58 33.98 17.65 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.339 0.518 . . . . 0.0 111.895 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.3 p -130.69 171.12 13.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.018 0.927 . . . . 0.0 108.869 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -143.77 153.26 42.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -94.48 133.78 37.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.372 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -134.64 160.25 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.07 114.89 26.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -152.89 0.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.972 1.309 . . . . 0.0 108.417 171.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.81 52.87 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 130.233 3.778 . . . . 0.0 115.3 166.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.97 3.49 89.13 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 117.818 0.809 . . . . 0.0 113.756 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -121.49 166.63 13.87 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.966 1.307 . . . . 0.0 107.566 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -108.6 120.65 43.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.07 155.63 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -111.33 118.87 37.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.9 145.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.366 1.867 . . . . 0.0 109.145 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.02 141.18 56.29 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 120.053 1.297 . . . . 0.0 107.69 166.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -73.18 -6.88 48.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.87 0.843 . . . . 0.0 112.368 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 t -136.07 23.24 3.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.434 1.894 . . . . 0.0 110.288 -163.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -172.92 -38.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.94 1.696 . . . . 0.0 109.2 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.63 25.97 68.65 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 125.14 1.352 . . . . 0.0 113.216 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.99 143.87 57.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.565 1.146 . . . . 0.0 108.972 174.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.97 91.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.991 1.716 . . . . 0.0 107.501 -169.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.5 mt -79.38 -48.3 14.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.631 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -146.27 163.03 36.76 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.467 1.507 . . . . 0.0 108.043 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.0 t -140.58 142.83 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.72 148.96 51.48 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 161.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.25 158.72 16.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.072 0.949 . . . . 0.0 112.44 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.3 -24.52 55.74 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 126.15 1.834 . . . . 0.0 115.083 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -63.84 -21.13 66.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 120.141 1.97 . . . . 0.0 112.694 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.48 0.67 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 121.271 -0.893 . . . . 0.0 111.564 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -66.29 -41.62 89.54 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.397 -1.439 . . . . 0.0 110.952 162.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -131.48 16.71 4.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.475 1.11 . . . . 0.0 112.848 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.5 133.44 29.94 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.894 2.077 . . . . 0.0 107.961 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.567 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.11 105.08 0.89 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.749 2.02 . . . . 0.0 107.058 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 44.02 49.58 7.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.555 1.942 . . . . 0.0 113.282 170.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.36 -95.59 1.82 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.18 -26.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.885 1.274 . . . . 0.0 110.539 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.74 -16.62 64.37 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.476 1.11 . . . . 0.0 112.798 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -57.94 -24.73 59.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.672 1.589 . . . . 0.0 112.457 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.98 -1.27 34.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 0.0 111.98 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.77 104.07 10.1 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.862 0.755 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.14 125.57 29.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -65.84 -30.15 70.72 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.519 -1.363 . . . . 0.0 110.422 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.78 153.85 28.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.69 176.26 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.058 1.343 . . . . 0.0 108.554 171.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.3 m -126.74 139.07 53.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.45 151.11 37.69 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.33 35.18 13.19 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.875 0.87 . . . . 0.0 111.871 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 58.54 37.94 25.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.906 2.482 . . . . 0.0 112.691 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -138.12 133.19 33.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.998 1.719 . . . . 0.0 107.506 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.28 154.42 21.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.546 0.738 . . . . 0.0 109.688 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -147.5 154.28 40.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.079 1.752 . . . . 0.0 110.435 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -145.81 165.21 29.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.231 1.412 . . . . 0.0 109.364 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -66.7 100.65 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.87 -1.92 19.69 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.042 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -79.51 -174.44 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.266 1.033 . . . . 0.0 108.679 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 164.81 20.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.712 1.605 . . . . 0.0 109.606 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.97 163.89 16.25 Favored Pre-proline 0 N--CA 1.47 0.534 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.11 155.54 47.29 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.756 1.637 . . . . 0.0 110.221 162.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.78 -16.39 57.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp -56.25 -18.19 9.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.018 1.727 . . . . 0.0 112.508 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -116.35 -11.35 11.23 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.29 1.036 . . . . 0.0 113.268 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.5 -13.96 59.21 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-N 118.744 0.702 . . . . 0.0 110.61 171.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -64.88 145.04 99.05 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.163 -0.961 . . . . 0.0 108.44 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.1 -3.8 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.178 2.585 . . . . 0.0 114.209 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.02 -12.67 1.54 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.884 -1.135 . . . . 0.0 113.334 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -127.02 3.12 6.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.803 1.241 . . . . 0.0 112.042 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 116.84 5.71 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.429 2.691 . . . . 0.0 111.4 -170.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.76 122.14 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.813 1.645 . . . . 0.0 107.85 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -131.94 -5.14 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.82 34.57 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.445 1.93 . . . . 0.0 112.312 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.02 -29.25 70.15 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 120.737 -1.227 . . . . 0.0 110.916 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -56.88 -13.3 2.51 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.322 1.449 . . . . 0.0 113.712 172.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.15 1.77 7.89 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.722 1.609 . . . . 0.0 113.341 -173.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 -118.0 161.17 20.24 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.842 1.657 . . . . 0.0 109.493 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.01 58.63 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.151 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.61 155.41 73.55 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.013 1.325 . . . . 0.0 109.472 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.99 164.72 34.79 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.441 2.761 . . . . 0.0 113.095 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.29 84.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.045 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.46 -59.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.594 0.891 . . . . 0.0 113.263 -166.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 176.61 -162.3 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 131.527 3.931 . . . . 0.0 105.681 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.08 2.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.178 2.191 . . . . 0.0 112.388 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.32 47.32 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 p -142.02 165.76 26.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.154 0.981 . . . . 0.0 110.883 168.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -137.49 157.49 46.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.889 0.476 . . . . 0.0 110.195 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -84.53 151.68 24.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p -138.73 176.89 8.31 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.689 1.596 . . . . 0.0 109.119 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 8.0 t80 -116.85 104.4 11.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.616 1.167 . . . . 0.0 108.661 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.92 98.67 7.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.396 1.878 . . . . 0.0 108.176 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.31 11.22 64.1 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.444 1.02 . . . . 0.0 113.904 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 109.63 -12.42 32.8 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.973 1.386 . . . . 0.0 113.311 -172.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -94.51 120.17 34.33 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.468 2.307 . . . . 0.0 107.202 -171.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.465 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 30.7 m-85 -64.55 114.5 4.41 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.369 -0.832 . . . . 0.0 108.887 162.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.97 154.88 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -109.32 130.47 55.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.513 1.125 . . . . 0.0 109.864 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.6 pt -131.5 142.36 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.804 1.241 . . . . 0.0 110.061 -173.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 138.82 53.0 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.902 0.774 . . . . 0.0 109.772 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.51 -14.89 62.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.88 0.872 . . . . 0.0 112.113 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -128.59 1.37 5.55 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.115 1.766 . . . . 0.0 110.484 -167.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.16 -35.38 0.24 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.989 -1.069 . . . . 0.0 111.907 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.44 20.43 79.38 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.759 0.695 . . . . 0.0 113.228 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 132.99 55.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.26 92.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 127.568 2.347 . . . . 0.0 105.781 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.35 -54.07 16.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -151.16 170.69 18.83 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.743 0.817 . . . . 0.0 109.681 -170.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.2 p -143.23 140.78 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 1 C-N-CA 132.07 4.148 . . . . 0.0 105.113 171.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -142.79 112.37 6.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.412 -1.28 . . . . 0.0 108.262 160.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -49.19 146.73 3.44 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.904 1.229 . . . . 0.0 113.117 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -44.53 -26.15 0.98 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.732 -1.594 . . . . 0.0 116.175 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -49.67 -30.79 9.69 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.875 1.837 . . . . 0.0 112.686 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.06 -22.57 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.947 0.899 . . . . 0.0 112.379 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.16 -30.62 71.73 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 111.305 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -93.21 8.45 40.18 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.471 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -72.96 172.38 11.06 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.242 0.544 . . . . 0.0 110.594 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.325 0.65 . . . . 0.0 110.426 179.699 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.73 171.77 7.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.573 1.149 . . . . 0.0 110.696 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.71 52.44 0.82 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 109.884 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.47 -103.34 2.21 Favored Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt -141.48 -17.08 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 -20.43 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.437 0.562 . . . . 0.0 112.019 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -52.82 -26.51 14.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.007 2.123 . . . . 0.0 113.797 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -96.58 0.65 50.34 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.51 1.524 . . . . 0.0 112.31 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.65 118.43 22.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.406 1.457 . . . . 0.0 108.581 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.4 -167.97 1.91 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 123.872 1.796 . . . . 0.0 106.753 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 -19.76 6.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.167 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -170.79 170.59 6.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -159.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -170.47 -178.38 2.68 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.862 1.665 . . . . 0.0 109.37 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -125.47 137.96 53.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 164.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.2 43.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 164.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.55 30.17 16.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.099 0.952 . . . . 0.0 112.06 176.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 58.35 25.22 12.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.672 1.189 . . . . 0.0 111.796 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 m -127.29 128.86 46.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.023 2.529 . . . . 0.0 106.768 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.88 152.96 29.35 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.831 0.853 . . . . 0.0 109.468 174.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -146.28 158.1 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.415 1.086 . . . . 0.0 110.024 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -139.73 164.44 29.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.135 1.774 . . . . 0.0 109.174 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.91 117.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 166.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -5.78 56.1 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.169 -1.351 . . . . 0.0 113.892 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.55 -177.11 3.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.082 1.941 . . . . 0.0 107.484 165.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 157.09 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.257 -1.527 . . . . 0.0 108.524 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.16 162.45 34.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.906 0.775 . . . . 0.0 109.452 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.99 162.46 34.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.0 2.467 . . . . 0.0 111.633 163.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -17.08 24.92 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.581 1.153 . . . . 0.0 112.998 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.18 -21.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.057 1.343 . . . . 0.0 112.44 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.95 -6.59 10.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.882 0.873 . . . . 0.0 112.774 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.81 -33.62 72.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.946 1.248 . . . . 0.0 109.873 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.2 t -49.35 144.3 8.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.644 1.578 . . . . 0.0 109.286 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.785 1.657 . . . . 0.0 113.015 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -54.69 -29.18 52.21 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -116.44 4.22 13.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.688 1.195 . . . . 0.0 111.204 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -80.85 118.07 22.04 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.446 2.299 . . . . 0.0 109.389 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.46 76.88 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -61.54 -30.44 70.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.366 -0.834 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.82 104.77 1.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -127.08 -15.03 5.38 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.813 -1.179 . . . . 0.0 113.795 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -30.72 32.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.047 1.294 . . . . 0.0 112.092 -177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -89.03 44.16 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.064 0.847 . . . . 0.0 108.805 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -146.7 -170.28 3.48 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.214 2.206 . . . . 0.0 106.503 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.85 -15.76 24.74 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.654 0.782 . . . . 0.0 111.607 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.96 150.77 96.22 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.05 169.35 20.75 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.609 1.54 . . . . 0.0 109.14 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 146.58 79.34 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.8 169.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.99 -167.43 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.518 3.479 . . . . 0.0 111.266 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 165.39 11.74 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 165.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.87 46.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.431 1.493 . . . . 0.0 113.026 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.59 23.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.957 2.218 . . . . 0.0 111.686 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 p -140.06 165.12 28.21 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.19 -1.183 . . . . 0.0 111.162 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -147.12 156.26 42.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.201 0.6 . . . . 0.0 111.203 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -77.97 134.41 37.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.304 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -127.47 165.7 19.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.926 1.29 . . . . 0.0 109.429 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.11 105.65 15.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.249 1.419 . . . . 0.0 108.392 177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 97.4 mmm -78.53 -154.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.452 1.501 . . . . 0.0 108.934 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.21 64.94 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 128.909 3.147 . . . . 0.0 111.895 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.61 14.67 79.54 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.448 -1.751 . . . . 0.0 114.569 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.23 159.05 43.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.846 1.823 . . . . 0.0 108.863 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.06 137.23 35.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.19 158.6 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 121.523 -0.736 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.69 114.3 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.447 1.099 . . . . 0.0 109.066 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.47 144.99 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.102 0.961 . . . . 0.0 110.047 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' THR . 1.3 p -73.07 137.83 45.52 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -77.8 10.63 2.62 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.682 1.23 . . . . 0.0 113.26 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' THR . 4.5 t -139.44 7.68 2.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.749 2.02 . . . . 0.0 110.827 -167.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -167.14 -49.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.937 1.295 . . . . 0.0 109.059 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.45 19.55 17.98 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.174 1.369 . . . . 0.0 112.563 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 131.11 45.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.618 -0.931 . . . . 0.0 110.283 -173.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.76 91.95 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.507 1.523 . . . . 0.0 107.778 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.27 -42.66 25.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.418 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -149.15 155.28 40.43 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.183 0.993 . . . . 0.0 108.531 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.64 125.79 31.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -126.74 119.11 26.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 107.652 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.12 145.0 27.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.485 1.514 . . . . 0.0 111.702 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -7.26 40.02 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.196 -1.565 . . . . 0.0 114.521 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.3 -22.42 62.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.312 1.556 . . . . 0.0 111.049 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 -30.0 45.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-N 120.317 1.417 . . . . 0.0 111.126 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -53.05 -35.93 60.05 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.015 1.326 . . . . 0.0 111.316 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -87.22 20.79 2.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.802 0.841 . . . . 0.0 111.586 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -117.0 49.68 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.992 1.317 . . . . 0.0 111.805 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 115.815 -2.04 . . . . 0.0 108.828 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.9 36.28 1.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.863 2.065 . . . . 0.0 114.431 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.48 69.45 1.21 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.551 1.14 . . . . 0.0 110.839 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.62 -101.46 2.0 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 126.062 1.792 . . . . 0.0 109.924 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 pt -117.99 -21.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.82 -20.6 65.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.735 0.814 . . . . 0.0 111.029 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -65.15 -18.9 65.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.423 1.889 . . . . 0.0 113.969 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -102.69 2.95 36.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.329 1.052 . . . . 0.0 110.975 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 97.4 1.58 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.837 1.199 . . . . 0.0 109.141 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.8 143.31 46.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.0 -12.58 44.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.653 0.206 . . . . 0.0 110.713 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 177.87 164.93 0.67 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.165 2.186 . . . . 0.0 108.19 -164.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -168.56 -175.09 2.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.55 1.54 . . . . 0.0 109.589 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.88 47.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.83 152.95 38.51 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 162.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.83 30.19 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.289 1.043 . . . . 0.0 112.679 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 56.43 14.74 1.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.583 1.953 . . . . 0.0 113.122 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 m -100.12 117.22 33.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.729 2.012 . . . . 0.0 105.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.99 37.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.8 0.84 . . . . 0.0 109.81 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -148.1 154.01 39.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 110.956 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -146.65 161.86 39.66 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.577 1.551 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.91 122.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.65 7.95 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.014 -1.992 . . . . 0.0 113.867 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.06 -170.32 0.45 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 120.02 1.91 . . . . 0.0 109.871 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.02 160.72 32.82 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.676 1.99 . . . . 0.0 108.74 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.7 m -107.71 163.74 16.31 Favored Pre-proline 0 N--CA 1.476 0.872 0 O-C-N 120.576 -1.327 . . . . 0.0 112.671 -174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 41.8 Cg_endo -72.33 163.39 38.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.492 2.795 . . . . 0.0 114.198 169.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.79 66.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 112.23 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.62 -21.92 54.98 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 119.033 0.833 . . . . 0.0 111.044 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 22.5 m-85 -109.32 11.09 25.43 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.58 -23.22 19.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.904 . . . . 0.0 111.952 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 t -69.44 147.81 97.0 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.598 0.759 . . . . 0.0 111.107 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.39 -4.62 9.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.609 3.539 . . . . 0.0 113.768 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.57 -22.83 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.16 1.784 . . . . 0.0 113.325 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -121.49 -6.12 9.26 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.636 1.175 . . . . 0.0 111.507 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.79 123.59 20.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.97 1.308 . . . . 0.0 111.047 -172.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -104.27 96.01 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.99 -37.41 87.03 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.567 -0.708 . . . . 0.0 110.36 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -89.02 109.06 19.95 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.191 0.996 . . . . 0.0 109.352 -167.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . 0.273 23.0 p-90 -112.83 -47.21 3.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 116.782 -1.58 . . . . 0.0 114.992 -170.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.71 -37.67 76.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.221 1.828 . . . . 0.0 111.11 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -55.7 -36.2 66.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.078 0.551 . . . . 0.0 111.932 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -88.97 24.14 2.17 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.095 -1.003 . . . . 0.0 111.397 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.31 6.32 5.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.292 2.637 . . . . 0.0 112.706 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.65 156.06 35.76 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 120.856 -1.152 . . . . 0.0 112.696 -159.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 166.82 25.9 Favored 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.581 4.187 . . . . 0.0 111.277 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.48 153.23 51.08 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.824 1.25 . . . . 0.0 110.478 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -65.46 170.37 11.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.159 1.906 . . . . 0.0 110.364 165.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.76 160.31 32.83 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 103.38 0.56 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.134 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.89 32.59 4.05 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.765 1.65 . . . . 0.0 111.057 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.8 p -150.58 173.6 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.613 -1.522 . . . . 0.0 110.239 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -156.09 158.81 38.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.722 0.772 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.97 144.1 37.05 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.801 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -131.93 172.26 12.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.09 1.356 . . . . 0.0 108.87 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.91 122.05 46.4 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.9 mmt -90.07 -162.71 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.119 1.367 . . . . 0.0 108.09 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.42 -12.02 5.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 127.32 2.39 . . . . 0.0 116.426 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.19 4.93 0.02 OUTLIER Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.888 1.709 . . . . 0.0 112.713 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -129.54 152.26 49.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 110.408 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.81 130.03 44.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.721 1.208 . . . . 0.0 108.602 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.61 155.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.43 115.81 24.22 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.662 1.585 . . . . 0.0 109.116 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.45 142.06 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.2 1.0 . . . . 0.0 109.396 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 143.62 50.66 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 122.753 0.421 . . . . 0.0 110.473 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -66.52 -18.38 65.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 t -120.25 -9.37 9.54 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.26 1.824 . . . . 0.0 110.83 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -144.92 -45.96 0.23 Allowed 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.38 1.072 . . . . 0.0 108.89 -165.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 22.4 66.62 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.663 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 131.61 51.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.539 1.17 . . . . 0.0 108.375 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.08 91.12 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 126.678 1.991 . . . . 0.0 105.881 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.36 -55.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.36 148.8 28.57 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.674 0.67 . . . . 0.0 109.568 -169.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -128.89 137.21 57.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -131.14 147.94 52.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.16 155.79 39.28 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.717 -0.615 . . . . 0.0 110.232 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.31 -11.55 59.41 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.796 1.188 . . . . 0.0 112.607 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.1 -32.96 56.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.763 1.625 . . . . 0.0 111.823 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.51 -23.33 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.422 0.555 . . . . 0.0 112.117 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -63.07 -30.32 71.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.562 -0.712 . . . . 0.0 111.65 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -77.46 -25.74 50.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.459 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -65.06 142.95 58.23 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.283 1.033 . . . . 0.0 109.05 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 . . . . . 0 C--O 1.251 1.15 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.185 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.7 54.13 0.47 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.271 1.428 . . . . 0.0 111.539 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 44.5 50.2 8.21 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 112.903 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.69 -99.73 2.21 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -132.71 -20.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 124.972 1.309 . . . . 0.0 111.671 -165.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.51 -27.86 62.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.426 1.09 . . . . 0.0 112.103 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -53.09 -34.46 56.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.033 1.333 . . . . 0.0 113.067 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.81 -6.82 58.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.886 0.874 . . . . 0.0 111.729 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 101.23 3.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.768 1.167 . . . . 0.0 109.13 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.79 129.15 37.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -64.35 -28.6 69.81 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 120.049 -1.657 . . . . 0.0 110.106 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.81 158.99 39.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.354 0.662 . . . . 0.0 110.145 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CD1' ' CE ' ' A' ' 57' ' ' MET . 54.9 p90 -160.04 -177.99 6.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.984 1.314 . . . . 0.0 110.877 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -133.88 139.21 46.05 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.922 1.289 . . . . 0.0 108.172 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.33 31.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.958 0.903 . . . . 0.0 109.778 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.54 41.25 4.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.951 1.7 . . . . 0.0 112.26 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 59.62 49.14 8.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.529 1.932 . . . . 0.0 111.066 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 m -152.73 144.77 23.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.882 1.673 . . . . 0.0 108.652 168.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.95 147.93 25.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.332 2.253 . . . . 0.0 110.01 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.03 160.25 41.68 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.914 1.686 . . . . 0.0 111.863 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -141.97 169.14 18.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.871 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm -58.85 121.87 7.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 5.87 70.32 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.866 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.66 -172.81 3.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.731 1.766 . . . . 0.0 108.976 160.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.47 139.99 53.24 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 109.001 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.88 160.23 78.83 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.18 166.64 26.2 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.434 2.089 . . . . 0.0 110.261 161.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.0 -23.51 33.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.879 1.272 . . . . 0.0 112.141 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.8 mtp -55.88 -16.84 5.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.248 1.819 . . . . 0.0 113.694 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -118.92 -1.56 10.98 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -24.2 43.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.241 0.928 . . . . 0.0 110.372 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.38 154.22 23.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 127.17 2.188 . . . . 0.0 113.618 -174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -67.64 -5.43 14.22 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.434 4.089 . . . . 0.0 113.928 171.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -58.92 -63.89 1.14 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.605 1.162 . . . . 0.0 108.867 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -87.15 2.91 48.42 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.626 1.57 . . . . 0.0 112.709 -168.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.08 132.53 53.77 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.892 2.077 . . . . 0.0 110.314 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mm -119.06 80.04 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.529 1.131 . . . . 0.0 108.246 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -52.73 -29.05 24.85 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.017 -1.052 . . . . 0.0 112.099 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 0.45 17.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.705 1.202 . . . . 0.0 113.794 -165.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -59.66 -3.21 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -166.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -40.33 71.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 122.391 2.36 . . . . 0.0 112.908 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -137.54 55.86 1.78 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 110.337 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -137.48 34.88 2.48 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.607 1.163 . . . . 0.0 110.459 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.449 HD22 ' CA ' ' A' ' 83' ' ' ARG . 9.5 m120 75.32 -36.56 0.31 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 129.074 2.95 . . . . 0.0 113.714 172.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.83 149.99 61.66 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 126.212 1.805 . . . . 0.0 110.8 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.02 165.24 33.2 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.591 2.194 . . . . 0.0 111.78 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.76 97.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 165.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.47 172.76 12.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.563 2.176 . . . . 0.0 111.303 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 161.34 27.13 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 107.85 0.63 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.934 1.293 . . . . 0.0 110.569 175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.74 9.06 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.456 1.503 . . . . 0.0 112.414 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.5 p -146.63 166.38 26.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.816 1.308 . . . . 0.0 110.958 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -156.04 157.23 35.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.755 0.822 . . . . 0.0 111.259 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.06 130.73 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 p -124.84 154.94 40.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 105.8 11.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.582 ' CE ' HD21 ' A' ' 60' ' ' ASN . 8.2 ptm -77.4 -154.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.97 62.55 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 1 C-N-CA 131.672 4.463 . . . . 0.0 112.89 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.64 6.75 88.91 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 126.309 1.909 . . . . 0.0 114.457 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.582 HD21 ' CE ' ' A' ' 57' ' ' MET . 14.3 m-80 -125.03 164.76 19.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.57 1.548 . . . . 0.0 106.828 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -95.74 131.71 41.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 m -119.43 149.23 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 120.159 1.345 . . . . 0.0 109.238 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.38 119.3 32.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.66 146.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.852 1.261 . . . . 0.0 108.455 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.449 ' HG1' ' CG ' ' A' ' 68' ' ' GLU . 0.8 OUTLIER -78.64 152.48 31.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.06 0.391 . . . . 0.0 111.515 177.073 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -34.81 78.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.442 165.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -86.97 -7.87 57.75 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.061 -1.024 . . . . 0.0 111.822 -171.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.449 ' CG ' ' HG1' ' A' ' 65' ' ' THR . 14.4 pt-20 -155.14 -35.55 0.09 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 172.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.5 49.58 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.813 -172.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 132.03 51.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.967 0.883 . . . . 0.0 108.95 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.88 82.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 129.174 2.989 . . . . 0.0 106.807 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.89 -50.08 58.36 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -145.27 168.09 21.28 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.898 1.279 . . . . 0.0 108.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.1 p -133.94 149.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 C-N-CA 133.786 4.835 . . . . 0.0 105.222 167.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -140.05 130.63 25.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 151.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.34 146.43 9.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.662 0.664 . . . . 0.0 109.526 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.7 -26.82 11.2 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.519 -1.156 . . . . 0.0 113.206 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -54.74 -24.93 24.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.115 1.766 . . . . 0.0 112.161 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -55.98 -33.05 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.062 0.846 . . . . 0.0 110.996 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -61.43 -13.46 20.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.429 1.891 . . . . 0.0 112.433 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.16 -8.62 15.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.199 0.909 . . . . 0.0 112.977 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -81.0 34.7 0.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.395 1.878 . . . . 0.0 110.978 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' CA ' HD22 ' A' ' 44' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 C-N-CA 125.98 1.712 . . . . 0.0 111.641 -156.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.23 -26.2 67.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.16 0.584 . . . . 0.0 111.163 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -23.02 65.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.634 1.574 . . . . 0.0 113.837 171.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -101.36 4.5 41.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.996 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.89 111.28 21.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 121.017 1.735 . . . . 0.0 109.497 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 10' ' ' LEU . 4.0 mp -81.92 -165.51 1.01 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.412 1.577 . . . . 0.0 106.841 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -134.3 -13.96 2.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.725 -2.034 . . . . 0.0 113.236 164.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 178.49 159.09 0.53 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.882 0.765 . . . . 0.0 110.502 -163.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 4.7 p90 -167.33 -175.54 2.94 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.659 1.584 . . . . 0.0 109.159 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -128.49 135.49 49.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 157.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.54 161.98 33.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 158.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 20.65 11.96 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 163.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 62.29 29.45 17.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.331 1.853 . . . . 0.0 112.586 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -129.96 122.51 28.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.611 2.364 . . . . 0.0 107.626 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.58 147.0 30.96 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.4 m-85 -147.21 158.49 43.97 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.811 0.844 . . . . 0.0 110.292 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.16 173.44 11.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.964 1.306 . . . . 0.0 109.0 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.64 108.22 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.77 2.37 39.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.598 -1.668 . . . . 0.0 114.822 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -178.06 1.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.481 1.64 . . . . 0.0 108.135 161.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.18 146.99 48.33 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.667 -1.27 . . . . 0.0 107.581 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.6 m -79.09 162.1 65.68 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.84 162.26 39.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.797 2.331 . . . . 0.0 111.077 162.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -16.3 44.15 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.437 1.095 . . . . 0.0 112.153 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtt -60.06 -17.24 38.0 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 124.874 1.27 . . . . 0.0 112.158 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -119.95 1.72 10.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.6 -26.22 57.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.461 1.028 . . . . 0.0 110.269 167.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -57.99 144.4 75.5 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.66 -4.24 14.23 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 112.724 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.04 -14.95 18.9 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.795 2.038 . . . . 0.0 114.005 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.6 -5.09 8.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.253 1.421 . . . . 0.0 112.237 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.27 106.74 2.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.906 2.082 . . . . 0.0 110.15 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 56' ' ' TYR . 2.7 mp -90.57 83.62 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -63.72 -16.92 62.36 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.273 -0.892 . . . . 0.0 111.115 167.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -90.11 70.77 7.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.148 2.179 . . . . 0.0 108.022 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -111.92 -19.45 12.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -72.17 -35.99 69.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.767 1.167 . . . . 0.0 111.483 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -78.13 38.1 0.27 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.552 0.615 . . . . 0.0 110.034 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -146.39 166.1 27.36 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 127.271 2.228 . . . . 0.0 106.611 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.38 -16.47 62.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.167 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.85 148.71 75.55 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 0.0 112.265 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -74.1 157.85 46.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.086 2.524 . . . . 0.0 112.757 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.65 142.58 96.13 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.607 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.37 162.89 39.2 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.058 2.505 . . . . 0.0 112.189 -171.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.406 ' H ' HD21 ' A' ' 63' ' ' LEU . 25.9 m-20 -68.54 160.57 29.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.95 50.72 1.42 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.453 1.501 . . . . 0.0 113.266 -161.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.53 38.9 0.02 OUTLIER Glycine 0 CA--C 1.528 0.9 0 C-N-CA 127.37 2.414 . . . . 0.0 109.835 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.9 p -148.37 172.17 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.645 1.223 . . . . 0.0 110.577 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -145.58 156.41 43.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.173 0.511 . . . . 0.0 111.956 169.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -73.33 141.41 47.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.983 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.27 131.95 35.12 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.141 2.177 . . . . 0.0 106.256 -169.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.542 ' HB2' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.16 100.34 11.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.48 -155.66 0.07 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 108.309 169.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.98 60.99 0.53 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 127.355 2.407 . . . . 0.0 113.89 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.4 66.13 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.381 0.591 . . . . 0.0 113.329 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -134.87 154.74 51.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.61 115.54 30.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.73 149.33 7.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' HD23 ' A' ' 72' ' ' LEU . 67.8 tp -100.92 126.08 47.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.03 135.79 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 C-N-CA 123.81 0.844 . . . . 0.0 110.056 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 133.77 52.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 108.617 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.15 -2.27 23.91 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.808 -1.183 . . . . 0.0 112.044 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -127.15 13.2 7.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.68 1.592 . . . . 0.0 109.534 -170.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -164.38 -48.24 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.401 1.08 . . . . 0.0 109.814 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 33.95 66.48 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 126.753 2.12 . . . . 0.0 112.18 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.535 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -55.8 143.01 32.7 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 160.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.0 86.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 70' ' ' LYS . 2.3 mm? -63.62 -49.67 72.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.207 1.003 . . . . 0.0 110.117 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -146.21 161.05 41.1 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.689 1.596 . . . . 0.0 108.762 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 10' ' ' LEU . 42.6 t -144.2 131.58 17.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.257 1.823 . . . . 0.0 107.592 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.038 1.335 . . . . 0.0 108.626 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.53 160.32 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.965 0.506 . . . . 0.0 109.831 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.31 71.06 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.482 -1.177 . . . . 0.0 113.778 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.32 -20.72 65.74 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.813 1.806 . . . . 0.0 112.86 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.7 tt -59.11 -20.18 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.203 1.001 . . . . 0.0 112.198 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.58 -35.34 72.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.871 1.268 . . . . 0.0 111.958 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.43 -17.89 29.49 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.867 0.758 . . . . 0.0 111.068 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -61.99 152.06 33.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 108.558 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 127.859 2.464 . . . . 0.0 105.598 -170.625 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 pt . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.89 -26.21 68.5 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.2 0.6 . . . . 0.0 112.52 -168.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -58.62 -30.33 67.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.36 1.064 . . . . 0.0 112.515 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.32 -3.97 49.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.416 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.65 89.58 2.24 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.921 1.237 . . . . 0.0 110.849 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.53 133.99 43.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 107.207 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -87.0 -20.19 27.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.971 0.805 . . . . 0.0 111.911 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -154.17 161.3 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.947 1.699 . . . . 0.0 108.789 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.92 175.34 13.69 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.959 1.704 . . . . 0.0 108.664 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 m -130.6 121.58 25.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.47 153.91 51.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 58.08 29.25 17.54 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.245 1.021 . . . . 0.0 111.427 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 58.69 14.81 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.435 1.894 . . . . 0.0 113.325 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -115.03 126.81 55.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.21 149.29 25.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -146.19 152.69 39.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.603 0.761 . . . . 0.0 110.015 -172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -134.94 165.48 25.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.004 1.321 . . . . 0.0 108.209 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.22 115.48 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.3 59.1 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.752 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -176.25 1.15 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.72 1.76 . . . . 0.0 107.943 153.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.79 159.89 28.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.52 1.928 . . . . 0.0 109.537 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.86 158.09 32.44 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.055 -1.028 . . . . 0.0 110.98 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.13 160.39 47.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.648 2.232 . . . . 0.0 110.949 164.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.76 -13.21 41.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -23.13 10.59 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.272 1.829 . . . . 0.0 112.351 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.55 -20.12 9.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.713 0.633 . . . . 0.0 111.88 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.5 mt -70.4 -23.67 62.79 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.516 -0.74 . . . . 0.0 111.435 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -57.3 143.19 74.21 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.041 0.936 . . . . 0.0 108.73 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.65 -4.18 11.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.558 3.505 . . . . 0.0 113.395 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.23 -33.83 74.13 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.244 1.817 . . . . 0.0 113.198 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -114.41 4.97 15.5 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.01 94.87 0.11 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.994 2.117 . . . . 0.0 110.141 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.38 74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 123.929 1.823 . . . . 0.0 107.456 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -59.15 -37.43 77.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.023 160.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -78.33 80.09 4.75 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.215 1.406 . . . . 0.0 111.689 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -83.52 -37.94 22.39 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.955 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -46.41 -51.09 15.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.241 1.016 . . . . 0.0 112.901 -169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -79.53 12.83 2.29 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 112.529 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -118.93 162.34 18.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 161.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.21 -6.48 23.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.354 1.062 . . . . 0.0 112.859 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.42 159.65 57.51 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.885 1.674 . . . . 0.0 112.143 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.03 175.02 11.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.017 3.144 . . . . 0.0 109.884 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.37 158.96 25.76 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.884 0.874 . . . . 0.0 110.502 166.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.3 168.1 23.23 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.476 2.118 . . . . 0.0 110.537 165.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -78.2 161.22 27.48 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 163.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.32 112.56 4.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.516 0.726 . . . . 0.0 109.801 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.11 23.68 31.6 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.159 0.436 . . . . 0.0 112.404 -176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.3 p -135.55 167.65 20.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 117.891 0.846 . . . . 0.0 109.276 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -150.99 157.58 43.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.437 0.637 . . . . 0.0 110.427 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -82.86 149.15 27.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.6 p -140.08 155.51 47.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.138 0.575 . . . . 0.0 109.907 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -97.15 85.41 3.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.03 98.81 8.7 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.722 1.609 . . . . 0.0 107.275 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.85 80.43 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.147 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.95 2.6 59.41 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.545 1.673 . . . . 0.0 112.253 -170.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -113.75 148.52 36.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.099 1.45 . . . . 0.0 107.931 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -95.82 108.85 21.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.11 130.25 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -169.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.84 118.14 31.04 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.154 1.382 . . . . 0.0 108.198 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.48 140.41 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.861 0.864 . . . . 0.0 109.823 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.69 136.32 54.14 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -13.06 60.43 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.467 -0.771 . . . . 0.0 112.503 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -132.25 19.44 4.43 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.62 1.968 . . . . 0.0 109.53 -162.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -170.13 -40.01 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.889 1.276 . . . . 0.0 110.078 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.59 26.72 74.19 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.517 -1.157 . . . . 0.0 112.938 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -59.03 141.12 54.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.9 mt -79.24 85.03 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.83 -49.31 68.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.341 0.657 . . . . 0.0 110.258 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -152.09 160.52 43.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.505 1.922 . . . . 0.0 107.344 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.97 147.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.1 153.19 50.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 159.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -61.01 155.02 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.911 0.885 . . . . 0.0 109.574 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.91 64.51 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.465 1.031 . . . . 0.0 113.1 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -50.23 -31.97 15.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.489 1.115 . . . . 0.0 112.776 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -59.81 -19.69 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.549 1.14 . . . . 0.0 112.745 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.1 -28.22 67.66 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.444 1.02 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.11 -0.46 33.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.789 0.836 . . . . 0.0 111.892 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -62.73 171.53 2.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.196 1.398 . . . . 0.0 110.621 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.15 -165.554 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -63.21 -28.93 70.38 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.613 1.965 . . . . 0.0 111.374 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -61.28 -28.98 69.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.742 0.817 . . . . 0.0 112.271 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -98.05 -2.22 40.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.275 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.03 86.87 0.55 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.343 0.974 . . . . 0.0 109.633 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.17 145.73 54.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -102.86 -16.0 16.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.125 0.42 . . . . 0.0 112.011 170.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.54 164.25 38.56 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.63 175.63 13.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.692 1.597 . . . . 0.0 108.067 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -131.53 125.44 32.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.48 156.19 48.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.81 29.7 12.38 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.314 -0.866 . . . . 0.0 112.937 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 53.85 22.77 3.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.1 2.16 . . . . 0.0 112.5 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.1 m -120.29 128.05 52.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.441 2.296 . . . . 0.0 105.775 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -84.09 150.8 25.32 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.069 0.948 . . . . 0.0 110.062 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -151.7 141.31 21.74 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 124.798 1.239 . . . . 0.0 110.211 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -124.4 167.18 14.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.42 1.488 . . . . 0.0 109.856 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.59 113.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.6 -4.51 32.72 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.092 -1.394 . . . . 0.0 113.458 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.18 -171.34 1.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.002 1.401 . . . . 0.0 107.968 166.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 149.48 50.43 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.172 -1.58 . . . . 0.0 109.382 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.6 158.14 43.22 Favored Pre-proline 0 N--CA 1.468 0.447 0 C-N-CA 124.15 0.98 . . . . 0.0 111.016 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.2 164.26 33.33 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.328 2.685 . . . . 0.0 111.619 165.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -16.11 44.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 112.703 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.2 mmt -53.64 -30.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.45 1.1 . . . . 0.0 111.884 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -102.94 -2.5 27.6 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.21 -23.59 24.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.097 0.862 . . . . 0.0 110.935 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.72 144.1 85.86 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 -4.62 9.88 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.554 3.503 . . . . 0.0 113.343 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.45 -16.85 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.25 2.22 . . . . 0.0 113.207 172.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -121.26 -1.84 9.66 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.59 1.086 . . . . 0.0 110.932 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.9 97.24 4.53 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.729 1.612 . . . . 0.0 112.502 -163.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -81.47 82.6 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 107.756 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.87 -30.92 69.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.647 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.98 36.38 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.436 1.894 . . . . 0.0 113.734 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -56.67 -34.47 67.38 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.398 -1.439 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.91 -39.35 93.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.584 1.554 . . . . 0.0 113.07 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -24.86 42.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.406 1.003 . . . . 0.0 110.647 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -80.05 -177.44 6.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.649 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.87 -19.66 40.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.467 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.93 144.67 76.4 Favored Pre-proline 0 CA--C 1.537 0.469 0 O-C-N 121.017 -1.052 . . . . 0.0 111.156 -161.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.95 164.48 27.13 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.75 2.967 . . . . 0.0 113.596 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.22 97.11 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.575 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.2 172.39 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.204 2.603 . . . . 0.0 110.608 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.48 167.73 19.8 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.851 -1.156 . . . . 0.0 109.294 168.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 34.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 115.397 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.9 33.17 0.06 OUTLIER Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.301 1.905 . . . . 0.0 110.303 173.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.0 p -144.24 166.12 25.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.121 0.961 . . . . 0.0 110.768 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -155.75 156.25 34.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.269 0.557 . . . . 0.0 111.315 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.32 143.93 31.86 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.347 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 p -138.67 179.52 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.306 1.842 . . . . 0.0 110.07 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -107.7 145.6 33.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.65 1.58 . . . . 0.0 107.822 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.9 147.21 29.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 166.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.81 -4.83 0.01 OUTLIER Glycine 0 CA--C 1.55 2.22 0 N-CA-C 117.589 1.796 . . . . 0.0 117.589 170.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.31 -10.75 19.77 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 121.144 2.472 . . . . 0.0 113.778 -167.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -103.0 173.13 6.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.548 2.739 . . . . 0.0 110.224 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -112.38 134.87 53.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.08 1.352 . . . . 0.0 109.261 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.72 154.06 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 119.69 1.132 . . . . 0.0 110.968 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.11 120.1 39.39 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.287 1.035 . . . . 0.0 109.031 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.3 pt -127.77 150.13 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.726 1.21 . . . . 0.0 109.483 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.13 140.69 39.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.032 0.833 . . . . 0.0 109.505 172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -14.73 61.78 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.407 1.083 . . . . 0.0 112.45 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -119.54 2.58 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.739 1.615 . . . . 0.0 111.1 -162.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -163.37 -45.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.982 0.913 . . . . 0.0 109.035 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.55 21.65 53.24 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.1 0.857 . . . . 0.0 112.497 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 130.33 43.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.22 95.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.792 1.637 . . . . 0.0 106.766 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 mt -80.09 -52.97 7.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.888 0.875 . . . . 0.0 109.574 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -144.59 160.5 41.05 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.779 0.832 . . . . 0.0 109.625 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.6 t -134.13 142.35 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -134.99 137.71 43.28 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 162.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -60.38 149.12 34.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.69 -15.12 32.27 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.948 1.737 . . . . 0.0 113.261 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.92 -30.29 61.41 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.393 1.597 . . . . 0.0 112.135 171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.81 -1.72 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.012 0.925 . . . . 0.0 111.745 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -60.05 -43.1 95.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.32 -1.487 . . . . 0.0 111.511 164.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -88.02 -17.64 30.74 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -64.59 160.98 18.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.915 1.286 . . . . 0.0 109.404 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.698 1.199 . . . . 0.0 107.836 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.47 -34.61 69.2 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.931 1.692 . . . . 0.0 112.38 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -58.64 -28.97 66.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.541 0.737 . . . . 0.0 112.585 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -98.02 -2.51 40.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.834 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.93 87.13 1.31 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.279 0.945 . . . . 0.0 109.031 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.25 166.6 23.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -124.96 -25.11 3.93 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.265 0.626 . . . . 0.0 112.553 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 157.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.806 1.242 . . . . 0.0 107.933 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.5 177.04 11.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -131.24 129.29 41.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 163.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.79 149.27 46.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.98 34.15 24.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.199 1.0 . . . . 0.0 111.452 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 59.83 35.69 21.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.8 1.64 . . . . 0.0 112.01 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -136.98 121.05 17.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.832 1.653 . . . . 0.0 107.35 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -79.59 150.23 31.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.695 0.798 . . . . 0.0 109.017 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -150.05 159.36 44.47 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.41 1.484 . . . . 0.0 110.595 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -145.6 165.42 28.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.392 1.877 . . . . 0.0 108.781 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.93 120.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.38 3.9 84.0 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 117.454 -1.748 . . . . 0.0 113.559 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.21 178.41 2.34 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.017 1.908 . . . . 0.0 108.68 156.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.71 142.89 50.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.608 1.163 . . . . 0.0 109.073 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.32 163.77 35.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.171 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.98 154.22 63.0 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.458 2.772 . . . . 0.0 112.653 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.61 54.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.582 1.553 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -55.45 -22.6 21.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.588 1.155 . . . . 0.0 113.019 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 13.8 m-85 -113.9 -10.3 12.96 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.865 0.728 . . . . 0.0 112.906 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.23 -30.33 68.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.191 0.451 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -65.49 144.11 98.86 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.543 0.737 . . . . 0.0 109.716 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.05 -4.85 9.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.246 3.297 . . . . 0.0 115.449 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -54.97 -33.96 62.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.898 1.279 . . . . 0.0 112.086 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -103.21 -8.56 20.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.964 0.802 . . . . 0.0 112.086 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.73 100.36 0.91 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.769 2.827 . . . . 0.0 111.952 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.93 85.58 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.764 1.226 . . . . 0.0 108.694 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -67.48 -10.86 55.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.356 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -95.44 89.51 5.45 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.72 1.208 . . . . 0.0 107.914 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -132.19 -25.71 1.97 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.924 -1.036 . . . . 0.0 113.557 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.21 -36.33 79.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.277 1.399 . . . . 0.0 111.613 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -82.82 8.52 12.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.624 0.77 . . . . 0.0 111.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -123.18 165.7 16.45 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.586 -1.322 . . . . 0.0 108.96 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.74 -22.63 56.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 -169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.58 156.41 17.13 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 125.211 1.404 . . . . 0.0 110.498 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.61 172.57 13.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.303 1.335 . . . . 0.0 110.774 168.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.5 165.51 2.16 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.491 164.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -67.97 171.46 12.36 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 120.97 1.113 . . . . 0.0 109.825 160.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' H ' HD21 ' A' ' 63' ' ' LEU . 3.3 m-20 -82.92 161.46 21.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 158.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.49 112.55 3.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.7 7.99 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.581 1.086 . . . . 0.0 111.907 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -149.42 169.02 21.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.889 1.845 . . . . 0.0 111.89 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -149.03 163.91 36.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.623 0.769 . . . . 0.0 110.354 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.95 141.95 28.29 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.279 0.631 . . . . 0.0 109.631 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -128.51 172.16 11.42 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -103.35 111.59 24.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 110.343 173.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 ttm -129.89 118.0 21.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.823 1.649 . . . . 0.0 109.869 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 -11.27 4.08 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.922 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.07 -7.17 19.2 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.538 1.669 . . . . 0.0 112.319 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -109.85 172.94 6.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.657 1.583 . . . . 0.0 110.302 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.38 117.92 35.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 108.545 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.0 145.84 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD21 ' H ' ' A' ' 49' ' ' ASP . 66.9 tp -101.19 126.68 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.01 142.57 43.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.967 0.907 . . . . 0.0 110.239 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.44 131.26 44.99 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.423 0.689 . . . . 0.0 109.594 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.98 5.8 6.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.934 1.349 . . . . 0.0 113.503 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -127.7 1.22 6.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.895 2.478 . . . . 0.0 110.938 -171.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -166.87 -60.11 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.309 0.644 . . . . 0.0 109.36 -164.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 24.92 9.89 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 124.761 1.172 . . . . 0.0 113.931 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -60.48 129.11 39.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.548 2.174 . . . . 0.0 109.319 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 86.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 129.229 3.012 . . . . 0.0 106.067 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.69 -44.63 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -145.64 161.31 40.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.457 0.703 . . . . 0.0 109.331 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.68 137.99 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -126.84 142.42 51.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 157.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 79' ' ' ILE . 10.3 t70 -59.49 151.14 24.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.72 -22.78 27.0 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.744 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.5 -29.6 25.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.048 1.424 . . . . 0.0 112.506 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 76' ' ' ASP . 14.8 tt -64.77 -9.09 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.025 0.93 . . . . 0.0 112.613 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.17 -50.79 44.44 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 120.424 -1.422 . . . . 0.0 110.546 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -80.15 -16.27 55.27 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.759 0.824 . . . . 0.0 111.921 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -55.36 124.9 18.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.736 2.414 . . . . 0.0 107.447 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 O-C-N 121.922 -0.486 . . . . 0.0 111.351 -162.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -27.66 65.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.835 0.289 . . . . 0.0 111.756 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -61.59 -23.02 65.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.625 0.77 . . . . 0.0 112.674 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -102.44 -8.26 21.26 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.77 0.828 . . . . 0.0 110.905 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.11 92.13 4.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.22 162.84 27.05 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -112.66 -23.22 10.33 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.181 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -158.76 160.94 36.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.592 1.557 . . . . 0.0 109.032 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -157.18 -177.29 6.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.749 2.019 . . . . 0.0 108.808 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -135.93 114.94 12.24 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.76 152.42 45.4 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.274 1.6 p30 50.99 27.47 3.25 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 61.67 14.67 6.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.072 2.549 . . . . 0.0 112.732 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.9 m -98.23 124.29 42.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.527 2.331 . . . . 0.0 105.935 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.33 143.99 48.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -142.18 143.29 32.88 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 109.481 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -127.7 170.34 12.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.48 113.62 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.64 -2.08 42.28 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.431 -1.76 . . . . 0.0 114.386 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.36 -171.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.085 1.943 . . . . 0.0 108.684 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.08 143.46 51.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.533 -1.354 . . . . 0.0 108.803 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.91 162.96 71.9 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.597 -0.689 . . . . 0.0 110.297 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.41 161.9 42.98 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.484 2.789 . . . . 0.0 110.779 159.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.38 44.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mmt -54.21 -20.09 6.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.198 1.799 . . . . 0.0 111.991 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -122.84 -8.77 8.37 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.063 0.945 . . . . 0.0 112.995 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.78 -18.08 56.82 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.901 0.88 . . . . 0.0 111.435 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -60.74 144.48 89.56 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.33 -4.35 14.79 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.195 3.263 . . . . 0.0 115.332 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -51.13 -30.85 17.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.724 2.01 . . . . 0.0 114.927 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.45 2.97 14.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.148 0.979 . . . . 0.0 110.975 -167.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -66.42 129.29 39.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.196 1.798 . . . . 0.0 110.858 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -106.82 90.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 108.268 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -22.93 63.0 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.686 -0.634 . . . . 0.0 111.285 163.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.12 30.67 0.58 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.808 1.243 . . . . 0.0 111.87 -166.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -75.35 -29.93 60.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.647 1.579 . . . . 0.0 115.167 -167.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -67.93 -38.16 82.54 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.864 1.666 . . . . 0.0 112.629 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -61.86 -11.24 11.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.978 0.911 . . . . 0.0 112.357 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.34 157.78 16.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -70.61 2.35 4.16 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.565 -0.709 . . . . 0.0 112.184 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.41 148.16 85.67 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 120.896 -1.127 . . . . 0.0 110.367 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.63 165.24 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.464 2.109 . . . . 0.0 111.798 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 149.63 89.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.834 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.37 171.15 14.55 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.298 2.665 . . . . 0.0 111.506 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.49 168.98 18.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.808 1.289 . . . . 0.0 109.398 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.55 38.88 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.219 2.608 . . . . 0.0 113.986 -167.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.97 37.71 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.239 1.876 . . . . 0.0 110.461 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.4 p -148.62 166.95 26.78 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.654 -0.91 . . . . 0.0 109.816 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -146.73 152.29 38.58 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.837 0.827 . . . . 0.0 111.054 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.47 144.81 46.1 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -133.62 162.65 31.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 109.868 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.23 65.87 0.74 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.944 0.898 . . . . 0.0 110.942 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 102.7 6.87 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.8 75.17 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.464 164.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.3 -5.6 33.77 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.118 1.459 . . . . 0.0 112.734 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -113.64 162.67 15.95 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.374 1.47 . . . . 0.0 107.325 -172.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 45.3 m-85 -109.77 111.23 22.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.04 132.48 69.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 tp -92.59 117.05 29.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.864 0.866 . . . . 0.0 108.697 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.4 pt -116.25 142.31 30.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.843 0.857 . . . . 0.0 109.499 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 143.03 51.4 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.58 9.74 5.69 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.683 0.793 . . . . 0.0 112.023 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -147.64 16.78 1.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.904 1.681 . . . . 0.0 110.525 -163.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -171.48 -45.37 0.02 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 126.536 1.934 . . . . 0.0 108.286 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 26.18 50.07 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.624 -1.098 . . . . 0.0 112.22 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.36 138.49 58.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -79.0 84.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.593 1.957 . . . . 0.0 106.176 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.12 -44.47 84.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.806 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -152.14 158.73 43.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.693 1.197 . . . . 0.0 108.894 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -135.52 143.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -135.87 145.72 46.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.084 1.353 . . . . 0.0 107.572 161.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.72 155.99 36.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.639 0.654 . . . . 0.0 111.86 172.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -58.08 -25.05 56.23 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 124.619 1.104 . . . . 0.0 114.132 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.38 -27.49 36.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.887 1.344 . . . . 0.0 113.116 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.9 -20.2 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.941 0.896 . . . . 0.0 112.504 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.7 -44.92 96.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.656 0.782 . . . . 0.0 109.725 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.15 -17.14 38.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.752 0.821 . . . . 0.0 111.478 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -58.2 147.24 31.0 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 128.075 2.55 . . . . 0.0 109.552 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 . . . . . 0 C--O 1.248 1.022 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 172.124 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -34.1 72.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 111.746 -168.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -55.96 -33.85 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.486 1.115 . . . . 0.0 112.144 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.05 -4.71 56.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.648 -1.168 . . . . 0.0 110.784 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.81 90.98 0.81 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.731 1.605 . . . . 0.0 110.506 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.12 128.02 32.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.03 -16.57 37.79 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 0.986 . . . . 0.0 112.817 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.68 164.59 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -155.0 174.96 14.43 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 107.393 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -133.26 128.03 34.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' A' ' 57' ' ' MET . . . -145.83 137.03 24.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 44.59 62.42 2.05 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 110.003 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.263 1.7 p90 44.96 31.61 0.72 Allowed 'General case' 0 C--O 1.232 0.174 1 C-N-CA 132.004 4.122 . . . . 0.0 113.013 174.914 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 m -131.84 124.86 30.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -80.73 157.04 25.97 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -152.91 156.09 38.26 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.354 1.062 . . . . 0.0 110.26 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -140.2 167.67 21.61 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.929 1.692 . . . . 0.0 109.431 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.14 108.84 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.08 -7.02 21.52 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.326 -1.819 . . . . 0.0 114.162 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -174.8 1.49 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.771 1.786 . . . . 0.0 110.263 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.04 150.69 42.76 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.443 -1.411 . . . . 0.0 109.044 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.91 159.84 39.35 Favored Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 161.2 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.545 2.163 . . . . 0.0 111.557 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.58 -10.58 19.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.639 0.776 . . . . 0.0 112.748 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.88 -26.13 65.63 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.803 0.841 . . . . 0.0 111.549 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -107.83 -10.25 15.6 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.7 mt -75.9 -24.79 55.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.675 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -55.95 145.25 54.67 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.004 0.921 . . . . 0.0 109.943 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.87 -9.74 22.43 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 124.722 3.615 . . . . 0.0 112.17 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -56.04 -27.8 54.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.432 1.493 . . . . 0.0 113.504 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -117.02 2.52 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.806 0.842 . . . . 0.0 111.191 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -59.73 104.66 0.3 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 128.28 2.632 . . . . 0.0 111.301 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mm -77.03 79.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -39.65 73.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.931 169.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -88.82 66.06 7.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.311 1.044 . . . . 0.0 110.119 -174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -65.31 -50.25 66.37 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.047 -0.408 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.03 96.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.953 0.501 . . . . 0.0 111.985 -158.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.69 -25.8 60.8 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.527 1.131 . . . . 0.0 113.265 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.86 27.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.835 -1.165 . . . . 0.0 111.321 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m120 68.01 -3.67 1.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.988 2.115 . . . . 0.0 112.252 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.66 163.84 42.42 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.533 1.933 . . . . 0.0 111.847 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.46 175.23 11.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.446 2.764 . . . . 0.0 112.541 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 164.35 19.63 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 111.765 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -72.52 -169.66 0.5 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.047 2.498 . . . . 0.0 111.117 162.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.58 -172.34 2.48 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 158.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 104.05 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.803 169.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.28 -12.48 54.71 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.583 1.087 . . . . 0.0 114.587 169.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.2 p -73.41 168.52 19.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.822 1.311 . . . . 0.0 109.23 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -158.72 151.56 22.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.615 -0.678 . . . . 0.0 109.654 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -81.88 143.57 31.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -133.7 162.1 32.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.527 0.731 . . . . 0.0 110.644 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -96.32 96.95 9.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.989 1.316 . . . . 0.0 108.259 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.93 96.6 6.15 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.233 1.813 . . . . 0.0 106.848 -174.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.13 79.61 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.904 -1.498 . . . . 0.0 113.824 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.94 6.92 64.82 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.614 1.707 . . . . 0.0 112.373 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.31 147.14 31.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.403 1.602 . . . . 0.0 107.712 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 37.4 m-85 -96.94 114.29 25.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.08 131.92 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.45 112.76 24.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.02 143.57 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.193 0.997 . . . . 0.0 110.2 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.06 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -59.61 -18.57 42.42 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -115.85 12.35 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 126.295 1.838 . . . . 0.0 110.215 -161.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.94 -51.62 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.801 -1.187 . . . . 0.0 109.385 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.52 29.69 35.39 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 126.013 1.768 . . . . 0.0 112.594 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 138.32 58.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.379 1.09 . . . . 0.0 108.978 176.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.6 mt -79.7 84.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.66 -45.67 78.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.542 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -153.33 163.26 40.23 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.798 2.039 . . . . 0.0 107.633 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.7 t -137.13 151.53 27.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.21 157.97 42.96 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 156.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -63.63 156.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.392 0.677 . . . . 0.0 109.266 168.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -63.62 -22.36 65.9 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 124.764 1.173 . . . . 0.0 113.601 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.72 -17.39 34.37 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.62 1.21 . . . . 0.0 113.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.02 -26.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.973 0.909 . . . . 0.0 112.465 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -65.91 -12.04 51.68 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.675 -0.64 . . . . 0.0 111.544 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.43 18.44 12.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.57 -173.47 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 108.273 163.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.814 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.46 -32.38 68.69 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.984 0.811 . . . . 0.0 112.886 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -58.66 -27.25 64.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.803 0.841 . . . . 0.0 112.893 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -97.91 -1.65 42.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.956 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.18 90.22 5.48 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.199 1.363 . . . . 0.0 109.663 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.91 128.89 34.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -83.82 -17.87 39.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.264 0.484 . . . . 0.0 112.3 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.28 165.7 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.719 2.408 . . . . 0.0 107.236 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.11 179.61 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.715 1.206 . . . . 0.0 108.308 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -130.44 136.6 49.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.89 43.95 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 164.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.15 38.11 26.68 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.139 0.971 . . . . 0.0 111.666 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 60.02 14.31 4.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.443 1.897 . . . . 0.0 113.757 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.4 m -119.19 126.97 52.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.171 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -87.07 149.17 24.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -145.6 155.97 43.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.017 0.927 . . . . 0.0 110.798 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -139.61 164.0 31.07 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.405 1.482 . . . . 0.0 109.145 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.76 115.87 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 164.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.33 -0.09 55.81 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 117.676 -1.625 . . . . 0.0 114.811 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.89 -178.28 3.18 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.324 1.562 . . . . 0.0 109.851 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.39 152.25 41.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.952 1.701 . . . . 0.0 110.44 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.43 158.76 31.14 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 121.401 -0.812 . . . . 0.0 112.22 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 72.4 Cg_endo -68.62 158.0 59.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.799 2.333 . . . . 0.0 111.774 165.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -14.43 62.89 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.501 1.12 . . . . 0.0 113.487 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 14.8 ptp -56.08 -22.7 29.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.894 0.878 . . . . 0.0 112.935 172.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.68 -10.63 14.07 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.4 -20.13 55.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.883 0.873 . . . . 0.0 111.299 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -64.03 152.5 87.43 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.246 1.418 . . . . 0.0 110.463 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.19 -7.77 16.58 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.127 2.551 . . . . 0.0 114.262 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.56 -18.97 55.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.13 0.972 . . . . 0.0 113.276 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -122.45 -5.36 8.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 112.496 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 106.9 1.51 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.7 1.6 . . . . 0.0 112.186 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 56' ' ' TYR . 8.4 mm -79.01 78.77 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 O-C-N 120.832 -1.167 . . . . 0.0 107.966 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -61.76 -28.75 69.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.008 -1.057 . . . . 0.0 112.664 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -93.2 65.32 3.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.804 1.242 . . . . 0.0 109.698 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -82.9 -44.36 15.47 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -30.81 69.08 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.724 0.693 . . . . 0.0 111.024 -170.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -78.8 17.24 0.74 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.377 1.471 . . . . 0.0 113.308 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HB2' HD12 ' A' ' 45' ' ' LEU . 4.4 mtt85 -129.56 22.89 5.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.286 1.403 . . . . 0.0 113.28 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 57.4 8.09 0.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.414 1.886 . . . . 0.0 114.035 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 43' ' ' ARG . 2.5 mt -90.59 165.25 23.5 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.689 -1.257 . . . . 0.0 110.956 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.18 170.14 20.64 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.617 3.545 . . . . 0.0 111.641 168.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.78 165.49 2.4 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 127.21 2.204 . . . . 0.0 112.292 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.54 -164.65 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.764 2.976 . . . . 0.0 111.235 160.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.66 -169.84 1.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 158.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.51 105.75 13.82 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.46 -1.4 . . . . 0.0 110.594 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.93 44.43 7.69 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 p -140.28 166.78 23.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -152.86 145.6 24.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.904 0.859 . . . . 0.0 110.512 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -72.84 147.48 45.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.82 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -139.4 170.28 16.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.746 2.818 . . . . 0.0 108.332 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' HD11 ' A' ' 37' ' ' ILE . 16.8 t80 -116.62 78.66 1.22 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.575 0.625 . . . . 0.0 112.18 -172.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 97.86 11.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.727 2.011 . . . . 0.0 109.611 -172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.86 11.4 63.03 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.354 -0.841 . . . . 0.0 114.623 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.8 -15.73 37.29 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.198 0.999 . . . . 0.0 112.054 -170.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -89.08 138.4 31.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.633 1.217 . . . . 0.0 108.303 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.7 112.47 18.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.93 125.22 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 tp -89.87 111.78 22.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.44 150.34 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 123.057 0.543 . . . . 0.0 110.211 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.65 139.29 43.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.511 0.724 . . . . 0.0 109.433 169.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.53 -17.41 64.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.422 0.629 . . . . 0.0 110.86 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 p -100.26 -5.19 27.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.163 2.185 . . . . 0.0 112.716 -161.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -174.79 -44.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 109.003 -157.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.42 28.4 61.75 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.362 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.32 132.47 53.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.814 1.307 . . . . 0.0 108.347 163.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.34 86.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 128.666 2.786 . . . . 0.0 105.512 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.97 -46.78 83.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -152.63 163.7 39.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.018 1.327 . . . . 0.0 109.653 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.63 145.15 26.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.06 157.79 45.91 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.806 1.643 . . . . 0.0 107.143 164.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.2 157.51 34.43 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -28.63 62.96 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.271 2.367 . . . . 0.0 113.142 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -62.96 -20.3 65.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.024 0.93 . . . . 0.0 112.514 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.45 -21.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 111.889 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.53 -7.44 10.22 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 112.781 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -119.47 -0.97 10.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.005 1.322 . . . . 0.0 111.911 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -74.43 165.58 24.95 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.344 1.858 . . . . 0.0 109.488 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 129.328 3.051 . . . . 0.0 106.117 -178.038 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.91 -22.64 64.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 118.065 0.393 . . . . 0.0 110.879 -169.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.71 -26.18 68.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.509 1.124 . . . . 0.0 113.015 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -99.5 0.34 42.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.72 1.208 . . . . 0.0 111.641 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.49 101.19 0.95 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.92 151.08 25.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -101.28 -12.56 18.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.527 0.731 . . . . 0.0 111.81 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -177.05 156.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -155.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -172.15 -179.1 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 109.232 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -125.95 135.32 51.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.06 137.82 46.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.71 34.38 23.73 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.337 1.065 . . . . 0.0 110.751 168.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 59.34 14.79 3.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.835 2.454 . . . . 0.0 114.376 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -103.08 134.54 46.34 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.489 1.516 . . . . 0.0 107.267 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -90.25 141.88 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.347 1.859 . . . . 0.0 109.161 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -146.45 155.62 42.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.047 0.385 . . . . 0.0 111.71 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -145.31 167.58 22.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.734 1.214 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.0 mm -58.86 117.31 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.17 -11.84 55.36 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.003 -1.443 . . . . 0.0 114.323 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.53 -178.44 4.1 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.79 1.795 . . . . 0.0 107.164 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.78 148.09 43.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 119.349 -2.094 . . . . 0.0 108.951 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.38 163.4 66.42 Favored Pre-proline 0 CA--C 1.538 0.5 0 O-C-N 121.581 -0.699 . . . . 0.0 110.396 170.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.14 160.91 39.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.286 2.657 . . . . 0.0 111.378 160.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.15 -23.5 67.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.571 1.148 . . . . 0.0 113.132 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.571 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 6.7 ptm -53.78 -20.93 6.34 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.823 1.249 . . . . 0.0 113.594 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 8.6 m-85 -117.55 -8.15 11.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.646 1.178 . . . . 0.0 112.557 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -79.03 -25.8 43.22 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.594 1.558 . . . . 0.0 110.873 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 t -62.35 144.79 94.88 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.69 -9.57 21.37 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.649 2.233 . . . . 0.0 114.463 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -55.55 -36.51 66.87 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.062 0.945 . . . . 0.0 110.968 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.78 -11.12 16.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.767 0.827 . . . . 0.0 111.052 -173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -61.07 111.04 1.54 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.944 1.698 . . . . 0.0 109.956 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.6 mt -87.99 90.63 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -73.43 -28.52 62.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.572 164.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.23 68.95 9.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.356 0.98 . . . . 0.0 109.137 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -69.92 -57.26 5.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -44.83 -47.76 11.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.44 1.496 . . . . 0.0 114.839 -159.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -63.31 -21.64 66.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -75.22 -165.34 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.26 2.62 31.78 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.845 -1.159 . . . . 0.0 111.431 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 79' ' ' ILE . 2.5 mm? -65.04 156.15 81.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 121.325 -0.86 . . . . 0.0 112.204 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.05 171.48 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.678 3.585 . . . . 0.0 111.061 161.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.02 158.36 26.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 112.484 173.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.99 158.92 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.356 2.037 . . . . 0.0 111.01 167.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.608 ' H ' HD21 ' A' ' 63' ' ' LEU . 31.8 m-20 -62.06 149.1 42.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.72 101.27 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.435 0.694 . . . . 0.0 110.504 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.49 12.98 10.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.621 -1.1 . . . . 0.0 113.378 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.7 p -132.4 176.08 8.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.136 1.468 . . . . 0.0 111.06 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -149.49 154.37 38.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.132 0.973 . . . . 0.0 110.474 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -72.77 156.05 39.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.971 0.509 . . . . 0.0 109.865 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -147.46 167.97 23.08 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.48 106.16 16.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.297 1.839 . . . . 0.0 108.342 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG2' HG22 ' A' ' 62' ' ' VAL . 86.7 mmm -81.56 -154.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.193 1.797 . . . . 0.0 109.693 175.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.03 58.51 0.55 Allowed Glycine 0 C--N 1.338 0.679 0 C-N-CA 129.607 3.48 . . . . 0.0 111.701 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.23 56.8 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 125.676 1.608 . . . . 0.0 113.992 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -130.96 158.66 39.65 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.073 1.436 . . . . 0.0 108.87 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -102.95 125.79 49.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 108.694 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 57' ' ' MET . 16.4 m -127.71 151.02 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.648 -0.657 . . . . 0.0 109.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.608 HD21 ' H ' ' A' ' 49' ' ' ASP . 63.7 tp -103.46 127.99 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.684 HD12 HD23 ' A' ' 31' ' ' LEU . 10.4 pt -131.67 131.91 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 125.429 1.492 . . . . 0.0 110.538 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.78 134.52 57.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -8.6 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.086 -1.009 . . . . 0.0 111.377 172.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 t -134.05 12.01 3.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.928 2.091 . . . . 0.0 109.494 -158.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -171.91 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 0.0 111.425 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.1 37.95 24.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.481 1.515 . . . . 0.0 113.01 -165.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -58.84 145.63 40.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 159.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.2 mt -81.78 91.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.8 mm? -61.31 -56.92 15.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.35 163.09 35.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.468 1.507 . . . . 0.0 110.395 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.1 t -137.18 136.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.326 1.851 . . . . 0.0 107.304 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.59 142.99 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.153 0.981 . . . . 0.0 108.357 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.41 146.19 54.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.59 -20.96 40.67 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.446 1.022 . . . . 0.0 112.798 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -49.65 -30.94 9.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.509 1.124 . . . . 0.0 112.42 171.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 tt -58.36 -25.49 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.72 1.208 . . . . 0.0 112.574 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.31 -35.28 76.92 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.565 0.62 . . . . 0.0 110.657 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.73 2.37 51.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.708 0.803 . . . . 0.0 113.048 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -84.15 -174.66 5.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.341 0.656 . . . . 0.0 110.116 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 C--O 1.248 0.987 0 C-N-CA 127.073 2.149 . . . . 0.0 109.207 -172.914 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.4 pt . . . . . 0 C--O 1.224 -0.274 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.59 -24.83 65.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.101 1.76 . . . . 0.0 113.049 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.27 -34.86 77.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.289 0.636 . . . . 0.0 112.293 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -90.49 -3.84 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.099 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.39 0.78 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.432 1.014 . . . . 0.0 108.723 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.6 164.01 14.93 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -124.99 -20.06 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.46 1.504 . . . . 0.0 111.351 -172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -159.17 163.04 36.4 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.772 2.029 . . . . 0.0 107.505 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -163.71 175.56 10.43 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 110.148 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 m -127.74 112.68 15.06 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.47 158.48 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 25.39 12.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.264 0.938 . . . . 0.0 111.978 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 58.43 16.62 4.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.429 1.891 . . . . 0.0 113.133 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.7 m -117.8 125.9 51.43 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.661 1.984 . . . . 0.0 105.961 -171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -80.5 149.01 30.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -147.9 157.31 43.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.038 1.335 . . . . 0.0 109.495 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.68 167.67 21.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.318 1.447 . . . . 0.0 108.566 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.35 119.3 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.19 -13.35 40.44 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 117.782 -1.566 . . . . 0.0 114.014 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.86 -171.17 1.02 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 119.592 1.696 . . . . 0.0 107.879 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 142.56 50.49 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 118.379 -2.701 . . . . 0.0 109.981 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.36 156.56 73.63 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 121.547 -0.721 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.38 156.6 61.37 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.408 2.072 . . . . 0.0 110.564 165.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -61.22 -17.25 52.3 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.1 mmt -51.8 -27.44 12.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.533 1.533 . . . . 0.0 113.231 173.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.5 -7.31 15.18 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.8 mt -79.23 -23.75 43.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.584 1.154 . . . . 0.0 112.071 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -56.17 149.25 37.07 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.45 1.1 . . . . 0.0 110.262 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.77 -8.59 15.98 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.433 2.756 . . . . 0.0 113.18 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.02 -29.29 70.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.831 2.052 . . . . 0.0 111.861 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.38 1.22 9.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.671 1.188 . . . . 0.0 111.668 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 91.28 0.15 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.624 2.77 . . . . 0.0 108.915 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.78 112.61 5.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -88.55 -31.49 18.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 117.392 -1.29 . . . . 0.0 111.053 167.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.07 88.18 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.963 1.256 . . . . 0.0 110.655 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -104.15 -33.84 8.59 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.555 0.742 . . . . 0.0 111.972 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.76 -28.24 69.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.131 0.878 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -83.43 29.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.776 1.231 . . . . 0.0 110.754 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -141.49 169.14 18.16 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.862 2.465 . . . . 0.0 107.364 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.6 -13.91 62.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.737 1.215 . . . . 0.0 111.987 166.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.74 157.2 80.52 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.303 -0.873 . . . . 0.0 111.764 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -71.01 169.36 20.69 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.947 3.098 . . . . 0.0 111.253 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 149.72 77.14 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.72 166.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.96 169.54 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.108 2.539 . . . . 0.0 110.502 168.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -77.67 167.74 21.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.895 0.878 . . . . 0.0 108.666 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.03 42.24 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 114.426 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.65 56.12 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -159.91 171.78 18.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.305 0.642 . . . . 0.0 111.175 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -145.92 156.92 43.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.439 0.563 . . . . 0.0 110.95 167.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -80.94 153.17 27.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -136.53 168.81 18.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.397 1.079 . . . . 0.0 110.729 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -106.03 84.94 2.12 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.376 1.471 . . . . 0.0 107.646 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.3 mtp -94.85 102.06 13.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.131 0.972 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.33 6.29 86.28 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.663 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.27 4.1 53.59 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.068 1.434 . . . . 0.0 112.007 -167.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -115.09 143.71 44.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 53.8 m-85 -93.88 113.38 25.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 74' ' ' VAL . 3.6 m -127.49 143.25 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -172.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 tp -102.6 122.9 45.32 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.1 pt -124.68 149.06 28.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.007 0.923 . . . . 0.0 109.872 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.65 136.75 41.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.08 -25.16 65.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.655 0.741 . . . . 0.0 112.388 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 t -123.12 27.13 7.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.152 1.781 . . . . 0.0 110.147 -161.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -173.96 -36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.783 1.633 . . . . 0.0 110.552 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.32 21.46 77.66 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.079 1.323 . . . . 0.0 113.894 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 136.18 57.85 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.543 1.137 . . . . 0.0 108.59 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.48 87.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.2 mt -70.67 -49.24 49.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.167 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -152.52 157.94 41.83 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 109.695 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 62' ' ' VAL . 52.0 t -140.67 130.17 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.626 1.97 . . . . 0.0 107.087 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -129.43 148.19 51.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.631 1.173 . . . . 0.0 108.73 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 79' ' ' ILE . 23.2 t70 -68.64 157.81 35.4 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.817 -0.552 . . . . 0.0 111.241 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -61.73 -27.2 67.92 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-O 118.454 -1.192 . . . . 0.0 113.975 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -55.88 -27.62 52.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.961 1.381 . . . . 0.0 112.738 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 76' ' ' ASP . 16.3 tt -55.67 -26.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.579 1.152 . . . . 0.0 112.324 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -62.79 -30.34 71.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.375 0.534 . . . . 0.0 111.24 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -99.17 4.38 46.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.03 0.932 . . . . 0.0 111.627 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -69.7 -178.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.273 1.829 . . . . 0.0 110.039 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 . . . . . 0 C--O 1.245 0.855 0 O-C-N 120.77 -1.206 . . . . 0.0 111.122 -166.862 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.13 -22.99 67.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.011 0.924 . . . . 0.0 112.727 -170.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -60.4 -30.69 69.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.057 0.943 . . . . 0.0 112.693 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.52 -3.49 46.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.156 0.983 . . . . 0.0 110.688 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.88 82.24 7.6 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 109.365 -168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.96 151.27 46.74 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -16.24 15.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.071 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -156.66 157.62 35.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.067 1.347 . . . . 0.0 109.652 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -158.77 177.28 11.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.094 1.758 . . . . 0.0 109.286 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -126.13 128.75 47.81 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.08 44.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.45 38.04 4.96 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.948 1.356 . . . . 0.0 112.243 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 60.74 34.51 19.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.929 2.091 . . . . 0.0 112.953 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 m -142.33 131.85 23.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.594 1.557 . . . . 0.0 107.163 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.9 147.74 36.85 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.49 144.2 39.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.864 1.265 . . . . 0.0 108.48 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.04 174.46 7.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.05 122.66 18.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.81 -1.54 55.41 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.342 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.93 -171.38 2.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.098 1.449 . . . . 0.0 108.678 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.29 127.31 25.9 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.325 -1.484 . . . . 0.0 110.894 -169.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.8 m -70.03 158.32 87.65 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 123.22 0.608 . . . . 0.0 111.492 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.52 159.96 51.1 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.187 1.925 . . . . 0.0 111.023 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.09 -15.89 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.325 0.65 . . . . 0.0 112.54 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -25.97 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 112.097 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -116.43 -9.49 11.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.72 1.208 . . . . 0.0 113.24 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.01 -18.41 37.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.525 0.73 . . . . 0.0 111.32 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 t -53.01 150.81 9.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.212 0.605 . . . . 0.0 109.408 166.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.96 -4.39 15.04 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.866 2.378 . . . . 0.0 113.842 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -57.3 -23.93 51.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 113.246 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -121.57 10.13 10.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.746 1.157 . . . . 0.0 113.199 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.23 106.39 0.61 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.686 2.394 . . . . 0.0 112.371 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.4 mm -73.91 79.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.312 1.045 . . . . 0.0 108.724 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.54 -32.44 73.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.353 -0.842 . . . . 0.0 110.8 166.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -76.65 34.34 0.14 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.843 1.257 . . . . 0.0 114.017 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -75.64 -32.83 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -65.04 -32.34 74.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.43 1.468 . . . . 0.0 110.547 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.61 27.24 0.86 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.686 0.794 . . . . 0.0 111.737 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -132.05 165.53 23.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.02 1.728 . . . . 0.0 107.614 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.515 HD21 ' HA ' ' A' ' 83' ' ' ARG . 2.1 m120 -73.81 -19.87 60.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.44 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.61 151.56 61.11 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.371 1.069 . . . . 0.0 110.331 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.43 164.47 32.55 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.693 1.596 . . . . 0.0 110.359 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.6 157.64 36.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.411 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.59 162.1 32.64 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.324 1.35 . . . . 0.0 110.083 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -70.74 167.54 18.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 162.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.65 61.25 1.79 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 113.252 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.31 41.28 0.04 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.159 1.837 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.3 p -151.04 169.91 20.67 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.841 -0.799 . . . . 0.0 110.728 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -147.01 157.21 43.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.101 0.961 . . . . 0.0 110.184 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -98.56 137.3 37.42 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.283 0.633 . . . . 0.0 109.421 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -137.58 159.11 42.88 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.642 -0.661 . . . . 0.0 110.015 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -99.92 61.27 1.11 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.83 0.824 . . . . 0.0 112.391 -167.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 102.89 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.985 2.114 . . . . 0.0 109.82 -164.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.33 14.12 59.19 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.335 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.29 -1.52 37.53 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.851 1.825 . . . . 0.0 112.965 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -114.84 161.47 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.74 1.77 . . . . 0.0 107.909 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 65.7 m-85 -105.05 113.84 27.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.16 135.08 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -92.27 110.88 22.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.655 1.182 . . . . 0.0 108.543 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.55 142.32 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.706 1.202 . . . . 0.0 108.683 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.77 143.7 54.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.82 -12.66 61.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -140.34 24.1 2.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.274 1.43 . . . . 0.0 109.176 -159.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -165.78 -44.42 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.469 1.508 . . . . 0.0 109.166 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.39 25.03 71.57 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.292 0.949 . . . . 0.0 113.306 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 133.39 55.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 167.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.73 88.69 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.049 2.139 . . . . 0.0 106.515 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -45.95 66.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.287 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -152.17 160.9 43.3 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 109.673 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.2 141.72 40.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.172 1.789 . . . . 0.0 106.42 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -139.14 140.25 37.84 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.267 1.827 . . . . 0.0 106.378 165.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.98 155.84 35.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.431 1.014 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -51.49 -31.06 28.13 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.642 1.591 . . . . 0.0 112.789 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.56 -33.68 6.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.489 1.916 . . . . 0.0 112.551 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 tt -69.4 -12.09 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.534 1.134 . . . . 0.0 112.025 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -67.07 -34.93 78.72 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.845 -1.159 . . . . 0.0 111.182 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -91.32 -17.62 25.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.651 0.78 . . . . 0.0 111.329 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.11 141.64 55.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 128.27 2.628 . . . . 0.0 108.838 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HA ' HD21 ' A' ' 44' ' ' ASN . 12.2 mtt-85 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -53.53 -29.95 39.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.623 1.569 . . . . 0.0 112.651 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.2 -21.02 66.41 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -107.89 4.04 24.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.927 1.291 . . . . 0.0 110.766 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.63 94.51 1.01 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.12 163.64 24.36 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -121.79 -19.09 6.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.004 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.6 164.64 24.05 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.406 1.882 . . . . 0.0 107.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -168.59 -176.64 2.85 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.292 1.837 . . . . 0.0 109.084 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -135.67 133.45 38.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.106 0.962 . . . . 0.0 108.716 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.69 35.41 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.047 0.939 . . . . 0.0 109.409 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.2 39.81 20.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.924 1.29 . . . . 0.0 109.968 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.42 15.5 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.442 2.697 . . . . 0.0 114.855 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 m -114.21 131.82 56.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.419 1.488 . . . . 0.0 107.425 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.85 155.74 23.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.73 0.695 . . . . 0.0 109.373 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -149.26 153.66 37.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.408 1.483 . . . . 0.0 110.485 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -136.64 165.98 24.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.1 1.36 . . . . 0.0 107.365 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.7 mm -59.81 125.84 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 168.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.35 44.02 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.677 -1.624 . . . . 0.0 114.162 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.52 -175.89 0.91 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.213 1.506 . . . . 0.0 109.62 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 131.74 45.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 119.92 -1.737 . . . . 0.0 110.27 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' CG2' ' A' ' 64' ' ' ILE . 17.3 m -72.84 164.1 63.15 Favored Pre-proline 0 N--CA 1.467 0.397 0 C-N-CA 126.052 1.741 . . . . 0.0 111.984 -174.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 74.1 Cg_endo -74.09 158.5 45.52 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.497 2.798 . . . . 0.0 112.234 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.43 68.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.042 1.337 . . . . 0.0 111.797 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 19.6 ptt? -66.8 -33.44 75.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.358 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 25.5 m-85 -87.04 -4.3 59.15 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 118.261 -1.375 . . . . 0.0 114.146 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.37 -21.39 62.88 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.148 0.886 . . . . 0.0 110.95 168.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -69.62 148.7 96.89 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 121.899 -0.5 . . . . 0.0 111.035 -172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.5 -14.87 42.02 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.053 3.169 . . . . 0.0 111.809 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.48 -30.16 60.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.439 1.896 . . . . 0.0 112.563 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -112.62 -8.28 13.82 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.211 1.404 . . . . 0.0 111.833 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -80.77 118.22 22.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.808 1.643 . . . . 0.0 111.28 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.01 92.78 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 -21.09 63.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 111.63 169.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.57 40.12 0.29 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.621 1.168 . . . . 0.0 112.95 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -53.52 -41.45 66.38 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.279 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -61.71 -27.57 68.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.996 1.726 . . . . 0.0 114.68 -167.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -84.99 -14.86 46.13 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.461 1.482 . . . . 0.0 112.746 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 -83.74 172.11 12.54 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 166.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -109.78 8.15 24.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.325 -0.86 . . . . 0.0 111.491 -158.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.72 166.97 10.08 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 129.28 3.032 . . . . 0.0 112.613 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.07 175.5 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 121.387 1.391 . . . . 0.0 111.6 153.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 164.18 2.2 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.796 1.238 . . . . 0.0 111.238 166.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.63 167.93 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.278 1.319 . . . . 0.0 110.459 160.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -81.03 170.49 16.16 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.42 -0.8 . . . . 0.0 109.788 160.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.75 108.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.372 1.469 . . . . 0.0 110.909 167.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.64 29.78 51.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.764 174.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.6 p -130.77 171.36 13.21 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.475 1.138 . . . . 0.0 110.365 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -151.26 164.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.386 0.613 . . . . 0.0 111.445 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CD1' HD13 ' A' ' 63' ' ' LEU . 78.5 m95 -106.32 121.34 44.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.293 1.037 . . . . 0.0 110.129 -168.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.4 p -109.0 -179.97 4.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.303 1.441 . . . . 0.0 110.139 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -131.2 80.85 1.96 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.824 1.193 . . . . 0.0 111.323 -172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtp -99.18 105.5 17.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.593 1.557 . . . . 0.0 111.325 -168.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.09 15.31 62.73 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 118.711 -1.049 . . . . 0.0 113.787 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.58 8.6 59.49 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.105 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.75 127.91 54.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.228 1.514 . . . . 0.0 106.917 172.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 73.3 m-85 -85.29 121.2 27.68 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG12 HG13 ' A' ' 74' ' ' VAL . 13.3 m -127.3 145.46 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 118.847 0.748 . . . . 0.0 109.785 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' HD23 ' A' ' 72' ' ' LEU . 34.8 tp -103.53 126.67 50.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 26' ' ' VAL . 10.9 pt -131.09 135.33 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 138.89 57.87 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.412 -0.805 . . . . 0.0 109.012 170.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.94 -13.94 60.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.6 0.714 . . . . 0.0 110.726 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 p -109.04 -6.24 15.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.097 1.359 . . . . 0.0 111.011 -161.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.43 -37.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.701 1.201 . . . . 0.0 109.684 -160.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 26' ' ' VAL . . . 59.26 41.0 96.6 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 125.753 1.644 . . . . 0.0 111.888 -172.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' O ' HD22 ' A' ' 72' ' ' LEU . 9.6 tmtt? -65.69 133.99 52.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.13 93.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.517 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.4 mm? -65.26 -53.04 50.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -147.91 167.48 24.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 111.584 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 62' ' ' VAL . 68.7 t -142.55 141.18 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 127.448 2.299 . . . . 0.0 105.706 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -136.48 151.62 49.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.986 1.714 . . . . 0.0 108.019 167.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.59 153.32 40.26 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -62.88 -19.09 60.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 126.074 1.797 . . . . 0.0 113.0 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -57.02 -25.17 58.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.699 1.249 . . . . 0.0 111.405 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.27 -23.8 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.718 -0.613 . . . . 0.0 111.618 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -66.27 -13.05 59.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.856 1.207 . . . . 0.0 112.629 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -100.42 -4.94 27.95 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.417 -0.802 . . . . 0.0 110.251 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -77.53 69.89 3.84 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.419 2.287 . . . . 0.0 110.101 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.395 2.678 . . . . 0.0 117.144 158.044 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.1 pt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.84 -32.72 70.93 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 112.429 -168.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -56.13 -29.52 60.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.449 1.499 . . . . 0.0 113.618 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.99 -1.45 42.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.9 96.18 0.57 Allowed 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.748 1.158 . . . . 0.0 108.246 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.62 140.38 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -84.57 -20.34 31.64 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 122.304 -0.247 . . . . 0.0 110.932 168.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -157.61 162.73 38.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.037 1.335 . . . . 0.0 108.927 -168.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.27 177.32 11.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.377 1.071 . . . . 0.0 108.651 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -126.92 132.52 50.86 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.64 153.91 46.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 27.01 15.76 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.379 0.991 . . . . 0.0 112.692 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 57.64 14.64 2.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.062 -172.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.2 m -111.52 137.2 49.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 128.271 2.628 . . . . 0.0 105.791 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.04 154.15 18.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -149.7 153.4 36.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.254 0.621 . . . . 0.0 109.953 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -143.28 169.06 18.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.648 0.779 . . . . 0.0 109.045 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.16 93.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.87 5.46 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-O 117.809 -1.551 . . . . 0.0 114.174 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.92 176.04 1.78 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.469 1.634 . . . . 0.0 108.384 166.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -134.71 138.5 44.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -82.19 157.81 67.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.2 158.01 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 110.653 166.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.74 43.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.39 1.076 . . . . 0.0 112.479 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtm -51.92 -35.94 47.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.062 1.345 . . . . 0.0 111.824 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -97.24 -7.44 32.26 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.93 -18.97 61.34 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.665 0.666 . . . . 0.0 110.158 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.4 p -55.29 158.08 5.79 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.03 1.332 . . . . 0.0 111.497 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.37 -12.24 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.981 2.454 . . . . 0.0 113.032 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.87 -21.85 66.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.554 1.141 . . . . 0.0 112.408 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -115.51 13.36 16.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.932 1.693 . . . . 0.0 111.243 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -89.48 82.38 6.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.864 2.066 . . . . 0.0 111.218 -162.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.5 71.29 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.491 1.516 . . . . 0.0 110.905 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -68.6 -23.09 64.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.197 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -74.1 94.36 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 170.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -125.4 -27.05 3.5 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.812 -1.18 . . . . 0.0 113.641 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -51.42 -44.1 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.721 0.691 . . . . 0.0 109.177 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 -24.2 8.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.825 2.45 . . . . 0.0 115.453 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -116.07 177.06 4.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.478 1.511 . . . . 0.0 108.32 -170.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -9.58 59.66 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.07 -0.394 . . . . 0.0 111.022 -172.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.22 144.94 98.35 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 123.364 0.666 . . . . 0.0 109.816 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.11 159.86 24.62 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.796 2.331 . . . . 0.0 108.959 166.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.42 147.42 68.59 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.841 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -63.62 158.15 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.427 1.418 . . . . 0.0 108.767 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -72.52 156.41 39.05 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.48 65.06 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.533 1.533 . . . . 0.0 112.362 -164.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 25.57 0.05 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 128.004 2.716 . . . . 0.0 110.94 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.0 p -143.84 167.49 22.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.163 1.481 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -146.55 152.35 38.81 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.024 0.53 . . . . 0.0 111.726 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -92.06 128.43 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -131.8 155.44 47.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.297 0.639 . . . . 0.0 111.035 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 11.5 t80 -91.11 119.76 31.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.465 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtt -141.57 110.43 6.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.558 1.072 . . . . 0.0 111.266 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 1.98 33.85 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.106 0.86 . . . . 0.0 113.499 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.461 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.99 -18.15 19.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.824 1.678 . . . . 0.0 111.833 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -82.97 162.83 21.35 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.707 1.203 . . . . 0.0 109.5 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 34.3 m-85 -109.87 118.11 35.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.478 1.511 . . . . 0.0 107.6 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 74' ' ' VAL . 3.1 m -131.72 131.45 62.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -89.0 111.02 21.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -106.96 147.88 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.614 1.166 . . . . 0.0 108.09 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 141.75 52.15 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.3 -10.73 60.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.669 0.747 . . . . 0.0 112.543 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -124.05 -5.77 7.87 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.263 2.225 . . . . 0.0 111.299 -161.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -152.92 -32.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.36 1.464 . . . . 0.0 109.461 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.1 16.16 80.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 124.101 0.858 . . . . 0.0 113.138 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.5 OUTLIER -62.41 131.63 49.86 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.596 -0.943 . . . . 0.0 108.567 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.26 94.58 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.62 -52.56 14.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.867 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -150.15 162.53 40.26 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.116 1.366 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.566 HG13 HG12 ' A' ' 62' ' ' VAL . 86.9 t -139.58 136.45 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -133.89 143.52 48.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.37 1.068 . . . . 0.0 108.171 168.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.99 144.1 57.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -55.39 -22.78 32.01 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.337 1.446 . . . . 0.0 114.135 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.86 -20.46 57.27 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.182 1.491 . . . . 0.0 113.585 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.27 -16.8 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 112.169 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.59 -49.38 69.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.862 -1.149 . . . . 0.0 110.056 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -82.52 -17.74 43.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.24 0.616 . . . . 0.0 111.707 -168.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.12 124.09 10.8 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 130.308 3.443 . . . . 0.0 108.747 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.016 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 79' ' ' ILE . 23.3 pt . . . . . 0 C--O 1.226 -0.135 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.61 -15.58 63.57 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.88 0.472 . . . . 0.0 111.811 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.9 -21.95 66.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.297 1.439 . . . . 0.0 112.586 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.65 0.73 31.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.808 1.243 . . . . 0.0 111.722 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.599 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . . . -79.8 106.77 12.07 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.987 1.267 . . . . 0.0 109.574 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.93 HD13 HG12 ' A' ' 74' ' ' VAL . 2.9 mp -72.41 -162.12 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HE2' ' OE1' ' A' ' 12' ' ' GLU . 15.4 ptmt -134.92 -16.62 1.94 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 119.956 -1.715 . . . . 0.0 109.968 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.6 pt-20 -165.29 170.64 14.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -162.47 172.57 15.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.683 0.793 . . . . 0.0 109.501 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.11 141.3 45.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 159.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.25 142.74 32.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 160.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.64 31.14 12.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 170.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 70.15 13.72 7.72 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.451 2.701 . . . . 0.0 114.042 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.9 m -105.46 133.03 50.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 107.845 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.65 149.32 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.125 1.77 . . . . 0.0 110.25 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -157.12 146.9 20.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.887 0.875 . . . . 0.0 111.039 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -140.44 167.61 21.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.799 0.84 . . . . 0.0 110.475 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 mm -61.19 101.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.46 -10.97 9.77 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 117.577 -1.68 . . . . 0.0 116.16 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB2' HD12 ' A' ' 71' ' ' ILE . 14.8 m-20 -73.58 -174.76 1.8 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 121.005 2.403 . . . . 0.0 109.45 171.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.09 139.6 53.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.648 -1.282 . . . . 0.0 108.872 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.21 159.36 82.56 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 121.338 -0.851 . . . . 0.0 109.266 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.16 155.95 42.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.712 2.275 . . . . 0.0 111.137 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 31' ' ' LEU . . . -64.33 -11.48 32.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.15 -33.73 71.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 109.581 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -102.21 -8.3 21.43 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 28' ' ' ALA . 3.6 mm? -59.21 -27.06 65.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.2 -0.428 . . . . 0.0 109.98 167.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.3 p -64.42 144.45 98.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 117.837 0.29 . . . . 0.0 111.725 -168.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.39 -6.0 18.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.08 1.853 . . . . 0.0 111.871 -171.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.01 -38.36 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.095 2.158 . . . . 0.0 111.719 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -106.97 7.02 29.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.261 1.425 . . . . 0.0 111.702 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -90.92 107.84 19.46 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.296 1.839 . . . . 0.0 110.633 -171.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.0 mp -81.56 66.83 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.468 1.507 . . . . 0.0 110.211 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -54.23 -26.48 28.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.755 1.222 . . . . 0.0 112.133 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -72.84 90.34 1.43 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.834 1.654 . . . . 0.0 108.743 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -114.46 -28.84 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.379 1.445 . . . . 0.0 113.285 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.17 -38.84 77.43 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.773 1.229 . . . . 0.0 111.765 -168.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -119.28 44.7 2.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.807 1.243 . . . . 0.0 109.069 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -124.05 29.11 6.55 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.766 0.826 . . . . 0.0 112.4 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 m120 52.7 27.05 4.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.015 1.326 . . . . 0.0 111.853 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.9 mt -127.93 159.02 68.79 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 120.424 1.465 . . . . 0.0 110.448 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.32 173.47 13.78 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.025 2.483 . . . . 0.0 111.73 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.79 151.55 97.09 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.176 0.99 . . . . 0.0 110.947 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.31 164.89 34.27 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.559 3.506 . . . . 0.0 111.41 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.66 167.56 14.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.865 0.84 . . . . 0.0 109.186 163.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.65 51.82 0.28 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.586 2.355 . . . . 0.0 115.15 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.79 43.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 126.275 1.893 . . . . 0.0 109.156 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.2 p -154.73 168.38 27.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.469 1.135 . . . . 0.0 111.584 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -155.53 156.09 34.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.205 1.003 . . . . 0.0 109.962 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -80.57 141.31 35.19 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.277 1.031 . . . . 0.0 108.699 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.3 t -130.99 158.61 39.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.475 1.11 . . . . 0.0 108.692 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HB2' HD11 ' A' ' 37' ' ' ILE . 7.4 t80 -96.02 109.24 21.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.478 1.111 . . . . 0.0 108.592 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.87 112.86 13.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.943 1.297 . . . . 0.0 110.827 -170.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.57 -1.13 15.43 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.292 -175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.67 -12.52 25.26 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 120.066 1.933 . . . . 0.0 113.341 -164.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.76 163.01 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 118.642 1.221 . . . . 0.0 109.482 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -101.17 111.52 23.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.863 1.665 . . . . 0.0 108.376 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 74' ' ' VAL . 4.5 m -121.49 135.9 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.396 -0.815 . . . . 0.0 109.964 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 tp -89.11 113.3 24.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.563 1.545 . . . . 0.0 110.1 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.408 ' CD1' HD13 ' A' ' 31' ' ' LEU . 1.9 pp -119.28 142.28 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.598 1.159 . . . . 0.0 109.159 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 137.13 41.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.903 0.881 . . . . 0.0 109.408 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.06 1.85 4.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.944 0.898 . . . . 0.0 113.018 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 t -143.3 9.12 1.63 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.241 1.416 . . . . 0.0 110.775 -168.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -155.64 -42.65 0.08 Allowed 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.568 -1.332 . . . . 0.0 108.528 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 16.62 71.55 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.742 0.687 . . . . 0.0 111.461 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 139.72 58.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.35 1.075 . . . . 0.0 109.043 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 24' ' ' ASP . 71.4 mt -81.43 79.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.629 1.571 . . . . 0.0 107.523 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.54 -47.14 76.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -149.86 162.67 39.85 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.186 1.794 . . . . 0.0 108.878 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.93 HG12 HD13 ' A' ' 10' ' ' LEU . 45.0 t -140.62 136.93 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 9' ' ' ALA . 47.2 m-85 -137.27 144.83 42.9 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.994 1.718 . . . . 0.0 107.289 172.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 79' ' ' ILE . 52.1 t0 -70.57 159.42 34.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.83 0.741 . . . . 0.0 111.612 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.25 -28.71 72.69 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.04 0.829 . . . . 0.0 111.902 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.18 -21.51 33.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 112.455 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 5' ' ' ILE . 10.5 tt -61.88 -30.73 49.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.156 0.889 . . . . 0.0 111.469 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -66.57 -12.45 57.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 111.774 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.78 -8.01 20.14 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.488 1.115 . . . . 0.0 112.192 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -54.16 170.95 0.12 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.926 2.091 . . . . 0.0 110.046 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -173.585 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 C--O 1.226 -0.165 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -56.89 -19.51 18.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.139 2.176 . . . . 0.0 112.179 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.76 -33.93 77.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 0.0 112.576 170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -95.07 0.63 54.58 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.088 1.355 . . . . 0.0 111.81 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 87.4 1.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.927 0.891 . . . . 0.0 109.386 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.77 158.98 35.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -105.51 -13.3 15.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.112 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.82 160.76 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.717 1.607 . . . . 0.0 109.039 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -159.66 175.38 13.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.697 1.599 . . . . 0.0 108.869 168.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -117.38 143.67 45.74 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.07 153.77 34.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 166.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.07 24.13 13.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.165 0.893 . . . . 0.0 111.752 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 56.64 17.23 2.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.066 2.146 . . . . 0.0 113.54 -170.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -108.33 128.75 55.03 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.57 1.948 . . . . 0.0 106.787 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -82.55 149.27 27.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.596 1.559 . . . . 0.0 110.092 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -152.49 153.91 34.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.827 0.851 . . . . 0.0 111.052 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -139.62 165.17 27.97 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.422 1.089 . . . . 0.0 108.837 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.63 112.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.77 -9.81 34.71 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.288 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.44 -175.93 2.11 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 119.494 1.647 . . . . 0.0 107.142 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.09 161.33 21.17 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 119.046 -2.284 . . . . 0.0 108.243 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -90.81 163.11 31.27 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 109.883 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.86 155.63 61.96 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.645 2.23 . . . . 0.0 110.97 158.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -62.44 -17.91 60.48 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.862 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 mmt -49.89 -22.17 1.41 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.907 2.083 . . . . 0.0 113.454 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -116.8 -10.16 11.1 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.374 0.988 . . . . 0.0 112.699 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.8 mt -72.56 -31.68 65.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.157 0.889 . . . . 0.0 110.945 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 t -50.94 144.67 13.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.071 1.348 . . . . 0.0 109.263 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.12 -11.32 31.79 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.011 2.474 . . . . 0.0 112.711 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.17 -18.85 11.27 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 112.97 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -118.93 -1.44 11.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 112.358 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -70.37 99.51 1.59 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.724 1.61 . . . . 0.0 110.659 -168.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 mt -81.39 83.84 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -62.52 -23.32 66.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.477 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -83.67 104.89 14.15 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.539 1.063 . . . . 0.0 111.014 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.43 -25.92 2.6 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 117.652 -1.166 . . . . 0.0 114.112 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -33.92 73.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.959 1.254 . . . . 0.0 112.193 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.7 26.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.818 1.247 . . . . 0.0 111.327 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -141.32 163.76 32.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.571 1.149 . . . . 0.0 108.448 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -64.74 -28.54 69.65 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.752 0.821 . . . . 0.0 112.449 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.65 153.76 7.58 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 124.476 1.11 . . . . 0.0 112.255 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.19 177.43 8.87 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.904 2.403 . . . . 0.0 111.209 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.57 164.46 7.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.338 1.455 . . . . 0.0 111.429 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -67.52 178.2 3.4 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.619 2.212 . . . . 0.0 109.266 157.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -85.38 179.11 7.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 162.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.91 37.4 0.24 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.263 1.425 . . . . 0.0 114.72 -166.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 43.83 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.049 1.785 . . . . 0.0 109.757 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 3.3 p -147.05 172.41 13.79 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.58 -1.541 . . . . 0.0 109.604 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -145.56 149.33 34.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.774 0.321 . . . . 0.0 111.636 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.46 142.88 38.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -134.16 170.44 15.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.591 1.156 . . . . 0.0 109.94 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 25.8 t80 -106.55 104.22 13.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.418 1.087 . . . . 0.0 108.666 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.68 102.11 9.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.734 1.614 . . . . 0.0 109.149 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.98 3.14 50.63 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.992 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 111.23 -1.33 28.2 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.464 1.132 . . . . 0.0 113.04 -169.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -120.48 140.0 52.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.651 1.58 . . . . 0.0 107.673 -167.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.1 120.39 28.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.65 144.4 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 tp -102.11 125.18 48.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.2 pt -130.03 135.18 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.885 0.874 . . . . 0.0 111.942 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 52' ' ' SER . 0.0 OUTLIER -60.12 129.7 43.03 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.421 0.688 . . . . 0.0 111.348 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.94 15.73 0.84 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.743 1.217 . . . . 0.0 112.633 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -143.13 4.93 1.46 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.151 2.58 . . . . 0.0 111.642 -171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -168.69 -50.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.9 1.28 . . . . 0.0 108.876 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.43 41.7 29.63 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.439 1.971 . . . . 0.0 111.17 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -61.11 153.75 24.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 159.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.0 mt -87.61 89.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 -47.98 69.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 110.484 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -144.59 158.95 43.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.91 0.884 . . . . 0.0 110.679 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.87 130.89 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.988 2.115 . . . . 0.0 106.062 166.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -125.58 142.33 51.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 160.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -63.7 151.53 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.357 0.526 . . . . 0.0 110.039 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.84 -18.77 47.73 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.575 1.083 . . . . 0.0 113.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.37 -27.73 38.43 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.437 1.119 . . . . 0.0 111.907 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -63.33 -20.57 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 112.735 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.18 -50.68 72.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.362 0.983 . . . . 0.0 109.978 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.66 -15.51 58.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.878 1.671 . . . . 0.0 112.274 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -85.27 88.27 7.47 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -174.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 127.267 2.227 . . . . 0.0 112.575 178.613 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.15 -30.87 71.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.895 0.478 . . . . 0.0 111.449 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -64.0 -20.68 66.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.388 1.875 . . . . 0.0 112.802 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -105.34 2.2 28.62 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.202 1.401 . . . . 0.0 111.25 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.61 96.22 1.53 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.48 157.24 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -129.71 0.46 4.9 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.357 1.063 . . . . 0.0 111.528 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -173.04 161.01 4.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.929 2.891 . . . . 0.0 106.457 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -169.51 177.48 4.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.235 1.414 . . . . 0.0 109.329 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -132.52 140.58 48.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 165.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.8 41.87 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 165.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t0 54.14 27.02 7.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 61.24 29.06 18.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.52 1.928 . . . . 0.0 111.704 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 m -125.8 135.83 52.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -110.16 150.29 28.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 109.476 -171.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -148.67 146.37 28.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.565 -160.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -144.28 167.07 23.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.668 1.587 . . . . 0.0 108.266 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 mm -69.81 118.23 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.89 -11.0 57.46 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.866 -1.519 . . . . 0.0 113.71 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.14 -179.85 2.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.804 1.802 . . . . 0.0 107.363 166.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.58 157.31 31.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 119.306 -2.121 . . . . 0.0 107.617 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 64' ' ' ILE . 18.4 m -84.96 165.23 38.18 Favored Pre-proline 0 C--O 1.238 0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 111.444 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 73.3 Cg_endo -71.18 158.56 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.18 2.586 . . . . 0.0 111.42 163.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.8 67.52 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.02 0.928 . . . . 0.0 112.025 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 18.9 ptp -54.8 -20.44 8.58 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 126.104 1.762 . . . . 0.0 114.273 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.455 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 10.8 m-85 -110.2 3.73 20.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.34 -23.0 35.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 111.508 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 t -66.65 145.53 98.95 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.197 0.999 . . . . 0.0 110.89 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.96 -6.71 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.531 3.487 . . . . 0.0 114.351 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -51.63 -42.44 62.02 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.44 1.096 . . . . 0.0 110.971 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.21 -12.15 19.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.521 0.728 . . . . 0.0 112.216 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -60.76 99.95 0.1 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.878 2.471 . . . . 0.0 112.211 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -78.18 79.31 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.123 1.769 . . . . 0.0 106.4 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -62.73 -29.24 70.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.6 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -76.05 76.59 2.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 111.639 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -98.54 -19.19 17.76 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.588 -0.695 . . . . 0.0 111.405 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -0.87 13.5 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.571 -1.331 . . . . 0.0 112.976 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.47 12.45 6.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.838 1.655 . . . . 0.0 111.775 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -120.86 173.58 7.14 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 120.842 -1.161 . . . . 0.0 107.953 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.03 -12.66 49.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.044 0.537 . . . . 0.0 112.079 -170.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.44 152.64 95.42 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.996 1.318 . . . . 0.0 109.904 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.46 167.14 19.52 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.245 2.63 . . . . 0.0 111.628 170.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.21 144.3 97.46 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.893 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.04 173.37 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.243 2.629 . . . . 0.0 110.847 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.66 175.64 9.99 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.005 0.922 . . . . 0.0 110.096 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.76 99.66 0.12 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.589 1.556 . . . . 0.0 111.422 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.3 49.36 20.84 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.169 -0.957 . . . . 0.0 111.058 -175.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -132.02 171.09 14.04 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 159.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.4 154.41 34.41 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.013 0.435 . . . . 0.0 111.113 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -75.62 143.51 42.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.523 175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -129.75 172.8 11.27 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.268 1.427 . . . . 0.0 109.02 168.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 114.47 28.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.42 ' CG ' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -89.41 -154.33 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.328 0.967 . . . . 0.0 110.016 175.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 57' ' ' MET . . . -46.55 7.63 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 1 C-N-CA 132.65 4.929 . . . . 0.0 117.862 170.357 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 57' ' ' MET . . . 138.37 -19.5 3.21 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 127.193 2.33 . . . . 0.0 110.883 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' OD1' HG13 ' A' ' 62' ' ' VAL . 15.5 p30 -92.5 162.9 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.346 1.458 . . . . 0.0 110.55 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.24 125.84 52.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.374 1.469 . . . . 0.0 107.496 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 60' ' ' ASN . 2.5 m -129.53 156.37 41.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 72' ' ' LEU . 64.0 tp -117.62 125.33 50.56 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.418 ' CG2' HG11 ' A' ' 26' ' ' VAL . 1.1 pt -130.72 136.55 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 124.397 1.079 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.61 135.45 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.744 0.818 . . . . 0.0 109.644 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -6.25 8.94 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.818 -0.551 . . . . 0.0 112.221 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -135.85 12.68 3.4 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.673 1.589 . . . . 0.0 110.145 -158.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -170.95 -31.4 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 125.887 1.675 . . . . 0.0 109.822 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.43 35.65 21.83 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.271 1.415 . . . . 0.0 111.661 -165.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.469 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -64.86 152.61 42.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 170.121 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.7 mt -86.97 86.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.7 mm? -64.4 -51.76 61.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -149.8 161.88 41.38 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 109.364 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.13 142.35 40.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -132.49 152.14 51.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 161.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.49 160.8 28.41 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.877 -0.514 . . . . 0.0 111.02 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -22.19 71.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 124.451 1.024 . . . . 0.0 113.037 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -59.87 -18.57 45.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 112.296 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.33 -19.73 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 112.946 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -72.3 -35.06 68.56 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.512 1.051 . . . . 0.0 111.746 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -76.74 -16.42 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.775 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -72.77 174.53 7.54 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.075 0.941 . . . . 0.0 110.378 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 . . . . . 0 C--O 1.246 0.916 0 C-N-CA 126.359 1.864 . . . . 0.0 110.518 -161.36 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.92 -25.88 58.26 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.865 1.666 . . . . 0.0 113.166 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -65.75 -27.17 68.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.81 0.43 57.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.321 1.049 . . . . 0.0 110.507 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.56 90.96 2.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.851 1.26 . . . . 0.0 111.628 -167.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.8 129.37 34.49 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.402 1.081 . . . . 0.0 108.303 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -92.01 -15.95 27.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.095 0.862 . . . . 0.0 112.393 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.83 166.4 29.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.312 1.445 . . . . 0.0 107.625 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 44.4 p90 -156.72 176.8 12.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.047 0.939 . . . . 0.0 108.881 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -129.89 129.82 44.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.34 142.43 32.48 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 44.34 51.77 7.51 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.02 1.328 . . . . 0.0 109.961 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.299 2.6 p90 48.24 24.19 0.65 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.014 3.326 . . . . 0.0 114.601 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.6 m -115.48 138.0 51.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.669 1.988 . . . . 0.0 107.407 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -89.78 150.71 22.15 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.019 0.928 . . . . 0.0 109.33 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.8 m-85 -149.86 154.03 37.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.116 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -135.43 160.82 37.25 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.981 0.912 . . . . 0.0 108.644 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.27 113.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 -13.26 25.24 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.496 -1.724 . . . . 0.0 114.066 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.8 -172.38 1.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.078 1.939 . . . . 0.0 109.602 169.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.84 148.8 49.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.543 1.537 . . . . 0.0 108.966 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.67 154.55 45.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.681 -0.675 . . . . 0.0 110.234 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.28 165.63 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.929 2.419 . . . . 0.0 112.021 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -8.93 32.99 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.884 0.874 . . . . 0.0 112.708 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -22.81 60.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.801 1.64 . . . . 0.0 110.838 170.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -110.66 -23.67 10.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.872 0.869 . . . . 0.0 113.153 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -76.97 -18.02 58.5 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.304 0.502 . . . . 0.0 111.456 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 t -54.06 147.98 23.45 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.346 1.858 . . . . 0.0 110.508 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.38 -11.37 31.2 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.71 -9.72 15.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.764 1.625 . . . . 0.0 113.761 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -132.12 0.19 3.78 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.527 1.058 . . . . 0.0 112.591 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.26 136.9 57.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.645 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -118.71 88.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.696 1.599 . . . . 0.0 108.672 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.41 -14.23 62.79 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.702 -0.624 . . . . 0.0 111.839 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.16 43.12 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.053 1.341 . . . . 0.0 110.516 -162.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -70.6 -15.49 62.75 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.97 -25.58 67.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.397 0.999 . . . . 0.0 111.74 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.09 39.36 0.76 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 119.564 1.075 . . . . 0.0 111.712 -171.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 174.15 156.56 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 130.11 3.364 . . . . 0.0 106.684 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -81.82 0.75 37.98 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.734 . . . . 0.0 111.621 -174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.22 151.87 16.97 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 119.261 0.937 . . . . 0.0 111.179 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.79 168.42 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.077 1.851 . . . . 0.0 110.481 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.52 158.18 11.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.282 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.9 162.51 37.5 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.734 1.623 . . . . 0.0 110.232 167.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -70.73 162.66 28.69 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 162.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 109.25 1.96 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.926 -1.109 . . . . 0.0 110.92 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.58 33.98 17.65 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.339 0.518 . . . . 0.0 111.895 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.3 p -130.69 171.12 13.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.018 0.927 . . . . 0.0 108.869 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -143.77 153.26 42.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -94.48 133.78 37.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.372 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -134.64 160.25 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.07 114.89 26.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.654 ' HG2' HG13 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -90.35 -152.89 0.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.972 1.309 . . . . 0.0 108.417 171.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.81 52.87 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 130.233 3.778 . . . . 0.0 115.3 166.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.97 3.49 89.13 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 117.818 0.809 . . . . 0.0 113.756 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' HB2' ' HE3' ' A' ' 57' ' ' MET . 10.3 m-80 -121.49 166.63 13.87 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.966 1.307 . . . . 0.0 107.566 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -108.6 120.65 43.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 57' ' ' MET . 30.4 m -112.07 155.63 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -111.33 118.87 37.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.528 HD12 HD23 ' A' ' 31' ' ' LEU . 3.8 pt -116.9 145.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.366 1.867 . . . . 0.0 109.145 -174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.02 141.18 56.29 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 120.053 1.297 . . . . 0.0 107.69 166.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -73.18 -6.88 48.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.87 0.843 . . . . 0.0 112.368 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 t -136.07 23.24 3.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.434 1.894 . . . . 0.0 110.288 -163.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -172.92 -38.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.94 1.696 . . . . 0.0 109.2 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.63 25.97 68.65 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 125.14 1.352 . . . . 0.0 113.216 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.99 143.87 57.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.565 1.146 . . . . 0.0 108.972 174.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.97 91.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.991 1.716 . . . . 0.0 107.501 -169.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.5 mt -79.38 -48.3 14.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.631 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -146.27 163.03 36.76 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.467 1.507 . . . . 0.0 108.043 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 62' ' ' VAL . 42.0 t -140.58 142.83 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 166.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.72 148.96 51.48 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 161.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 79' ' ' ILE . 19.1 t70 -62.25 158.72 16.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.072 0.949 . . . . 0.0 112.44 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.3 -24.52 55.74 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 126.15 1.834 . . . . 0.0 115.083 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -63.84 -21.13 66.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 120.141 1.97 . . . . 0.0 112.694 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 76' ' ' ASP . 9.8 tt -67.48 0.67 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 121.271 -0.893 . . . . 0.0 111.564 172.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -66.29 -41.62 89.54 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.397 -1.439 . . . . 0.0 110.952 162.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -131.48 16.71 4.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.475 1.11 . . . . 0.0 112.848 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -51.5 133.44 29.94 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.894 2.077 . . . . 0.0 107.961 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.567 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 121.124 0.488 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.74 -16.62 64.37 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.476 1.11 . . . . 0.0 112.798 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -57.94 -24.73 59.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.672 1.589 . . . . 0.0 112.457 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.98 -1.27 34.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 0.0 111.98 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.77 104.07 10.1 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.862 0.755 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.14 125.57 29.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -65.84 -30.15 70.72 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.519 -1.363 . . . . 0.0 110.422 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.78 153.85 28.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.69 176.26 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.058 1.343 . . . . 0.0 108.554 171.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.3 m -126.74 139.07 53.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.45 151.11 37.69 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.33 35.18 13.19 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.875 0.87 . . . . 0.0 111.871 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 58.54 37.94 25.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.906 2.482 . . . . 0.0 112.691 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -138.12 133.19 33.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.998 1.719 . . . . 0.0 107.506 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.28 154.42 21.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.546 0.738 . . . . 0.0 109.688 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -147.5 154.28 40.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.079 1.752 . . . . 0.0 110.435 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -145.81 165.21 29.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.231 1.412 . . . . 0.0 109.364 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -66.7 100.65 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.87 -1.92 19.69 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.042 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -79.51 -174.44 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.266 1.033 . . . . 0.0 108.679 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 164.81 20.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.712 1.605 . . . . 0.0 109.606 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.97 163.89 16.25 Favored Pre-proline 0 N--CA 1.47 0.534 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.11 155.54 47.29 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.756 1.637 . . . . 0.0 110.221 162.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.78 -16.39 57.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp -56.25 -18.19 9.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.018 1.727 . . . . 0.0 112.508 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 57' ' ' MET . 69.8 m-85 -116.35 -11.35 11.23 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.29 1.036 . . . . 0.0 113.268 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.5 -13.96 59.21 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-N 118.744 0.702 . . . . 0.0 110.61 171.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -64.88 145.04 99.05 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.163 -0.961 . . . . 0.0 108.44 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.1 -3.8 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.178 2.585 . . . . 0.0 114.209 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.02 -12.67 1.54 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.884 -1.135 . . . . 0.0 113.334 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -127.02 3.12 6.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.803 1.241 . . . . 0.0 112.042 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 116.84 5.71 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.429 2.691 . . . . 0.0 111.4 -170.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.76 122.14 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.813 1.645 . . . . 0.0 107.85 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -131.94 -5.14 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.82 34.57 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.445 1.93 . . . . 0.0 112.312 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.02 -29.25 70.15 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 120.737 -1.227 . . . . 0.0 110.916 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -56.88 -13.3 2.51 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.322 1.449 . . . . 0.0 113.712 172.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.15 1.77 7.89 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.722 1.609 . . . . 0.0 113.341 -173.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 -118.0 161.17 20.24 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.842 1.657 . . . . 0.0 109.493 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.01 58.63 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.151 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.61 155.41 73.55 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.013 1.325 . . . . 0.0 109.472 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.99 164.72 34.79 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.441 2.761 . . . . 0.0 113.095 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.29 84.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.045 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.483 ' CB ' HD11 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -81.46 -59.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.594 0.891 . . . . 0.0 113.263 -166.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 176.61 -162.3 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 131.527 3.931 . . . . 0.0 105.681 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.08 2.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.178 2.191 . . . . 0.0 112.388 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.32 47.32 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 p -142.02 165.76 26.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.154 0.981 . . . . 0.0 110.883 168.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -137.49 157.49 46.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.889 0.476 . . . . 0.0 110.195 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -84.53 151.68 24.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p -138.73 176.89 8.31 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.689 1.596 . . . . 0.0 109.119 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 8.0 t80 -116.85 104.4 11.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.616 1.167 . . . . 0.0 108.661 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 30' ' ' TYR . 42.7 ttm -112.92 98.67 7.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.396 1.878 . . . . 0.0 108.176 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.31 11.22 64.1 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.444 1.02 . . . . 0.0 113.904 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 109.63 -12.42 32.8 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.973 1.386 . . . . 0.0 113.311 -172.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -94.51 120.17 34.33 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.468 2.307 . . . . 0.0 107.202 -171.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.485 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 30.7 m-85 -64.55 114.5 4.41 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.369 -0.832 . . . . 0.0 108.887 162.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG12 ' HB ' ' A' ' 74' ' ' VAL . 4.2 m -123.97 154.88 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 48' ' ' PRO . 27.0 tp -109.32 130.47 55.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.513 1.125 . . . . 0.0 109.864 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.6 pt -131.5 142.36 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.804 1.241 . . . . 0.0 110.061 -173.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 138.82 53.0 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.902 0.774 . . . . 0.0 109.772 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.51 -14.89 62.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.88 0.872 . . . . 0.0 112.113 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -128.59 1.37 5.55 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.115 1.766 . . . . 0.0 110.484 -167.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.16 -35.38 0.24 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.989 -1.069 . . . . 0.0 111.907 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.44 20.43 79.38 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.759 0.695 . . . . 0.0 113.228 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 132.99 55.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.26 92.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 127.568 2.347 . . . . 0.0 105.781 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.35 -54.07 16.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -151.16 170.69 18.83 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.743 0.817 . . . . 0.0 109.681 -170.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.2 p -143.23 140.78 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 1 C-N-CA 132.07 4.148 . . . . 0.0 105.113 171.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -142.79 112.37 6.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.412 -1.28 . . . . 0.0 108.262 160.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -49.19 146.73 3.44 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.904 1.229 . . . . 0.0 113.117 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.485 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -44.53 -26.15 0.98 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.732 -1.594 . . . . 0.0 116.175 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -49.67 -30.79 9.69 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.875 1.837 . . . . 0.0 112.686 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.06 -22.57 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.947 0.899 . . . . 0.0 112.379 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.16 -30.62 71.73 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 111.305 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -93.21 8.45 40.18 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.471 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -72.96 172.38 11.06 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.242 0.544 . . . . 0.0 110.594 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.325 0.65 . . . . 0.0 110.426 179.699 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 -20.43 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.437 0.562 . . . . 0.0 112.019 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -52.82 -26.51 14.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.007 2.123 . . . . 0.0 113.797 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -96.58 0.65 50.34 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.51 1.524 . . . . 0.0 112.31 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.65 118.43 22.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.406 1.457 . . . . 0.0 108.581 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.887 HD13 HG12 ' A' ' 74' ' ' VAL . 1.9 mp -83.4 -167.97 1.91 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 123.872 1.796 . . . . 0.0 106.753 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 -19.76 6.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.167 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -170.79 170.59 6.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -159.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -170.47 -178.38 2.68 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.862 1.665 . . . . 0.0 109.37 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -125.47 137.96 53.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 164.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.2 43.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 164.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.55 30.17 16.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.099 0.952 . . . . 0.0 112.06 176.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 58.35 25.22 12.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.672 1.189 . . . . 0.0 111.796 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 m -127.29 128.86 46.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.023 2.529 . . . . 0.0 106.768 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.88 152.96 29.35 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.831 0.853 . . . . 0.0 109.468 174.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -146.28 158.1 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.415 1.086 . . . . 0.0 110.024 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -139.73 164.44 29.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.135 1.774 . . . . 0.0 109.174 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.91 117.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 166.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -5.78 56.1 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.169 -1.351 . . . . 0.0 113.892 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.55 -177.11 3.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.082 1.941 . . . . 0.0 107.484 165.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 157.09 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.257 -1.527 . . . . 0.0 108.524 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.16 162.45 34.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.906 0.775 . . . . 0.0 109.452 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.99 162.46 34.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.0 2.467 . . . . 0.0 111.633 163.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -17.08 24.92 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.581 1.153 . . . . 0.0 112.998 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.18 -21.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.057 1.343 . . . . 0.0 112.44 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.95 -6.59 10.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.882 0.873 . . . . 0.0 112.774 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.81 -33.62 72.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.946 1.248 . . . . 0.0 109.873 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.2 t -49.35 144.3 8.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.644 1.578 . . . . 0.0 109.286 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.785 1.657 . . . . 0.0 113.015 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -54.69 -29.18 52.21 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -116.44 4.22 13.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.688 1.195 . . . . 0.0 111.204 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -80.85 118.07 22.04 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.446 2.299 . . . . 0.0 109.389 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.46 76.88 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -61.54 -30.44 70.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.366 -0.834 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.82 104.77 1.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -127.08 -15.03 5.38 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.813 -1.179 . . . . 0.0 113.795 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -30.72 32.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.047 1.294 . . . . 0.0 112.092 -177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -89.03 44.16 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.064 0.847 . . . . 0.0 108.805 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -146.7 -170.28 3.48 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.214 2.206 . . . . 0.0 106.503 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.85 -15.76 24.74 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.654 0.782 . . . . 0.0 111.607 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.96 150.77 96.22 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.05 169.35 20.75 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.609 1.54 . . . . 0.0 109.14 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 146.58 79.34 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.8 169.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.99 -167.43 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.518 3.479 . . . . 0.0 111.266 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 165.39 11.74 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 165.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.87 46.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.431 1.493 . . . . 0.0 113.026 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.59 23.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.957 2.218 . . . . 0.0 111.686 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 p -140.06 165.12 28.21 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.19 -1.183 . . . . 0.0 111.162 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -147.12 156.26 42.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.201 0.6 . . . . 0.0 111.203 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -77.97 134.41 37.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.304 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -127.47 165.7 19.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.926 1.29 . . . . 0.0 109.429 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.11 105.65 15.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.249 1.419 . . . . 0.0 108.392 177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG2' HG22 ' A' ' 62' ' ' VAL . 97.4 mmm -78.53 -154.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.452 1.501 . . . . 0.0 108.934 174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.21 64.94 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 128.909 3.147 . . . . 0.0 111.895 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.61 14.67 79.54 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.448 -1.751 . . . . 0.0 114.569 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.23 159.05 43.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.846 1.823 . . . . 0.0 108.863 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.06 137.23 35.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 57' ' ' MET . 5.8 m -136.19 158.6 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 121.523 -0.736 . . . . 0.0 109.442 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.69 114.3 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.447 1.099 . . . . 0.0 109.066 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.47 144.99 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.102 0.961 . . . . 0.0 110.047 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 p -73.07 137.83 45.52 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -77.8 10.63 2.62 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.682 1.23 . . . . 0.0 113.26 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -139.44 7.68 2.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.749 2.02 . . . . 0.0 110.827 -167.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -167.14 -49.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.937 1.295 . . . . 0.0 109.059 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.45 19.55 17.98 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.174 1.369 . . . . 0.0 112.563 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 131.11 45.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.618 -0.931 . . . . 0.0 110.283 -173.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.76 91.95 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.507 1.523 . . . . 0.0 107.778 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.27 -42.66 25.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.418 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -149.15 155.28 40.43 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.183 0.993 . . . . 0.0 108.531 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.887 HG12 HD13 ' A' ' 10' ' ' LEU . 88.5 t -137.64 125.79 31.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -126.74 119.11 26.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 107.652 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.12 145.0 27.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.485 1.514 . . . . 0.0 111.702 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -7.26 40.02 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.196 -1.565 . . . . 0.0 114.521 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.3 -22.42 62.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.312 1.556 . . . . 0.0 111.049 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 -30.0 45.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-N 120.317 1.417 . . . . 0.0 111.126 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -53.05 -35.93 60.05 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.015 1.326 . . . . 0.0 111.316 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -87.22 20.79 2.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.802 0.841 . . . . 0.0 111.586 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -117.0 49.68 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.992 1.317 . . . . 0.0 111.805 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 115.815 -2.04 . . . . 0.0 108.828 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 CA--C 1.522 -0.102 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.82 -20.6 65.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.735 0.814 . . . . 0.0 111.029 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -65.15 -18.9 65.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.423 1.889 . . . . 0.0 113.969 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -102.69 2.95 36.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.329 1.052 . . . . 0.0 110.975 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 97.4 1.58 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.837 1.199 . . . . 0.0 109.141 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.8 143.31 46.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.0 -12.58 44.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.653 0.206 . . . . 0.0 110.713 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 177.87 164.93 0.67 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.165 2.186 . . . . 0.0 108.19 -164.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -168.56 -175.09 2.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.55 1.54 . . . . 0.0 109.589 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.88 47.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.83 152.95 38.51 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 162.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.83 30.19 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.289 1.043 . . . . 0.0 112.679 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 56.43 14.74 1.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.583 1.953 . . . . 0.0 113.122 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 m -100.12 117.22 33.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.729 2.012 . . . . 0.0 105.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.99 37.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.8 0.84 . . . . 0.0 109.81 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -148.1 154.01 39.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 110.956 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -146.65 161.86 39.66 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.577 1.551 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.91 122.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.65 7.95 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.014 -1.992 . . . . 0.0 113.867 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.06 -170.32 0.45 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 120.02 1.91 . . . . 0.0 109.871 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.02 160.72 32.82 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.676 1.99 . . . . 0.0 108.74 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 27' ' ' PRO . 20.7 m -107.71 163.74 16.31 Favored Pre-proline 0 N--CA 1.476 0.872 0 O-C-N 120.576 -1.327 . . . . 0.0 112.671 -174.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 41.8 Cg_endo -72.33 163.39 38.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.492 2.795 . . . . 0.0 114.198 169.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.79 66.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 112.23 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.62 -21.92 54.98 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 119.033 0.833 . . . . 0.0 111.044 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 22.5 m-85 -109.32 11.09 25.43 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.58 -23.22 19.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.904 . . . . 0.0 111.952 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 t -69.44 147.81 97.0 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.598 0.759 . . . . 0.0 111.107 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.39 -4.62 9.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.609 3.539 . . . . 0.0 113.768 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.57 -22.83 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.16 1.784 . . . . 0.0 113.325 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -121.49 -6.12 9.26 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.636 1.175 . . . . 0.0 111.507 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.79 123.59 20.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.97 1.308 . . . . 0.0 111.047 -172.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -104.27 96.01 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.99 -37.41 87.03 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.567 -0.708 . . . . 0.0 110.36 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -89.02 109.06 19.95 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.191 0.996 . . . . 0.0 109.352 -167.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . 0.273 23.0 p-90 -112.83 -47.21 3.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 116.782 -1.58 . . . . 0.0 114.992 -170.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.71 -37.67 76.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.221 1.828 . . . . 0.0 111.11 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -55.7 -36.2 66.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.078 0.551 . . . . 0.0 111.932 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -88.97 24.14 2.17 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.095 -1.003 . . . . 0.0 111.397 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.31 6.32 5.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.292 2.637 . . . . 0.0 112.706 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.65 156.06 35.76 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 120.856 -1.152 . . . . 0.0 112.696 -159.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 166.82 25.9 Favored 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.581 4.187 . . . . 0.0 111.277 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.48 153.23 51.08 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.824 1.25 . . . . 0.0 110.478 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -65.46 170.37 11.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.159 1.906 . . . . 0.0 110.364 165.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.76 160.31 32.83 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 103.38 0.56 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.134 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.89 32.59 4.05 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.765 1.65 . . . . 0.0 111.057 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.8 p -150.58 173.6 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.613 -1.522 . . . . 0.0 110.239 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -156.09 158.81 38.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.722 0.772 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.97 144.1 37.05 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.801 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -131.93 172.26 12.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.09 1.356 . . . . 0.0 108.87 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.91 122.05 46.4 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.424 ' CG ' HG21 ' A' ' 62' ' ' VAL . 7.9 mmt -90.07 -162.71 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.119 1.367 . . . . 0.0 108.09 167.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.42 -12.02 5.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 127.32 2.39 . . . . 0.0 116.426 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.19 4.93 0.02 OUTLIER Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.888 1.709 . . . . 0.0 112.713 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -129.54 152.26 49.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 110.408 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.81 130.03 44.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.721 1.208 . . . . 0.0 108.602 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 57' ' ' MET . 1.6 m -135.61 155.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.43 115.81 24.22 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.662 1.585 . . . . 0.0 109.116 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.45 142.06 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.2 1.0 . . . . 0.0 109.396 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 143.62 50.66 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 122.753 0.421 . . . . 0.0 110.473 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -66.52 -18.38 65.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 t -120.25 -9.37 9.54 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.26 1.824 . . . . 0.0 110.83 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -144.92 -45.96 0.23 Allowed 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.38 1.072 . . . . 0.0 108.89 -165.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 22.4 66.62 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.663 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 131.61 51.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.539 1.17 . . . . 0.0 108.375 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.08 91.12 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 126.678 1.991 . . . . 0.0 105.881 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.36 -55.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.36 148.8 28.57 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.674 0.67 . . . . 0.0 109.568 -169.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -128.89 137.21 57.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -131.14 147.94 52.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.16 155.79 39.28 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.717 -0.615 . . . . 0.0 110.232 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.31 -11.55 59.41 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.796 1.188 . . . . 0.0 112.607 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.1 -32.96 56.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.763 1.625 . . . . 0.0 111.823 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.51 -23.33 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.422 0.555 . . . . 0.0 112.117 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -63.07 -30.32 71.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.562 -0.712 . . . . 0.0 111.65 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -77.46 -25.74 50.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.459 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -65.06 142.95 58.23 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.283 1.033 . . . . 0.0 109.05 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 . . . . . 0 C--O 1.251 1.15 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.51 -27.86 62.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.426 1.09 . . . . 0.0 112.103 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -53.09 -34.46 56.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.033 1.333 . . . . 0.0 113.067 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.81 -6.82 58.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.886 0.874 . . . . 0.0 111.729 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 101.23 3.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.768 1.167 . . . . 0.0 109.13 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.79 129.15 37.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -64.35 -28.6 69.81 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 120.049 -1.657 . . . . 0.0 110.106 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.81 158.99 39.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.354 0.662 . . . . 0.0 110.145 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CD1' ' CE ' ' A' ' 57' ' ' MET . 54.9 p90 -160.04 -177.99 6.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.984 1.314 . . . . 0.0 110.877 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -133.88 139.21 46.05 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.922 1.289 . . . . 0.0 108.172 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.33 31.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.958 0.903 . . . . 0.0 109.778 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.54 41.25 4.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.951 1.7 . . . . 0.0 112.26 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 59.62 49.14 8.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.529 1.932 . . . . 0.0 111.066 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 m -152.73 144.77 23.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.882 1.673 . . . . 0.0 108.652 168.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.95 147.93 25.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.332 2.253 . . . . 0.0 110.01 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.03 160.25 41.68 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.914 1.686 . . . . 0.0 111.863 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -141.97 169.14 18.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.871 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm -58.85 121.87 7.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 5.87 70.32 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.866 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.66 -172.81 3.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.731 1.766 . . . . 0.0 108.976 160.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.47 139.99 53.24 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 109.001 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.88 160.23 78.83 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.18 166.64 26.2 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.434 2.089 . . . . 0.0 110.261 161.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.0 -23.51 33.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.879 1.272 . . . . 0.0 112.141 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.8 mtp -55.88 -16.84 5.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.248 1.819 . . . . 0.0 113.694 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -118.92 -1.56 10.98 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -24.2 43.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.241 0.928 . . . . 0.0 110.372 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.38 154.22 23.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 127.17 2.188 . . . . 0.0 113.618 -174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -67.64 -5.43 14.22 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.434 4.089 . . . . 0.0 113.928 171.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -58.92 -63.89 1.14 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.605 1.162 . . . . 0.0 108.867 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -87.15 2.91 48.42 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.626 1.57 . . . . 0.0 112.709 -168.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.08 132.53 53.77 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.892 2.077 . . . . 0.0 110.314 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mm -119.06 80.04 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.529 1.131 . . . . 0.0 108.246 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -52.73 -29.05 24.85 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.017 -1.052 . . . . 0.0 112.099 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 0.45 17.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.705 1.202 . . . . 0.0 113.794 -165.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -59.66 -3.21 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -166.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -40.33 71.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 122.391 2.36 . . . . 0.0 112.908 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -137.54 55.86 1.78 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 110.337 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -137.48 34.88 2.48 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.607 1.163 . . . . 0.0 110.459 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 75.32 -36.56 0.31 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 129.074 2.95 . . . . 0.0 113.714 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.83 149.99 61.66 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 126.212 1.805 . . . . 0.0 110.8 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.02 165.24 33.2 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.591 2.194 . . . . 0.0 111.78 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.76 97.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 165.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.47 172.76 12.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.563 2.176 . . . . 0.0 111.303 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 161.34 27.13 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 107.85 0.63 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.934 1.293 . . . . 0.0 110.569 175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.74 9.06 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.456 1.503 . . . . 0.0 112.414 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.5 p -146.63 166.38 26.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.816 1.308 . . . . 0.0 110.958 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -156.04 157.23 35.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.755 0.822 . . . . 0.0 111.259 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.06 130.73 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 p -124.84 154.94 40.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 105.8 11.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.455 ' CE ' ' CD1' ' A' ' 13' ' ' PHE . 8.2 ptm -77.4 -154.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.97 62.55 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 1 C-N-CA 131.672 4.463 . . . . 0.0 112.89 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.64 6.75 88.91 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 126.309 1.909 . . . . 0.0 114.457 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.537 HD21 ' HA ' ' A' ' 76' ' ' ASP . 8.7 m120 -125.03 164.76 19.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.57 1.548 . . . . 0.0 106.828 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -95.74 131.71 41.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 74' ' ' VAL . 3.9 m -119.43 149.23 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 120.159 1.345 . . . . 0.0 109.238 170.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.38 119.3 32.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.66 146.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.852 1.261 . . . . 0.0 108.455 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.64 152.48 31.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.06 0.391 . . . . 0.0 111.515 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -34.81 78.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.442 165.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -86.97 -7.87 57.75 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.061 -1.024 . . . . 0.0 111.822 -171.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 70' ' ' LYS . 14.4 pt-20 -155.14 -35.55 0.09 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 172.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.5 49.58 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.813 -172.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -61.75 132.03 51.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.967 0.883 . . . . 0.0 108.95 176.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.88 82.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 129.174 2.989 . . . . 0.0 106.807 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.89 -50.08 58.36 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -145.27 168.09 21.28 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.898 1.279 . . . . 0.0 108.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.1 p -133.94 149.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 C-N-CA 133.786 4.835 . . . . 0.0 105.222 167.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -140.05 130.63 25.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 151.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.537 ' HA ' HD21 ' A' ' 60' ' ' ASN . 9.0 t70 -52.34 146.43 9.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.662 0.664 . . . . 0.0 109.526 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.7 -26.82 11.2 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.519 -1.156 . . . . 0.0 113.206 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -54.74 -24.93 24.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.115 1.766 . . . . 0.0 112.161 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -55.98 -33.05 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.062 0.846 . . . . 0.0 110.996 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -61.43 -13.46 20.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.429 1.891 . . . . 0.0 112.433 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.16 -8.62 15.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.199 0.909 . . . . 0.0 112.977 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -81.0 34.7 0.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.395 1.878 . . . . 0.0 110.978 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 C-N-CA 125.98 1.712 . . . . 0.0 111.641 -156.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.44 153.52 43.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 162.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.88 58.4 1.6 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.86 -107.57 0.59 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.46 -18.64 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.42 -167.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.23 -26.2 67.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.16 0.584 . . . . 0.0 111.163 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -23.02 65.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.634 1.574 . . . . 0.0 113.837 171.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -101.36 4.5 41.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.996 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.89 111.28 21.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 121.017 1.735 . . . . 0.0 109.497 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 10' ' ' LEU . 4.0 mp -81.92 -165.51 1.01 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.412 1.577 . . . . 0.0 106.841 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -134.3 -13.96 2.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.725 -2.034 . . . . 0.0 113.236 164.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 178.49 159.09 0.53 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.882 0.765 . . . . 0.0 110.502 -163.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 4.7 p90 -167.33 -175.54 2.94 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.659 1.584 . . . . 0.0 109.159 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -128.49 135.49 49.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 157.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.54 161.98 33.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 158.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 20.65 11.96 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 163.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 62.29 29.45 17.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.331 1.853 . . . . 0.0 112.586 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -129.96 122.51 28.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.611 2.364 . . . . 0.0 107.626 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.58 147.0 30.96 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.4 m-85 -147.21 158.49 43.97 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.811 0.844 . . . . 0.0 110.292 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.16 173.44 11.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.964 1.306 . . . . 0.0 109.0 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.64 108.22 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.77 2.37 39.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.598 -1.668 . . . . 0.0 114.822 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -178.06 1.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.481 1.64 . . . . 0.0 108.135 161.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.18 146.99 48.33 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.667 -1.27 . . . . 0.0 107.581 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.6 m -79.09 162.1 65.68 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.84 162.26 39.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.797 2.331 . . . . 0.0 111.077 162.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -16.3 44.15 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.437 1.095 . . . . 0.0 112.153 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtt -60.06 -17.24 38.0 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 124.874 1.27 . . . . 0.0 112.158 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -119.95 1.72 10.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.6 -26.22 57.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.461 1.028 . . . . 0.0 110.269 167.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -57.99 144.4 75.5 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.66 -4.24 14.23 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 112.724 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.04 -14.95 18.9 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.795 2.038 . . . . 0.0 114.005 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.6 -5.09 8.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.253 1.421 . . . . 0.0 112.237 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.27 106.74 2.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.906 2.082 . . . . 0.0 110.15 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 56' ' ' TYR . 2.7 mp -90.57 83.62 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -63.72 -16.92 62.36 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.273 -0.892 . . . . 0.0 111.115 167.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -90.11 70.77 7.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.148 2.179 . . . . 0.0 108.022 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -111.92 -19.45 12.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -72.17 -35.99 69.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.767 1.167 . . . . 0.0 111.483 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -78.13 38.1 0.27 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.552 0.615 . . . . 0.0 110.034 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -146.39 166.1 27.36 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 127.271 2.228 . . . . 0.0 106.611 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.38 -16.47 62.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.167 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.85 148.71 75.55 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 0.0 112.265 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -74.1 157.85 46.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.086 2.524 . . . . 0.0 112.757 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.65 142.58 96.13 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.607 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.37 162.89 39.2 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.058 2.505 . . . . 0.0 112.189 -171.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.406 ' H ' HD21 ' A' ' 63' ' ' LEU . 25.9 m-20 -68.54 160.57 29.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.95 50.72 1.42 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.453 1.501 . . . . 0.0 113.266 -161.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.53 38.9 0.02 OUTLIER Glycine 0 CA--C 1.528 0.9 0 C-N-CA 127.37 2.414 . . . . 0.0 109.835 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.9 p -148.37 172.17 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.645 1.223 . . . . 0.0 110.577 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -145.58 156.41 43.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.173 0.511 . . . . 0.0 111.956 169.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -73.33 141.41 47.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.983 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.27 131.95 35.12 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.141 2.177 . . . . 0.0 106.256 -169.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.542 ' HB2' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.16 100.34 11.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.48 -155.66 0.07 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 108.309 169.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.98 60.99 0.53 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 127.355 2.407 . . . . 0.0 113.89 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.4 66.13 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.381 0.591 . . . . 0.0 113.329 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -134.87 154.74 51.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.61 115.54 30.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.73 149.33 7.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' HD23 ' A' ' 72' ' ' LEU . 67.8 tp -100.92 126.08 47.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.03 135.79 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 C-N-CA 123.81 0.844 . . . . 0.0 110.056 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 133.77 52.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 108.617 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.15 -2.27 23.91 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.808 -1.183 . . . . 0.0 112.044 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -127.15 13.2 7.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.68 1.592 . . . . 0.0 109.534 -170.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -164.38 -48.24 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.401 1.08 . . . . 0.0 109.814 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 33.95 66.48 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 126.753 2.12 . . . . 0.0 112.18 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -55.8 143.01 32.7 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 160.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.0 86.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 70' ' ' LYS . 2.3 mm? -63.62 -49.67 72.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.207 1.003 . . . . 0.0 110.117 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -146.21 161.05 41.1 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.689 1.596 . . . . 0.0 108.762 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 10' ' ' LEU . 42.6 t -144.2 131.58 17.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.257 1.823 . . . . 0.0 107.592 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.038 1.335 . . . . 0.0 108.626 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.53 160.32 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.965 0.506 . . . . 0.0 109.831 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.31 71.06 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.482 -1.177 . . . . 0.0 113.778 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.32 -20.72 65.74 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.813 1.806 . . . . 0.0 112.86 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.7 tt -59.11 -20.18 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.203 1.001 . . . . 0.0 112.198 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.58 -35.34 72.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.871 1.268 . . . . 0.0 111.958 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.43 -17.89 29.49 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.867 0.758 . . . . 0.0 111.068 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -61.99 152.06 33.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 108.558 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 127.859 2.464 . . . . 0.0 105.598 -170.625 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.95 -169.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.24 1.416 . . . . 0.0 111.893 -167.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.23 61.46 1.3 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.62 -172.27 33.33 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 pt -65.11 -16.39 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 113.893 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.89 -26.21 68.5 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.2 0.6 . . . . 0.0 112.52 -168.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -58.62 -30.33 67.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.36 1.064 . . . . 0.0 112.515 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.32 -3.97 49.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.416 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.65 89.58 2.24 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.921 1.237 . . . . 0.0 110.849 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.53 133.99 43.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 107.207 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -87.0 -20.19 27.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.971 0.805 . . . . 0.0 111.911 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -154.17 161.3 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.947 1.699 . . . . 0.0 108.789 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.92 175.34 13.69 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.959 1.704 . . . . 0.0 108.664 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 m -130.6 121.58 25.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.47 153.91 51.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 58.08 29.25 17.54 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.245 1.021 . . . . 0.0 111.427 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 58.69 14.81 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.435 1.894 . . . . 0.0 113.325 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -115.03 126.81 55.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.21 149.29 25.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -146.19 152.69 39.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.603 0.761 . . . . 0.0 110.015 -172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -134.94 165.48 25.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.004 1.321 . . . . 0.0 108.209 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.22 115.48 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.3 59.1 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.752 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -176.25 1.15 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.72 1.76 . . . . 0.0 107.943 153.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.79 159.89 28.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.52 1.928 . . . . 0.0 109.537 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.86 158.09 32.44 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.055 -1.028 . . . . 0.0 110.98 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.13 160.39 47.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.648 2.232 . . . . 0.0 110.949 164.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.76 -13.21 41.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -23.13 10.59 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.272 1.829 . . . . 0.0 112.351 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.55 -20.12 9.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.713 0.633 . . . . 0.0 111.88 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.5 mt -70.4 -23.67 62.79 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.516 -0.74 . . . . 0.0 111.435 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -57.3 143.19 74.21 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.041 0.936 . . . . 0.0 108.73 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.65 -4.18 11.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.558 3.505 . . . . 0.0 113.395 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.23 -33.83 74.13 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.244 1.817 . . . . 0.0 113.198 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -114.41 4.97 15.5 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.01 94.87 0.11 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.994 2.117 . . . . 0.0 110.141 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.38 74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 123.929 1.823 . . . . 0.0 107.456 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -59.15 -37.43 77.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.023 160.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -78.33 80.09 4.75 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.215 1.406 . . . . 0.0 111.689 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -83.52 -37.94 22.39 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.955 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -46.41 -51.09 15.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.241 1.016 . . . . 0.0 112.901 -169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -79.53 12.83 2.29 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 112.529 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -118.93 162.34 18.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 161.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.21 -6.48 23.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.354 1.062 . . . . 0.0 112.859 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.42 159.65 57.51 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.885 1.674 . . . . 0.0 112.143 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.03 175.02 11.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.017 3.144 . . . . 0.0 109.884 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.37 158.96 25.76 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.884 0.874 . . . . 0.0 110.502 166.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.3 168.1 23.23 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.476 2.118 . . . . 0.0 110.537 165.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -78.2 161.22 27.48 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 163.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.32 112.56 4.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.516 0.726 . . . . 0.0 109.801 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.11 23.68 31.6 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.159 0.436 . . . . 0.0 112.404 -176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.3 p -135.55 167.65 20.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 117.891 0.846 . . . . 0.0 109.276 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -150.99 157.58 43.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.437 0.637 . . . . 0.0 110.427 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -82.86 149.15 27.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.6 p -140.08 155.51 47.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.138 0.575 . . . . 0.0 109.907 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -97.15 85.41 3.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.03 98.81 8.7 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.722 1.609 . . . . 0.0 107.275 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.85 80.43 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.147 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.95 2.6 59.41 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.545 1.673 . . . . 0.0 112.253 -170.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -113.75 148.52 36.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.099 1.45 . . . . 0.0 107.931 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -95.82 108.85 21.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.11 130.25 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -169.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.84 118.14 31.04 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.154 1.382 . . . . 0.0 108.198 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.48 140.41 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.861 0.864 . . . . 0.0 109.823 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.69 136.32 54.14 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -13.06 60.43 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.467 -0.771 . . . . 0.0 112.503 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -132.25 19.44 4.43 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.62 1.968 . . . . 0.0 109.53 -162.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -170.13 -40.01 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.889 1.276 . . . . 0.0 110.078 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.59 26.72 74.19 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.517 -1.157 . . . . 0.0 112.938 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -59.03 141.12 54.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.9 mt -79.24 85.03 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.83 -49.31 68.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.341 0.657 . . . . 0.0 110.258 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -152.09 160.52 43.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.505 1.922 . . . . 0.0 107.344 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.97 147.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.1 153.19 50.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 159.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -61.01 155.02 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.911 0.885 . . . . 0.0 109.574 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.91 64.51 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.465 1.031 . . . . 0.0 113.1 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -50.23 -31.97 15.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.489 1.115 . . . . 0.0 112.776 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -59.81 -19.69 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.549 1.14 . . . . 0.0 112.745 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.1 -28.22 67.66 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.444 1.02 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.11 -0.46 33.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.789 0.836 . . . . 0.0 111.892 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -62.73 171.53 2.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.196 1.398 . . . . 0.0 110.621 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.15 -165.554 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.43 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.95 165.3 13.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.876 2.07 . . . . 0.0 106.866 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.83 89.76 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 166.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.84 -169.47 21.65 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 160.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 pt -74.46 -10.26 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -63.21 -28.93 70.38 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.613 1.965 . . . . 0.0 111.374 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -61.28 -28.98 69.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.742 0.817 . . . . 0.0 112.271 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -98.05 -2.22 40.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.275 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.03 86.87 0.55 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.343 0.974 . . . . 0.0 109.633 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.17 145.73 54.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -102.86 -16.0 16.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.125 0.42 . . . . 0.0 112.011 170.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.54 164.25 38.56 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.63 175.63 13.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.692 1.597 . . . . 0.0 108.067 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -131.53 125.44 32.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.48 156.19 48.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.81 29.7 12.38 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.314 -0.866 . . . . 0.0 112.937 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 53.85 22.77 3.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.1 2.16 . . . . 0.0 112.5 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.1 m -120.29 128.05 52.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.441 2.296 . . . . 0.0 105.775 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -84.09 150.8 25.32 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.069 0.948 . . . . 0.0 110.062 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -151.7 141.31 21.74 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 124.798 1.239 . . . . 0.0 110.211 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -124.4 167.18 14.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.42 1.488 . . . . 0.0 109.856 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.59 113.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.6 -4.51 32.72 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.092 -1.394 . . . . 0.0 113.458 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.18 -171.34 1.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.002 1.401 . . . . 0.0 107.968 166.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 149.48 50.43 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.172 -1.58 . . . . 0.0 109.382 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.6 158.14 43.22 Favored Pre-proline 0 N--CA 1.468 0.447 0 C-N-CA 124.15 0.98 . . . . 0.0 111.016 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.2 164.26 33.33 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.328 2.685 . . . . 0.0 111.619 165.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -16.11 44.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 112.703 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.2 mmt -53.64 -30.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.45 1.1 . . . . 0.0 111.884 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -102.94 -2.5 27.6 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.21 -23.59 24.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.097 0.862 . . . . 0.0 110.935 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.72 144.1 85.86 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 -4.62 9.88 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.554 3.503 . . . . 0.0 113.343 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.45 -16.85 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.25 2.22 . . . . 0.0 113.207 172.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -121.26 -1.84 9.66 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.59 1.086 . . . . 0.0 110.932 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.9 97.24 4.53 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.729 1.612 . . . . 0.0 112.502 -163.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -81.47 82.6 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 107.756 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.87 -30.92 69.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.647 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.98 36.38 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.436 1.894 . . . . 0.0 113.734 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -56.67 -34.47 67.38 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.398 -1.439 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.91 -39.35 93.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.584 1.554 . . . . 0.0 113.07 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -24.86 42.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.406 1.003 . . . . 0.0 110.647 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -80.05 -177.44 6.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.649 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.87 -19.66 40.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.467 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.93 144.67 76.4 Favored Pre-proline 0 CA--C 1.537 0.469 0 O-C-N 121.017 -1.052 . . . . 0.0 111.156 -161.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.95 164.48 27.13 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.75 2.967 . . . . 0.0 113.596 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.22 97.11 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.575 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.2 172.39 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.204 2.603 . . . . 0.0 110.608 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.48 167.73 19.8 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.851 -1.156 . . . . 0.0 109.294 168.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 34.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 115.397 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.9 33.17 0.06 OUTLIER Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.301 1.905 . . . . 0.0 110.303 173.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.0 p -144.24 166.12 25.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.121 0.961 . . . . 0.0 110.768 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -155.75 156.25 34.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.269 0.557 . . . . 0.0 111.315 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.32 143.93 31.86 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.347 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 p -138.67 179.52 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.306 1.842 . . . . 0.0 110.07 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -107.7 145.6 33.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.65 1.58 . . . . 0.0 107.822 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.9 147.21 29.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 166.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.81 -4.83 0.01 OUTLIER Glycine 0 CA--C 1.55 2.22 0 N-CA-C 117.589 1.796 . . . . 0.0 117.589 170.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.31 -10.75 19.77 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 121.144 2.472 . . . . 0.0 113.778 -167.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -103.0 173.13 6.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.548 2.739 . . . . 0.0 110.224 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -112.38 134.87 53.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.08 1.352 . . . . 0.0 109.261 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.72 154.06 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 119.69 1.132 . . . . 0.0 110.968 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.11 120.1 39.39 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.287 1.035 . . . . 0.0 109.031 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.3 pt -127.77 150.13 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.726 1.21 . . . . 0.0 109.483 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.13 140.69 39.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.032 0.833 . . . . 0.0 109.505 172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -14.73 61.78 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.407 1.083 . . . . 0.0 112.45 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -119.54 2.58 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.739 1.615 . . . . 0.0 111.1 -162.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -163.37 -45.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.982 0.913 . . . . 0.0 109.035 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.55 21.65 53.24 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.1 0.857 . . . . 0.0 112.497 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 130.33 43.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.22 95.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.792 1.637 . . . . 0.0 106.766 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 mt -80.09 -52.97 7.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.888 0.875 . . . . 0.0 109.574 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -144.59 160.5 41.05 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.779 0.832 . . . . 0.0 109.625 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.6 t -134.13 142.35 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -134.99 137.71 43.28 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 162.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -60.38 149.12 34.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.69 -15.12 32.27 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.948 1.737 . . . . 0.0 113.261 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.92 -30.29 61.41 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.393 1.597 . . . . 0.0 112.135 171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.81 -1.72 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.012 0.925 . . . . 0.0 111.745 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -60.05 -43.1 95.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.32 -1.487 . . . . 0.0 111.511 164.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -88.02 -17.64 30.74 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -64.59 160.98 18.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.915 1.286 . . . . 0.0 109.404 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.698 1.199 . . . . 0.0 107.836 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.78 -176.7 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.075 1.35 . . . . 0.0 111.088 -154.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.38 56.79 7.39 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.332 1.053 . . . . 0.0 111.693 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.77 -172.59 49.02 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 159.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 pt -67.58 -11.18 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 124.831 1.252 . . . . 0.0 112.904 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.47 -34.61 69.2 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.931 1.692 . . . . 0.0 112.38 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -58.64 -28.97 66.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.541 0.737 . . . . 0.0 112.585 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -98.02 -2.51 40.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.834 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.93 87.13 1.31 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.279 0.945 . . . . 0.0 109.031 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.25 166.6 23.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -124.96 -25.11 3.93 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.265 0.626 . . . . 0.0 112.553 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 157.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.806 1.242 . . . . 0.0 107.933 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.5 177.04 11.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -131.24 129.29 41.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 163.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.79 149.27 46.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.98 34.15 24.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.199 1.0 . . . . 0.0 111.452 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 59.83 35.69 21.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.8 1.64 . . . . 0.0 112.01 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -136.98 121.05 17.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.832 1.653 . . . . 0.0 107.35 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -79.59 150.23 31.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.695 0.798 . . . . 0.0 109.017 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -150.05 159.36 44.47 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.41 1.484 . . . . 0.0 110.595 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -145.6 165.42 28.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.392 1.877 . . . . 0.0 108.781 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.93 120.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.38 3.9 84.0 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 117.454 -1.748 . . . . 0.0 113.559 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.21 178.41 2.34 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.017 1.908 . . . . 0.0 108.68 156.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.71 142.89 50.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.608 1.163 . . . . 0.0 109.073 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.32 163.77 35.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.171 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.98 154.22 63.0 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.458 2.772 . . . . 0.0 112.653 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.61 54.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.582 1.553 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -55.45 -22.6 21.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.588 1.155 . . . . 0.0 113.019 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 13.8 m-85 -113.9 -10.3 12.96 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.865 0.728 . . . . 0.0 112.906 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.23 -30.33 68.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.191 0.451 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -65.49 144.11 98.86 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.543 0.737 . . . . 0.0 109.716 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.05 -4.85 9.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.246 3.297 . . . . 0.0 115.449 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -54.97 -33.96 62.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.898 1.279 . . . . 0.0 112.086 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -103.21 -8.56 20.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.964 0.802 . . . . 0.0 112.086 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.73 100.36 0.91 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.769 2.827 . . . . 0.0 111.952 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.93 85.58 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.764 1.226 . . . . 0.0 108.694 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -67.48 -10.86 55.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.356 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -95.44 89.51 5.45 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.72 1.208 . . . . 0.0 107.914 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -132.19 -25.71 1.97 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.924 -1.036 . . . . 0.0 113.557 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.21 -36.33 79.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.277 1.399 . . . . 0.0 111.613 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -82.82 8.52 12.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.624 0.77 . . . . 0.0 111.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -123.18 165.7 16.45 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.586 -1.322 . . . . 0.0 108.96 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.74 -22.63 56.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 -169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.58 156.41 17.13 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 125.211 1.404 . . . . 0.0 110.498 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.61 172.57 13.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.303 1.335 . . . . 0.0 110.774 168.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.5 165.51 2.16 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.491 164.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -67.97 171.46 12.36 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 120.97 1.113 . . . . 0.0 109.825 160.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' H ' HD21 ' A' ' 63' ' ' LEU . 3.3 m-20 -82.92 161.46 21.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 158.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.49 112.55 3.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.7 7.99 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.581 1.086 . . . . 0.0 111.907 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -149.42 169.02 21.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.889 1.845 . . . . 0.0 111.89 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -149.03 163.91 36.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.623 0.769 . . . . 0.0 110.354 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.95 141.95 28.29 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.279 0.631 . . . . 0.0 109.631 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -128.51 172.16 11.42 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -103.35 111.59 24.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 110.343 173.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 ttm -129.89 118.0 21.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.823 1.649 . . . . 0.0 109.869 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 -11.27 4.08 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.922 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.07 -7.17 19.2 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.538 1.669 . . . . 0.0 112.319 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -109.85 172.94 6.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.657 1.583 . . . . 0.0 110.302 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.38 117.92 35.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 108.545 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.0 145.84 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD21 ' H ' ' A' ' 49' ' ' ASP . 66.9 tp -101.19 126.68 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.01 142.57 43.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.967 0.907 . . . . 0.0 110.239 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.44 131.26 44.99 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.423 0.689 . . . . 0.0 109.594 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.98 5.8 6.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.934 1.349 . . . . 0.0 113.503 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -127.7 1.22 6.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.895 2.478 . . . . 0.0 110.938 -171.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -166.87 -60.11 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.309 0.644 . . . . 0.0 109.36 -164.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 24.92 9.89 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 124.761 1.172 . . . . 0.0 113.931 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -60.48 129.11 39.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.548 2.174 . . . . 0.0 109.319 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 86.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 129.229 3.012 . . . . 0.0 106.067 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.69 -44.63 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -145.64 161.31 40.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.457 0.703 . . . . 0.0 109.331 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.68 137.99 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -126.84 142.42 51.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 157.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 79' ' ' ILE . 10.3 t70 -59.49 151.14 24.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.72 -22.78 27.0 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.744 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.5 -29.6 25.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.048 1.424 . . . . 0.0 112.506 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 76' ' ' ASP . 14.8 tt -64.77 -9.09 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.025 0.93 . . . . 0.0 112.613 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.17 -50.79 44.44 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 120.424 -1.422 . . . . 0.0 110.546 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -80.15 -16.27 55.27 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.759 0.824 . . . . 0.0 111.921 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -55.36 124.9 18.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.736 2.414 . . . . 0.0 107.447 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 O-C-N 121.922 -0.486 . . . . 0.0 111.351 -162.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.08 63.77 1.47 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.377 1.871 . . . . 0.0 107.31 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.62 33.63 4.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.331 1.452 . . . . 0.0 109.951 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.67 -152.7 6.29 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt -54.41 -20.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.728 2.011 . . . . 0.0 114.506 -163.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -27.66 65.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.835 0.289 . . . . 0.0 111.756 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -61.59 -23.02 65.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.625 0.77 . . . . 0.0 112.674 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -102.44 -8.26 21.26 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.77 0.828 . . . . 0.0 110.905 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.11 92.13 4.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.22 162.84 27.05 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -112.66 -23.22 10.33 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.181 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -158.76 160.94 36.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.592 1.557 . . . . 0.0 109.032 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -157.18 -177.29 6.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.749 2.019 . . . . 0.0 108.808 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -135.93 114.94 12.24 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.76 152.42 45.4 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.274 1.6 p30 50.99 27.47 3.25 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 61.67 14.67 6.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.072 2.549 . . . . 0.0 112.732 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.9 m -98.23 124.29 42.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.527 2.331 . . . . 0.0 105.935 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.33 143.99 48.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -142.18 143.29 32.88 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 109.481 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -127.7 170.34 12.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.48 113.62 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.64 -2.08 42.28 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.431 -1.76 . . . . 0.0 114.386 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.36 -171.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.085 1.943 . . . . 0.0 108.684 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.08 143.46 51.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.533 -1.354 . . . . 0.0 108.803 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.91 162.96 71.9 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.597 -0.689 . . . . 0.0 110.297 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.41 161.9 42.98 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.484 2.789 . . . . 0.0 110.779 159.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.38 44.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mmt -54.21 -20.09 6.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.198 1.799 . . . . 0.0 111.991 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -122.84 -8.77 8.37 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.063 0.945 . . . . 0.0 112.995 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.78 -18.08 56.82 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.901 0.88 . . . . 0.0 111.435 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -60.74 144.48 89.56 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.33 -4.35 14.79 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.195 3.263 . . . . 0.0 115.332 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -51.13 -30.85 17.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.724 2.01 . . . . 0.0 114.927 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.45 2.97 14.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.148 0.979 . . . . 0.0 110.975 -167.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -66.42 129.29 39.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.196 1.798 . . . . 0.0 110.858 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -106.82 90.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 108.268 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -22.93 63.0 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.686 -0.634 . . . . 0.0 111.285 163.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.12 30.67 0.58 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.808 1.243 . . . . 0.0 111.87 -166.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -75.35 -29.93 60.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.647 1.579 . . . . 0.0 115.167 -167.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -67.93 -38.16 82.54 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.864 1.666 . . . . 0.0 112.629 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -61.86 -11.24 11.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.978 0.911 . . . . 0.0 112.357 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.34 157.78 16.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -70.61 2.35 4.16 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.565 -0.709 . . . . 0.0 112.184 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.41 148.16 85.67 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 120.896 -1.127 . . . . 0.0 110.367 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.63 165.24 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.464 2.109 . . . . 0.0 111.798 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 149.63 89.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.834 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.37 171.15 14.55 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.298 2.665 . . . . 0.0 111.506 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.49 168.98 18.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.808 1.289 . . . . 0.0 109.398 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.55 38.88 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.219 2.608 . . . . 0.0 113.986 -167.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.97 37.71 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.239 1.876 . . . . 0.0 110.461 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.4 p -148.62 166.95 26.78 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.654 -0.91 . . . . 0.0 109.816 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -146.73 152.29 38.58 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.837 0.827 . . . . 0.0 111.054 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.47 144.81 46.1 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -133.62 162.65 31.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 109.868 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.23 65.87 0.74 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.944 0.898 . . . . 0.0 110.942 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 102.7 6.87 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.8 75.17 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.464 164.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.3 -5.6 33.77 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.118 1.459 . . . . 0.0 112.734 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -113.64 162.67 15.95 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.374 1.47 . . . . 0.0 107.325 -172.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 45.3 m-85 -109.77 111.23 22.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.04 132.48 69.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 tp -92.59 117.05 29.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.864 0.866 . . . . 0.0 108.697 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.4 pt -116.25 142.31 30.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.843 0.857 . . . . 0.0 109.499 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 143.03 51.4 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.58 9.74 5.69 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.683 0.793 . . . . 0.0 112.023 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -147.64 16.78 1.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.904 1.681 . . . . 0.0 110.525 -163.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -171.48 -45.37 0.02 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 126.536 1.934 . . . . 0.0 108.286 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 26.18 50.07 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.624 -1.098 . . . . 0.0 112.22 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.36 138.49 58.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -79.0 84.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.593 1.957 . . . . 0.0 106.176 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.12 -44.47 84.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.806 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -152.14 158.73 43.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.693 1.197 . . . . 0.0 108.894 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -135.52 143.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -135.87 145.72 46.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.084 1.353 . . . . 0.0 107.572 161.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.72 155.99 36.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.639 0.654 . . . . 0.0 111.86 172.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -58.08 -25.05 56.23 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 124.619 1.104 . . . . 0.0 114.132 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.38 -27.49 36.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.887 1.344 . . . . 0.0 113.116 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.9 -20.2 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.941 0.896 . . . . 0.0 112.504 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.7 -44.92 96.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.656 0.782 . . . . 0.0 109.725 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.15 -17.14 38.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.752 0.821 . . . . 0.0 111.478 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -58.2 147.24 31.0 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 128.075 2.55 . . . . 0.0 109.552 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 . . . . . 0 C--O 1.248 1.022 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 172.124 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.77 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.78 -176.06 4.11 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.968 1.384 . . . . 0.0 109.614 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.97 3.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.673 1.989 . . . . 0.0 112.387 -167.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.16 -155.82 7.31 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.332 1.92 . . . . 0.0 109.703 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 pt -78.39 -10.97 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -34.1 72.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 111.746 -168.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -55.96 -33.85 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.486 1.115 . . . . 0.0 112.144 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.05 -4.71 56.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.648 -1.168 . . . . 0.0 110.784 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.81 90.98 0.81 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.731 1.605 . . . . 0.0 110.506 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.12 128.02 32.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.03 -16.57 37.79 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 0.986 . . . . 0.0 112.817 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.68 164.59 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -155.0 174.96 14.43 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 107.393 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -133.26 128.03 34.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' A' ' 57' ' ' MET . . . -145.83 137.03 24.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 44.59 62.42 2.05 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 110.003 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.263 1.7 p90 44.96 31.61 0.72 Allowed 'General case' 0 C--O 1.232 0.174 1 C-N-CA 132.004 4.122 . . . . 0.0 113.013 174.914 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 m -131.84 124.86 30.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -80.73 157.04 25.97 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -152.91 156.09 38.26 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.354 1.062 . . . . 0.0 110.26 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -140.2 167.67 21.61 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.929 1.692 . . . . 0.0 109.431 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.14 108.84 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.08 -7.02 21.52 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.326 -1.819 . . . . 0.0 114.162 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -174.8 1.49 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.771 1.786 . . . . 0.0 110.263 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.04 150.69 42.76 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.443 -1.411 . . . . 0.0 109.044 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.91 159.84 39.35 Favored Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 161.2 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.545 2.163 . . . . 0.0 111.557 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.58 -10.58 19.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.639 0.776 . . . . 0.0 112.748 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.88 -26.13 65.63 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.803 0.841 . . . . 0.0 111.549 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -107.83 -10.25 15.6 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.7 mt -75.9 -24.79 55.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.675 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -55.95 145.25 54.67 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.004 0.921 . . . . 0.0 109.943 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.87 -9.74 22.43 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 124.722 3.615 . . . . 0.0 112.17 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -56.04 -27.8 54.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.432 1.493 . . . . 0.0 113.504 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -117.02 2.52 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.806 0.842 . . . . 0.0 111.191 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -59.73 104.66 0.3 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 128.28 2.632 . . . . 0.0 111.301 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mm -77.03 79.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -39.65 73.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.931 169.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -88.82 66.06 7.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.311 1.044 . . . . 0.0 110.119 -174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -65.31 -50.25 66.37 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.047 -0.408 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.03 96.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.953 0.501 . . . . 0.0 111.985 -158.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.69 -25.8 60.8 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.527 1.131 . . . . 0.0 113.265 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.86 27.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.835 -1.165 . . . . 0.0 111.321 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m120 68.01 -3.67 1.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.988 2.115 . . . . 0.0 112.252 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.66 163.84 42.42 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.533 1.933 . . . . 0.0 111.847 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.46 175.23 11.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.446 2.764 . . . . 0.0 112.541 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 164.35 19.63 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 111.765 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -72.52 -169.66 0.5 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.047 2.498 . . . . 0.0 111.117 162.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.58 -172.34 2.48 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 158.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 104.05 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.803 169.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.28 -12.48 54.71 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.583 1.087 . . . . 0.0 114.587 169.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.2 p -73.41 168.52 19.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.822 1.311 . . . . 0.0 109.23 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -158.72 151.56 22.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.615 -0.678 . . . . 0.0 109.654 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -81.88 143.57 31.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -133.7 162.1 32.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.527 0.731 . . . . 0.0 110.644 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -96.32 96.95 9.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.989 1.316 . . . . 0.0 108.259 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.93 96.6 6.15 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.233 1.813 . . . . 0.0 106.848 -174.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.13 79.61 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.904 -1.498 . . . . 0.0 113.824 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.94 6.92 64.82 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.614 1.707 . . . . 0.0 112.373 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.31 147.14 31.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.403 1.602 . . . . 0.0 107.712 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 37.4 m-85 -96.94 114.29 25.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.08 131.92 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.45 112.76 24.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.02 143.57 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.193 0.997 . . . . 0.0 110.2 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.06 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -59.61 -18.57 42.42 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -115.85 12.35 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 126.295 1.838 . . . . 0.0 110.215 -161.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.94 -51.62 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.801 -1.187 . . . . 0.0 109.385 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.52 29.69 35.39 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 126.013 1.768 . . . . 0.0 112.594 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 138.32 58.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.379 1.09 . . . . 0.0 108.978 176.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.6 mt -79.7 84.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.66 -45.67 78.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.542 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -153.33 163.26 40.23 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.798 2.039 . . . . 0.0 107.633 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.7 t -137.13 151.53 27.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.21 157.97 42.96 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 156.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -63.63 156.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.392 0.677 . . . . 0.0 109.266 168.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -63.62 -22.36 65.9 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 124.764 1.173 . . . . 0.0 113.601 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.72 -17.39 34.37 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.62 1.21 . . . . 0.0 113.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.02 -26.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.973 0.909 . . . . 0.0 112.465 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -65.91 -12.04 51.68 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.675 -0.64 . . . . 0.0 111.544 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.43 18.44 12.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.57 -173.47 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 108.273 163.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.814 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.552 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.67 35.08 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 120.064 1.932 . . . . 0.0 108.664 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.03 -0.69 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.68 -142.55 12.35 Favored Glycine 0 N--CA 1.461 0.333 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 pt -93.64 -12.02 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.46 -32.38 68.69 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.984 0.811 . . . . 0.0 112.886 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -58.66 -27.25 64.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.803 0.841 . . . . 0.0 112.893 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -97.91 -1.65 42.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.956 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.18 90.22 5.48 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.199 1.363 . . . . 0.0 109.663 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.91 128.89 34.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -83.82 -17.87 39.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.264 0.484 . . . . 0.0 112.3 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.28 165.7 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.719 2.408 . . . . 0.0 107.236 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.11 179.61 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.715 1.206 . . . . 0.0 108.308 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -130.44 136.6 49.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.89 43.95 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 164.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.15 38.11 26.68 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.139 0.971 . . . . 0.0 111.666 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 60.02 14.31 4.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.443 1.897 . . . . 0.0 113.757 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.4 m -119.19 126.97 52.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.171 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -87.07 149.17 24.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -145.6 155.97 43.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.017 0.927 . . . . 0.0 110.798 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -139.61 164.0 31.07 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.405 1.482 . . . . 0.0 109.145 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.76 115.87 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 164.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.33 -0.09 55.81 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 117.676 -1.625 . . . . 0.0 114.811 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.89 -178.28 3.18 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.324 1.562 . . . . 0.0 109.851 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.39 152.25 41.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.952 1.701 . . . . 0.0 110.44 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.43 158.76 31.14 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 121.401 -0.812 . . . . 0.0 112.22 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 72.4 Cg_endo -68.62 158.0 59.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.799 2.333 . . . . 0.0 111.774 165.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -14.43 62.89 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.501 1.12 . . . . 0.0 113.487 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 14.8 ptp -56.08 -22.7 29.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.894 0.878 . . . . 0.0 112.935 172.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.68 -10.63 14.07 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.4 -20.13 55.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.883 0.873 . . . . 0.0 111.299 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -64.03 152.5 87.43 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.246 1.418 . . . . 0.0 110.463 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.19 -7.77 16.58 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.127 2.551 . . . . 0.0 114.262 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.56 -18.97 55.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.13 0.972 . . . . 0.0 113.276 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -122.45 -5.36 8.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 112.496 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 106.9 1.51 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.7 1.6 . . . . 0.0 112.186 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 56' ' ' TYR . 8.4 mm -79.01 78.77 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 O-C-N 120.832 -1.167 . . . . 0.0 107.966 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -61.76 -28.75 69.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.008 -1.057 . . . . 0.0 112.664 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -93.2 65.32 3.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.804 1.242 . . . . 0.0 109.698 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -82.9 -44.36 15.47 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -30.81 69.08 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.724 0.693 . . . . 0.0 111.024 -170.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -78.8 17.24 0.74 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.377 1.471 . . . . 0.0 113.308 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HB2' HD12 ' A' ' 45' ' ' LEU . 4.4 mtt85 -129.56 22.89 5.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.286 1.403 . . . . 0.0 113.28 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 57.4 8.09 0.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.414 1.886 . . . . 0.0 114.035 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 43' ' ' ARG . 2.5 mt -90.59 165.25 23.5 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.689 -1.257 . . . . 0.0 110.956 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.18 170.14 20.64 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.617 3.545 . . . . 0.0 111.641 168.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.78 165.49 2.4 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 127.21 2.204 . . . . 0.0 112.292 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.54 -164.65 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.764 2.976 . . . . 0.0 111.235 160.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.66 -169.84 1.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 158.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.51 105.75 13.82 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.46 -1.4 . . . . 0.0 110.594 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.93 44.43 7.69 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 p -140.28 166.78 23.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -152.86 145.6 24.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.904 0.859 . . . . 0.0 110.512 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -72.84 147.48 45.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.82 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -139.4 170.28 16.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.746 2.818 . . . . 0.0 108.332 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' HD11 ' A' ' 37' ' ' ILE . 16.8 t80 -116.62 78.66 1.22 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.575 0.625 . . . . 0.0 112.18 -172.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 97.86 11.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.727 2.011 . . . . 0.0 109.611 -172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.86 11.4 63.03 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.354 -0.841 . . . . 0.0 114.623 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.8 -15.73 37.29 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.198 0.999 . . . . 0.0 112.054 -170.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -89.08 138.4 31.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.633 1.217 . . . . 0.0 108.303 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.7 112.47 18.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.93 125.22 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 tp -89.87 111.78 22.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.44 150.34 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 123.057 0.543 . . . . 0.0 110.211 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.65 139.29 43.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.511 0.724 . . . . 0.0 109.433 169.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.53 -17.41 64.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.422 0.629 . . . . 0.0 110.86 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 p -100.26 -5.19 27.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.163 2.185 . . . . 0.0 112.716 -161.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -174.79 -44.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 109.003 -157.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.42 28.4 61.75 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.362 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.32 132.47 53.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.814 1.307 . . . . 0.0 108.347 163.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.34 86.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 128.666 2.786 . . . . 0.0 105.512 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.97 -46.78 83.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -152.63 163.7 39.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.018 1.327 . . . . 0.0 109.653 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.63 145.15 26.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.06 157.79 45.91 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.806 1.643 . . . . 0.0 107.143 164.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.2 157.51 34.43 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -28.63 62.96 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.271 2.367 . . . . 0.0 113.142 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -62.96 -20.3 65.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.024 0.93 . . . . 0.0 112.514 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.45 -21.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 111.889 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.53 -7.44 10.22 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 112.781 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -119.47 -0.97 10.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.005 1.322 . . . . 0.0 111.911 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -74.43 165.58 24.95 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.344 1.858 . . . . 0.0 109.488 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 129.328 3.051 . . . . 0.0 106.117 -178.038 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 CA-C-O 118.709 -1.05 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.52 28.15 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.284 2.634 . . . . 0.0 117.703 156.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.79 77.25 2.09 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.336 0.971 . . . . 0.0 110.373 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.93 -111.84 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 106.593 -2.603 . . . . 0.0 106.593 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 pt -121.3 -19.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.91 -22.64 64.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 118.065 0.393 . . . . 0.0 110.879 -169.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.71 -26.18 68.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.509 1.124 . . . . 0.0 113.015 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -99.5 0.34 42.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.72 1.208 . . . . 0.0 111.641 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.49 101.19 0.95 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.92 151.08 25.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -101.28 -12.56 18.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.527 0.731 . . . . 0.0 111.81 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -177.05 156.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -155.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -172.15 -179.1 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 109.232 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -125.95 135.32 51.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.06 137.82 46.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.71 34.38 23.73 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.337 1.065 . . . . 0.0 110.751 168.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 59.34 14.79 3.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.835 2.454 . . . . 0.0 114.376 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -103.08 134.54 46.34 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.489 1.516 . . . . 0.0 107.267 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -90.25 141.88 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.347 1.859 . . . . 0.0 109.161 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -146.45 155.62 42.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.047 0.385 . . . . 0.0 111.71 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -145.31 167.58 22.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.734 1.214 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.0 mm -58.86 117.31 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.17 -11.84 55.36 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.003 -1.443 . . . . 0.0 114.323 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.53 -178.44 4.1 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.79 1.795 . . . . 0.0 107.164 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.78 148.09 43.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 119.349 -2.094 . . . . 0.0 108.951 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.38 163.4 66.42 Favored Pre-proline 0 CA--C 1.538 0.5 0 O-C-N 121.581 -0.699 . . . . 0.0 110.396 170.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.14 160.91 39.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.286 2.657 . . . . 0.0 111.378 160.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.15 -23.5 67.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.571 1.148 . . . . 0.0 113.132 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.571 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 6.7 ptm -53.78 -20.93 6.34 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.823 1.249 . . . . 0.0 113.594 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 8.6 m-85 -117.55 -8.15 11.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.646 1.178 . . . . 0.0 112.557 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -79.03 -25.8 43.22 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.594 1.558 . . . . 0.0 110.873 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 t -62.35 144.79 94.88 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.69 -9.57 21.37 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.649 2.233 . . . . 0.0 114.463 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -55.55 -36.51 66.87 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.062 0.945 . . . . 0.0 110.968 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.78 -11.12 16.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.767 0.827 . . . . 0.0 111.052 -173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -61.07 111.04 1.54 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.944 1.698 . . . . 0.0 109.956 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.6 mt -87.99 90.63 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -73.43 -28.52 62.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.572 164.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.23 68.95 9.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.356 0.98 . . . . 0.0 109.137 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -69.92 -57.26 5.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -44.83 -47.76 11.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.44 1.496 . . . . 0.0 114.839 -159.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -63.31 -21.64 66.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -75.22 -165.34 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.26 2.62 31.78 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.845 -1.159 . . . . 0.0 111.431 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 79' ' ' ILE . 2.5 mm? -65.04 156.15 81.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 121.325 -0.86 . . . . 0.0 112.204 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.05 171.48 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.678 3.585 . . . . 0.0 111.061 161.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.02 158.36 26.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 112.484 173.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.99 158.92 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.356 2.037 . . . . 0.0 111.01 167.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.608 ' H ' HD21 ' A' ' 63' ' ' LEU . 31.8 m-20 -62.06 149.1 42.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.72 101.27 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.435 0.694 . . . . 0.0 110.504 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.49 12.98 10.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.621 -1.1 . . . . 0.0 113.378 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.7 p -132.4 176.08 8.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.136 1.468 . . . . 0.0 111.06 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -149.49 154.37 38.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.132 0.973 . . . . 0.0 110.474 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -72.77 156.05 39.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.971 0.509 . . . . 0.0 109.865 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -147.46 167.97 23.08 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.48 106.16 16.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.297 1.839 . . . . 0.0 108.342 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG2' HG22 ' A' ' 62' ' ' VAL . 86.7 mmm -81.56 -154.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.193 1.797 . . . . 0.0 109.693 175.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.03 58.51 0.55 Allowed Glycine 0 C--N 1.338 0.679 0 C-N-CA 129.607 3.48 . . . . 0.0 111.701 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.23 56.8 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 125.676 1.608 . . . . 0.0 113.992 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -130.96 158.66 39.65 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.073 1.436 . . . . 0.0 108.87 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -102.95 125.79 49.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 108.694 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 57' ' ' MET . 16.4 m -127.71 151.02 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.648 -0.657 . . . . 0.0 109.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.608 HD21 ' H ' ' A' ' 49' ' ' ASP . 63.7 tp -103.46 127.99 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.684 HD12 HD23 ' A' ' 31' ' ' LEU . 10.4 pt -131.67 131.91 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 125.429 1.492 . . . . 0.0 110.538 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.78 134.52 57.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -8.6 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.086 -1.009 . . . . 0.0 111.377 172.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 t -134.05 12.01 3.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.928 2.091 . . . . 0.0 109.494 -158.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -171.91 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 0.0 111.425 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.1 37.95 24.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.481 1.515 . . . . 0.0 113.01 -165.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -58.84 145.63 40.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 159.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.2 mt -81.78 91.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.8 mm? -61.31 -56.92 15.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.35 163.09 35.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.468 1.507 . . . . 0.0 110.395 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.1 t -137.18 136.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.326 1.851 . . . . 0.0 107.304 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.59 142.99 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.153 0.981 . . . . 0.0 108.357 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.41 146.19 54.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.59 -20.96 40.67 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.446 1.022 . . . . 0.0 112.798 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -49.65 -30.94 9.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.509 1.124 . . . . 0.0 112.42 171.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 tt -58.36 -25.49 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.72 1.208 . . . . 0.0 112.574 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.31 -35.28 76.92 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.565 0.62 . . . . 0.0 110.657 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.73 2.37 51.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.708 0.803 . . . . 0.0 113.048 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -84.15 -174.66 5.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.341 0.656 . . . . 0.0 110.116 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 C--O 1.248 0.987 0 C-N-CA 127.073 2.149 . . . . 0.0 109.207 -172.914 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.91 160.76 42.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.412 1.106 . . . . 0.0 108.96 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.09 24.98 1.78 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.118 0.967 . . . . 0.0 110.289 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.86 -170.01 21.67 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 125.51 1.529 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.4 pt -62.35 -18.71 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.318 1.047 . . . . 0.0 113.478 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.59 -24.83 65.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.101 1.76 . . . . 0.0 113.049 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.27 -34.86 77.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.289 0.636 . . . . 0.0 112.293 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -90.49 -3.84 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.099 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.39 0.78 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.432 1.014 . . . . 0.0 108.723 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.6 164.01 14.93 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -124.99 -20.06 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.46 1.504 . . . . 0.0 111.351 -172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -159.17 163.04 36.4 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.772 2.029 . . . . 0.0 107.505 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -163.71 175.56 10.43 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 110.148 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 m -127.74 112.68 15.06 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.47 158.48 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 25.39 12.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.264 0.938 . . . . 0.0 111.978 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 58.43 16.62 4.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.429 1.891 . . . . 0.0 113.133 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.7 m -117.8 125.9 51.43 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.661 1.984 . . . . 0.0 105.961 -171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -80.5 149.01 30.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -147.9 157.31 43.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.038 1.335 . . . . 0.0 109.495 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.68 167.67 21.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.318 1.447 . . . . 0.0 108.566 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.35 119.3 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.19 -13.35 40.44 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 117.782 -1.566 . . . . 0.0 114.014 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.86 -171.17 1.02 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 119.592 1.696 . . . . 0.0 107.879 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 142.56 50.49 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 118.379 -2.701 . . . . 0.0 109.981 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.36 156.56 73.63 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 121.547 -0.721 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.38 156.6 61.37 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.408 2.072 . . . . 0.0 110.564 165.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -61.22 -17.25 52.3 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.1 mmt -51.8 -27.44 12.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.533 1.533 . . . . 0.0 113.231 173.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.5 -7.31 15.18 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.8 mt -79.23 -23.75 43.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.584 1.154 . . . . 0.0 112.071 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -56.17 149.25 37.07 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.45 1.1 . . . . 0.0 110.262 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.77 -8.59 15.98 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.433 2.756 . . . . 0.0 113.18 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.02 -29.29 70.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.831 2.052 . . . . 0.0 111.861 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.38 1.22 9.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.671 1.188 . . . . 0.0 111.668 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 91.28 0.15 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.624 2.77 . . . . 0.0 108.915 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.78 112.61 5.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -88.55 -31.49 18.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 117.392 -1.29 . . . . 0.0 111.053 167.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.07 88.18 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.963 1.256 . . . . 0.0 110.655 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -104.15 -33.84 8.59 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.555 0.742 . . . . 0.0 111.972 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.76 -28.24 69.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.131 0.878 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -83.43 29.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.776 1.231 . . . . 0.0 110.754 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -141.49 169.14 18.16 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.862 2.465 . . . . 0.0 107.364 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.6 -13.91 62.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.737 1.215 . . . . 0.0 111.987 166.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.74 157.2 80.52 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.303 -0.873 . . . . 0.0 111.764 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -71.01 169.36 20.69 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.947 3.098 . . . . 0.0 111.253 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 149.72 77.14 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.72 166.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.96 169.54 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.108 2.539 . . . . 0.0 110.502 168.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -77.67 167.74 21.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.895 0.878 . . . . 0.0 108.666 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.03 42.24 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 114.426 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.65 56.12 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -159.91 171.78 18.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.305 0.642 . . . . 0.0 111.175 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -145.92 156.92 43.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.439 0.563 . . . . 0.0 110.95 167.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -80.94 153.17 27.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -136.53 168.81 18.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.397 1.079 . . . . 0.0 110.729 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -106.03 84.94 2.12 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.376 1.471 . . . . 0.0 107.646 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.3 mtp -94.85 102.06 13.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.131 0.972 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.33 6.29 86.28 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.663 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.27 4.1 53.59 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.068 1.434 . . . . 0.0 112.007 -167.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -115.09 143.71 44.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 53.8 m-85 -93.88 113.38 25.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 74' ' ' VAL . 3.6 m -127.49 143.25 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -172.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 tp -102.6 122.9 45.32 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.1 pt -124.68 149.06 28.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.007 0.923 . . . . 0.0 109.872 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.65 136.75 41.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.08 -25.16 65.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.655 0.741 . . . . 0.0 112.388 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 t -123.12 27.13 7.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.152 1.781 . . . . 0.0 110.147 -161.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -173.96 -36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.783 1.633 . . . . 0.0 110.552 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.32 21.46 77.66 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.079 1.323 . . . . 0.0 113.894 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 136.18 57.85 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.543 1.137 . . . . 0.0 108.59 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.48 87.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.2 mt -70.67 -49.24 49.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.167 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -152.52 157.94 41.83 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 109.695 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 62' ' ' VAL . 52.0 t -140.67 130.17 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.626 1.97 . . . . 0.0 107.087 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -129.43 148.19 51.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.631 1.173 . . . . 0.0 108.73 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 79' ' ' ILE . 23.2 t70 -68.64 157.81 35.4 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.817 -0.552 . . . . 0.0 111.241 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -61.73 -27.2 67.92 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-O 118.454 -1.192 . . . . 0.0 113.975 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -55.88 -27.62 52.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.961 1.381 . . . . 0.0 112.738 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 76' ' ' ASP . 16.3 tt -55.67 -26.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.579 1.152 . . . . 0.0 112.324 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -62.79 -30.34 71.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.375 0.534 . . . . 0.0 111.24 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -99.17 4.38 46.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.03 0.932 . . . . 0.0 111.627 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -69.7 -178.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.273 1.829 . . . . 0.0 110.039 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 . . . . . 0 C--O 1.245 0.855 0 O-C-N 120.77 -1.206 . . . . 0.0 111.122 -166.862 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.324 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.63 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.825 2.05 . . . . 0.0 111.219 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.94 -6.08 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.581 1.553 . . . . 0.0 110.699 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.49 -168.53 44.38 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 164.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.79 -16.49 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 124.428 1.091 . . . . 0.0 112.968 -168.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.13 -22.99 67.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.011 0.924 . . . . 0.0 112.727 -170.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -60.4 -30.69 69.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.057 0.943 . . . . 0.0 112.693 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.52 -3.49 46.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.156 0.983 . . . . 0.0 110.688 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.88 82.24 7.6 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 109.365 -168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.96 151.27 46.74 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -16.24 15.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.071 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -156.66 157.62 35.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.067 1.347 . . . . 0.0 109.652 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -158.77 177.28 11.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.094 1.758 . . . . 0.0 109.286 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -126.13 128.75 47.81 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.08 44.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.45 38.04 4.96 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.948 1.356 . . . . 0.0 112.243 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 60.74 34.51 19.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.929 2.091 . . . . 0.0 112.953 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 m -142.33 131.85 23.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.594 1.557 . . . . 0.0 107.163 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.9 147.74 36.85 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.49 144.2 39.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.864 1.265 . . . . 0.0 108.48 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.04 174.46 7.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.05 122.66 18.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.81 -1.54 55.41 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.342 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.93 -171.38 2.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.098 1.449 . . . . 0.0 108.678 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.29 127.31 25.9 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.325 -1.484 . . . . 0.0 110.894 -169.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.8 m -70.03 158.32 87.65 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 123.22 0.608 . . . . 0.0 111.492 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.52 159.96 51.1 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.187 1.925 . . . . 0.0 111.023 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.09 -15.89 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.325 0.65 . . . . 0.0 112.54 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -25.97 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 112.097 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -116.43 -9.49 11.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.72 1.208 . . . . 0.0 113.24 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.01 -18.41 37.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.525 0.73 . . . . 0.0 111.32 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 t -53.01 150.81 9.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.212 0.605 . . . . 0.0 109.408 166.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.96 -4.39 15.04 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.866 2.378 . . . . 0.0 113.842 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -57.3 -23.93 51.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 113.246 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -121.57 10.13 10.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.746 1.157 . . . . 0.0 113.199 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.23 106.39 0.61 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.686 2.394 . . . . 0.0 112.371 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.4 mm -73.91 79.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.312 1.045 . . . . 0.0 108.724 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.54 -32.44 73.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.353 -0.842 . . . . 0.0 110.8 166.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -76.65 34.34 0.14 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.843 1.257 . . . . 0.0 114.017 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -75.64 -32.83 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -65.04 -32.34 74.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.43 1.468 . . . . 0.0 110.547 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.61 27.24 0.86 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.686 0.794 . . . . 0.0 111.737 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -132.05 165.53 23.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.02 1.728 . . . . 0.0 107.614 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.515 HD21 ' HA ' ' A' ' 83' ' ' ARG . 2.1 m120 -73.81 -19.87 60.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.44 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.61 151.56 61.11 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.371 1.069 . . . . 0.0 110.331 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.43 164.47 32.55 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.693 1.596 . . . . 0.0 110.359 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.6 157.64 36.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.411 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.59 162.1 32.64 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.324 1.35 . . . . 0.0 110.083 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -70.74 167.54 18.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 162.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.65 61.25 1.79 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 113.252 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.31 41.28 0.04 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.159 1.837 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.3 p -151.04 169.91 20.67 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.841 -0.799 . . . . 0.0 110.728 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -147.01 157.21 43.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.101 0.961 . . . . 0.0 110.184 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -98.56 137.3 37.42 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.283 0.633 . . . . 0.0 109.421 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -137.58 159.11 42.88 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.642 -0.661 . . . . 0.0 110.015 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -99.92 61.27 1.11 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.83 0.824 . . . . 0.0 112.391 -167.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 102.89 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.985 2.114 . . . . 0.0 109.82 -164.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.33 14.12 59.19 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.335 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.29 -1.52 37.53 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.851 1.825 . . . . 0.0 112.965 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -114.84 161.47 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.74 1.77 . . . . 0.0 107.909 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 65.7 m-85 -105.05 113.84 27.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.16 135.08 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -92.27 110.88 22.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.655 1.182 . . . . 0.0 108.543 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.55 142.32 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.706 1.202 . . . . 0.0 108.683 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.77 143.7 54.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.82 -12.66 61.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -140.34 24.1 2.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.274 1.43 . . . . 0.0 109.176 -159.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -165.78 -44.42 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.469 1.508 . . . . 0.0 109.166 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.39 25.03 71.57 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.292 0.949 . . . . 0.0 113.306 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 133.39 55.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 167.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.73 88.69 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.049 2.139 . . . . 0.0 106.515 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -45.95 66.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.287 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -152.17 160.9 43.3 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 109.673 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.2 141.72 40.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.172 1.789 . . . . 0.0 106.42 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -139.14 140.25 37.84 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.267 1.827 . . . . 0.0 106.378 165.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.98 155.84 35.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.431 1.014 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -51.49 -31.06 28.13 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.642 1.591 . . . . 0.0 112.789 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.56 -33.68 6.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.489 1.916 . . . . 0.0 112.551 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 tt -69.4 -12.09 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.534 1.134 . . . . 0.0 112.025 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -67.07 -34.93 78.72 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.845 -1.159 . . . . 0.0 111.182 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -91.32 -17.62 25.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.651 0.78 . . . . 0.0 111.329 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.11 141.64 55.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 128.27 2.628 . . . . 0.0 108.838 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HA ' HD21 ' A' ' 44' ' ' ASN . 12.2 mtt-85 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.1 141.16 56.26 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 155.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.31 49.8 0.83 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.235 1.414 . . . . 0.0 110.435 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.84 -168.87 23.38 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 pt -59.68 -16.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -165.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -53.53 -29.95 39.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.623 1.569 . . . . 0.0 112.651 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.2 -21.02 66.41 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -107.89 4.04 24.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.927 1.291 . . . . 0.0 110.766 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.63 94.51 1.01 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.12 163.64 24.36 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -121.79 -19.09 6.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.004 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.6 164.64 24.05 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.406 1.882 . . . . 0.0 107.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -168.59 -176.64 2.85 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.292 1.837 . . . . 0.0 109.084 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -135.67 133.45 38.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.106 0.962 . . . . 0.0 108.716 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.69 35.41 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.047 0.939 . . . . 0.0 109.409 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.2 39.81 20.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.924 1.29 . . . . 0.0 109.968 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.42 15.5 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.442 2.697 . . . . 0.0 114.855 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 m -114.21 131.82 56.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.419 1.488 . . . . 0.0 107.425 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.85 155.74 23.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.73 0.695 . . . . 0.0 109.373 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -149.26 153.66 37.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.408 1.483 . . . . 0.0 110.485 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -136.64 165.98 24.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.1 1.36 . . . . 0.0 107.365 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.7 mm -59.81 125.84 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 168.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.35 44.02 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.677 -1.624 . . . . 0.0 114.162 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.52 -175.89 0.91 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.213 1.506 . . . . 0.0 109.62 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 131.74 45.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 119.92 -1.737 . . . . 0.0 110.27 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' CG2' ' A' ' 64' ' ' ILE . 17.3 m -72.84 164.1 63.15 Favored Pre-proline 0 N--CA 1.467 0.397 0 C-N-CA 126.052 1.741 . . . . 0.0 111.984 -174.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 74.1 Cg_endo -74.09 158.5 45.52 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.497 2.798 . . . . 0.0 112.234 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.43 68.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.042 1.337 . . . . 0.0 111.797 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 19.6 ptt? -66.8 -33.44 75.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.358 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 25.5 m-85 -87.04 -4.3 59.15 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 118.261 -1.375 . . . . 0.0 114.146 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.37 -21.39 62.88 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.148 0.886 . . . . 0.0 110.95 168.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -69.62 148.7 96.89 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 121.899 -0.5 . . . . 0.0 111.035 -172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.5 -14.87 42.02 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.053 3.169 . . . . 0.0 111.809 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.48 -30.16 60.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.439 1.896 . . . . 0.0 112.563 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -112.62 -8.28 13.82 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.211 1.404 . . . . 0.0 111.833 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -80.77 118.22 22.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.808 1.643 . . . . 0.0 111.28 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.01 92.78 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 -21.09 63.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 111.63 169.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.57 40.12 0.29 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.621 1.168 . . . . 0.0 112.95 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -53.52 -41.45 66.38 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.279 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -61.71 -27.57 68.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.996 1.726 . . . . 0.0 114.68 -167.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -84.99 -14.86 46.13 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.461 1.482 . . . . 0.0 112.746 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 -83.74 172.11 12.54 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 166.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -109.78 8.15 24.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.325 -0.86 . . . . 0.0 111.491 -158.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.72 166.97 10.08 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 129.28 3.032 . . . . 0.0 112.613 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.07 175.5 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 121.387 1.391 . . . . 0.0 111.6 153.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 164.18 2.2 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.796 1.238 . . . . 0.0 111.238 166.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.63 167.93 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.278 1.319 . . . . 0.0 110.459 160.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -81.03 170.49 16.16 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.42 -0.8 . . . . 0.0 109.788 160.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.75 108.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.372 1.469 . . . . 0.0 110.909 167.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.64 29.78 51.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.764 174.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.6 p -130.77 171.36 13.21 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.475 1.138 . . . . 0.0 110.365 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -151.26 164.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.386 0.613 . . . . 0.0 111.445 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CD1' HD13 ' A' ' 63' ' ' LEU . 78.5 m95 -106.32 121.34 44.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.293 1.037 . . . . 0.0 110.129 -168.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.4 p -109.0 -179.97 4.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.303 1.441 . . . . 0.0 110.139 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -131.2 80.85 1.96 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.824 1.193 . . . . 0.0 111.323 -172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtp -99.18 105.5 17.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.593 1.557 . . . . 0.0 111.325 -168.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.09 15.31 62.73 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 118.711 -1.049 . . . . 0.0 113.787 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.58 8.6 59.49 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.105 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.75 127.91 54.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.228 1.514 . . . . 0.0 106.917 172.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 73.3 m-85 -85.29 121.2 27.68 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG12 HG13 ' A' ' 74' ' ' VAL . 13.3 m -127.3 145.46 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 118.847 0.748 . . . . 0.0 109.785 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' HD23 ' A' ' 72' ' ' LEU . 34.8 tp -103.53 126.67 50.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 26' ' ' VAL . 10.9 pt -131.09 135.33 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 138.89 57.87 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.412 -0.805 . . . . 0.0 109.012 170.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.94 -13.94 60.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.6 0.714 . . . . 0.0 110.726 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 p -109.04 -6.24 15.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.097 1.359 . . . . 0.0 111.011 -161.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.43 -37.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.701 1.201 . . . . 0.0 109.684 -160.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 26' ' ' VAL . . . 59.26 41.0 96.6 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 125.753 1.644 . . . . 0.0 111.888 -172.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' O ' HD22 ' A' ' 72' ' ' LEU . 9.6 tmtt? -65.69 133.99 52.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.13 93.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.517 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.4 mm? -65.26 -53.04 50.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -147.91 167.48 24.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 111.584 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 62' ' ' VAL . 68.7 t -142.55 141.18 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 127.448 2.299 . . . . 0.0 105.706 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -136.48 151.62 49.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.986 1.714 . . . . 0.0 108.019 167.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.59 153.32 40.26 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -62.88 -19.09 60.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 126.074 1.797 . . . . 0.0 113.0 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -57.02 -25.17 58.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.699 1.249 . . . . 0.0 111.405 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.27 -23.8 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.718 -0.613 . . . . 0.0 111.618 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -66.27 -13.05 59.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.856 1.207 . . . . 0.0 112.629 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -100.42 -4.94 27.95 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.417 -0.802 . . . . 0.0 110.251 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -77.53 69.89 3.84 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.419 2.287 . . . . 0.0 110.101 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.395 2.678 . . . . 0.0 117.144 158.044 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.443 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 152.71 19.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.711 0.805 . . . . 0.0 110.43 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.13 88.59 1.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.279 166.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.09 36.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 154.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.1 pt -68.51 -11.92 15.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 125.208 1.403 . . . . 0.0 113.268 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.84 -32.72 70.93 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 112.429 -168.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -56.13 -29.52 60.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.449 1.499 . . . . 0.0 113.618 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.99 -1.45 42.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.9 96.18 0.57 Allowed 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.748 1.158 . . . . 0.0 108.246 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.62 140.38 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -84.57 -20.34 31.64 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 122.304 -0.247 . . . . 0.0 110.932 168.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -157.61 162.73 38.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.037 1.335 . . . . 0.0 108.927 -168.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.27 177.32 11.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.377 1.071 . . . . 0.0 108.651 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -126.92 132.52 50.86 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.64 153.91 46.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 27.01 15.76 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.379 0.991 . . . . 0.0 112.692 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 57.64 14.64 2.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.062 -172.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.2 m -111.52 137.2 49.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 128.271 2.628 . . . . 0.0 105.791 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.04 154.15 18.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -149.7 153.4 36.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.254 0.621 . . . . 0.0 109.953 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -143.28 169.06 18.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.648 0.779 . . . . 0.0 109.045 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.16 93.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.87 5.46 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-O 117.809 -1.551 . . . . 0.0 114.174 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.92 176.04 1.78 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.469 1.634 . . . . 0.0 108.384 166.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -134.71 138.5 44.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -82.19 157.81 67.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.2 158.01 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 110.653 166.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.74 43.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.39 1.076 . . . . 0.0 112.479 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtm -51.92 -35.94 47.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.062 1.345 . . . . 0.0 111.824 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -97.24 -7.44 32.26 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.93 -18.97 61.34 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.665 0.666 . . . . 0.0 110.158 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.4 p -55.29 158.08 5.79 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.03 1.332 . . . . 0.0 111.497 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.37 -12.24 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.981 2.454 . . . . 0.0 113.032 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.87 -21.85 66.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.554 1.141 . . . . 0.0 112.408 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -115.51 13.36 16.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.932 1.693 . . . . 0.0 111.243 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -89.48 82.38 6.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.864 2.066 . . . . 0.0 111.218 -162.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.5 71.29 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.491 1.516 . . . . 0.0 110.905 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -68.6 -23.09 64.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.197 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -74.1 94.36 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 170.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -125.4 -27.05 3.5 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.812 -1.18 . . . . 0.0 113.641 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -51.42 -44.1 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.721 0.691 . . . . 0.0 109.177 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 -24.2 8.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.825 2.45 . . . . 0.0 115.453 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -116.07 177.06 4.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.478 1.511 . . . . 0.0 108.32 -170.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -9.58 59.66 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.07 -0.394 . . . . 0.0 111.022 -172.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.22 144.94 98.35 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 123.364 0.666 . . . . 0.0 109.816 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.11 159.86 24.62 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.796 2.331 . . . . 0.0 108.959 166.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.42 147.42 68.59 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.841 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -63.62 158.15 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.427 1.418 . . . . 0.0 108.767 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -72.52 156.41 39.05 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.48 65.06 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.533 1.533 . . . . 0.0 112.362 -164.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 25.57 0.05 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 128.004 2.716 . . . . 0.0 110.94 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.0 p -143.84 167.49 22.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.163 1.481 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -146.55 152.35 38.81 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.024 0.53 . . . . 0.0 111.726 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -92.06 128.43 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -131.8 155.44 47.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.297 0.639 . . . . 0.0 111.035 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 11.5 t80 -91.11 119.76 31.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.465 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtt -141.57 110.43 6.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.558 1.072 . . . . 0.0 111.266 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 1.98 33.85 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.106 0.86 . . . . 0.0 113.499 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.461 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.99 -18.15 19.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.824 1.678 . . . . 0.0 111.833 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -82.97 162.83 21.35 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.707 1.203 . . . . 0.0 109.5 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 34.3 m-85 -109.87 118.11 35.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.478 1.511 . . . . 0.0 107.6 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 74' ' ' VAL . 3.1 m -131.72 131.45 62.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -89.0 111.02 21.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -106.96 147.88 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.614 1.166 . . . . 0.0 108.09 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 141.75 52.15 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.3 -10.73 60.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.669 0.747 . . . . 0.0 112.543 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -124.05 -5.77 7.87 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.263 2.225 . . . . 0.0 111.299 -161.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -152.92 -32.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.36 1.464 . . . . 0.0 109.461 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.1 16.16 80.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 124.101 0.858 . . . . 0.0 113.138 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.5 OUTLIER -62.41 131.63 49.86 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.596 -0.943 . . . . 0.0 108.567 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.26 94.58 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.62 -52.56 14.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.867 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -150.15 162.53 40.26 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.116 1.366 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.566 HG13 HG12 ' A' ' 62' ' ' VAL . 86.9 t -139.58 136.45 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -133.89 143.52 48.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.37 1.068 . . . . 0.0 108.171 168.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.99 144.1 57.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -55.39 -22.78 32.01 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.337 1.446 . . . . 0.0 114.135 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.86 -20.46 57.27 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.182 1.491 . . . . 0.0 113.585 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.27 -16.8 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 112.169 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.59 -49.38 69.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.862 -1.149 . . . . 0.0 110.056 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -82.52 -17.74 43.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.24 0.616 . . . . 0.0 111.707 -168.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.12 124.09 10.8 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 130.308 3.443 . . . . 0.0 108.747 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.016 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.45 -1.75 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.13 169.36 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.104 1.452 . . . . 0.0 108.201 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.16 12.93 1.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.03 -105.44 3.0 Favored Glycine 0 C--O 1.219 -0.791 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 79' ' ' ILE . 23.3 pt -117.93 -20.4 5.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.653 -0.91 . . . . 0.0 111.787 -174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.61 -15.58 63.57 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.88 0.472 . . . . 0.0 111.811 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.9 -21.95 66.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.297 1.439 . . . . 0.0 112.586 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.65 0.73 31.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.808 1.243 . . . . 0.0 111.722 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.599 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . . . -79.8 106.77 12.07 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.987 1.267 . . . . 0.0 109.574 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.93 HD13 HG12 ' A' ' 74' ' ' VAL . 2.9 mp -72.41 -162.12 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HE2' ' OE1' ' A' ' 12' ' ' GLU . 15.4 ptmt -134.92 -16.62 1.94 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 119.956 -1.715 . . . . 0.0 109.968 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.6 pt-20 -165.29 170.64 14.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -162.47 172.57 15.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.683 0.793 . . . . 0.0 109.501 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.11 141.3 45.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 159.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.25 142.74 32.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 160.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.64 31.14 12.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 170.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 70.15 13.72 7.72 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.451 2.701 . . . . 0.0 114.042 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.9 m -105.46 133.03 50.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 107.845 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.65 149.32 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.125 1.77 . . . . 0.0 110.25 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -157.12 146.9 20.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.887 0.875 . . . . 0.0 111.039 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -140.44 167.61 21.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.799 0.84 . . . . 0.0 110.475 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 mm -61.19 101.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.46 -10.97 9.77 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 117.577 -1.68 . . . . 0.0 116.16 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB2' HD12 ' A' ' 71' ' ' ILE . 14.8 m-20 -73.58 -174.76 1.8 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 121.005 2.403 . . . . 0.0 109.45 171.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.09 139.6 53.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.648 -1.282 . . . . 0.0 108.872 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.21 159.36 82.56 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 121.338 -0.851 . . . . 0.0 109.266 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.16 155.95 42.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.712 2.275 . . . . 0.0 111.137 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 31' ' ' LEU . . . -64.33 -11.48 32.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.15 -33.73 71.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 109.581 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -102.21 -8.3 21.43 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 28' ' ' ALA . 3.6 mm? -59.21 -27.06 65.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.2 -0.428 . . . . 0.0 109.98 167.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.3 p -64.42 144.45 98.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 117.837 0.29 . . . . 0.0 111.725 -168.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.39 -6.0 18.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.08 1.853 . . . . 0.0 111.871 -171.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.01 -38.36 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.095 2.158 . . . . 0.0 111.719 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -106.97 7.02 29.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.261 1.425 . . . . 0.0 111.702 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -90.92 107.84 19.46 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.296 1.839 . . . . 0.0 110.633 -171.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.0 mp -81.56 66.83 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.468 1.507 . . . . 0.0 110.211 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -54.23 -26.48 28.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.755 1.222 . . . . 0.0 112.133 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -72.84 90.34 1.43 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.834 1.654 . . . . 0.0 108.743 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -114.46 -28.84 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.379 1.445 . . . . 0.0 113.285 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.17 -38.84 77.43 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.773 1.229 . . . . 0.0 111.765 -168.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -119.28 44.7 2.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.807 1.243 . . . . 0.0 109.069 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -124.05 29.11 6.55 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.766 0.826 . . . . 0.0 112.4 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 m120 52.7 27.05 4.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.015 1.326 . . . . 0.0 111.853 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.9 mt -127.93 159.02 68.79 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 120.424 1.465 . . . . 0.0 110.448 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.32 173.47 13.78 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.025 2.483 . . . . 0.0 111.73 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.79 151.55 97.09 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.176 0.99 . . . . 0.0 110.947 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.31 164.89 34.27 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.559 3.506 . . . . 0.0 111.41 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.66 167.56 14.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.865 0.84 . . . . 0.0 109.186 163.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.65 51.82 0.28 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.586 2.355 . . . . 0.0 115.15 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.79 43.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 126.275 1.893 . . . . 0.0 109.156 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.2 p -154.73 168.38 27.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.469 1.135 . . . . 0.0 111.584 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -155.53 156.09 34.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.205 1.003 . . . . 0.0 109.962 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -80.57 141.31 35.19 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.277 1.031 . . . . 0.0 108.699 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.3 t -130.99 158.61 39.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.475 1.11 . . . . 0.0 108.692 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HB2' HD11 ' A' ' 37' ' ' ILE . 7.4 t80 -96.02 109.24 21.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.478 1.111 . . . . 0.0 108.592 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.87 112.86 13.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.943 1.297 . . . . 0.0 110.827 -170.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.57 -1.13 15.43 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.292 -175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.67 -12.52 25.26 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 120.066 1.933 . . . . 0.0 113.341 -164.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.76 163.01 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 118.642 1.221 . . . . 0.0 109.482 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -101.17 111.52 23.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.863 1.665 . . . . 0.0 108.376 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 74' ' ' VAL . 4.5 m -121.49 135.9 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.396 -0.815 . . . . 0.0 109.964 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 tp -89.11 113.3 24.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.563 1.545 . . . . 0.0 110.1 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.408 ' CD1' HD13 ' A' ' 31' ' ' LEU . 1.9 pp -119.28 142.28 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.598 1.159 . . . . 0.0 109.159 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 137.13 41.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.903 0.881 . . . . 0.0 109.408 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.06 1.85 4.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.944 0.898 . . . . 0.0 113.018 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 t -143.3 9.12 1.63 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.241 1.416 . . . . 0.0 110.775 -168.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -155.64 -42.65 0.08 Allowed 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.568 -1.332 . . . . 0.0 108.528 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 16.62 71.55 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.742 0.687 . . . . 0.0 111.461 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 139.72 58.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.35 1.075 . . . . 0.0 109.043 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 24' ' ' ASP . 71.4 mt -81.43 79.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.629 1.571 . . . . 0.0 107.523 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.54 -47.14 76.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -149.86 162.67 39.85 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.186 1.794 . . . . 0.0 108.878 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.93 HG12 HD13 ' A' ' 10' ' ' LEU . 45.0 t -140.62 136.93 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 9' ' ' ALA . 47.2 m-85 -137.27 144.83 42.9 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.994 1.718 . . . . 0.0 107.289 172.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 79' ' ' ILE . 52.1 t0 -70.57 159.42 34.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.83 0.741 . . . . 0.0 111.612 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.25 -28.71 72.69 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.04 0.829 . . . . 0.0 111.902 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.18 -21.51 33.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 112.455 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 5' ' ' ILE . 10.5 tt -61.88 -30.73 49.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.156 0.889 . . . . 0.0 111.469 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -66.57 -12.45 57.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 111.774 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.78 -8.01 20.14 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.488 1.115 . . . . 0.0 112.192 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -54.16 170.95 0.12 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.926 2.091 . . . . 0.0 110.046 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -173.585 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.026 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.69 32.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.397 2.679 . . . . 0.0 116.436 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.02 51.62 2.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 111.724 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.81 10.18 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -53.56 -25.98 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -56.89 -19.51 18.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.139 2.176 . . . . 0.0 112.179 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.76 -33.93 77.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 0.0 112.576 170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -95.07 0.63 54.58 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.088 1.355 . . . . 0.0 111.81 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 87.4 1.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.927 0.891 . . . . 0.0 109.386 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.77 158.98 35.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -105.51 -13.3 15.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.112 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.82 160.76 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.717 1.607 . . . . 0.0 109.039 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -159.66 175.38 13.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.697 1.599 . . . . 0.0 108.869 168.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -117.38 143.67 45.74 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.07 153.77 34.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 166.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.07 24.13 13.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.165 0.893 . . . . 0.0 111.752 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 56.64 17.23 2.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.066 2.146 . . . . 0.0 113.54 -170.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -108.33 128.75 55.03 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.57 1.948 . . . . 0.0 106.787 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -82.55 149.27 27.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.596 1.559 . . . . 0.0 110.092 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -152.49 153.91 34.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.827 0.851 . . . . 0.0 111.052 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -139.62 165.17 27.97 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.422 1.089 . . . . 0.0 108.837 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.63 112.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.77 -9.81 34.71 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.288 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.44 -175.93 2.11 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 119.494 1.647 . . . . 0.0 107.142 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.09 161.33 21.17 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 119.046 -2.284 . . . . 0.0 108.243 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -90.81 163.11 31.27 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 109.883 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.86 155.63 61.96 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.645 2.23 . . . . 0.0 110.97 158.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -62.44 -17.91 60.48 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.862 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 mmt -49.89 -22.17 1.41 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.907 2.083 . . . . 0.0 113.454 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -116.8 -10.16 11.1 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.374 0.988 . . . . 0.0 112.699 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.8 mt -72.56 -31.68 65.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.157 0.889 . . . . 0.0 110.945 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 t -50.94 144.67 13.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.071 1.348 . . . . 0.0 109.263 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.12 -11.32 31.79 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.011 2.474 . . . . 0.0 112.711 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.17 -18.85 11.27 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 112.97 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -118.93 -1.44 11.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 112.358 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -70.37 99.51 1.59 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.724 1.61 . . . . 0.0 110.659 -168.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 mt -81.39 83.84 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -62.52 -23.32 66.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.477 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -83.67 104.89 14.15 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.539 1.063 . . . . 0.0 111.014 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.43 -25.92 2.6 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 117.652 -1.166 . . . . 0.0 114.112 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -33.92 73.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.959 1.254 . . . . 0.0 112.193 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.7 26.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.818 1.247 . . . . 0.0 111.327 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -141.32 163.76 32.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.571 1.149 . . . . 0.0 108.448 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -64.74 -28.54 69.65 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.752 0.821 . . . . 0.0 112.449 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.65 153.76 7.58 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 124.476 1.11 . . . . 0.0 112.255 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.19 177.43 8.87 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.904 2.403 . . . . 0.0 111.209 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.57 164.46 7.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.338 1.455 . . . . 0.0 111.429 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -67.52 178.2 3.4 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.619 2.212 . . . . 0.0 109.266 157.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -85.38 179.11 7.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 162.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.91 37.4 0.24 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.263 1.425 . . . . 0.0 114.72 -166.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 43.83 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.049 1.785 . . . . 0.0 109.757 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 3.3 p -147.05 172.41 13.79 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.58 -1.541 . . . . 0.0 109.604 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -145.56 149.33 34.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.774 0.321 . . . . 0.0 111.636 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.46 142.88 38.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -134.16 170.44 15.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.591 1.156 . . . . 0.0 109.94 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 25.8 t80 -106.55 104.22 13.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.418 1.087 . . . . 0.0 108.666 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.68 102.11 9.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.734 1.614 . . . . 0.0 109.149 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.98 3.14 50.63 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.992 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 111.23 -1.33 28.2 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.464 1.132 . . . . 0.0 113.04 -169.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -120.48 140.0 52.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.651 1.58 . . . . 0.0 107.673 -167.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.1 120.39 28.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.65 144.4 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 tp -102.11 125.18 48.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.2 pt -130.03 135.18 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.885 0.874 . . . . 0.0 111.942 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 52' ' ' SER . 0.0 OUTLIER -60.12 129.7 43.03 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.421 0.688 . . . . 0.0 111.348 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.94 15.73 0.84 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.743 1.217 . . . . 0.0 112.633 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -143.13 4.93 1.46 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.151 2.58 . . . . 0.0 111.642 -171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -168.69 -50.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.9 1.28 . . . . 0.0 108.876 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.43 41.7 29.63 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.439 1.971 . . . . 0.0 111.17 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -61.11 153.75 24.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 159.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.0 mt -87.61 89.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 -47.98 69.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 110.484 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -144.59 158.95 43.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.91 0.884 . . . . 0.0 110.679 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.87 130.89 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.988 2.115 . . . . 0.0 106.062 166.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -125.58 142.33 51.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 160.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -63.7 151.53 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.357 0.526 . . . . 0.0 110.039 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.84 -18.77 47.73 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.575 1.083 . . . . 0.0 113.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.37 -27.73 38.43 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.437 1.119 . . . . 0.0 111.907 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -63.33 -20.57 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 112.735 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.18 -50.68 72.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.362 0.983 . . . . 0.0 109.978 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.66 -15.51 58.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.878 1.671 . . . . 0.0 112.274 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -85.27 88.27 7.47 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -174.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 127.267 2.227 . . . . 0.0 112.575 178.613 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.04 168.5 15.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.89 1.676 . . . . 0.0 107.312 164.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.29 73.73 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.24 -105.58 0.23 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 pt -120.72 -17.27 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.15 -30.87 71.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.895 0.478 . . . . 0.0 111.449 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -64.0 -20.68 66.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.388 1.875 . . . . 0.0 112.802 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -105.34 2.2 28.62 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.202 1.401 . . . . 0.0 111.25 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.61 96.22 1.53 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.48 157.24 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -129.71 0.46 4.9 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.357 1.063 . . . . 0.0 111.528 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -173.04 161.01 4.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.929 2.891 . . . . 0.0 106.457 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -169.51 177.48 4.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.235 1.414 . . . . 0.0 109.329 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -132.52 140.58 48.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 165.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.8 41.87 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 165.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t0 54.14 27.02 7.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 61.24 29.06 18.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.52 1.928 . . . . 0.0 111.704 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 m -125.8 135.83 52.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -110.16 150.29 28.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 109.476 -171.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -148.67 146.37 28.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.565 -160.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -144.28 167.07 23.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.668 1.587 . . . . 0.0 108.266 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 mm -69.81 118.23 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.89 -11.0 57.46 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.866 -1.519 . . . . 0.0 113.71 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.14 -179.85 2.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.804 1.802 . . . . 0.0 107.363 166.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.58 157.31 31.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 119.306 -2.121 . . . . 0.0 107.617 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 64' ' ' ILE . 18.4 m -84.96 165.23 38.18 Favored Pre-proline 0 C--O 1.238 0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 111.444 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 73.3 Cg_endo -71.18 158.56 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.18 2.586 . . . . 0.0 111.42 163.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.8 67.52 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.02 0.928 . . . . 0.0 112.025 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 18.9 ptp -54.8 -20.44 8.58 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 126.104 1.762 . . . . 0.0 114.273 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.455 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 10.8 m-85 -110.2 3.73 20.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.34 -23.0 35.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 111.508 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 t -66.65 145.53 98.95 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.197 0.999 . . . . 0.0 110.89 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.96 -6.71 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.531 3.487 . . . . 0.0 114.351 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -51.63 -42.44 62.02 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.44 1.096 . . . . 0.0 110.971 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.21 -12.15 19.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.521 0.728 . . . . 0.0 112.216 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -60.76 99.95 0.1 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.878 2.471 . . . . 0.0 112.211 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -78.18 79.31 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.123 1.769 . . . . 0.0 106.4 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -62.73 -29.24 70.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.6 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -76.05 76.59 2.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 111.639 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -98.54 -19.19 17.76 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.588 -0.695 . . . . 0.0 111.405 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -0.87 13.5 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.571 -1.331 . . . . 0.0 112.976 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.47 12.45 6.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.838 1.655 . . . . 0.0 111.775 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -120.86 173.58 7.14 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 120.842 -1.161 . . . . 0.0 107.953 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.03 -12.66 49.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.044 0.537 . . . . 0.0 112.079 -170.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.44 152.64 95.42 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.996 1.318 . . . . 0.0 109.904 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.46 167.14 19.52 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.245 2.63 . . . . 0.0 111.628 170.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.21 144.3 97.46 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.893 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.04 173.37 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.243 2.629 . . . . 0.0 110.847 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.66 175.64 9.99 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.005 0.922 . . . . 0.0 110.096 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.76 99.66 0.12 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.589 1.556 . . . . 0.0 111.422 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.3 49.36 20.84 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.169 -0.957 . . . . 0.0 111.058 -175.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -132.02 171.09 14.04 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 159.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.4 154.41 34.41 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.013 0.435 . . . . 0.0 111.113 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -75.62 143.51 42.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.523 175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -129.75 172.8 11.27 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.268 1.427 . . . . 0.0 109.02 168.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 114.47 28.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.42 ' CG ' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -89.41 -154.33 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.328 0.967 . . . . 0.0 110.016 175.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 57' ' ' MET . . . -46.55 7.63 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 1 C-N-CA 132.65 4.929 . . . . 0.0 117.862 170.357 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 57' ' ' MET . . . 138.37 -19.5 3.21 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 127.193 2.33 . . . . 0.0 110.883 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' OD1' HG13 ' A' ' 62' ' ' VAL . 15.5 p30 -92.5 162.9 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.346 1.458 . . . . 0.0 110.55 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.24 125.84 52.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.374 1.469 . . . . 0.0 107.496 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 60' ' ' ASN . 2.5 m -129.53 156.37 41.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 72' ' ' LEU . 64.0 tp -117.62 125.33 50.56 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.418 ' CG2' HG11 ' A' ' 26' ' ' VAL . 1.1 pt -130.72 136.55 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 124.397 1.079 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.61 135.45 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.744 0.818 . . . . 0.0 109.644 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -6.25 8.94 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.818 -0.551 . . . . 0.0 112.221 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -135.85 12.68 3.4 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.673 1.589 . . . . 0.0 110.145 -158.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -170.95 -31.4 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 125.887 1.675 . . . . 0.0 109.822 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.43 35.65 21.83 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.271 1.415 . . . . 0.0 111.661 -165.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.469 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -64.86 152.61 42.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 170.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.7 mt -86.97 86.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.7 mm? -64.4 -51.76 61.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -149.8 161.88 41.38 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 109.364 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.13 142.35 40.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -132.49 152.14 51.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 161.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.49 160.8 28.41 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.877 -0.514 . . . . 0.0 111.02 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -22.19 71.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 124.451 1.024 . . . . 0.0 113.037 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -59.87 -18.57 45.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 112.296 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.33 -19.73 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 112.946 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -72.3 -35.06 68.56 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.512 1.051 . . . . 0.0 111.746 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -76.74 -16.42 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.775 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -72.77 174.53 7.54 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.075 0.941 . . . . 0.0 110.378 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 . . . . . 0 C--O 1.246 0.916 0 C-N-CA 126.359 1.864 . . . . 0.0 110.518 -161.36 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.98 -162.97 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.137 0.975 . . . . 0.0 109.74 -152.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.57 0.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.165 2.186 . . . . 0.0 116.189 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.83 -160.37 32.92 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 164.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 pt -62.66 -20.25 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -165.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.92 -25.88 58.26 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.865 1.666 . . . . 0.0 113.166 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -65.75 -27.17 68.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.81 0.43 57.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.321 1.049 . . . . 0.0 110.507 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.56 90.96 2.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.851 1.26 . . . . 0.0 111.628 -167.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.8 129.37 34.49 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.402 1.081 . . . . 0.0 108.303 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -92.01 -15.95 27.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.095 0.862 . . . . 0.0 112.393 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.83 166.4 29.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.312 1.445 . . . . 0.0 107.625 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 44.4 p90 -156.72 176.8 12.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.047 0.939 . . . . 0.0 108.881 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -129.89 129.82 44.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.34 142.43 32.48 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 44.34 51.77 7.51 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.02 1.328 . . . . 0.0 109.961 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.299 2.6 p90 48.24 24.19 0.65 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.014 3.326 . . . . 0.0 114.601 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.6 m -115.48 138.0 51.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.669 1.988 . . . . 0.0 107.407 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -89.78 150.71 22.15 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.019 0.928 . . . . 0.0 109.33 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.8 m-85 -149.86 154.03 37.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.116 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -135.43 160.82 37.25 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.981 0.912 . . . . 0.0 108.644 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.27 113.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 -13.26 25.24 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.496 -1.724 . . . . 0.0 114.066 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.8 -172.38 1.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.078 1.939 . . . . 0.0 109.602 169.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.84 148.8 49.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.543 1.537 . . . . 0.0 108.966 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.67 154.55 45.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.681 -0.675 . . . . 0.0 110.234 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.28 165.63 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.929 2.419 . . . . 0.0 112.021 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -8.93 32.99 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.884 0.874 . . . . 0.0 112.708 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -22.81 60.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.801 1.64 . . . . 0.0 110.838 170.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -110.66 -23.67 10.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.872 0.869 . . . . 0.0 113.153 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -76.97 -18.02 58.5 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.304 0.502 . . . . 0.0 111.456 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 t -54.06 147.98 23.45 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.346 1.858 . . . . 0.0 110.508 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.38 -11.37 31.2 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.71 -9.72 15.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.764 1.625 . . . . 0.0 113.761 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -132.12 0.19 3.78 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.527 1.058 . . . . 0.0 112.591 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.26 136.9 57.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.645 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -118.71 88.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.696 1.599 . . . . 0.0 108.672 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.41 -14.23 62.79 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.702 -0.624 . . . . 0.0 111.839 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.16 43.12 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.053 1.341 . . . . 0.0 110.516 -162.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -70.6 -15.49 62.75 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.97 -25.58 67.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.397 0.999 . . . . 0.0 111.74 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.09 39.36 0.76 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 119.564 1.075 . . . . 0.0 111.712 -171.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 174.15 156.56 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 130.11 3.364 . . . . 0.0 106.684 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -81.82 0.75 37.98 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.734 . . . . 0.0 111.621 -174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.22 151.87 16.97 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 119.261 0.937 . . . . 0.0 111.179 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.79 168.42 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.077 1.851 . . . . 0.0 110.481 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.52 158.18 11.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.282 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.9 162.51 37.5 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.734 1.623 . . . . 0.0 110.232 167.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -70.73 162.66 28.69 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 162.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 109.25 1.96 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.926 -1.109 . . . . 0.0 110.92 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.58 33.98 17.65 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.339 0.518 . . . . 0.0 111.895 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.3 p -130.69 171.12 13.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.018 0.927 . . . . 0.0 108.869 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -143.77 153.26 42.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -94.48 133.78 37.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.372 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -134.64 160.25 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.07 114.89 26.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.654 ' HG2' HG13 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -90.35 -152.89 0.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.972 1.309 . . . . 0.0 108.417 171.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.81 52.87 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 130.233 3.778 . . . . 0.0 115.3 166.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.97 3.49 89.13 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 117.818 0.809 . . . . 0.0 113.756 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' HB2' ' HE3' ' A' ' 57' ' ' MET . 10.3 m-80 -121.49 166.63 13.87 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.966 1.307 . . . . 0.0 107.566 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -108.6 120.65 43.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 57' ' ' MET . 30.4 m -112.07 155.63 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -111.33 118.87 37.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.528 HD12 HD23 ' A' ' 31' ' ' LEU . 3.8 pt -116.9 145.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.366 1.867 . . . . 0.0 109.145 -174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.02 141.18 56.29 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 120.053 1.297 . . . . 0.0 107.69 166.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -73.18 -6.88 48.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.87 0.843 . . . . 0.0 112.368 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 t -136.07 23.24 3.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.434 1.894 . . . . 0.0 110.288 -163.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -172.92 -38.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.94 1.696 . . . . 0.0 109.2 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.63 25.97 68.65 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 125.14 1.352 . . . . 0.0 113.216 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.99 143.87 57.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.565 1.146 . . . . 0.0 108.972 174.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.97 91.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.991 1.716 . . . . 0.0 107.501 -169.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.5 mt -79.38 -48.3 14.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.631 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -146.27 163.03 36.76 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.467 1.507 . . . . 0.0 108.043 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 62' ' ' VAL . 42.0 t -140.58 142.83 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 166.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.72 148.96 51.48 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 161.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 79' ' ' ILE . 19.1 t70 -62.25 158.72 16.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.072 0.949 . . . . 0.0 112.44 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.3 -24.52 55.74 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 126.15 1.834 . . . . 0.0 115.083 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -63.84 -21.13 66.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 120.141 1.97 . . . . 0.0 112.694 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 76' ' ' ASP . 9.8 tt -67.48 0.67 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 121.271 -0.893 . . . . 0.0 111.564 172.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -66.29 -41.62 89.54 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.397 -1.439 . . . . 0.0 110.952 162.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -131.48 16.71 4.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.475 1.11 . . . . 0.0 112.848 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -51.5 133.44 29.94 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.894 2.077 . . . . 0.0 107.961 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.567 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.11 105.08 0.89 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.749 2.02 . . . . 0.0 107.058 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 44.02 49.58 7.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.555 1.942 . . . . 0.0 113.282 170.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.36 -95.59 1.82 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.18 -26.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.885 1.274 . . . . 0.0 110.539 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.74 -16.62 64.37 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.476 1.11 . . . . 0.0 112.798 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -57.94 -24.73 59.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.672 1.589 . . . . 0.0 112.457 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.98 -1.27 34.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 0.0 111.98 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.77 104.07 10.1 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.862 0.755 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.14 125.57 29.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -65.84 -30.15 70.72 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.519 -1.363 . . . . 0.0 110.422 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.78 153.85 28.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.69 176.26 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.058 1.343 . . . . 0.0 108.554 171.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.3 m -126.74 139.07 53.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.45 151.11 37.69 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.33 35.18 13.19 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.875 0.87 . . . . 0.0 111.871 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 58.54 37.94 25.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.906 2.482 . . . . 0.0 112.691 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -138.12 133.19 33.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.998 1.719 . . . . 0.0 107.506 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.28 154.42 21.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.546 0.738 . . . . 0.0 109.688 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -147.5 154.28 40.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.079 1.752 . . . . 0.0 110.435 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -145.81 165.21 29.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.231 1.412 . . . . 0.0 109.364 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -66.7 100.65 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.87 -1.92 19.69 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.042 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -79.51 -174.44 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.266 1.033 . . . . 0.0 108.679 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 164.81 20.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.712 1.605 . . . . 0.0 109.606 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.97 163.89 16.25 Favored Pre-proline 0 N--CA 1.47 0.534 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.11 155.54 47.29 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.756 1.637 . . . . 0.0 110.221 162.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.78 -16.39 57.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp -56.25 -18.19 9.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.018 1.727 . . . . 0.0 112.508 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 57' ' ' MET . 69.8 m-85 -116.35 -11.35 11.23 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.29 1.036 . . . . 0.0 113.268 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.5 -13.96 59.21 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-N 118.744 0.702 . . . . 0.0 110.61 171.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -64.88 145.04 99.05 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.163 -0.961 . . . . 0.0 108.44 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.1 -3.8 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.178 2.585 . . . . 0.0 114.209 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.02 -12.67 1.54 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.884 -1.135 . . . . 0.0 113.334 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -127.02 3.12 6.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.803 1.241 . . . . 0.0 112.042 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 116.84 5.71 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.429 2.691 . . . . 0.0 111.4 -170.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.76 122.14 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.813 1.645 . . . . 0.0 107.85 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -131.94 -5.14 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.82 34.57 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.445 1.93 . . . . 0.0 112.312 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.02 -29.25 70.15 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 120.737 -1.227 . . . . 0.0 110.916 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -56.88 -13.3 2.51 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.322 1.449 . . . . 0.0 113.712 172.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.15 1.77 7.89 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.722 1.609 . . . . 0.0 113.341 -173.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 -118.0 161.17 20.24 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.842 1.657 . . . . 0.0 109.493 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.01 58.63 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.151 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.61 155.41 73.55 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.013 1.325 . . . . 0.0 109.472 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.99 164.72 34.79 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.441 2.761 . . . . 0.0 113.095 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.29 84.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.045 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' CB ' HD11 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -81.46 -59.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.594 0.891 . . . . 0.0 113.263 -166.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 176.61 -162.3 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 131.527 3.931 . . . . 0.0 105.681 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.08 2.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.178 2.191 . . . . 0.0 112.388 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.32 47.32 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 p -142.02 165.76 26.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.154 0.981 . . . . 0.0 110.883 168.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -137.49 157.49 46.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.889 0.476 . . . . 0.0 110.195 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -84.53 151.68 24.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p -138.73 176.89 8.31 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.689 1.596 . . . . 0.0 109.119 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 8.0 t80 -116.85 104.4 11.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.616 1.167 . . . . 0.0 108.661 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 30' ' ' TYR . 42.7 ttm -112.92 98.67 7.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.396 1.878 . . . . 0.0 108.176 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.31 11.22 64.1 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.444 1.02 . . . . 0.0 113.904 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 109.63 -12.42 32.8 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.973 1.386 . . . . 0.0 113.311 -172.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -94.51 120.17 34.33 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.468 2.307 . . . . 0.0 107.202 -171.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.485 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 30.7 m-85 -64.55 114.5 4.41 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.369 -0.832 . . . . 0.0 108.887 162.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG12 ' HB ' ' A' ' 74' ' ' VAL . 4.2 m -123.97 154.88 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 48' ' ' PRO . 27.0 tp -109.32 130.47 55.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.513 1.125 . . . . 0.0 109.864 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.6 pt -131.5 142.36 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.804 1.241 . . . . 0.0 110.061 -173.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 138.82 53.0 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.902 0.774 . . . . 0.0 109.772 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.51 -14.89 62.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.88 0.872 . . . . 0.0 112.113 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -128.59 1.37 5.55 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.115 1.766 . . . . 0.0 110.484 -167.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.16 -35.38 0.24 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.989 -1.069 . . . . 0.0 111.907 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.44 20.43 79.38 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.759 0.695 . . . . 0.0 113.228 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 132.99 55.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.26 92.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 127.568 2.347 . . . . 0.0 105.781 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.35 -54.07 16.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -151.16 170.69 18.83 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.743 0.817 . . . . 0.0 109.681 -170.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.2 p -143.23 140.78 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 1 C-N-CA 132.07 4.148 . . . . 0.0 105.113 171.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -142.79 112.37 6.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.412 -1.28 . . . . 0.0 108.262 160.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -49.19 146.73 3.44 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.904 1.229 . . . . 0.0 113.117 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.485 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -44.53 -26.15 0.98 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.732 -1.594 . . . . 0.0 116.175 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -49.67 -30.79 9.69 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.875 1.837 . . . . 0.0 112.686 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.06 -22.57 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.947 0.899 . . . . 0.0 112.379 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.16 -30.62 71.73 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 111.305 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -93.21 8.45 40.18 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.471 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -72.96 172.38 11.06 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.242 0.544 . . . . 0.0 110.594 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.325 0.65 . . . . 0.0 110.426 179.699 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.73 171.77 7.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.573 1.149 . . . . 0.0 110.696 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.71 52.44 0.82 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 109.884 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.47 -103.34 2.21 Favored Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt -141.48 -17.08 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 -20.43 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.437 0.562 . . . . 0.0 112.019 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -52.82 -26.51 14.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.007 2.123 . . . . 0.0 113.797 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -96.58 0.65 50.34 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.51 1.524 . . . . 0.0 112.31 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.65 118.43 22.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.406 1.457 . . . . 0.0 108.581 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.887 HD13 HG12 ' A' ' 74' ' ' VAL . 1.9 mp -83.4 -167.97 1.91 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 123.872 1.796 . . . . 0.0 106.753 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 -19.76 6.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.167 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -170.79 170.59 6.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -159.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -170.47 -178.38 2.68 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.862 1.665 . . . . 0.0 109.37 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -125.47 137.96 53.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 164.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.2 43.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 164.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.55 30.17 16.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.099 0.952 . . . . 0.0 112.06 176.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 58.35 25.22 12.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.672 1.189 . . . . 0.0 111.796 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 m -127.29 128.86 46.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.023 2.529 . . . . 0.0 106.768 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.88 152.96 29.35 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.831 0.853 . . . . 0.0 109.468 174.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -146.28 158.1 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.415 1.086 . . . . 0.0 110.024 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -139.73 164.44 29.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.135 1.774 . . . . 0.0 109.174 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.91 117.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 166.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -5.78 56.1 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.169 -1.351 . . . . 0.0 113.892 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.55 -177.11 3.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.082 1.941 . . . . 0.0 107.484 165.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 157.09 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.257 -1.527 . . . . 0.0 108.524 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.16 162.45 34.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.906 0.775 . . . . 0.0 109.452 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.99 162.46 34.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.0 2.467 . . . . 0.0 111.633 163.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -17.08 24.92 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.581 1.153 . . . . 0.0 112.998 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.18 -21.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.057 1.343 . . . . 0.0 112.44 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.95 -6.59 10.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.882 0.873 . . . . 0.0 112.774 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.81 -33.62 72.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.946 1.248 . . . . 0.0 109.873 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.2 t -49.35 144.3 8.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.644 1.578 . . . . 0.0 109.286 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.785 1.657 . . . . 0.0 113.015 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -54.69 -29.18 52.21 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -116.44 4.22 13.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.688 1.195 . . . . 0.0 111.204 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -80.85 118.07 22.04 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.446 2.299 . . . . 0.0 109.389 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.46 76.88 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -61.54 -30.44 70.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.366 -0.834 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.82 104.77 1.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -127.08 -15.03 5.38 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.813 -1.179 . . . . 0.0 113.795 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -30.72 32.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.047 1.294 . . . . 0.0 112.092 -177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -89.03 44.16 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.064 0.847 . . . . 0.0 108.805 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -146.7 -170.28 3.48 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.214 2.206 . . . . 0.0 106.503 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.85 -15.76 24.74 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.654 0.782 . . . . 0.0 111.607 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.96 150.77 96.22 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.05 169.35 20.75 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.609 1.54 . . . . 0.0 109.14 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 146.58 79.34 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.8 169.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.99 -167.43 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.518 3.479 . . . . 0.0 111.266 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 165.39 11.74 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 165.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.87 46.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.431 1.493 . . . . 0.0 113.026 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.59 23.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.957 2.218 . . . . 0.0 111.686 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 p -140.06 165.12 28.21 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.19 -1.183 . . . . 0.0 111.162 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -147.12 156.26 42.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.201 0.6 . . . . 0.0 111.203 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -77.97 134.41 37.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.304 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -127.47 165.7 19.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.926 1.29 . . . . 0.0 109.429 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.11 105.65 15.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.249 1.419 . . . . 0.0 108.392 177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG2' HG22 ' A' ' 62' ' ' VAL . 97.4 mmm -78.53 -154.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.452 1.501 . . . . 0.0 108.934 174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.21 64.94 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 128.909 3.147 . . . . 0.0 111.895 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.61 14.67 79.54 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.448 -1.751 . . . . 0.0 114.569 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.23 159.05 43.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.846 1.823 . . . . 0.0 108.863 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.06 137.23 35.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 57' ' ' MET . 5.8 m -136.19 158.6 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 121.523 -0.736 . . . . 0.0 109.442 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.69 114.3 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.447 1.099 . . . . 0.0 109.066 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.47 144.99 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.102 0.961 . . . . 0.0 110.047 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 p -73.07 137.83 45.52 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -77.8 10.63 2.62 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.682 1.23 . . . . 0.0 113.26 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -139.44 7.68 2.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.749 2.02 . . . . 0.0 110.827 -167.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -167.14 -49.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.937 1.295 . . . . 0.0 109.059 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.45 19.55 17.98 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.174 1.369 . . . . 0.0 112.563 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 131.11 45.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.618 -0.931 . . . . 0.0 110.283 -173.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.76 91.95 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.507 1.523 . . . . 0.0 107.778 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.27 -42.66 25.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.418 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -149.15 155.28 40.43 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.183 0.993 . . . . 0.0 108.531 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.887 HG12 HD13 ' A' ' 10' ' ' LEU . 88.5 t -137.64 125.79 31.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -126.74 119.11 26.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 107.652 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.12 145.0 27.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.485 1.514 . . . . 0.0 111.702 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -7.26 40.02 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.196 -1.565 . . . . 0.0 114.521 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.3 -22.42 62.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.312 1.556 . . . . 0.0 111.049 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 -30.0 45.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-N 120.317 1.417 . . . . 0.0 111.126 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -53.05 -35.93 60.05 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.015 1.326 . . . . 0.0 111.316 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -87.22 20.79 2.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.802 0.841 . . . . 0.0 111.586 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -117.0 49.68 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.992 1.317 . . . . 0.0 111.805 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 115.815 -2.04 . . . . 0.0 108.828 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.9 36.28 1.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.863 2.065 . . . . 0.0 114.431 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.48 69.45 1.21 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.551 1.14 . . . . 0.0 110.839 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.62 -101.46 2.0 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 126.062 1.792 . . . . 0.0 109.924 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 pt -117.99 -21.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.82 -20.6 65.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.735 0.814 . . . . 0.0 111.029 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -65.15 -18.9 65.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.423 1.889 . . . . 0.0 113.969 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -102.69 2.95 36.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.329 1.052 . . . . 0.0 110.975 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 97.4 1.58 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.837 1.199 . . . . 0.0 109.141 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.8 143.31 46.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.0 -12.58 44.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.653 0.206 . . . . 0.0 110.713 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 177.87 164.93 0.67 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.165 2.186 . . . . 0.0 108.19 -164.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -168.56 -175.09 2.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.55 1.54 . . . . 0.0 109.589 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.88 47.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.83 152.95 38.51 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 162.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.83 30.19 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.289 1.043 . . . . 0.0 112.679 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 56.43 14.74 1.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.583 1.953 . . . . 0.0 113.122 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 m -100.12 117.22 33.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.729 2.012 . . . . 0.0 105.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.99 37.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.8 0.84 . . . . 0.0 109.81 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -148.1 154.01 39.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 110.956 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -146.65 161.86 39.66 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.577 1.551 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.91 122.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.65 7.95 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.014 -1.992 . . . . 0.0 113.867 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.06 -170.32 0.45 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 120.02 1.91 . . . . 0.0 109.871 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.02 160.72 32.82 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.676 1.99 . . . . 0.0 108.74 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 27' ' ' PRO . 20.7 m -107.71 163.74 16.31 Favored Pre-proline 0 N--CA 1.476 0.872 0 O-C-N 120.576 -1.327 . . . . 0.0 112.671 -174.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 41.8 Cg_endo -72.33 163.39 38.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.492 2.795 . . . . 0.0 114.198 169.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.79 66.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 112.23 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.62 -21.92 54.98 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 119.033 0.833 . . . . 0.0 111.044 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 22.5 m-85 -109.32 11.09 25.43 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.58 -23.22 19.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.904 . . . . 0.0 111.952 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 t -69.44 147.81 97.0 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.598 0.759 . . . . 0.0 111.107 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.39 -4.62 9.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.609 3.539 . . . . 0.0 113.768 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.57 -22.83 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.16 1.784 . . . . 0.0 113.325 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -121.49 -6.12 9.26 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.636 1.175 . . . . 0.0 111.507 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.79 123.59 20.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.97 1.308 . . . . 0.0 111.047 -172.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -104.27 96.01 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.99 -37.41 87.03 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.567 -0.708 . . . . 0.0 110.36 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -89.02 109.06 19.95 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.191 0.996 . . . . 0.0 109.352 -167.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . 0.273 23.0 p-90 -112.83 -47.21 3.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 116.782 -1.58 . . . . 0.0 114.992 -170.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.71 -37.67 76.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.221 1.828 . . . . 0.0 111.11 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -55.7 -36.2 66.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.078 0.551 . . . . 0.0 111.932 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -88.97 24.14 2.17 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.095 -1.003 . . . . 0.0 111.397 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.31 6.32 5.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.292 2.637 . . . . 0.0 112.706 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.65 156.06 35.76 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 120.856 -1.152 . . . . 0.0 112.696 -159.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 166.82 25.9 Favored 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.581 4.187 . . . . 0.0 111.277 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.48 153.23 51.08 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.824 1.25 . . . . 0.0 110.478 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -65.46 170.37 11.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.159 1.906 . . . . 0.0 110.364 165.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.76 160.31 32.83 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 103.38 0.56 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.134 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.89 32.59 4.05 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.765 1.65 . . . . 0.0 111.057 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.8 p -150.58 173.6 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.613 -1.522 . . . . 0.0 110.239 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -156.09 158.81 38.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.722 0.772 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.97 144.1 37.05 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.801 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -131.93 172.26 12.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.09 1.356 . . . . 0.0 108.87 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.91 122.05 46.4 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.424 ' CG ' HG21 ' A' ' 62' ' ' VAL . 7.9 mmt -90.07 -162.71 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.119 1.367 . . . . 0.0 108.09 167.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.42 -12.02 5.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 127.32 2.39 . . . . 0.0 116.426 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.19 4.93 0.02 OUTLIER Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.888 1.709 . . . . 0.0 112.713 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -129.54 152.26 49.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 110.408 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.81 130.03 44.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.721 1.208 . . . . 0.0 108.602 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 57' ' ' MET . 1.6 m -135.61 155.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.43 115.81 24.22 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.662 1.585 . . . . 0.0 109.116 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.45 142.06 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.2 1.0 . . . . 0.0 109.396 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 143.62 50.66 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 122.753 0.421 . . . . 0.0 110.473 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -66.52 -18.38 65.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 t -120.25 -9.37 9.54 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.26 1.824 . . . . 0.0 110.83 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -144.92 -45.96 0.23 Allowed 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.38 1.072 . . . . 0.0 108.89 -165.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 22.4 66.62 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.663 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 131.61 51.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.539 1.17 . . . . 0.0 108.375 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.08 91.12 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 126.678 1.991 . . . . 0.0 105.881 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.36 -55.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.36 148.8 28.57 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.674 0.67 . . . . 0.0 109.568 -169.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -128.89 137.21 57.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -131.14 147.94 52.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.16 155.79 39.28 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.717 -0.615 . . . . 0.0 110.232 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.31 -11.55 59.41 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.796 1.188 . . . . 0.0 112.607 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.1 -32.96 56.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.763 1.625 . . . . 0.0 111.823 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.51 -23.33 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.422 0.555 . . . . 0.0 112.117 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -63.07 -30.32 71.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.562 -0.712 . . . . 0.0 111.65 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -77.46 -25.74 50.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.459 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -65.06 142.95 58.23 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.283 1.033 . . . . 0.0 109.05 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 . . . . . 0 C--O 1.251 1.15 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.185 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.7 54.13 0.47 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.271 1.428 . . . . 0.0 111.539 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 44.5 50.2 8.21 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 112.903 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.69 -99.73 2.21 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -132.71 -20.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 124.972 1.309 . . . . 0.0 111.671 -165.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.51 -27.86 62.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.426 1.09 . . . . 0.0 112.103 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -53.09 -34.46 56.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.033 1.333 . . . . 0.0 113.067 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.81 -6.82 58.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.886 0.874 . . . . 0.0 111.729 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 101.23 3.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.768 1.167 . . . . 0.0 109.13 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.79 129.15 37.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -64.35 -28.6 69.81 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 120.049 -1.657 . . . . 0.0 110.106 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.81 158.99 39.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.354 0.662 . . . . 0.0 110.145 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CD1' ' CE ' ' A' ' 57' ' ' MET . 54.9 p90 -160.04 -177.99 6.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.984 1.314 . . . . 0.0 110.877 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -133.88 139.21 46.05 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.922 1.289 . . . . 0.0 108.172 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.33 31.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.958 0.903 . . . . 0.0 109.778 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.54 41.25 4.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.951 1.7 . . . . 0.0 112.26 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 59.62 49.14 8.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.529 1.932 . . . . 0.0 111.066 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 m -152.73 144.77 23.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.882 1.673 . . . . 0.0 108.652 168.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.95 147.93 25.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.332 2.253 . . . . 0.0 110.01 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.03 160.25 41.68 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.914 1.686 . . . . 0.0 111.863 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -141.97 169.14 18.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.871 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm -58.85 121.87 7.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 5.87 70.32 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.866 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.66 -172.81 3.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.731 1.766 . . . . 0.0 108.976 160.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.47 139.99 53.24 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 109.001 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.88 160.23 78.83 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.18 166.64 26.2 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.434 2.089 . . . . 0.0 110.261 161.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.0 -23.51 33.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.879 1.272 . . . . 0.0 112.141 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.8 mtp -55.88 -16.84 5.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.248 1.819 . . . . 0.0 113.694 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -118.92 -1.56 10.98 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -24.2 43.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.241 0.928 . . . . 0.0 110.372 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.38 154.22 23.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 127.17 2.188 . . . . 0.0 113.618 -174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -67.64 -5.43 14.22 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.434 4.089 . . . . 0.0 113.928 171.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -58.92 -63.89 1.14 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.605 1.162 . . . . 0.0 108.867 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -87.15 2.91 48.42 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.626 1.57 . . . . 0.0 112.709 -168.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.08 132.53 53.77 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.892 2.077 . . . . 0.0 110.314 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mm -119.06 80.04 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.529 1.131 . . . . 0.0 108.246 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -52.73 -29.05 24.85 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.017 -1.052 . . . . 0.0 112.099 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 0.45 17.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.705 1.202 . . . . 0.0 113.794 -165.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -59.66 -3.21 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -166.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -40.33 71.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 122.391 2.36 . . . . 0.0 112.908 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -137.54 55.86 1.78 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 110.337 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -137.48 34.88 2.48 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.607 1.163 . . . . 0.0 110.459 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 75.32 -36.56 0.31 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 129.074 2.95 . . . . 0.0 113.714 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.83 149.99 61.66 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 126.212 1.805 . . . . 0.0 110.8 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.02 165.24 33.2 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.591 2.194 . . . . 0.0 111.78 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.76 97.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 165.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.47 172.76 12.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.563 2.176 . . . . 0.0 111.303 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 161.34 27.13 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 107.85 0.63 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.934 1.293 . . . . 0.0 110.569 175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.74 9.06 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.456 1.503 . . . . 0.0 112.414 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.5 p -146.63 166.38 26.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.816 1.308 . . . . 0.0 110.958 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -156.04 157.23 35.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.755 0.822 . . . . 0.0 111.259 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.06 130.73 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 p -124.84 154.94 40.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 105.8 11.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.455 ' CE ' ' CD1' ' A' ' 13' ' ' PHE . 8.2 ptm -77.4 -154.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.97 62.55 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 1 C-N-CA 131.672 4.463 . . . . 0.0 112.89 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.64 6.75 88.91 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 126.309 1.909 . . . . 0.0 114.457 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.537 HD21 ' HA ' ' A' ' 76' ' ' ASP . 8.7 m120 -125.03 164.76 19.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.57 1.548 . . . . 0.0 106.828 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -95.74 131.71 41.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 74' ' ' VAL . 3.9 m -119.43 149.23 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 120.159 1.345 . . . . 0.0 109.238 170.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.38 119.3 32.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.66 146.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.852 1.261 . . . . 0.0 108.455 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.64 152.48 31.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.06 0.391 . . . . 0.0 111.515 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -34.81 78.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.442 165.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -86.97 -7.87 57.75 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.061 -1.024 . . . . 0.0 111.822 -171.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 70' ' ' LYS . 14.4 pt-20 -155.14 -35.55 0.09 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 172.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.5 49.58 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.813 -172.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -61.75 132.03 51.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.967 0.883 . . . . 0.0 108.95 176.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.88 82.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 129.174 2.989 . . . . 0.0 106.807 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.89 -50.08 58.36 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -145.27 168.09 21.28 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.898 1.279 . . . . 0.0 108.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.1 p -133.94 149.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 C-N-CA 133.786 4.835 . . . . 0.0 105.222 167.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -140.05 130.63 25.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 151.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.537 ' HA ' HD21 ' A' ' 60' ' ' ASN . 9.0 t70 -52.34 146.43 9.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.662 0.664 . . . . 0.0 109.526 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.7 -26.82 11.2 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.519 -1.156 . . . . 0.0 113.206 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -54.74 -24.93 24.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.115 1.766 . . . . 0.0 112.161 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -55.98 -33.05 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.062 0.846 . . . . 0.0 110.996 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -61.43 -13.46 20.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.429 1.891 . . . . 0.0 112.433 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.16 -8.62 15.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.199 0.909 . . . . 0.0 112.977 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -81.0 34.7 0.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.395 1.878 . . . . 0.0 110.978 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 C-N-CA 125.98 1.712 . . . . 0.0 111.641 -156.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.23 -26.2 67.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.16 0.584 . . . . 0.0 111.163 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -23.02 65.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.634 1.574 . . . . 0.0 113.837 171.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -101.36 4.5 41.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.996 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.89 111.28 21.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 121.017 1.735 . . . . 0.0 109.497 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 10' ' ' LEU . 4.0 mp -81.92 -165.51 1.01 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.412 1.577 . . . . 0.0 106.841 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -134.3 -13.96 2.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.725 -2.034 . . . . 0.0 113.236 164.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 178.49 159.09 0.53 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.882 0.765 . . . . 0.0 110.502 -163.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 4.7 p90 -167.33 -175.54 2.94 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.659 1.584 . . . . 0.0 109.159 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -128.49 135.49 49.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 157.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.54 161.98 33.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 158.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 20.65 11.96 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 163.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 62.29 29.45 17.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.331 1.853 . . . . 0.0 112.586 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -129.96 122.51 28.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.611 2.364 . . . . 0.0 107.626 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.58 147.0 30.96 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.4 m-85 -147.21 158.49 43.97 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.811 0.844 . . . . 0.0 110.292 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.16 173.44 11.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.964 1.306 . . . . 0.0 109.0 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.64 108.22 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.77 2.37 39.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.598 -1.668 . . . . 0.0 114.822 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -178.06 1.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.481 1.64 . . . . 0.0 108.135 161.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.18 146.99 48.33 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.667 -1.27 . . . . 0.0 107.581 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.6 m -79.09 162.1 65.68 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.84 162.26 39.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.797 2.331 . . . . 0.0 111.077 162.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -16.3 44.15 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.437 1.095 . . . . 0.0 112.153 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtt -60.06 -17.24 38.0 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 124.874 1.27 . . . . 0.0 112.158 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -119.95 1.72 10.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.6 -26.22 57.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.461 1.028 . . . . 0.0 110.269 167.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -57.99 144.4 75.5 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.66 -4.24 14.23 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 112.724 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.04 -14.95 18.9 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.795 2.038 . . . . 0.0 114.005 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.6 -5.09 8.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.253 1.421 . . . . 0.0 112.237 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.27 106.74 2.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.906 2.082 . . . . 0.0 110.15 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 56' ' ' TYR . 2.7 mp -90.57 83.62 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -63.72 -16.92 62.36 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.273 -0.892 . . . . 0.0 111.115 167.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -90.11 70.77 7.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.148 2.179 . . . . 0.0 108.022 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -111.92 -19.45 12.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -72.17 -35.99 69.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.767 1.167 . . . . 0.0 111.483 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -78.13 38.1 0.27 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.552 0.615 . . . . 0.0 110.034 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -146.39 166.1 27.36 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 127.271 2.228 . . . . 0.0 106.611 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.38 -16.47 62.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.167 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.85 148.71 75.55 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 0.0 112.265 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -74.1 157.85 46.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.086 2.524 . . . . 0.0 112.757 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.65 142.58 96.13 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.607 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.37 162.89 39.2 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.058 2.505 . . . . 0.0 112.189 -171.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.406 ' H ' HD21 ' A' ' 63' ' ' LEU . 25.9 m-20 -68.54 160.57 29.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.95 50.72 1.42 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.453 1.501 . . . . 0.0 113.266 -161.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.53 38.9 0.02 OUTLIER Glycine 0 CA--C 1.528 0.9 0 C-N-CA 127.37 2.414 . . . . 0.0 109.835 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.9 p -148.37 172.17 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.645 1.223 . . . . 0.0 110.577 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -145.58 156.41 43.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.173 0.511 . . . . 0.0 111.956 169.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -73.33 141.41 47.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.983 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.27 131.95 35.12 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.141 2.177 . . . . 0.0 106.256 -169.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.542 ' HB2' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.16 100.34 11.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.48 -155.66 0.07 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 108.309 169.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.98 60.99 0.53 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 127.355 2.407 . . . . 0.0 113.89 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.4 66.13 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.381 0.591 . . . . 0.0 113.329 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -134.87 154.74 51.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.61 115.54 30.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.73 149.33 7.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' HD23 ' A' ' 72' ' ' LEU . 67.8 tp -100.92 126.08 47.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.03 135.79 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 C-N-CA 123.81 0.844 . . . . 0.0 110.056 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 133.77 52.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 108.617 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.15 -2.27 23.91 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.808 -1.183 . . . . 0.0 112.044 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -127.15 13.2 7.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.68 1.592 . . . . 0.0 109.534 -170.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -164.38 -48.24 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.401 1.08 . . . . 0.0 109.814 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 33.95 66.48 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 126.753 2.12 . . . . 0.0 112.18 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.535 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -55.8 143.01 32.7 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 160.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.0 86.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 70' ' ' LYS . 2.3 mm? -63.62 -49.67 72.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.207 1.003 . . . . 0.0 110.117 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -146.21 161.05 41.1 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.689 1.596 . . . . 0.0 108.762 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 10' ' ' LEU . 42.6 t -144.2 131.58 17.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.257 1.823 . . . . 0.0 107.592 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.038 1.335 . . . . 0.0 108.626 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.53 160.32 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.965 0.506 . . . . 0.0 109.831 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.31 71.06 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.482 -1.177 . . . . 0.0 113.778 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.32 -20.72 65.74 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.813 1.806 . . . . 0.0 112.86 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.7 tt -59.11 -20.18 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.203 1.001 . . . . 0.0 112.198 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.58 -35.34 72.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.871 1.268 . . . . 0.0 111.958 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.43 -17.89 29.49 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.867 0.758 . . . . 0.0 111.068 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -61.99 152.06 33.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 108.558 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 127.859 2.464 . . . . 0.0 105.598 -170.625 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 pt . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.89 -26.21 68.5 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.2 0.6 . . . . 0.0 112.52 -168.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -58.62 -30.33 67.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.36 1.064 . . . . 0.0 112.515 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.32 -3.97 49.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.416 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.65 89.58 2.24 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.921 1.237 . . . . 0.0 110.849 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.53 133.99 43.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 107.207 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -87.0 -20.19 27.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.971 0.805 . . . . 0.0 111.911 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -154.17 161.3 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.947 1.699 . . . . 0.0 108.789 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.92 175.34 13.69 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.959 1.704 . . . . 0.0 108.664 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 m -130.6 121.58 25.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.47 153.91 51.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 58.08 29.25 17.54 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.245 1.021 . . . . 0.0 111.427 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 58.69 14.81 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.435 1.894 . . . . 0.0 113.325 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -115.03 126.81 55.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.21 149.29 25.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -146.19 152.69 39.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.603 0.761 . . . . 0.0 110.015 -172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -134.94 165.48 25.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.004 1.321 . . . . 0.0 108.209 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.22 115.48 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.3 59.1 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.752 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -176.25 1.15 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.72 1.76 . . . . 0.0 107.943 153.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.79 159.89 28.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.52 1.928 . . . . 0.0 109.537 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.86 158.09 32.44 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.055 -1.028 . . . . 0.0 110.98 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.13 160.39 47.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.648 2.232 . . . . 0.0 110.949 164.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.76 -13.21 41.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -23.13 10.59 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.272 1.829 . . . . 0.0 112.351 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.55 -20.12 9.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.713 0.633 . . . . 0.0 111.88 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.5 mt -70.4 -23.67 62.79 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.516 -0.74 . . . . 0.0 111.435 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -57.3 143.19 74.21 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.041 0.936 . . . . 0.0 108.73 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.65 -4.18 11.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.558 3.505 . . . . 0.0 113.395 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.23 -33.83 74.13 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.244 1.817 . . . . 0.0 113.198 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -114.41 4.97 15.5 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.01 94.87 0.11 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.994 2.117 . . . . 0.0 110.141 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.38 74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 123.929 1.823 . . . . 0.0 107.456 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -59.15 -37.43 77.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.023 160.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -78.33 80.09 4.75 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.215 1.406 . . . . 0.0 111.689 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -83.52 -37.94 22.39 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.955 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -46.41 -51.09 15.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.241 1.016 . . . . 0.0 112.901 -169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -79.53 12.83 2.29 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 112.529 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -118.93 162.34 18.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 161.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.21 -6.48 23.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.354 1.062 . . . . 0.0 112.859 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.42 159.65 57.51 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.885 1.674 . . . . 0.0 112.143 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.03 175.02 11.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.017 3.144 . . . . 0.0 109.884 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.37 158.96 25.76 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.884 0.874 . . . . 0.0 110.502 166.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.3 168.1 23.23 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.476 2.118 . . . . 0.0 110.537 165.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -78.2 161.22 27.48 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 163.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.32 112.56 4.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.516 0.726 . . . . 0.0 109.801 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.11 23.68 31.6 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.159 0.436 . . . . 0.0 112.404 -176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.3 p -135.55 167.65 20.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 117.891 0.846 . . . . 0.0 109.276 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -150.99 157.58 43.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.437 0.637 . . . . 0.0 110.427 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -82.86 149.15 27.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.6 p -140.08 155.51 47.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.138 0.575 . . . . 0.0 109.907 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -97.15 85.41 3.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.03 98.81 8.7 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.722 1.609 . . . . 0.0 107.275 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.85 80.43 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.147 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.95 2.6 59.41 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.545 1.673 . . . . 0.0 112.253 -170.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -113.75 148.52 36.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.099 1.45 . . . . 0.0 107.931 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -95.82 108.85 21.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.11 130.25 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -169.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.84 118.14 31.04 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.154 1.382 . . . . 0.0 108.198 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.48 140.41 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.861 0.864 . . . . 0.0 109.823 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.69 136.32 54.14 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -13.06 60.43 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.467 -0.771 . . . . 0.0 112.503 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -132.25 19.44 4.43 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.62 1.968 . . . . 0.0 109.53 -162.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -170.13 -40.01 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.889 1.276 . . . . 0.0 110.078 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.59 26.72 74.19 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.517 -1.157 . . . . 0.0 112.938 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -59.03 141.12 54.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.9 mt -79.24 85.03 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.83 -49.31 68.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.341 0.657 . . . . 0.0 110.258 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -152.09 160.52 43.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.505 1.922 . . . . 0.0 107.344 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.97 147.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.1 153.19 50.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 159.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -61.01 155.02 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.911 0.885 . . . . 0.0 109.574 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.91 64.51 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.465 1.031 . . . . 0.0 113.1 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -50.23 -31.97 15.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.489 1.115 . . . . 0.0 112.776 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -59.81 -19.69 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.549 1.14 . . . . 0.0 112.745 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.1 -28.22 67.66 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.444 1.02 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.11 -0.46 33.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.789 0.836 . . . . 0.0 111.892 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -62.73 171.53 2.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.196 1.398 . . . . 0.0 110.621 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.15 -165.554 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -63.21 -28.93 70.38 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.613 1.965 . . . . 0.0 111.374 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -61.28 -28.98 69.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.742 0.817 . . . . 0.0 112.271 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -98.05 -2.22 40.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.275 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.03 86.87 0.55 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.343 0.974 . . . . 0.0 109.633 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.17 145.73 54.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -102.86 -16.0 16.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.125 0.42 . . . . 0.0 112.011 170.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.54 164.25 38.56 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.63 175.63 13.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.692 1.597 . . . . 0.0 108.067 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -131.53 125.44 32.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.48 156.19 48.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.81 29.7 12.38 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.314 -0.866 . . . . 0.0 112.937 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 53.85 22.77 3.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.1 2.16 . . . . 0.0 112.5 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.1 m -120.29 128.05 52.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.441 2.296 . . . . 0.0 105.775 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -84.09 150.8 25.32 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.069 0.948 . . . . 0.0 110.062 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -151.7 141.31 21.74 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 124.798 1.239 . . . . 0.0 110.211 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -124.4 167.18 14.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.42 1.488 . . . . 0.0 109.856 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.59 113.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.6 -4.51 32.72 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.092 -1.394 . . . . 0.0 113.458 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.18 -171.34 1.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.002 1.401 . . . . 0.0 107.968 166.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 149.48 50.43 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.172 -1.58 . . . . 0.0 109.382 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.6 158.14 43.22 Favored Pre-proline 0 N--CA 1.468 0.447 0 C-N-CA 124.15 0.98 . . . . 0.0 111.016 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.2 164.26 33.33 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.328 2.685 . . . . 0.0 111.619 165.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -16.11 44.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 112.703 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.2 mmt -53.64 -30.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.45 1.1 . . . . 0.0 111.884 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -102.94 -2.5 27.6 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.21 -23.59 24.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.097 0.862 . . . . 0.0 110.935 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.72 144.1 85.86 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 -4.62 9.88 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.554 3.503 . . . . 0.0 113.343 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.45 -16.85 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.25 2.22 . . . . 0.0 113.207 172.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -121.26 -1.84 9.66 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.59 1.086 . . . . 0.0 110.932 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.9 97.24 4.53 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.729 1.612 . . . . 0.0 112.502 -163.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -81.47 82.6 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 107.756 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.87 -30.92 69.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.647 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.98 36.38 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.436 1.894 . . . . 0.0 113.734 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -56.67 -34.47 67.38 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.398 -1.439 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.91 -39.35 93.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.584 1.554 . . . . 0.0 113.07 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -24.86 42.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.406 1.003 . . . . 0.0 110.647 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -80.05 -177.44 6.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.649 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.87 -19.66 40.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.467 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.93 144.67 76.4 Favored Pre-proline 0 CA--C 1.537 0.469 0 O-C-N 121.017 -1.052 . . . . 0.0 111.156 -161.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.95 164.48 27.13 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.75 2.967 . . . . 0.0 113.596 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.22 97.11 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.575 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.2 172.39 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.204 2.603 . . . . 0.0 110.608 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.48 167.73 19.8 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.851 -1.156 . . . . 0.0 109.294 168.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 34.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 115.397 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.9 33.17 0.06 OUTLIER Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.301 1.905 . . . . 0.0 110.303 173.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.0 p -144.24 166.12 25.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.121 0.961 . . . . 0.0 110.768 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -155.75 156.25 34.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.269 0.557 . . . . 0.0 111.315 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.32 143.93 31.86 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.347 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 p -138.67 179.52 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.306 1.842 . . . . 0.0 110.07 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -107.7 145.6 33.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.65 1.58 . . . . 0.0 107.822 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.9 147.21 29.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 166.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.81 -4.83 0.01 OUTLIER Glycine 0 CA--C 1.55 2.22 0 N-CA-C 117.589 1.796 . . . . 0.0 117.589 170.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.31 -10.75 19.77 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 121.144 2.472 . . . . 0.0 113.778 -167.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -103.0 173.13 6.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.548 2.739 . . . . 0.0 110.224 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -112.38 134.87 53.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.08 1.352 . . . . 0.0 109.261 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.72 154.06 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 119.69 1.132 . . . . 0.0 110.968 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.11 120.1 39.39 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.287 1.035 . . . . 0.0 109.031 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.3 pt -127.77 150.13 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.726 1.21 . . . . 0.0 109.483 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.13 140.69 39.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.032 0.833 . . . . 0.0 109.505 172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -14.73 61.78 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.407 1.083 . . . . 0.0 112.45 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -119.54 2.58 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.739 1.615 . . . . 0.0 111.1 -162.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -163.37 -45.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.982 0.913 . . . . 0.0 109.035 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.55 21.65 53.24 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.1 0.857 . . . . 0.0 112.497 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 130.33 43.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.22 95.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.792 1.637 . . . . 0.0 106.766 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 mt -80.09 -52.97 7.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.888 0.875 . . . . 0.0 109.574 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -144.59 160.5 41.05 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.779 0.832 . . . . 0.0 109.625 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.6 t -134.13 142.35 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -134.99 137.71 43.28 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 162.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -60.38 149.12 34.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.69 -15.12 32.27 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.948 1.737 . . . . 0.0 113.261 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.92 -30.29 61.41 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.393 1.597 . . . . 0.0 112.135 171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.81 -1.72 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.012 0.925 . . . . 0.0 111.745 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -60.05 -43.1 95.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.32 -1.487 . . . . 0.0 111.511 164.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -88.02 -17.64 30.74 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -64.59 160.98 18.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.915 1.286 . . . . 0.0 109.404 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.698 1.199 . . . . 0.0 107.836 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.47 -34.61 69.2 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.931 1.692 . . . . 0.0 112.38 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -58.64 -28.97 66.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.541 0.737 . . . . 0.0 112.585 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -98.02 -2.51 40.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.834 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.93 87.13 1.31 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.279 0.945 . . . . 0.0 109.031 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.25 166.6 23.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -124.96 -25.11 3.93 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.265 0.626 . . . . 0.0 112.553 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 157.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.806 1.242 . . . . 0.0 107.933 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.5 177.04 11.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -131.24 129.29 41.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 163.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.79 149.27 46.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.98 34.15 24.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.199 1.0 . . . . 0.0 111.452 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 59.83 35.69 21.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.8 1.64 . . . . 0.0 112.01 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -136.98 121.05 17.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.832 1.653 . . . . 0.0 107.35 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -79.59 150.23 31.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.695 0.798 . . . . 0.0 109.017 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -150.05 159.36 44.47 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.41 1.484 . . . . 0.0 110.595 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -145.6 165.42 28.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.392 1.877 . . . . 0.0 108.781 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.93 120.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.38 3.9 84.0 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 117.454 -1.748 . . . . 0.0 113.559 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.21 178.41 2.34 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.017 1.908 . . . . 0.0 108.68 156.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.71 142.89 50.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.608 1.163 . . . . 0.0 109.073 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.32 163.77 35.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.171 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.98 154.22 63.0 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.458 2.772 . . . . 0.0 112.653 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.61 54.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.582 1.553 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -55.45 -22.6 21.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.588 1.155 . . . . 0.0 113.019 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 13.8 m-85 -113.9 -10.3 12.96 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.865 0.728 . . . . 0.0 112.906 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.23 -30.33 68.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.191 0.451 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -65.49 144.11 98.86 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.543 0.737 . . . . 0.0 109.716 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.05 -4.85 9.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.246 3.297 . . . . 0.0 115.449 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -54.97 -33.96 62.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.898 1.279 . . . . 0.0 112.086 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -103.21 -8.56 20.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.964 0.802 . . . . 0.0 112.086 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.73 100.36 0.91 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.769 2.827 . . . . 0.0 111.952 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.93 85.58 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.764 1.226 . . . . 0.0 108.694 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -67.48 -10.86 55.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.356 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -95.44 89.51 5.45 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.72 1.208 . . . . 0.0 107.914 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -132.19 -25.71 1.97 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.924 -1.036 . . . . 0.0 113.557 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.21 -36.33 79.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.277 1.399 . . . . 0.0 111.613 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -82.82 8.52 12.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.624 0.77 . . . . 0.0 111.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -123.18 165.7 16.45 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.586 -1.322 . . . . 0.0 108.96 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.74 -22.63 56.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 -169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.58 156.41 17.13 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 125.211 1.404 . . . . 0.0 110.498 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.61 172.57 13.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.303 1.335 . . . . 0.0 110.774 168.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.5 165.51 2.16 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.491 164.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -67.97 171.46 12.36 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 120.97 1.113 . . . . 0.0 109.825 160.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' H ' HD21 ' A' ' 63' ' ' LEU . 3.3 m-20 -82.92 161.46 21.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 158.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.49 112.55 3.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.7 7.99 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.581 1.086 . . . . 0.0 111.907 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -149.42 169.02 21.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.889 1.845 . . . . 0.0 111.89 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -149.03 163.91 36.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.623 0.769 . . . . 0.0 110.354 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.95 141.95 28.29 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.279 0.631 . . . . 0.0 109.631 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -128.51 172.16 11.42 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -103.35 111.59 24.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 110.343 173.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 ttm -129.89 118.0 21.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.823 1.649 . . . . 0.0 109.869 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 -11.27 4.08 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.922 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.07 -7.17 19.2 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.538 1.669 . . . . 0.0 112.319 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -109.85 172.94 6.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.657 1.583 . . . . 0.0 110.302 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.38 117.92 35.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 108.545 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.0 145.84 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD21 ' H ' ' A' ' 49' ' ' ASP . 66.9 tp -101.19 126.68 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.01 142.57 43.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.967 0.907 . . . . 0.0 110.239 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.44 131.26 44.99 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.423 0.689 . . . . 0.0 109.594 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.98 5.8 6.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.934 1.349 . . . . 0.0 113.503 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -127.7 1.22 6.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.895 2.478 . . . . 0.0 110.938 -171.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -166.87 -60.11 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.309 0.644 . . . . 0.0 109.36 -164.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 24.92 9.89 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 124.761 1.172 . . . . 0.0 113.931 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -60.48 129.11 39.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.548 2.174 . . . . 0.0 109.319 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 86.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 129.229 3.012 . . . . 0.0 106.067 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.69 -44.63 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -145.64 161.31 40.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.457 0.703 . . . . 0.0 109.331 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.68 137.99 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -126.84 142.42 51.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 157.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 79' ' ' ILE . 10.3 t70 -59.49 151.14 24.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.72 -22.78 27.0 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.744 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.5 -29.6 25.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.048 1.424 . . . . 0.0 112.506 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 76' ' ' ASP . 14.8 tt -64.77 -9.09 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.025 0.93 . . . . 0.0 112.613 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.17 -50.79 44.44 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 120.424 -1.422 . . . . 0.0 110.546 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -80.15 -16.27 55.27 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.759 0.824 . . . . 0.0 111.921 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -55.36 124.9 18.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.736 2.414 . . . . 0.0 107.447 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 O-C-N 121.922 -0.486 . . . . 0.0 111.351 -162.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -27.66 65.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.835 0.289 . . . . 0.0 111.756 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -61.59 -23.02 65.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.625 0.77 . . . . 0.0 112.674 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -102.44 -8.26 21.26 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.77 0.828 . . . . 0.0 110.905 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.11 92.13 4.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.22 162.84 27.05 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -112.66 -23.22 10.33 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.181 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -158.76 160.94 36.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.592 1.557 . . . . 0.0 109.032 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -157.18 -177.29 6.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.749 2.019 . . . . 0.0 108.808 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -135.93 114.94 12.24 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.76 152.42 45.4 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.274 1.6 p30 50.99 27.47 3.25 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 61.67 14.67 6.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.072 2.549 . . . . 0.0 112.732 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.9 m -98.23 124.29 42.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.527 2.331 . . . . 0.0 105.935 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.33 143.99 48.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -142.18 143.29 32.88 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 109.481 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -127.7 170.34 12.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.48 113.62 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.64 -2.08 42.28 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.431 -1.76 . . . . 0.0 114.386 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.36 -171.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.085 1.943 . . . . 0.0 108.684 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.08 143.46 51.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.533 -1.354 . . . . 0.0 108.803 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.91 162.96 71.9 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.597 -0.689 . . . . 0.0 110.297 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.41 161.9 42.98 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.484 2.789 . . . . 0.0 110.779 159.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.38 44.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mmt -54.21 -20.09 6.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.198 1.799 . . . . 0.0 111.991 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -122.84 -8.77 8.37 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.063 0.945 . . . . 0.0 112.995 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.78 -18.08 56.82 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.901 0.88 . . . . 0.0 111.435 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -60.74 144.48 89.56 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.33 -4.35 14.79 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.195 3.263 . . . . 0.0 115.332 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -51.13 -30.85 17.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.724 2.01 . . . . 0.0 114.927 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.45 2.97 14.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.148 0.979 . . . . 0.0 110.975 -167.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -66.42 129.29 39.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.196 1.798 . . . . 0.0 110.858 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -106.82 90.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 108.268 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -22.93 63.0 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.686 -0.634 . . . . 0.0 111.285 163.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.12 30.67 0.58 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.808 1.243 . . . . 0.0 111.87 -166.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -75.35 -29.93 60.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.647 1.579 . . . . 0.0 115.167 -167.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -67.93 -38.16 82.54 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.864 1.666 . . . . 0.0 112.629 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -61.86 -11.24 11.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.978 0.911 . . . . 0.0 112.357 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.34 157.78 16.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -70.61 2.35 4.16 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.565 -0.709 . . . . 0.0 112.184 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.41 148.16 85.67 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 120.896 -1.127 . . . . 0.0 110.367 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.63 165.24 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.464 2.109 . . . . 0.0 111.798 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 149.63 89.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.834 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.37 171.15 14.55 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.298 2.665 . . . . 0.0 111.506 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.49 168.98 18.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.808 1.289 . . . . 0.0 109.398 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.55 38.88 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.219 2.608 . . . . 0.0 113.986 -167.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.97 37.71 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.239 1.876 . . . . 0.0 110.461 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.4 p -148.62 166.95 26.78 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.654 -0.91 . . . . 0.0 109.816 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -146.73 152.29 38.58 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.837 0.827 . . . . 0.0 111.054 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.47 144.81 46.1 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -133.62 162.65 31.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 109.868 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.23 65.87 0.74 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.944 0.898 . . . . 0.0 110.942 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 102.7 6.87 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.8 75.17 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.464 164.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.3 -5.6 33.77 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.118 1.459 . . . . 0.0 112.734 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -113.64 162.67 15.95 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.374 1.47 . . . . 0.0 107.325 -172.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 45.3 m-85 -109.77 111.23 22.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.04 132.48 69.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 tp -92.59 117.05 29.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.864 0.866 . . . . 0.0 108.697 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.4 pt -116.25 142.31 30.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.843 0.857 . . . . 0.0 109.499 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 143.03 51.4 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.58 9.74 5.69 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.683 0.793 . . . . 0.0 112.023 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -147.64 16.78 1.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.904 1.681 . . . . 0.0 110.525 -163.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -171.48 -45.37 0.02 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 126.536 1.934 . . . . 0.0 108.286 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 26.18 50.07 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.624 -1.098 . . . . 0.0 112.22 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.36 138.49 58.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -79.0 84.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.593 1.957 . . . . 0.0 106.176 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.12 -44.47 84.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.806 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -152.14 158.73 43.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.693 1.197 . . . . 0.0 108.894 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -135.52 143.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -135.87 145.72 46.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.084 1.353 . . . . 0.0 107.572 161.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.72 155.99 36.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.639 0.654 . . . . 0.0 111.86 172.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -58.08 -25.05 56.23 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 124.619 1.104 . . . . 0.0 114.132 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.38 -27.49 36.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.887 1.344 . . . . 0.0 113.116 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.9 -20.2 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.941 0.896 . . . . 0.0 112.504 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.7 -44.92 96.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.656 0.782 . . . . 0.0 109.725 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.15 -17.14 38.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.752 0.821 . . . . 0.0 111.478 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -58.2 147.24 31.0 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 128.075 2.55 . . . . 0.0 109.552 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 . . . . . 0 C--O 1.248 1.022 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 172.124 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -34.1 72.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 111.746 -168.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -55.96 -33.85 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.486 1.115 . . . . 0.0 112.144 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.05 -4.71 56.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.648 -1.168 . . . . 0.0 110.784 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.81 90.98 0.81 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.731 1.605 . . . . 0.0 110.506 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.12 128.02 32.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.03 -16.57 37.79 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 0.986 . . . . 0.0 112.817 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.68 164.59 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -155.0 174.96 14.43 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 107.393 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -133.26 128.03 34.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' A' ' 57' ' ' MET . . . -145.83 137.03 24.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 44.59 62.42 2.05 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 110.003 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.263 1.7 p90 44.96 31.61 0.72 Allowed 'General case' 0 C--O 1.232 0.174 1 C-N-CA 132.004 4.122 . . . . 0.0 113.013 174.914 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 m -131.84 124.86 30.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -80.73 157.04 25.97 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -152.91 156.09 38.26 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.354 1.062 . . . . 0.0 110.26 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -140.2 167.67 21.61 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.929 1.692 . . . . 0.0 109.431 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.14 108.84 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.08 -7.02 21.52 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.326 -1.819 . . . . 0.0 114.162 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -174.8 1.49 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.771 1.786 . . . . 0.0 110.263 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.04 150.69 42.76 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.443 -1.411 . . . . 0.0 109.044 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.91 159.84 39.35 Favored Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 161.2 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.545 2.163 . . . . 0.0 111.557 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.58 -10.58 19.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.639 0.776 . . . . 0.0 112.748 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.88 -26.13 65.63 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.803 0.841 . . . . 0.0 111.549 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -107.83 -10.25 15.6 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.7 mt -75.9 -24.79 55.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.675 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -55.95 145.25 54.67 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.004 0.921 . . . . 0.0 109.943 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.87 -9.74 22.43 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 124.722 3.615 . . . . 0.0 112.17 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -56.04 -27.8 54.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.432 1.493 . . . . 0.0 113.504 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -117.02 2.52 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.806 0.842 . . . . 0.0 111.191 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -59.73 104.66 0.3 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 128.28 2.632 . . . . 0.0 111.301 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mm -77.03 79.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -39.65 73.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.931 169.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -88.82 66.06 7.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.311 1.044 . . . . 0.0 110.119 -174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -65.31 -50.25 66.37 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.047 -0.408 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.03 96.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.953 0.501 . . . . 0.0 111.985 -158.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.69 -25.8 60.8 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.527 1.131 . . . . 0.0 113.265 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.86 27.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.835 -1.165 . . . . 0.0 111.321 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m120 68.01 -3.67 1.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.988 2.115 . . . . 0.0 112.252 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.66 163.84 42.42 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.533 1.933 . . . . 0.0 111.847 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.46 175.23 11.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.446 2.764 . . . . 0.0 112.541 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 164.35 19.63 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 111.765 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -72.52 -169.66 0.5 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.047 2.498 . . . . 0.0 111.117 162.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.58 -172.34 2.48 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 158.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 104.05 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.803 169.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.28 -12.48 54.71 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.583 1.087 . . . . 0.0 114.587 169.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.2 p -73.41 168.52 19.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.822 1.311 . . . . 0.0 109.23 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -158.72 151.56 22.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.615 -0.678 . . . . 0.0 109.654 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -81.88 143.57 31.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -133.7 162.1 32.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.527 0.731 . . . . 0.0 110.644 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -96.32 96.95 9.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.989 1.316 . . . . 0.0 108.259 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.93 96.6 6.15 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.233 1.813 . . . . 0.0 106.848 -174.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.13 79.61 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.904 -1.498 . . . . 0.0 113.824 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.94 6.92 64.82 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.614 1.707 . . . . 0.0 112.373 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.31 147.14 31.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.403 1.602 . . . . 0.0 107.712 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 37.4 m-85 -96.94 114.29 25.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.08 131.92 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.45 112.76 24.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.02 143.57 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.193 0.997 . . . . 0.0 110.2 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.06 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -59.61 -18.57 42.42 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -115.85 12.35 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 126.295 1.838 . . . . 0.0 110.215 -161.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.94 -51.62 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.801 -1.187 . . . . 0.0 109.385 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.52 29.69 35.39 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 126.013 1.768 . . . . 0.0 112.594 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 138.32 58.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.379 1.09 . . . . 0.0 108.978 176.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.6 mt -79.7 84.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.66 -45.67 78.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.542 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -153.33 163.26 40.23 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.798 2.039 . . . . 0.0 107.633 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.7 t -137.13 151.53 27.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.21 157.97 42.96 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 156.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -63.63 156.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.392 0.677 . . . . 0.0 109.266 168.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -63.62 -22.36 65.9 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 124.764 1.173 . . . . 0.0 113.601 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.72 -17.39 34.37 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.62 1.21 . . . . 0.0 113.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.02 -26.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.973 0.909 . . . . 0.0 112.465 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -65.91 -12.04 51.68 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.675 -0.64 . . . . 0.0 111.544 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.43 18.44 12.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.57 -173.47 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 108.273 163.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.814 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.46 -32.38 68.69 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.984 0.811 . . . . 0.0 112.886 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -58.66 -27.25 64.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.803 0.841 . . . . 0.0 112.893 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -97.91 -1.65 42.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.956 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.18 90.22 5.48 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.199 1.363 . . . . 0.0 109.663 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.91 128.89 34.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -83.82 -17.87 39.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.264 0.484 . . . . 0.0 112.3 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.28 165.7 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.719 2.408 . . . . 0.0 107.236 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.11 179.61 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.715 1.206 . . . . 0.0 108.308 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -130.44 136.6 49.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.89 43.95 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 164.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.15 38.11 26.68 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.139 0.971 . . . . 0.0 111.666 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 60.02 14.31 4.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.443 1.897 . . . . 0.0 113.757 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.4 m -119.19 126.97 52.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.171 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -87.07 149.17 24.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -145.6 155.97 43.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.017 0.927 . . . . 0.0 110.798 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -139.61 164.0 31.07 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.405 1.482 . . . . 0.0 109.145 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.76 115.87 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 164.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.33 -0.09 55.81 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 117.676 -1.625 . . . . 0.0 114.811 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.89 -178.28 3.18 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.324 1.562 . . . . 0.0 109.851 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.39 152.25 41.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.952 1.701 . . . . 0.0 110.44 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.43 158.76 31.14 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 121.401 -0.812 . . . . 0.0 112.22 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 72.4 Cg_endo -68.62 158.0 59.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.799 2.333 . . . . 0.0 111.774 165.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -14.43 62.89 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.501 1.12 . . . . 0.0 113.487 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 14.8 ptp -56.08 -22.7 29.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.894 0.878 . . . . 0.0 112.935 172.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.68 -10.63 14.07 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.4 -20.13 55.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.883 0.873 . . . . 0.0 111.299 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -64.03 152.5 87.43 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.246 1.418 . . . . 0.0 110.463 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.19 -7.77 16.58 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.127 2.551 . . . . 0.0 114.262 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.56 -18.97 55.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.13 0.972 . . . . 0.0 113.276 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -122.45 -5.36 8.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 112.496 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 106.9 1.51 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.7 1.6 . . . . 0.0 112.186 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 56' ' ' TYR . 8.4 mm -79.01 78.77 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 O-C-N 120.832 -1.167 . . . . 0.0 107.966 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -61.76 -28.75 69.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.008 -1.057 . . . . 0.0 112.664 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -93.2 65.32 3.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.804 1.242 . . . . 0.0 109.698 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -82.9 -44.36 15.47 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -30.81 69.08 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.724 0.693 . . . . 0.0 111.024 -170.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -78.8 17.24 0.74 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.377 1.471 . . . . 0.0 113.308 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HB2' HD12 ' A' ' 45' ' ' LEU . 4.4 mtt85 -129.56 22.89 5.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.286 1.403 . . . . 0.0 113.28 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 57.4 8.09 0.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.414 1.886 . . . . 0.0 114.035 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 43' ' ' ARG . 2.5 mt -90.59 165.25 23.5 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.689 -1.257 . . . . 0.0 110.956 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.18 170.14 20.64 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.617 3.545 . . . . 0.0 111.641 168.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.78 165.49 2.4 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 127.21 2.204 . . . . 0.0 112.292 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.54 -164.65 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.764 2.976 . . . . 0.0 111.235 160.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.66 -169.84 1.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 158.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.51 105.75 13.82 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.46 -1.4 . . . . 0.0 110.594 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.93 44.43 7.69 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 p -140.28 166.78 23.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -152.86 145.6 24.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.904 0.859 . . . . 0.0 110.512 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -72.84 147.48 45.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.82 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -139.4 170.28 16.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.746 2.818 . . . . 0.0 108.332 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' HD11 ' A' ' 37' ' ' ILE . 16.8 t80 -116.62 78.66 1.22 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.575 0.625 . . . . 0.0 112.18 -172.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 97.86 11.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.727 2.011 . . . . 0.0 109.611 -172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.86 11.4 63.03 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.354 -0.841 . . . . 0.0 114.623 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.8 -15.73 37.29 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.198 0.999 . . . . 0.0 112.054 -170.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -89.08 138.4 31.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.633 1.217 . . . . 0.0 108.303 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.7 112.47 18.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.93 125.22 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 tp -89.87 111.78 22.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.44 150.34 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 123.057 0.543 . . . . 0.0 110.211 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.65 139.29 43.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.511 0.724 . . . . 0.0 109.433 169.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.53 -17.41 64.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.422 0.629 . . . . 0.0 110.86 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 p -100.26 -5.19 27.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.163 2.185 . . . . 0.0 112.716 -161.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -174.79 -44.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 109.003 -157.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.42 28.4 61.75 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.362 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.32 132.47 53.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.814 1.307 . . . . 0.0 108.347 163.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.34 86.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 128.666 2.786 . . . . 0.0 105.512 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.97 -46.78 83.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -152.63 163.7 39.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.018 1.327 . . . . 0.0 109.653 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.63 145.15 26.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.06 157.79 45.91 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.806 1.643 . . . . 0.0 107.143 164.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.2 157.51 34.43 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -28.63 62.96 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.271 2.367 . . . . 0.0 113.142 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -62.96 -20.3 65.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.024 0.93 . . . . 0.0 112.514 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.45 -21.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 111.889 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.53 -7.44 10.22 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 112.781 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -119.47 -0.97 10.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.005 1.322 . . . . 0.0 111.911 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -74.43 165.58 24.95 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.344 1.858 . . . . 0.0 109.488 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 129.328 3.051 . . . . 0.0 106.117 -178.038 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.91 -22.64 64.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 118.065 0.393 . . . . 0.0 110.879 -169.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.71 -26.18 68.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.509 1.124 . . . . 0.0 113.015 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -99.5 0.34 42.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.72 1.208 . . . . 0.0 111.641 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.49 101.19 0.95 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.92 151.08 25.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -101.28 -12.56 18.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.527 0.731 . . . . 0.0 111.81 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -177.05 156.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -155.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -172.15 -179.1 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 109.232 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -125.95 135.32 51.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.06 137.82 46.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.71 34.38 23.73 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.337 1.065 . . . . 0.0 110.751 168.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 59.34 14.79 3.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.835 2.454 . . . . 0.0 114.376 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -103.08 134.54 46.34 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.489 1.516 . . . . 0.0 107.267 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -90.25 141.88 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.347 1.859 . . . . 0.0 109.161 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -146.45 155.62 42.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.047 0.385 . . . . 0.0 111.71 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -145.31 167.58 22.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.734 1.214 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.0 mm -58.86 117.31 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.17 -11.84 55.36 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.003 -1.443 . . . . 0.0 114.323 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.53 -178.44 4.1 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.79 1.795 . . . . 0.0 107.164 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.78 148.09 43.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 119.349 -2.094 . . . . 0.0 108.951 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.38 163.4 66.42 Favored Pre-proline 0 CA--C 1.538 0.5 0 O-C-N 121.581 -0.699 . . . . 0.0 110.396 170.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.14 160.91 39.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.286 2.657 . . . . 0.0 111.378 160.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.15 -23.5 67.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.571 1.148 . . . . 0.0 113.132 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.571 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 6.7 ptm -53.78 -20.93 6.34 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.823 1.249 . . . . 0.0 113.594 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 8.6 m-85 -117.55 -8.15 11.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.646 1.178 . . . . 0.0 112.557 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -79.03 -25.8 43.22 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.594 1.558 . . . . 0.0 110.873 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 t -62.35 144.79 94.88 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.69 -9.57 21.37 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.649 2.233 . . . . 0.0 114.463 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -55.55 -36.51 66.87 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.062 0.945 . . . . 0.0 110.968 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.78 -11.12 16.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.767 0.827 . . . . 0.0 111.052 -173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -61.07 111.04 1.54 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.944 1.698 . . . . 0.0 109.956 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.6 mt -87.99 90.63 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -73.43 -28.52 62.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.572 164.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.23 68.95 9.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.356 0.98 . . . . 0.0 109.137 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -69.92 -57.26 5.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -44.83 -47.76 11.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.44 1.496 . . . . 0.0 114.839 -159.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -63.31 -21.64 66.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -75.22 -165.34 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.26 2.62 31.78 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.845 -1.159 . . . . 0.0 111.431 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 79' ' ' ILE . 2.5 mm? -65.04 156.15 81.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 121.325 -0.86 . . . . 0.0 112.204 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.05 171.48 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.678 3.585 . . . . 0.0 111.061 161.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.02 158.36 26.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 112.484 173.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.99 158.92 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.356 2.037 . . . . 0.0 111.01 167.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.608 ' H ' HD21 ' A' ' 63' ' ' LEU . 31.8 m-20 -62.06 149.1 42.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.72 101.27 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.435 0.694 . . . . 0.0 110.504 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.49 12.98 10.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.621 -1.1 . . . . 0.0 113.378 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.7 p -132.4 176.08 8.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.136 1.468 . . . . 0.0 111.06 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -149.49 154.37 38.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.132 0.973 . . . . 0.0 110.474 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -72.77 156.05 39.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.971 0.509 . . . . 0.0 109.865 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -147.46 167.97 23.08 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.48 106.16 16.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.297 1.839 . . . . 0.0 108.342 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG2' HG22 ' A' ' 62' ' ' VAL . 86.7 mmm -81.56 -154.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.193 1.797 . . . . 0.0 109.693 175.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.03 58.51 0.55 Allowed Glycine 0 C--N 1.338 0.679 0 C-N-CA 129.607 3.48 . . . . 0.0 111.701 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.23 56.8 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 125.676 1.608 . . . . 0.0 113.992 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -130.96 158.66 39.65 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.073 1.436 . . . . 0.0 108.87 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -102.95 125.79 49.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 108.694 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 57' ' ' MET . 16.4 m -127.71 151.02 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.648 -0.657 . . . . 0.0 109.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.608 HD21 ' H ' ' A' ' 49' ' ' ASP . 63.7 tp -103.46 127.99 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.684 HD12 HD23 ' A' ' 31' ' ' LEU . 10.4 pt -131.67 131.91 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 125.429 1.492 . . . . 0.0 110.538 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.78 134.52 57.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -8.6 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.086 -1.009 . . . . 0.0 111.377 172.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 t -134.05 12.01 3.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.928 2.091 . . . . 0.0 109.494 -158.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -171.91 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 0.0 111.425 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.1 37.95 24.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.481 1.515 . . . . 0.0 113.01 -165.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -58.84 145.63 40.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 159.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.2 mt -81.78 91.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.8 mm? -61.31 -56.92 15.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.35 163.09 35.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.468 1.507 . . . . 0.0 110.395 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.1 t -137.18 136.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.326 1.851 . . . . 0.0 107.304 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.59 142.99 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.153 0.981 . . . . 0.0 108.357 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.41 146.19 54.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.59 -20.96 40.67 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.446 1.022 . . . . 0.0 112.798 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -49.65 -30.94 9.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.509 1.124 . . . . 0.0 112.42 171.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 tt -58.36 -25.49 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.72 1.208 . . . . 0.0 112.574 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.31 -35.28 76.92 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.565 0.62 . . . . 0.0 110.657 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.73 2.37 51.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.708 0.803 . . . . 0.0 113.048 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -84.15 -174.66 5.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.341 0.656 . . . . 0.0 110.116 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 C--O 1.248 0.987 0 C-N-CA 127.073 2.149 . . . . 0.0 109.207 -172.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.4 pt . . . . . 0 C--O 1.224 -0.274 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.59 -24.83 65.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.101 1.76 . . . . 0.0 113.049 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.27 -34.86 77.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.289 0.636 . . . . 0.0 112.293 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -90.49 -3.84 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.099 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.39 0.78 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.432 1.014 . . . . 0.0 108.723 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.6 164.01 14.93 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -124.99 -20.06 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.46 1.504 . . . . 0.0 111.351 -172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -159.17 163.04 36.4 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.772 2.029 . . . . 0.0 107.505 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -163.71 175.56 10.43 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 110.148 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 m -127.74 112.68 15.06 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.47 158.48 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 25.39 12.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.264 0.938 . . . . 0.0 111.978 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 58.43 16.62 4.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.429 1.891 . . . . 0.0 113.133 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.7 m -117.8 125.9 51.43 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.661 1.984 . . . . 0.0 105.961 -171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -80.5 149.01 30.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -147.9 157.31 43.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.038 1.335 . . . . 0.0 109.495 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.68 167.67 21.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.318 1.447 . . . . 0.0 108.566 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.35 119.3 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.19 -13.35 40.44 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 117.782 -1.566 . . . . 0.0 114.014 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.86 -171.17 1.02 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 119.592 1.696 . . . . 0.0 107.879 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 142.56 50.49 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 118.379 -2.701 . . . . 0.0 109.981 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.36 156.56 73.63 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 121.547 -0.721 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.38 156.6 61.37 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.408 2.072 . . . . 0.0 110.564 165.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -61.22 -17.25 52.3 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.1 mmt -51.8 -27.44 12.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.533 1.533 . . . . 0.0 113.231 173.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.5 -7.31 15.18 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.8 mt -79.23 -23.75 43.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.584 1.154 . . . . 0.0 112.071 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -56.17 149.25 37.07 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.45 1.1 . . . . 0.0 110.262 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.77 -8.59 15.98 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.433 2.756 . . . . 0.0 113.18 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.02 -29.29 70.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.831 2.052 . . . . 0.0 111.861 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.38 1.22 9.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.671 1.188 . . . . 0.0 111.668 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 91.28 0.15 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.624 2.77 . . . . 0.0 108.915 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.78 112.61 5.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -88.55 -31.49 18.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 117.392 -1.29 . . . . 0.0 111.053 167.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.07 88.18 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.963 1.256 . . . . 0.0 110.655 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -104.15 -33.84 8.59 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.555 0.742 . . . . 0.0 111.972 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.76 -28.24 69.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.131 0.878 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -83.43 29.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.776 1.231 . . . . 0.0 110.754 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -141.49 169.14 18.16 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.862 2.465 . . . . 0.0 107.364 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.6 -13.91 62.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.737 1.215 . . . . 0.0 111.987 166.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.74 157.2 80.52 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.303 -0.873 . . . . 0.0 111.764 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -71.01 169.36 20.69 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.947 3.098 . . . . 0.0 111.253 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 149.72 77.14 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.72 166.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.96 169.54 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.108 2.539 . . . . 0.0 110.502 168.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -77.67 167.74 21.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.895 0.878 . . . . 0.0 108.666 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.03 42.24 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 114.426 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.65 56.12 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -159.91 171.78 18.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.305 0.642 . . . . 0.0 111.175 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -145.92 156.92 43.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.439 0.563 . . . . 0.0 110.95 167.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -80.94 153.17 27.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -136.53 168.81 18.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.397 1.079 . . . . 0.0 110.729 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -106.03 84.94 2.12 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.376 1.471 . . . . 0.0 107.646 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.3 mtp -94.85 102.06 13.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.131 0.972 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.33 6.29 86.28 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.663 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.27 4.1 53.59 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.068 1.434 . . . . 0.0 112.007 -167.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -115.09 143.71 44.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 53.8 m-85 -93.88 113.38 25.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 74' ' ' VAL . 3.6 m -127.49 143.25 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -172.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 tp -102.6 122.9 45.32 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.1 pt -124.68 149.06 28.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.007 0.923 . . . . 0.0 109.872 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.65 136.75 41.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.08 -25.16 65.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.655 0.741 . . . . 0.0 112.388 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 t -123.12 27.13 7.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.152 1.781 . . . . 0.0 110.147 -161.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -173.96 -36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.783 1.633 . . . . 0.0 110.552 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.32 21.46 77.66 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.079 1.323 . . . . 0.0 113.894 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 136.18 57.85 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.543 1.137 . . . . 0.0 108.59 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.48 87.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.2 mt -70.67 -49.24 49.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.167 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -152.52 157.94 41.83 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 109.695 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 62' ' ' VAL . 52.0 t -140.67 130.17 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.626 1.97 . . . . 0.0 107.087 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -129.43 148.19 51.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.631 1.173 . . . . 0.0 108.73 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 79' ' ' ILE . 23.2 t70 -68.64 157.81 35.4 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.817 -0.552 . . . . 0.0 111.241 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -61.73 -27.2 67.92 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-O 118.454 -1.192 . . . . 0.0 113.975 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -55.88 -27.62 52.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.961 1.381 . . . . 0.0 112.738 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 76' ' ' ASP . 16.3 tt -55.67 -26.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.579 1.152 . . . . 0.0 112.324 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -62.79 -30.34 71.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.375 0.534 . . . . 0.0 111.24 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -99.17 4.38 46.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.03 0.932 . . . . 0.0 111.627 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -69.7 -178.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.273 1.829 . . . . 0.0 110.039 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 . . . . . 0 C--O 1.245 0.855 0 O-C-N 120.77 -1.206 . . . . 0.0 111.122 -166.862 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.13 -22.99 67.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.011 0.924 . . . . 0.0 112.727 -170.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -60.4 -30.69 69.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.057 0.943 . . . . 0.0 112.693 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.52 -3.49 46.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.156 0.983 . . . . 0.0 110.688 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.88 82.24 7.6 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 109.365 -168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.96 151.27 46.74 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -16.24 15.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.071 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -156.66 157.62 35.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.067 1.347 . . . . 0.0 109.652 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -158.77 177.28 11.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.094 1.758 . . . . 0.0 109.286 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -126.13 128.75 47.81 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.08 44.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.45 38.04 4.96 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.948 1.356 . . . . 0.0 112.243 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 60.74 34.51 19.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.929 2.091 . . . . 0.0 112.953 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 m -142.33 131.85 23.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.594 1.557 . . . . 0.0 107.163 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.9 147.74 36.85 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.49 144.2 39.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.864 1.265 . . . . 0.0 108.48 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.04 174.46 7.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.05 122.66 18.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.81 -1.54 55.41 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.342 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.93 -171.38 2.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.098 1.449 . . . . 0.0 108.678 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.29 127.31 25.9 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.325 -1.484 . . . . 0.0 110.894 -169.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.8 m -70.03 158.32 87.65 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 123.22 0.608 . . . . 0.0 111.492 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.52 159.96 51.1 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.187 1.925 . . . . 0.0 111.023 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.09 -15.89 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.325 0.65 . . . . 0.0 112.54 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -25.97 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 112.097 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -116.43 -9.49 11.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.72 1.208 . . . . 0.0 113.24 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.01 -18.41 37.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.525 0.73 . . . . 0.0 111.32 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 t -53.01 150.81 9.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.212 0.605 . . . . 0.0 109.408 166.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.96 -4.39 15.04 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.866 2.378 . . . . 0.0 113.842 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -57.3 -23.93 51.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 113.246 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -121.57 10.13 10.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.746 1.157 . . . . 0.0 113.199 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.23 106.39 0.61 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.686 2.394 . . . . 0.0 112.371 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.4 mm -73.91 79.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.312 1.045 . . . . 0.0 108.724 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.54 -32.44 73.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.353 -0.842 . . . . 0.0 110.8 166.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -76.65 34.34 0.14 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.843 1.257 . . . . 0.0 114.017 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -75.64 -32.83 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -65.04 -32.34 74.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.43 1.468 . . . . 0.0 110.547 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.61 27.24 0.86 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.686 0.794 . . . . 0.0 111.737 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -132.05 165.53 23.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.02 1.728 . . . . 0.0 107.614 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.515 HD21 ' HA ' ' A' ' 83' ' ' ARG . 2.1 m120 -73.81 -19.87 60.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.44 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.61 151.56 61.11 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.371 1.069 . . . . 0.0 110.331 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.43 164.47 32.55 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.693 1.596 . . . . 0.0 110.359 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.6 157.64 36.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.411 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.59 162.1 32.64 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.324 1.35 . . . . 0.0 110.083 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -70.74 167.54 18.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 162.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.65 61.25 1.79 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 113.252 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.31 41.28 0.04 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.159 1.837 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.3 p -151.04 169.91 20.67 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.841 -0.799 . . . . 0.0 110.728 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -147.01 157.21 43.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.101 0.961 . . . . 0.0 110.184 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -98.56 137.3 37.42 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.283 0.633 . . . . 0.0 109.421 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -137.58 159.11 42.88 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.642 -0.661 . . . . 0.0 110.015 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -99.92 61.27 1.11 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.83 0.824 . . . . 0.0 112.391 -167.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 102.89 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.985 2.114 . . . . 0.0 109.82 -164.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.33 14.12 59.19 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.335 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.29 -1.52 37.53 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.851 1.825 . . . . 0.0 112.965 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -114.84 161.47 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.74 1.77 . . . . 0.0 107.909 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 65.7 m-85 -105.05 113.84 27.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.16 135.08 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -92.27 110.88 22.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.655 1.182 . . . . 0.0 108.543 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.55 142.32 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.706 1.202 . . . . 0.0 108.683 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.77 143.7 54.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.82 -12.66 61.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -140.34 24.1 2.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.274 1.43 . . . . 0.0 109.176 -159.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -165.78 -44.42 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.469 1.508 . . . . 0.0 109.166 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.39 25.03 71.57 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.292 0.949 . . . . 0.0 113.306 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 133.39 55.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 167.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.73 88.69 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.049 2.139 . . . . 0.0 106.515 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -45.95 66.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.287 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -152.17 160.9 43.3 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 109.673 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.2 141.72 40.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.172 1.789 . . . . 0.0 106.42 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -139.14 140.25 37.84 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.267 1.827 . . . . 0.0 106.378 165.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.98 155.84 35.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.431 1.014 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -51.49 -31.06 28.13 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.642 1.591 . . . . 0.0 112.789 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.56 -33.68 6.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.489 1.916 . . . . 0.0 112.551 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 tt -69.4 -12.09 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.534 1.134 . . . . 0.0 112.025 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -67.07 -34.93 78.72 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.845 -1.159 . . . . 0.0 111.182 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -91.32 -17.62 25.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.651 0.78 . . . . 0.0 111.329 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.11 141.64 55.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 128.27 2.628 . . . . 0.0 108.838 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HA ' HD21 ' A' ' 44' ' ' ASN . 12.2 mtt-85 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -53.53 -29.95 39.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.623 1.569 . . . . 0.0 112.651 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.2 -21.02 66.41 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -107.89 4.04 24.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.927 1.291 . . . . 0.0 110.766 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.63 94.51 1.01 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.12 163.64 24.36 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -121.79 -19.09 6.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.004 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.6 164.64 24.05 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.406 1.882 . . . . 0.0 107.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -168.59 -176.64 2.85 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.292 1.837 . . . . 0.0 109.084 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -135.67 133.45 38.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.106 0.962 . . . . 0.0 108.716 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.69 35.41 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.047 0.939 . . . . 0.0 109.409 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.2 39.81 20.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.924 1.29 . . . . 0.0 109.968 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.42 15.5 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.442 2.697 . . . . 0.0 114.855 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 m -114.21 131.82 56.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.419 1.488 . . . . 0.0 107.425 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.85 155.74 23.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.73 0.695 . . . . 0.0 109.373 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -149.26 153.66 37.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.408 1.483 . . . . 0.0 110.485 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -136.64 165.98 24.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.1 1.36 . . . . 0.0 107.365 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.7 mm -59.81 125.84 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 168.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.35 44.02 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.677 -1.624 . . . . 0.0 114.162 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.52 -175.89 0.91 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.213 1.506 . . . . 0.0 109.62 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 131.74 45.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 119.92 -1.737 . . . . 0.0 110.27 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' CG2' ' A' ' 64' ' ' ILE . 17.3 m -72.84 164.1 63.15 Favored Pre-proline 0 N--CA 1.467 0.397 0 C-N-CA 126.052 1.741 . . . . 0.0 111.984 -174.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 74.1 Cg_endo -74.09 158.5 45.52 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.497 2.798 . . . . 0.0 112.234 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.43 68.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.042 1.337 . . . . 0.0 111.797 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 19.6 ptt? -66.8 -33.44 75.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.358 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 25.5 m-85 -87.04 -4.3 59.15 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 118.261 -1.375 . . . . 0.0 114.146 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.37 -21.39 62.88 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.148 0.886 . . . . 0.0 110.95 168.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -69.62 148.7 96.89 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 121.899 -0.5 . . . . 0.0 111.035 -172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.5 -14.87 42.02 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.053 3.169 . . . . 0.0 111.809 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.48 -30.16 60.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.439 1.896 . . . . 0.0 112.563 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -112.62 -8.28 13.82 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.211 1.404 . . . . 0.0 111.833 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -80.77 118.22 22.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.808 1.643 . . . . 0.0 111.28 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.01 92.78 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 -21.09 63.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 111.63 169.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.57 40.12 0.29 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.621 1.168 . . . . 0.0 112.95 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -53.52 -41.45 66.38 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.279 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -61.71 -27.57 68.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.996 1.726 . . . . 0.0 114.68 -167.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -84.99 -14.86 46.13 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.461 1.482 . . . . 0.0 112.746 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 -83.74 172.11 12.54 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 166.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -109.78 8.15 24.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.325 -0.86 . . . . 0.0 111.491 -158.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.72 166.97 10.08 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 129.28 3.032 . . . . 0.0 112.613 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.07 175.5 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 121.387 1.391 . . . . 0.0 111.6 153.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 164.18 2.2 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.796 1.238 . . . . 0.0 111.238 166.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.63 167.93 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.278 1.319 . . . . 0.0 110.459 160.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -81.03 170.49 16.16 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.42 -0.8 . . . . 0.0 109.788 160.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.75 108.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.372 1.469 . . . . 0.0 110.909 167.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.64 29.78 51.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.764 174.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.6 p -130.77 171.36 13.21 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.475 1.138 . . . . 0.0 110.365 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -151.26 164.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.386 0.613 . . . . 0.0 111.445 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CD1' HD13 ' A' ' 63' ' ' LEU . 78.5 m95 -106.32 121.34 44.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.293 1.037 . . . . 0.0 110.129 -168.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.4 p -109.0 -179.97 4.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.303 1.441 . . . . 0.0 110.139 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -131.2 80.85 1.96 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.824 1.193 . . . . 0.0 111.323 -172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtp -99.18 105.5 17.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.593 1.557 . . . . 0.0 111.325 -168.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.09 15.31 62.73 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 118.711 -1.049 . . . . 0.0 113.787 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.58 8.6 59.49 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.105 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.75 127.91 54.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.228 1.514 . . . . 0.0 106.917 172.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 73.3 m-85 -85.29 121.2 27.68 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG12 HG13 ' A' ' 74' ' ' VAL . 13.3 m -127.3 145.46 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 118.847 0.748 . . . . 0.0 109.785 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' HD23 ' A' ' 72' ' ' LEU . 34.8 tp -103.53 126.67 50.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 26' ' ' VAL . 10.9 pt -131.09 135.33 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 138.89 57.87 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.412 -0.805 . . . . 0.0 109.012 170.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.94 -13.94 60.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.6 0.714 . . . . 0.0 110.726 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 p -109.04 -6.24 15.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.097 1.359 . . . . 0.0 111.011 -161.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.43 -37.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.701 1.201 . . . . 0.0 109.684 -160.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 26' ' ' VAL . . . 59.26 41.0 96.6 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 125.753 1.644 . . . . 0.0 111.888 -172.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' O ' HD22 ' A' ' 72' ' ' LEU . 9.6 tmtt? -65.69 133.99 52.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.13 93.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.517 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.4 mm? -65.26 -53.04 50.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -147.91 167.48 24.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 111.584 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 62' ' ' VAL . 68.7 t -142.55 141.18 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 127.448 2.299 . . . . 0.0 105.706 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -136.48 151.62 49.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.986 1.714 . . . . 0.0 108.019 167.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.59 153.32 40.26 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -62.88 -19.09 60.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 126.074 1.797 . . . . 0.0 113.0 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -57.02 -25.17 58.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.699 1.249 . . . . 0.0 111.405 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.27 -23.8 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.718 -0.613 . . . . 0.0 111.618 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -66.27 -13.05 59.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.856 1.207 . . . . 0.0 112.629 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -100.42 -4.94 27.95 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.417 -0.802 . . . . 0.0 110.251 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -77.53 69.89 3.84 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.419 2.287 . . . . 0.0 110.101 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.395 2.678 . . . . 0.0 117.144 158.044 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.1 pt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.84 -32.72 70.93 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 112.429 -168.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -56.13 -29.52 60.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.449 1.499 . . . . 0.0 113.618 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.99 -1.45 42.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.9 96.18 0.57 Allowed 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.748 1.158 . . . . 0.0 108.246 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.62 140.38 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -84.57 -20.34 31.64 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 122.304 -0.247 . . . . 0.0 110.932 168.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -157.61 162.73 38.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.037 1.335 . . . . 0.0 108.927 -168.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.27 177.32 11.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.377 1.071 . . . . 0.0 108.651 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -126.92 132.52 50.86 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.64 153.91 46.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 27.01 15.76 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.379 0.991 . . . . 0.0 112.692 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 57.64 14.64 2.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.062 -172.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.2 m -111.52 137.2 49.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 128.271 2.628 . . . . 0.0 105.791 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.04 154.15 18.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -149.7 153.4 36.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.254 0.621 . . . . 0.0 109.953 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -143.28 169.06 18.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.648 0.779 . . . . 0.0 109.045 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.16 93.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.87 5.46 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-O 117.809 -1.551 . . . . 0.0 114.174 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.92 176.04 1.78 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.469 1.634 . . . . 0.0 108.384 166.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -134.71 138.5 44.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -82.19 157.81 67.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.2 158.01 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 110.653 166.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.74 43.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.39 1.076 . . . . 0.0 112.479 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtm -51.92 -35.94 47.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.062 1.345 . . . . 0.0 111.824 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -97.24 -7.44 32.26 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.93 -18.97 61.34 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.665 0.666 . . . . 0.0 110.158 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.4 p -55.29 158.08 5.79 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.03 1.332 . . . . 0.0 111.497 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.37 -12.24 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.981 2.454 . . . . 0.0 113.032 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.87 -21.85 66.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.554 1.141 . . . . 0.0 112.408 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -115.51 13.36 16.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.932 1.693 . . . . 0.0 111.243 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -89.48 82.38 6.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.864 2.066 . . . . 0.0 111.218 -162.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.5 71.29 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.491 1.516 . . . . 0.0 110.905 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -68.6 -23.09 64.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.197 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -74.1 94.36 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 170.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -125.4 -27.05 3.5 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.812 -1.18 . . . . 0.0 113.641 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -51.42 -44.1 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.721 0.691 . . . . 0.0 109.177 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 -24.2 8.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.825 2.45 . . . . 0.0 115.453 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -116.07 177.06 4.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.478 1.511 . . . . 0.0 108.32 -170.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -9.58 59.66 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.07 -0.394 . . . . 0.0 111.022 -172.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.22 144.94 98.35 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 123.364 0.666 . . . . 0.0 109.816 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.11 159.86 24.62 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.796 2.331 . . . . 0.0 108.959 166.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.42 147.42 68.59 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.841 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -63.62 158.15 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.427 1.418 . . . . 0.0 108.767 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -72.52 156.41 39.05 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.48 65.06 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.533 1.533 . . . . 0.0 112.362 -164.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 25.57 0.05 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 128.004 2.716 . . . . 0.0 110.94 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.0 p -143.84 167.49 22.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.163 1.481 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -146.55 152.35 38.81 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.024 0.53 . . . . 0.0 111.726 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -92.06 128.43 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -131.8 155.44 47.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.297 0.639 . . . . 0.0 111.035 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 11.5 t80 -91.11 119.76 31.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.465 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtt -141.57 110.43 6.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.558 1.072 . . . . 0.0 111.266 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 1.98 33.85 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.106 0.86 . . . . 0.0 113.499 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.461 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.99 -18.15 19.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.824 1.678 . . . . 0.0 111.833 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -82.97 162.83 21.35 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.707 1.203 . . . . 0.0 109.5 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 34.3 m-85 -109.87 118.11 35.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.478 1.511 . . . . 0.0 107.6 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 74' ' ' VAL . 3.1 m -131.72 131.45 62.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -89.0 111.02 21.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -106.96 147.88 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.614 1.166 . . . . 0.0 108.09 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 141.75 52.15 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.3 -10.73 60.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.669 0.747 . . . . 0.0 112.543 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -124.05 -5.77 7.87 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.263 2.225 . . . . 0.0 111.299 -161.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -152.92 -32.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.36 1.464 . . . . 0.0 109.461 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.1 16.16 80.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 124.101 0.858 . . . . 0.0 113.138 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.5 OUTLIER -62.41 131.63 49.86 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.596 -0.943 . . . . 0.0 108.567 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.26 94.58 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.62 -52.56 14.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.867 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -150.15 162.53 40.26 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.116 1.366 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.566 HG13 HG12 ' A' ' 62' ' ' VAL . 86.9 t -139.58 136.45 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -133.89 143.52 48.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.37 1.068 . . . . 0.0 108.171 168.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.99 144.1 57.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -55.39 -22.78 32.01 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.337 1.446 . . . . 0.0 114.135 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.86 -20.46 57.27 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.182 1.491 . . . . 0.0 113.585 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.27 -16.8 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 112.169 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.59 -49.38 69.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.862 -1.149 . . . . 0.0 110.056 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -82.52 -17.74 43.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.24 0.616 . . . . 0.0 111.707 -168.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.12 124.09 10.8 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 130.308 3.443 . . . . 0.0 108.747 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.016 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 79' ' ' ILE . 23.3 pt . . . . . 0 C--O 1.226 -0.135 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.61 -15.58 63.57 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.88 0.472 . . . . 0.0 111.811 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.9 -21.95 66.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.297 1.439 . . . . 0.0 112.586 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.65 0.73 31.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.808 1.243 . . . . 0.0 111.722 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.599 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . . . -79.8 106.77 12.07 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.987 1.267 . . . . 0.0 109.574 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.93 HD13 HG12 ' A' ' 74' ' ' VAL . 2.9 mp -72.41 -162.12 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HE2' ' OE1' ' A' ' 12' ' ' GLU . 15.4 ptmt -134.92 -16.62 1.94 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 119.956 -1.715 . . . . 0.0 109.968 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.6 pt-20 -165.29 170.64 14.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -162.47 172.57 15.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.683 0.793 . . . . 0.0 109.501 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.11 141.3 45.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 159.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.25 142.74 32.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 160.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.64 31.14 12.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 170.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 70.15 13.72 7.72 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.451 2.701 . . . . 0.0 114.042 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.9 m -105.46 133.03 50.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 107.845 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.65 149.32 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.125 1.77 . . . . 0.0 110.25 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -157.12 146.9 20.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.887 0.875 . . . . 0.0 111.039 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -140.44 167.61 21.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.799 0.84 . . . . 0.0 110.475 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 mm -61.19 101.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.46 -10.97 9.77 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 117.577 -1.68 . . . . 0.0 116.16 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB2' HD12 ' A' ' 71' ' ' ILE . 14.8 m-20 -73.58 -174.76 1.8 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 121.005 2.403 . . . . 0.0 109.45 171.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.09 139.6 53.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.648 -1.282 . . . . 0.0 108.872 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.21 159.36 82.56 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 121.338 -0.851 . . . . 0.0 109.266 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.16 155.95 42.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.712 2.275 . . . . 0.0 111.137 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 31' ' ' LEU . . . -64.33 -11.48 32.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.15 -33.73 71.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 109.581 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -102.21 -8.3 21.43 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 28' ' ' ALA . 3.6 mm? -59.21 -27.06 65.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.2 -0.428 . . . . 0.0 109.98 167.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.3 p -64.42 144.45 98.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 117.837 0.29 . . . . 0.0 111.725 -168.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.39 -6.0 18.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.08 1.853 . . . . 0.0 111.871 -171.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.01 -38.36 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.095 2.158 . . . . 0.0 111.719 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -106.97 7.02 29.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.261 1.425 . . . . 0.0 111.702 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -90.92 107.84 19.46 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.296 1.839 . . . . 0.0 110.633 -171.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.0 mp -81.56 66.83 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.468 1.507 . . . . 0.0 110.211 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -54.23 -26.48 28.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.755 1.222 . . . . 0.0 112.133 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -72.84 90.34 1.43 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.834 1.654 . . . . 0.0 108.743 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -114.46 -28.84 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.379 1.445 . . . . 0.0 113.285 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.17 -38.84 77.43 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.773 1.229 . . . . 0.0 111.765 -168.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -119.28 44.7 2.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.807 1.243 . . . . 0.0 109.069 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -124.05 29.11 6.55 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.766 0.826 . . . . 0.0 112.4 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 m120 52.7 27.05 4.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.015 1.326 . . . . 0.0 111.853 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.9 mt -127.93 159.02 68.79 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 120.424 1.465 . . . . 0.0 110.448 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.32 173.47 13.78 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.025 2.483 . . . . 0.0 111.73 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.79 151.55 97.09 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.176 0.99 . . . . 0.0 110.947 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.31 164.89 34.27 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.559 3.506 . . . . 0.0 111.41 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.66 167.56 14.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.865 0.84 . . . . 0.0 109.186 163.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.65 51.82 0.28 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.586 2.355 . . . . 0.0 115.15 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.79 43.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 126.275 1.893 . . . . 0.0 109.156 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.2 p -154.73 168.38 27.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.469 1.135 . . . . 0.0 111.584 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -155.53 156.09 34.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.205 1.003 . . . . 0.0 109.962 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -80.57 141.31 35.19 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.277 1.031 . . . . 0.0 108.699 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.3 t -130.99 158.61 39.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.475 1.11 . . . . 0.0 108.692 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HB2' HD11 ' A' ' 37' ' ' ILE . 7.4 t80 -96.02 109.24 21.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.478 1.111 . . . . 0.0 108.592 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.87 112.86 13.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.943 1.297 . . . . 0.0 110.827 -170.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.57 -1.13 15.43 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.292 -175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.67 -12.52 25.26 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 120.066 1.933 . . . . 0.0 113.341 -164.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.76 163.01 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 118.642 1.221 . . . . 0.0 109.482 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -101.17 111.52 23.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.863 1.665 . . . . 0.0 108.376 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 74' ' ' VAL . 4.5 m -121.49 135.9 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.396 -0.815 . . . . 0.0 109.964 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 tp -89.11 113.3 24.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.563 1.545 . . . . 0.0 110.1 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.408 ' CD1' HD13 ' A' ' 31' ' ' LEU . 1.9 pp -119.28 142.28 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.598 1.159 . . . . 0.0 109.159 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 137.13 41.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.903 0.881 . . . . 0.0 109.408 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.06 1.85 4.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.944 0.898 . . . . 0.0 113.018 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 t -143.3 9.12 1.63 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.241 1.416 . . . . 0.0 110.775 -168.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -155.64 -42.65 0.08 Allowed 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.568 -1.332 . . . . 0.0 108.528 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 16.62 71.55 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.742 0.687 . . . . 0.0 111.461 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 139.72 58.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.35 1.075 . . . . 0.0 109.043 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 24' ' ' ASP . 71.4 mt -81.43 79.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.629 1.571 . . . . 0.0 107.523 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.54 -47.14 76.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -149.86 162.67 39.85 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.186 1.794 . . . . 0.0 108.878 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.93 HG12 HD13 ' A' ' 10' ' ' LEU . 45.0 t -140.62 136.93 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 9' ' ' ALA . 47.2 m-85 -137.27 144.83 42.9 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.994 1.718 . . . . 0.0 107.289 172.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 79' ' ' ILE . 52.1 t0 -70.57 159.42 34.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.83 0.741 . . . . 0.0 111.612 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.25 -28.71 72.69 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.04 0.829 . . . . 0.0 111.902 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.18 -21.51 33.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 112.455 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 5' ' ' ILE . 10.5 tt -61.88 -30.73 49.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.156 0.889 . . . . 0.0 111.469 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -66.57 -12.45 57.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 111.774 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.78 -8.01 20.14 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.488 1.115 . . . . 0.0 112.192 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -54.16 170.95 0.12 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.926 2.091 . . . . 0.0 110.046 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -173.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 C--O 1.226 -0.165 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -56.89 -19.51 18.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.139 2.176 . . . . 0.0 112.179 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.76 -33.93 77.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 0.0 112.576 170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -95.07 0.63 54.58 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.088 1.355 . . . . 0.0 111.81 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 87.4 1.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.927 0.891 . . . . 0.0 109.386 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.77 158.98 35.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -105.51 -13.3 15.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.112 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.82 160.76 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.717 1.607 . . . . 0.0 109.039 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -159.66 175.38 13.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.697 1.599 . . . . 0.0 108.869 168.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -117.38 143.67 45.74 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.07 153.77 34.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 166.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.07 24.13 13.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.165 0.893 . . . . 0.0 111.752 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 56.64 17.23 2.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.066 2.146 . . . . 0.0 113.54 -170.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -108.33 128.75 55.03 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.57 1.948 . . . . 0.0 106.787 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -82.55 149.27 27.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.596 1.559 . . . . 0.0 110.092 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -152.49 153.91 34.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.827 0.851 . . . . 0.0 111.052 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -139.62 165.17 27.97 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.422 1.089 . . . . 0.0 108.837 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.63 112.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.77 -9.81 34.71 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.288 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.44 -175.93 2.11 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 119.494 1.647 . . . . 0.0 107.142 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.09 161.33 21.17 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 119.046 -2.284 . . . . 0.0 108.243 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -90.81 163.11 31.27 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 109.883 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.86 155.63 61.96 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.645 2.23 . . . . 0.0 110.97 158.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -62.44 -17.91 60.48 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.862 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 mmt -49.89 -22.17 1.41 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.907 2.083 . . . . 0.0 113.454 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -116.8 -10.16 11.1 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.374 0.988 . . . . 0.0 112.699 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.8 mt -72.56 -31.68 65.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.157 0.889 . . . . 0.0 110.945 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 t -50.94 144.67 13.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.071 1.348 . . . . 0.0 109.263 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.12 -11.32 31.79 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.011 2.474 . . . . 0.0 112.711 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.17 -18.85 11.27 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 112.97 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -118.93 -1.44 11.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 112.358 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -70.37 99.51 1.59 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.724 1.61 . . . . 0.0 110.659 -168.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 mt -81.39 83.84 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -62.52 -23.32 66.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.477 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -83.67 104.89 14.15 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.539 1.063 . . . . 0.0 111.014 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.43 -25.92 2.6 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 117.652 -1.166 . . . . 0.0 114.112 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -33.92 73.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.959 1.254 . . . . 0.0 112.193 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.7 26.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.818 1.247 . . . . 0.0 111.327 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -141.32 163.76 32.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.571 1.149 . . . . 0.0 108.448 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -64.74 -28.54 69.65 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.752 0.821 . . . . 0.0 112.449 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.65 153.76 7.58 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 124.476 1.11 . . . . 0.0 112.255 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.19 177.43 8.87 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.904 2.403 . . . . 0.0 111.209 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.57 164.46 7.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.338 1.455 . . . . 0.0 111.429 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -67.52 178.2 3.4 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.619 2.212 . . . . 0.0 109.266 157.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -85.38 179.11 7.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 162.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.91 37.4 0.24 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.263 1.425 . . . . 0.0 114.72 -166.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 43.83 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.049 1.785 . . . . 0.0 109.757 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 3.3 p -147.05 172.41 13.79 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.58 -1.541 . . . . 0.0 109.604 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -145.56 149.33 34.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.774 0.321 . . . . 0.0 111.636 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.46 142.88 38.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -134.16 170.44 15.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.591 1.156 . . . . 0.0 109.94 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 25.8 t80 -106.55 104.22 13.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.418 1.087 . . . . 0.0 108.666 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.68 102.11 9.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.734 1.614 . . . . 0.0 109.149 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.98 3.14 50.63 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.992 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 111.23 -1.33 28.2 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.464 1.132 . . . . 0.0 113.04 -169.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -120.48 140.0 52.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.651 1.58 . . . . 0.0 107.673 -167.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.1 120.39 28.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.65 144.4 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 tp -102.11 125.18 48.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.2 pt -130.03 135.18 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.885 0.874 . . . . 0.0 111.942 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 52' ' ' SER . 0.0 OUTLIER -60.12 129.7 43.03 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.421 0.688 . . . . 0.0 111.348 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.94 15.73 0.84 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.743 1.217 . . . . 0.0 112.633 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -143.13 4.93 1.46 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.151 2.58 . . . . 0.0 111.642 -171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -168.69 -50.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.9 1.28 . . . . 0.0 108.876 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.43 41.7 29.63 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.439 1.971 . . . . 0.0 111.17 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -61.11 153.75 24.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 159.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.0 mt -87.61 89.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 -47.98 69.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 110.484 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -144.59 158.95 43.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.91 0.884 . . . . 0.0 110.679 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.87 130.89 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.988 2.115 . . . . 0.0 106.062 166.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -125.58 142.33 51.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 160.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -63.7 151.53 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.357 0.526 . . . . 0.0 110.039 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.84 -18.77 47.73 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.575 1.083 . . . . 0.0 113.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.37 -27.73 38.43 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.437 1.119 . . . . 0.0 111.907 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -63.33 -20.57 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 112.735 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.18 -50.68 72.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.362 0.983 . . . . 0.0 109.978 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.66 -15.51 58.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.878 1.671 . . . . 0.0 112.274 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -85.27 88.27 7.47 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -174.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 127.267 2.227 . . . . 0.0 112.575 178.613 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.15 -30.87 71.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.895 0.478 . . . . 0.0 111.449 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -64.0 -20.68 66.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.388 1.875 . . . . 0.0 112.802 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -105.34 2.2 28.62 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.202 1.401 . . . . 0.0 111.25 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.61 96.22 1.53 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.48 157.24 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -129.71 0.46 4.9 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.357 1.063 . . . . 0.0 111.528 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -173.04 161.01 4.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.929 2.891 . . . . 0.0 106.457 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -169.51 177.48 4.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.235 1.414 . . . . 0.0 109.329 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -132.52 140.58 48.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 165.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.8 41.87 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 165.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t0 54.14 27.02 7.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 61.24 29.06 18.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.52 1.928 . . . . 0.0 111.704 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 m -125.8 135.83 52.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -110.16 150.29 28.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 109.476 -171.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -148.67 146.37 28.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.565 -160.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -144.28 167.07 23.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.668 1.587 . . . . 0.0 108.266 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 mm -69.81 118.23 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.89 -11.0 57.46 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.866 -1.519 . . . . 0.0 113.71 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.14 -179.85 2.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.804 1.802 . . . . 0.0 107.363 166.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.58 157.31 31.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 119.306 -2.121 . . . . 0.0 107.617 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 64' ' ' ILE . 18.4 m -84.96 165.23 38.18 Favored Pre-proline 0 C--O 1.238 0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 111.444 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 73.3 Cg_endo -71.18 158.56 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.18 2.586 . . . . 0.0 111.42 163.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.8 67.52 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.02 0.928 . . . . 0.0 112.025 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 18.9 ptp -54.8 -20.44 8.58 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 126.104 1.762 . . . . 0.0 114.273 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.455 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 10.8 m-85 -110.2 3.73 20.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.34 -23.0 35.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 111.508 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 t -66.65 145.53 98.95 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.197 0.999 . . . . 0.0 110.89 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.96 -6.71 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.531 3.487 . . . . 0.0 114.351 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -51.63 -42.44 62.02 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.44 1.096 . . . . 0.0 110.971 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.21 -12.15 19.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.521 0.728 . . . . 0.0 112.216 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -60.76 99.95 0.1 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.878 2.471 . . . . 0.0 112.211 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -78.18 79.31 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.123 1.769 . . . . 0.0 106.4 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -62.73 -29.24 70.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.6 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -76.05 76.59 2.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 111.639 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -98.54 -19.19 17.76 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.588 -0.695 . . . . 0.0 111.405 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -0.87 13.5 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.571 -1.331 . . . . 0.0 112.976 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.47 12.45 6.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.838 1.655 . . . . 0.0 111.775 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -120.86 173.58 7.14 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 120.842 -1.161 . . . . 0.0 107.953 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.03 -12.66 49.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.044 0.537 . . . . 0.0 112.079 -170.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.44 152.64 95.42 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.996 1.318 . . . . 0.0 109.904 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.46 167.14 19.52 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.245 2.63 . . . . 0.0 111.628 170.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.21 144.3 97.46 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.893 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.04 173.37 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.243 2.629 . . . . 0.0 110.847 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.66 175.64 9.99 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.005 0.922 . . . . 0.0 110.096 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.76 99.66 0.12 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.589 1.556 . . . . 0.0 111.422 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.3 49.36 20.84 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.169 -0.957 . . . . 0.0 111.058 -175.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -132.02 171.09 14.04 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 159.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.4 154.41 34.41 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.013 0.435 . . . . 0.0 111.113 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -75.62 143.51 42.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.523 175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -129.75 172.8 11.27 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.268 1.427 . . . . 0.0 109.02 168.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 114.47 28.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.42 ' CG ' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -89.41 -154.33 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.328 0.967 . . . . 0.0 110.016 175.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 57' ' ' MET . . . -46.55 7.63 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 1 C-N-CA 132.65 4.929 . . . . 0.0 117.862 170.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 57' ' ' MET . . . 138.37 -19.5 3.21 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 127.193 2.33 . . . . 0.0 110.883 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' OD1' HG13 ' A' ' 62' ' ' VAL . 15.5 p30 -92.5 162.9 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.346 1.458 . . . . 0.0 110.55 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.24 125.84 52.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.374 1.469 . . . . 0.0 107.496 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 60' ' ' ASN . 2.5 m -129.53 156.37 41.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 72' ' ' LEU . 64.0 tp -117.62 125.33 50.56 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.418 ' CG2' HG11 ' A' ' 26' ' ' VAL . 1.1 pt -130.72 136.55 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 124.397 1.079 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.61 135.45 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.744 0.818 . . . . 0.0 109.644 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -6.25 8.94 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.818 -0.551 . . . . 0.0 112.221 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -135.85 12.68 3.4 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.673 1.589 . . . . 0.0 110.145 -158.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -170.95 -31.4 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 125.887 1.675 . . . . 0.0 109.822 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.43 35.65 21.83 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.271 1.415 . . . . 0.0 111.661 -165.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.469 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -64.86 152.61 42.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 170.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.7 mt -86.97 86.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.7 mm? -64.4 -51.76 61.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -149.8 161.88 41.38 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 109.364 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.13 142.35 40.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -132.49 152.14 51.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 161.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.49 160.8 28.41 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.877 -0.514 . . . . 0.0 111.02 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -22.19 71.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 124.451 1.024 . . . . 0.0 113.037 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -59.87 -18.57 45.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 112.296 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.33 -19.73 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 112.946 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -72.3 -35.06 68.56 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.512 1.051 . . . . 0.0 111.746 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -76.74 -16.42 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.775 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.669 ' CD2' ' H ' ' A' ' 83' ' ' ARG . 15.0 t60 -72.77 174.53 7.54 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.075 0.941 . . . . 0.0 110.378 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.669 ' H ' ' CD2' ' A' ' 82' ' ' HIS . 11.7 ptm180 . . . . . 0 C--O 1.246 0.916 0 C-N-CA 126.359 1.864 . . . . 0.0 110.518 -161.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.92 -25.88 58.26 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.865 1.666 . . . . 0.0 113.166 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -65.75 -27.17 68.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.81 0.43 57.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.321 1.049 . . . . 0.0 110.507 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.56 90.96 2.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.851 1.26 . . . . 0.0 111.628 -167.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.8 129.37 34.49 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.402 1.081 . . . . 0.0 108.303 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -92.01 -15.95 27.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.095 0.862 . . . . 0.0 112.393 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.83 166.4 29.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.312 1.445 . . . . 0.0 107.625 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 44.4 p90 -156.72 176.8 12.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.047 0.939 . . . . 0.0 108.881 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -129.89 129.82 44.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.34 142.43 32.48 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 44.34 51.77 7.51 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.02 1.328 . . . . 0.0 109.961 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.299 2.6 p90 48.24 24.19 0.65 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.014 3.326 . . . . 0.0 114.601 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.6 m -115.48 138.0 51.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.669 1.988 . . . . 0.0 107.407 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -89.78 150.71 22.15 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.019 0.928 . . . . 0.0 109.33 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.8 m-85 -149.86 154.03 37.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.116 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -135.43 160.82 37.25 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.981 0.912 . . . . 0.0 108.644 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.27 113.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 -13.26 25.24 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.496 -1.724 . . . . 0.0 114.066 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.8 -172.38 1.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.078 1.939 . . . . 0.0 109.602 169.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.84 148.8 49.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.543 1.537 . . . . 0.0 108.966 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.67 154.55 45.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.681 -0.675 . . . . 0.0 110.234 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.28 165.63 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.929 2.419 . . . . 0.0 112.021 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -8.93 32.99 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.884 0.874 . . . . 0.0 112.708 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -22.81 60.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.801 1.64 . . . . 0.0 110.838 170.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -110.66 -23.67 10.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.872 0.869 . . . . 0.0 113.153 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -76.97 -18.02 58.5 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.304 0.502 . . . . 0.0 111.456 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 t -54.06 147.98 23.45 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.346 1.858 . . . . 0.0 110.508 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.38 -11.37 31.2 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.71 -9.72 15.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.764 1.625 . . . . 0.0 113.761 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -132.12 0.19 3.78 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.527 1.058 . . . . 0.0 112.591 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.26 136.9 57.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.645 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -118.71 88.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.696 1.599 . . . . 0.0 108.672 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.41 -14.23 62.79 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.702 -0.624 . . . . 0.0 111.839 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.16 43.12 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.053 1.341 . . . . 0.0 110.516 -162.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -70.6 -15.49 62.75 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.97 -25.58 67.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.397 0.999 . . . . 0.0 111.74 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.09 39.36 0.76 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 119.564 1.075 . . . . 0.0 111.712 -171.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 174.15 156.56 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 130.11 3.364 . . . . 0.0 106.684 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -81.82 0.75 37.98 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.734 . . . . 0.0 111.621 -174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.22 151.87 16.97 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 119.261 0.937 . . . . 0.0 111.179 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.79 168.42 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.077 1.851 . . . . 0.0 110.481 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.52 158.18 11.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.282 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.9 162.51 37.5 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.734 1.623 . . . . 0.0 110.232 167.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -70.73 162.66 28.69 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 162.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 109.25 1.96 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.926 -1.109 . . . . 0.0 110.92 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.58 33.98 17.65 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.339 0.518 . . . . 0.0 111.895 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.3 p -130.69 171.12 13.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.018 0.927 . . . . 0.0 108.869 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -143.77 153.26 42.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -94.48 133.78 37.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.372 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -134.64 160.25 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.07 114.89 26.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.654 ' HG2' HG13 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -90.35 -152.89 0.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.972 1.309 . . . . 0.0 108.417 171.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.81 52.87 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 130.233 3.778 . . . . 0.0 115.3 166.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.97 3.49 89.13 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 117.818 0.809 . . . . 0.0 113.756 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' HB2' ' HE3' ' A' ' 57' ' ' MET . 10.3 m-80 -121.49 166.63 13.87 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.966 1.307 . . . . 0.0 107.566 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -108.6 120.65 43.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 57' ' ' MET . 30.4 m -112.07 155.63 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -111.33 118.87 37.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.528 HD12 HD23 ' A' ' 31' ' ' LEU . 3.8 pt -116.9 145.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.366 1.867 . . . . 0.0 109.145 -174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.02 141.18 56.29 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 120.053 1.297 . . . . 0.0 107.69 166.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -73.18 -6.88 48.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.87 0.843 . . . . 0.0 112.368 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 t -136.07 23.24 3.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.434 1.894 . . . . 0.0 110.288 -163.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -172.92 -38.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.94 1.696 . . . . 0.0 109.2 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.63 25.97 68.65 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 125.14 1.352 . . . . 0.0 113.216 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.99 143.87 57.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.565 1.146 . . . . 0.0 108.972 174.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.97 91.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.991 1.716 . . . . 0.0 107.501 -169.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.5 mt -79.38 -48.3 14.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.631 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -146.27 163.03 36.76 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.467 1.507 . . . . 0.0 108.043 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 62' ' ' VAL . 42.0 t -140.58 142.83 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 166.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.72 148.96 51.48 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 161.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 79' ' ' ILE . 19.1 t70 -62.25 158.72 16.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.072 0.949 . . . . 0.0 112.44 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.3 -24.52 55.74 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 126.15 1.834 . . . . 0.0 115.083 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -63.84 -21.13 66.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 120.141 1.97 . . . . 0.0 112.694 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 76' ' ' ASP . 9.8 tt -67.48 0.67 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 121.271 -0.893 . . . . 0.0 111.564 172.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -66.29 -41.62 89.54 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.397 -1.439 . . . . 0.0 110.952 162.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -131.48 16.71 4.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.475 1.11 . . . . 0.0 112.848 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.5 133.44 29.94 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.894 2.077 . . . . 0.0 107.961 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.567 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 121.124 0.488 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.74 -16.62 64.37 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.476 1.11 . . . . 0.0 112.798 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -57.94 -24.73 59.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.672 1.589 . . . . 0.0 112.457 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.98 -1.27 34.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 0.0 111.98 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.77 104.07 10.1 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.862 0.755 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.14 125.57 29.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -65.84 -30.15 70.72 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.519 -1.363 . . . . 0.0 110.422 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.78 153.85 28.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.69 176.26 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.058 1.343 . . . . 0.0 108.554 171.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.3 m -126.74 139.07 53.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.45 151.11 37.69 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.33 35.18 13.19 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.875 0.87 . . . . 0.0 111.871 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 58.54 37.94 25.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.906 2.482 . . . . 0.0 112.691 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -138.12 133.19 33.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.998 1.719 . . . . 0.0 107.506 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.28 154.42 21.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.546 0.738 . . . . 0.0 109.688 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -147.5 154.28 40.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.079 1.752 . . . . 0.0 110.435 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -145.81 165.21 29.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.231 1.412 . . . . 0.0 109.364 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -66.7 100.65 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.87 -1.92 19.69 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.042 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -79.51 -174.44 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.266 1.033 . . . . 0.0 108.679 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 164.81 20.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.712 1.605 . . . . 0.0 109.606 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.97 163.89 16.25 Favored Pre-proline 0 N--CA 1.47 0.534 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.11 155.54 47.29 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.756 1.637 . . . . 0.0 110.221 162.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.78 -16.39 57.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp -56.25 -18.19 9.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.018 1.727 . . . . 0.0 112.508 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 57' ' ' MET . 69.8 m-85 -116.35 -11.35 11.23 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.29 1.036 . . . . 0.0 113.268 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.5 -13.96 59.21 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-N 118.744 0.702 . . . . 0.0 110.61 171.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -64.88 145.04 99.05 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.163 -0.961 . . . . 0.0 108.44 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.1 -3.8 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.178 2.585 . . . . 0.0 114.209 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.02 -12.67 1.54 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.884 -1.135 . . . . 0.0 113.334 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -127.02 3.12 6.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.803 1.241 . . . . 0.0 112.042 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 116.84 5.71 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.429 2.691 . . . . 0.0 111.4 -170.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.76 122.14 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.813 1.645 . . . . 0.0 107.85 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -131.94 -5.14 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.82 34.57 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.445 1.93 . . . . 0.0 112.312 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.02 -29.25 70.15 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 120.737 -1.227 . . . . 0.0 110.916 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -56.88 -13.3 2.51 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.322 1.449 . . . . 0.0 113.712 172.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.15 1.77 7.89 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.722 1.609 . . . . 0.0 113.341 -173.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 -118.0 161.17 20.24 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.842 1.657 . . . . 0.0 109.493 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.01 58.63 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.151 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.61 155.41 73.55 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.013 1.325 . . . . 0.0 109.472 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.99 164.72 34.79 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.441 2.761 . . . . 0.0 113.095 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.29 84.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.045 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.483 ' CB ' HD11 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -81.46 -59.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.594 0.891 . . . . 0.0 113.263 -166.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 176.61 -162.3 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 131.527 3.931 . . . . 0.0 105.681 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.08 2.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.178 2.191 . . . . 0.0 112.388 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.32 47.32 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 p -142.02 165.76 26.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.154 0.981 . . . . 0.0 110.883 168.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -137.49 157.49 46.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.889 0.476 . . . . 0.0 110.195 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -84.53 151.68 24.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p -138.73 176.89 8.31 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.689 1.596 . . . . 0.0 109.119 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 8.0 t80 -116.85 104.4 11.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.616 1.167 . . . . 0.0 108.661 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 30' ' ' TYR . 42.7 ttm -112.92 98.67 7.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.396 1.878 . . . . 0.0 108.176 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.31 11.22 64.1 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.444 1.02 . . . . 0.0 113.904 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 109.63 -12.42 32.8 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.973 1.386 . . . . 0.0 113.311 -172.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -94.51 120.17 34.33 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.468 2.307 . . . . 0.0 107.202 -171.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.485 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 30.7 m-85 -64.55 114.5 4.41 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.369 -0.832 . . . . 0.0 108.887 162.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG12 ' HB ' ' A' ' 74' ' ' VAL . 4.2 m -123.97 154.88 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 48' ' ' PRO . 27.0 tp -109.32 130.47 55.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.513 1.125 . . . . 0.0 109.864 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.6 pt -131.5 142.36 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.804 1.241 . . . . 0.0 110.061 -173.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 138.82 53.0 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.902 0.774 . . . . 0.0 109.772 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.51 -14.89 62.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.88 0.872 . . . . 0.0 112.113 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -128.59 1.37 5.55 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.115 1.766 . . . . 0.0 110.484 -167.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.16 -35.38 0.24 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.989 -1.069 . . . . 0.0 111.907 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.44 20.43 79.38 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.759 0.695 . . . . 0.0 113.228 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 132.99 55.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.26 92.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 127.568 2.347 . . . . 0.0 105.781 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.35 -54.07 16.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -151.16 170.69 18.83 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.743 0.817 . . . . 0.0 109.681 -170.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.2 p -143.23 140.78 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 1 C-N-CA 132.07 4.148 . . . . 0.0 105.113 171.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -142.79 112.37 6.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.412 -1.28 . . . . 0.0 108.262 160.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -49.19 146.73 3.44 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.904 1.229 . . . . 0.0 113.117 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.485 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -44.53 -26.15 0.98 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.732 -1.594 . . . . 0.0 116.175 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -49.67 -30.79 9.69 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.875 1.837 . . . . 0.0 112.686 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.06 -22.57 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.947 0.899 . . . . 0.0 112.379 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.16 -30.62 71.73 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 111.305 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -93.21 8.45 40.18 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.471 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -72.96 172.38 11.06 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.242 0.544 . . . . 0.0 110.594 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.325 0.65 . . . . 0.0 110.426 179.699 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 -20.43 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.437 0.562 . . . . 0.0 112.019 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -52.82 -26.51 14.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.007 2.123 . . . . 0.0 113.797 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -96.58 0.65 50.34 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.51 1.524 . . . . 0.0 112.31 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.65 118.43 22.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.406 1.457 . . . . 0.0 108.581 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.887 HD13 HG12 ' A' ' 74' ' ' VAL . 1.9 mp -83.4 -167.97 1.91 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 123.872 1.796 . . . . 0.0 106.753 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 -19.76 6.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.167 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -170.79 170.59 6.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -159.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -170.47 -178.38 2.68 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.862 1.665 . . . . 0.0 109.37 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -125.47 137.96 53.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 164.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.2 43.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 164.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.55 30.17 16.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.099 0.952 . . . . 0.0 112.06 176.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 58.35 25.22 12.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.672 1.189 . . . . 0.0 111.796 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 m -127.29 128.86 46.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.023 2.529 . . . . 0.0 106.768 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.88 152.96 29.35 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.831 0.853 . . . . 0.0 109.468 174.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -146.28 158.1 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.415 1.086 . . . . 0.0 110.024 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -139.73 164.44 29.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.135 1.774 . . . . 0.0 109.174 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.91 117.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 166.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -5.78 56.1 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.169 -1.351 . . . . 0.0 113.892 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.55 -177.11 3.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.082 1.941 . . . . 0.0 107.484 165.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 157.09 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.257 -1.527 . . . . 0.0 108.524 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.16 162.45 34.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.906 0.775 . . . . 0.0 109.452 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.99 162.46 34.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.0 2.467 . . . . 0.0 111.633 163.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -17.08 24.92 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.581 1.153 . . . . 0.0 112.998 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.18 -21.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.057 1.343 . . . . 0.0 112.44 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.95 -6.59 10.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.882 0.873 . . . . 0.0 112.774 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.81 -33.62 72.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.946 1.248 . . . . 0.0 109.873 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.2 t -49.35 144.3 8.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.644 1.578 . . . . 0.0 109.286 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.785 1.657 . . . . 0.0 113.015 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -54.69 -29.18 52.21 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -116.44 4.22 13.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.688 1.195 . . . . 0.0 111.204 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -80.85 118.07 22.04 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.446 2.299 . . . . 0.0 109.389 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.46 76.88 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -61.54 -30.44 70.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.366 -0.834 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.82 104.77 1.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -127.08 -15.03 5.38 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.813 -1.179 . . . . 0.0 113.795 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -30.72 32.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.047 1.294 . . . . 0.0 112.092 -177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -89.03 44.16 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.064 0.847 . . . . 0.0 108.805 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -146.7 -170.28 3.48 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.214 2.206 . . . . 0.0 106.503 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.85 -15.76 24.74 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.654 0.782 . . . . 0.0 111.607 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.96 150.77 96.22 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.05 169.35 20.75 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.609 1.54 . . . . 0.0 109.14 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 146.58 79.34 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.8 169.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.99 -167.43 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.518 3.479 . . . . 0.0 111.266 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 165.39 11.74 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 165.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.87 46.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.431 1.493 . . . . 0.0 113.026 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.59 23.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.957 2.218 . . . . 0.0 111.686 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 p -140.06 165.12 28.21 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.19 -1.183 . . . . 0.0 111.162 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -147.12 156.26 42.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.201 0.6 . . . . 0.0 111.203 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -77.97 134.41 37.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.304 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -127.47 165.7 19.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.926 1.29 . . . . 0.0 109.429 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.11 105.65 15.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.249 1.419 . . . . 0.0 108.392 177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG2' HG22 ' A' ' 62' ' ' VAL . 97.4 mmm -78.53 -154.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.452 1.501 . . . . 0.0 108.934 174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.21 64.94 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 128.909 3.147 . . . . 0.0 111.895 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.61 14.67 79.54 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.448 -1.751 . . . . 0.0 114.569 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.23 159.05 43.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.846 1.823 . . . . 0.0 108.863 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.06 137.23 35.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 57' ' ' MET . 5.8 m -136.19 158.6 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 121.523 -0.736 . . . . 0.0 109.442 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.69 114.3 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.447 1.099 . . . . 0.0 109.066 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.47 144.99 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.102 0.961 . . . . 0.0 110.047 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 p -73.07 137.83 45.52 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -77.8 10.63 2.62 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.682 1.23 . . . . 0.0 113.26 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -139.44 7.68 2.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.749 2.02 . . . . 0.0 110.827 -167.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -167.14 -49.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.937 1.295 . . . . 0.0 109.059 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.45 19.55 17.98 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.174 1.369 . . . . 0.0 112.563 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 131.11 45.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.618 -0.931 . . . . 0.0 110.283 -173.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.76 91.95 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.507 1.523 . . . . 0.0 107.778 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.27 -42.66 25.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.418 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -149.15 155.28 40.43 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.183 0.993 . . . . 0.0 108.531 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.887 HG12 HD13 ' A' ' 10' ' ' LEU . 88.5 t -137.64 125.79 31.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -126.74 119.11 26.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 107.652 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.12 145.0 27.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.485 1.514 . . . . 0.0 111.702 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -7.26 40.02 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.196 -1.565 . . . . 0.0 114.521 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.3 -22.42 62.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.312 1.556 . . . . 0.0 111.049 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 -30.0 45.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-N 120.317 1.417 . . . . 0.0 111.126 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -53.05 -35.93 60.05 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.015 1.326 . . . . 0.0 111.316 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -87.22 20.79 2.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.802 0.841 . . . . 0.0 111.586 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -117.0 49.68 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.992 1.317 . . . . 0.0 111.805 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 115.815 -2.04 . . . . 0.0 108.828 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 CA--C 1.522 -0.102 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.82 -20.6 65.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.735 0.814 . . . . 0.0 111.029 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -65.15 -18.9 65.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.423 1.889 . . . . 0.0 113.969 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -102.69 2.95 36.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.329 1.052 . . . . 0.0 110.975 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 97.4 1.58 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.837 1.199 . . . . 0.0 109.141 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.8 143.31 46.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.0 -12.58 44.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.653 0.206 . . . . 0.0 110.713 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 177.87 164.93 0.67 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.165 2.186 . . . . 0.0 108.19 -164.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -168.56 -175.09 2.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.55 1.54 . . . . 0.0 109.589 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.88 47.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.83 152.95 38.51 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 162.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.83 30.19 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.289 1.043 . . . . 0.0 112.679 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 56.43 14.74 1.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.583 1.953 . . . . 0.0 113.122 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 m -100.12 117.22 33.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.729 2.012 . . . . 0.0 105.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.99 37.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.8 0.84 . . . . 0.0 109.81 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -148.1 154.01 39.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 110.956 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -146.65 161.86 39.66 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.577 1.551 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.91 122.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.65 7.95 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.014 -1.992 . . . . 0.0 113.867 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.06 -170.32 0.45 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 120.02 1.91 . . . . 0.0 109.871 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.02 160.72 32.82 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.676 1.99 . . . . 0.0 108.74 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 27' ' ' PRO . 20.7 m -107.71 163.74 16.31 Favored Pre-proline 0 N--CA 1.476 0.872 0 O-C-N 120.576 -1.327 . . . . 0.0 112.671 -174.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 41.8 Cg_endo -72.33 163.39 38.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.492 2.795 . . . . 0.0 114.198 169.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.79 66.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 112.23 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.62 -21.92 54.98 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 119.033 0.833 . . . . 0.0 111.044 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 22.5 m-85 -109.32 11.09 25.43 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.58 -23.22 19.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.904 . . . . 0.0 111.952 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 t -69.44 147.81 97.0 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.598 0.759 . . . . 0.0 111.107 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.39 -4.62 9.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.609 3.539 . . . . 0.0 113.768 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.57 -22.83 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.16 1.784 . . . . 0.0 113.325 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -121.49 -6.12 9.26 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.636 1.175 . . . . 0.0 111.507 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.79 123.59 20.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.97 1.308 . . . . 0.0 111.047 -172.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -104.27 96.01 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.99 -37.41 87.03 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.567 -0.708 . . . . 0.0 110.36 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -89.02 109.06 19.95 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.191 0.996 . . . . 0.0 109.352 -167.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . 0.273 23.0 p-90 -112.83 -47.21 3.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 116.782 -1.58 . . . . 0.0 114.992 -170.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.71 -37.67 76.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.221 1.828 . . . . 0.0 111.11 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -55.7 -36.2 66.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.078 0.551 . . . . 0.0 111.932 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -88.97 24.14 2.17 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.095 -1.003 . . . . 0.0 111.397 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.31 6.32 5.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.292 2.637 . . . . 0.0 112.706 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.65 156.06 35.76 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 120.856 -1.152 . . . . 0.0 112.696 -159.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 166.82 25.9 Favored 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.581 4.187 . . . . 0.0 111.277 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.48 153.23 51.08 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.824 1.25 . . . . 0.0 110.478 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -65.46 170.37 11.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.159 1.906 . . . . 0.0 110.364 165.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.76 160.31 32.83 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 103.38 0.56 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.134 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.89 32.59 4.05 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.765 1.65 . . . . 0.0 111.057 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.8 p -150.58 173.6 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.613 -1.522 . . . . 0.0 110.239 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -156.09 158.81 38.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.722 0.772 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.97 144.1 37.05 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.801 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -131.93 172.26 12.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.09 1.356 . . . . 0.0 108.87 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.91 122.05 46.4 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.424 ' CG ' HG21 ' A' ' 62' ' ' VAL . 7.9 mmt -90.07 -162.71 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.119 1.367 . . . . 0.0 108.09 167.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.42 -12.02 5.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 127.32 2.39 . . . . 0.0 116.426 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.19 4.93 0.02 OUTLIER Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.888 1.709 . . . . 0.0 112.713 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -129.54 152.26 49.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 110.408 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.81 130.03 44.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.721 1.208 . . . . 0.0 108.602 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 57' ' ' MET . 1.6 m -135.61 155.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.43 115.81 24.22 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.662 1.585 . . . . 0.0 109.116 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.45 142.06 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.2 1.0 . . . . 0.0 109.396 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 143.62 50.66 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 122.753 0.421 . . . . 0.0 110.473 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -66.52 -18.38 65.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 t -120.25 -9.37 9.54 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.26 1.824 . . . . 0.0 110.83 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -144.92 -45.96 0.23 Allowed 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.38 1.072 . . . . 0.0 108.89 -165.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 22.4 66.62 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.663 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 131.61 51.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.539 1.17 . . . . 0.0 108.375 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.08 91.12 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 126.678 1.991 . . . . 0.0 105.881 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.36 -55.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.36 148.8 28.57 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.674 0.67 . . . . 0.0 109.568 -169.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -128.89 137.21 57.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -131.14 147.94 52.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.16 155.79 39.28 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.717 -0.615 . . . . 0.0 110.232 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.31 -11.55 59.41 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.796 1.188 . . . . 0.0 112.607 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.1 -32.96 56.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.763 1.625 . . . . 0.0 111.823 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.51 -23.33 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.422 0.555 . . . . 0.0 112.117 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -63.07 -30.32 71.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.562 -0.712 . . . . 0.0 111.65 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -77.46 -25.74 50.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.459 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -65.06 142.95 58.23 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.283 1.033 . . . . 0.0 109.05 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 . . . . . 0 C--O 1.251 1.15 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.51 -27.86 62.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.426 1.09 . . . . 0.0 112.103 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -53.09 -34.46 56.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.033 1.333 . . . . 0.0 113.067 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.81 -6.82 58.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.886 0.874 . . . . 0.0 111.729 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 101.23 3.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.768 1.167 . . . . 0.0 109.13 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.79 129.15 37.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -64.35 -28.6 69.81 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 120.049 -1.657 . . . . 0.0 110.106 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.81 158.99 39.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.354 0.662 . . . . 0.0 110.145 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CD1' ' CE ' ' A' ' 57' ' ' MET . 54.9 p90 -160.04 -177.99 6.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.984 1.314 . . . . 0.0 110.877 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -133.88 139.21 46.05 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.922 1.289 . . . . 0.0 108.172 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.33 31.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.958 0.903 . . . . 0.0 109.778 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.54 41.25 4.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.951 1.7 . . . . 0.0 112.26 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 59.62 49.14 8.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.529 1.932 . . . . 0.0 111.066 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 m -152.73 144.77 23.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.882 1.673 . . . . 0.0 108.652 168.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.95 147.93 25.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.332 2.253 . . . . 0.0 110.01 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.03 160.25 41.68 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.914 1.686 . . . . 0.0 111.863 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -141.97 169.14 18.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.871 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm -58.85 121.87 7.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 5.87 70.32 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.866 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.66 -172.81 3.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.731 1.766 . . . . 0.0 108.976 160.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.47 139.99 53.24 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 109.001 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.88 160.23 78.83 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.18 166.64 26.2 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.434 2.089 . . . . 0.0 110.261 161.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.0 -23.51 33.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.879 1.272 . . . . 0.0 112.141 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.8 mtp -55.88 -16.84 5.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.248 1.819 . . . . 0.0 113.694 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -118.92 -1.56 10.98 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -24.2 43.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.241 0.928 . . . . 0.0 110.372 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.38 154.22 23.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 127.17 2.188 . . . . 0.0 113.618 -174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -67.64 -5.43 14.22 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.434 4.089 . . . . 0.0 113.928 171.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -58.92 -63.89 1.14 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.605 1.162 . . . . 0.0 108.867 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -87.15 2.91 48.42 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.626 1.57 . . . . 0.0 112.709 -168.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.08 132.53 53.77 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.892 2.077 . . . . 0.0 110.314 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mm -119.06 80.04 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.529 1.131 . . . . 0.0 108.246 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -52.73 -29.05 24.85 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.017 -1.052 . . . . 0.0 112.099 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 0.45 17.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.705 1.202 . . . . 0.0 113.794 -165.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -59.66 -3.21 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -166.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -40.33 71.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 122.391 2.36 . . . . 0.0 112.908 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -137.54 55.86 1.78 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 110.337 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -137.48 34.88 2.48 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.607 1.163 . . . . 0.0 110.459 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.498 HD21 ' CA ' ' A' ' 83' ' ' ARG . 9.5 m120 75.32 -36.56 0.31 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 129.074 2.95 . . . . 0.0 113.714 172.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.83 149.99 61.66 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 126.212 1.805 . . . . 0.0 110.8 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.02 165.24 33.2 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.591 2.194 . . . . 0.0 111.78 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.76 97.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 165.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.47 172.76 12.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.563 2.176 . . . . 0.0 111.303 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 161.34 27.13 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 107.85 0.63 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.934 1.293 . . . . 0.0 110.569 175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.74 9.06 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.456 1.503 . . . . 0.0 112.414 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.5 p -146.63 166.38 26.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.816 1.308 . . . . 0.0 110.958 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -156.04 157.23 35.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.755 0.822 . . . . 0.0 111.259 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.06 130.73 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 p -124.84 154.94 40.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 105.8 11.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.603 ' CE ' HD22 ' A' ' 60' ' ' ASN . 8.2 ptm -77.4 -154.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.97 62.55 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 1 C-N-CA 131.672 4.463 . . . . 0.0 112.89 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.64 6.75 88.91 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 126.309 1.909 . . . . 0.0 114.457 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.603 HD22 ' CE ' ' A' ' 57' ' ' MET . 14.3 m-80 -125.03 164.76 19.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.57 1.548 . . . . 0.0 106.828 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -95.74 131.71 41.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 74' ' ' VAL . 3.9 m -119.43 149.23 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 120.159 1.345 . . . . 0.0 109.238 170.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.38 119.3 32.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.66 146.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.852 1.261 . . . . 0.0 108.455 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.64 152.48 31.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.06 0.391 . . . . 0.0 111.515 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -34.81 78.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.442 165.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -86.97 -7.87 57.75 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.061 -1.024 . . . . 0.0 111.822 -171.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 70' ' ' LYS . 14.4 pt-20 -155.14 -35.55 0.09 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 172.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.5 49.58 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.813 -172.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -61.75 132.03 51.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.967 0.883 . . . . 0.0 108.95 176.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.88 82.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 129.174 2.989 . . . . 0.0 106.807 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.89 -50.08 58.36 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -145.27 168.09 21.28 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.898 1.279 . . . . 0.0 108.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.1 p -133.94 149.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 C-N-CA 133.786 4.835 . . . . 0.0 105.222 167.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -140.05 130.63 25.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 151.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.34 146.43 9.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.662 0.664 . . . . 0.0 109.526 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.7 -26.82 11.2 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.519 -1.156 . . . . 0.0 113.206 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -54.74 -24.93 24.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.115 1.766 . . . . 0.0 112.161 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -55.98 -33.05 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.062 0.846 . . . . 0.0 110.996 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -61.43 -13.46 20.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.429 1.891 . . . . 0.0 112.433 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.16 -8.62 15.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.199 0.909 . . . . 0.0 112.977 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -81.0 34.7 0.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.395 1.878 . . . . 0.0 110.978 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.498 ' CA ' HD21 ' A' ' 44' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 C-N-CA 125.98 1.712 . . . . 0.0 111.641 -156.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.44 153.52 43.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 162.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.88 58.4 1.6 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.86 -107.57 0.59 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.46 -18.64 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.42 -167.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.23 -26.2 67.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.16 0.584 . . . . 0.0 111.163 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -23.02 65.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.634 1.574 . . . . 0.0 113.837 171.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -101.36 4.5 41.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.996 173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.89 111.28 21.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 121.017 1.735 . . . . 0.0 109.497 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 10' ' ' LEU . 4.0 mp -81.92 -165.51 1.01 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.412 1.577 . . . . 0.0 106.841 176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -134.3 -13.96 2.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.725 -2.034 . . . . 0.0 113.236 164.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 178.49 159.09 0.53 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.882 0.765 . . . . 0.0 110.502 -163.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 4.7 p90 -167.33 -175.54 2.94 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.659 1.584 . . . . 0.0 109.159 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -128.49 135.49 49.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 157.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.54 161.98 33.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 158.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 20.65 11.96 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 163.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 62.29 29.45 17.35 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.331 1.853 . . . . 0.0 112.586 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -129.96 122.51 28.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.611 2.364 . . . . 0.0 107.626 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.58 147.0 30.96 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.4 m-85 -147.21 158.49 43.97 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.811 0.844 . . . . 0.0 110.292 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.16 173.44 11.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.964 1.306 . . . . 0.0 109.0 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.64 108.22 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.77 2.37 39.91 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.598 -1.668 . . . . 0.0 114.822 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.92 -178.06 1.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.481 1.64 . . . . 0.0 108.135 161.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.18 146.99 48.33 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 120.667 -1.27 . . . . 0.0 107.581 171.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.6 m -79.09 162.1 65.68 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.84 162.26 39.74 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.797 2.331 . . . . 0.0 111.077 162.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -16.3 44.15 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.437 1.095 . . . . 0.0 112.153 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtt -60.06 -17.24 38.0 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 124.874 1.27 . . . . 0.0 112.158 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -119.95 1.72 10.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.6 -26.22 57.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.461 1.028 . . . . 0.0 110.269 167.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -57.99 144.4 75.5 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.66 -4.24 14.23 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 112.724 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.04 -14.95 18.9 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.795 2.038 . . . . 0.0 114.005 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.6 -5.09 8.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.253 1.421 . . . . 0.0 112.237 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -68.27 106.74 2.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.906 2.082 . . . . 0.0 110.15 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 56' ' ' TYR . 2.7 mp -90.57 83.62 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -63.72 -16.92 62.36 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.273 -0.892 . . . . 0.0 111.115 167.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -90.11 70.77 7.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.148 2.179 . . . . 0.0 108.022 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -111.92 -19.45 12.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -72.17 -35.99 69.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.767 1.167 . . . . 0.0 111.483 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -78.13 38.1 0.27 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.552 0.615 . . . . 0.0 110.034 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -146.39 166.1 27.36 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 127.271 2.228 . . . . 0.0 106.611 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.38 -16.47 62.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.167 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.85 148.71 75.55 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 0.0 112.265 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -74.1 157.85 46.14 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.086 2.524 . . . . 0.0 112.757 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.65 142.58 96.13 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 117.702 -1.142 . . . . 0.0 109.607 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.37 162.89 39.2 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.058 2.505 . . . . 0.0 112.189 -171.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.406 ' H ' HD21 ' A' ' 63' ' ' LEU . 25.9 m-20 -68.54 160.57 29.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.95 50.72 1.42 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.453 1.501 . . . . 0.0 113.266 -161.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.53 38.9 0.02 OUTLIER Glycine 0 CA--C 1.528 0.9 0 C-N-CA 127.37 2.414 . . . . 0.0 109.835 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.9 p -148.37 172.17 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.645 1.223 . . . . 0.0 110.577 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -145.58 156.41 43.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.173 0.511 . . . . 0.0 111.956 169.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -73.33 141.41 47.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.983 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.27 131.95 35.12 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.141 2.177 . . . . 0.0 106.256 -169.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.542 ' HB2' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -85.16 100.34 11.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.48 -155.66 0.07 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 108.309 169.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.98 60.99 0.53 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 127.355 2.407 . . . . 0.0 113.89 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.4 66.13 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.381 0.591 . . . . 0.0 113.329 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -134.87 154.74 51.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.61 115.54 30.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.73 149.33 7.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' HD23 ' A' ' 72' ' ' LEU . 67.8 tp -100.92 126.08 47.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.03 135.79 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 C-N-CA 123.81 0.844 . . . . 0.0 110.056 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 133.77 52.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 108.617 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.15 -2.27 23.91 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.808 -1.183 . . . . 0.0 112.044 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -127.15 13.2 7.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.68 1.592 . . . . 0.0 109.534 -170.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -164.38 -48.24 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.401 1.08 . . . . 0.0 109.814 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 33.95 66.48 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 126.753 2.12 . . . . 0.0 112.18 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -55.8 143.01 32.7 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 160.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.0 86.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 70' ' ' LYS . 2.3 mm? -63.62 -49.67 72.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.207 1.003 . . . . 0.0 110.117 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -146.21 161.05 41.1 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.689 1.596 . . . . 0.0 108.762 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 10' ' ' LEU . 42.6 t -144.2 131.58 17.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.257 1.823 . . . . 0.0 107.592 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.038 1.335 . . . . 0.0 108.626 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.53 160.32 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.965 0.506 . . . . 0.0 109.831 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.31 71.06 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.482 -1.177 . . . . 0.0 113.778 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.32 -20.72 65.74 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.813 1.806 . . . . 0.0 112.86 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.7 tt -59.11 -20.18 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.203 1.001 . . . . 0.0 112.198 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.58 -35.34 72.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.871 1.268 . . . . 0.0 111.958 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.43 -17.89 29.49 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.867 0.758 . . . . 0.0 111.068 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -61.99 152.06 33.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 108.558 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 127.859 2.464 . . . . 0.0 105.598 -170.625 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.95 -169.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.24 1.416 . . . . 0.0 111.893 -167.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.23 61.46 1.3 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.62 -172.27 33.33 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 pt -65.11 -16.39 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 113.893 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.89 -26.21 68.5 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.2 0.6 . . . . 0.0 112.52 -168.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -58.62 -30.33 67.18 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.36 1.064 . . . . 0.0 112.515 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.32 -3.97 49.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.416 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.65 89.58 2.24 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.921 1.237 . . . . 0.0 110.849 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.53 133.99 43.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 107.207 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -87.0 -20.19 27.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.971 0.805 . . . . 0.0 111.911 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -154.17 161.3 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.947 1.699 . . . . 0.0 108.789 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.92 175.34 13.69 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.959 1.704 . . . . 0.0 108.664 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 m -130.6 121.58 25.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.47 153.91 51.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 58.08 29.25 17.54 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.245 1.021 . . . . 0.0 111.427 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 58.69 14.81 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.435 1.894 . . . . 0.0 113.325 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -115.03 126.81 55.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.21 149.29 25.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -146.19 152.69 39.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.603 0.761 . . . . 0.0 110.015 -172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -134.94 165.48 25.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.004 1.321 . . . . 0.0 108.209 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.22 115.48 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.3 59.1 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.752 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -176.25 1.15 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.72 1.76 . . . . 0.0 107.943 153.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.79 159.89 28.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.52 1.928 . . . . 0.0 109.537 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -101.86 158.09 32.44 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.055 -1.028 . . . . 0.0 110.98 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.13 160.39 47.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.648 2.232 . . . . 0.0 110.949 164.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.76 -13.21 41.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -23.13 10.59 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 126.272 1.829 . . . . 0.0 112.351 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.55 -20.12 9.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.713 0.633 . . . . 0.0 111.88 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.5 mt -70.4 -23.67 62.79 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.516 -0.74 . . . . 0.0 111.435 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -57.3 143.19 74.21 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.041 0.936 . . . . 0.0 108.73 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.65 -4.18 11.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.558 3.505 . . . . 0.0 113.395 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.23 -33.83 74.13 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.244 1.817 . . . . 0.0 113.198 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -114.41 4.97 15.5 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.01 94.87 0.11 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.994 2.117 . . . . 0.0 110.141 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.38 74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 123.929 1.823 . . . . 0.0 107.456 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -59.15 -37.43 77.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.023 160.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -78.33 80.09 4.75 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.215 1.406 . . . . 0.0 111.689 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -83.52 -37.94 22.39 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.955 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -46.41 -51.09 15.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.241 1.016 . . . . 0.0 112.901 -169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -79.53 12.83 2.29 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 112.529 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -118.93 162.34 18.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 161.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.21 -6.48 23.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.354 1.062 . . . . 0.0 112.859 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.42 159.65 57.51 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.885 1.674 . . . . 0.0 112.143 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.03 175.02 11.04 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.017 3.144 . . . . 0.0 109.884 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.37 158.96 25.76 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.884 0.874 . . . . 0.0 110.502 166.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.3 168.1 23.23 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.476 2.118 . . . . 0.0 110.537 165.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -78.2 161.22 27.48 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 163.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.32 112.56 4.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.516 0.726 . . . . 0.0 109.801 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.11 23.68 31.6 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.159 0.436 . . . . 0.0 112.404 -176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.3 p -135.55 167.65 20.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 117.891 0.846 . . . . 0.0 109.276 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -150.99 157.58 43.06 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.437 0.637 . . . . 0.0 110.427 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -82.86 149.15 27.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.6 p -140.08 155.51 47.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.138 0.575 . . . . 0.0 109.907 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -97.15 85.41 3.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.03 98.81 8.7 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.722 1.609 . . . . 0.0 107.275 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.7 10.85 80.43 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 117.865 -1.519 . . . . 0.0 114.147 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.95 2.6 59.41 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.545 1.673 . . . . 0.0 112.253 -170.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -113.75 148.52 36.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.099 1.45 . . . . 0.0 107.931 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -95.82 108.85 21.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.11 130.25 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -169.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.84 118.14 31.04 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.154 1.382 . . . . 0.0 108.198 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.48 140.41 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.861 0.864 . . . . 0.0 109.823 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.69 136.32 54.14 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -13.06 60.43 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.467 -0.771 . . . . 0.0 112.503 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -132.25 19.44 4.43 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.62 1.968 . . . . 0.0 109.53 -162.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -170.13 -40.01 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.889 1.276 . . . . 0.0 110.078 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.59 26.72 74.19 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.517 -1.157 . . . . 0.0 112.938 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -59.03 141.12 54.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.9 mt -79.24 85.03 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.83 -49.31 68.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.341 0.657 . . . . 0.0 110.258 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -152.09 160.52 43.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.505 1.922 . . . . 0.0 107.344 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.97 147.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.1 153.19 50.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 159.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -61.01 155.02 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.911 0.885 . . . . 0.0 109.574 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.91 64.51 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.465 1.031 . . . . 0.0 113.1 170.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -50.23 -31.97 15.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.489 1.115 . . . . 0.0 112.776 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -59.81 -19.69 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.549 1.14 . . . . 0.0 112.745 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.1 -28.22 67.66 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.444 1.02 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.11 -0.46 33.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.789 0.836 . . . . 0.0 111.892 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -62.73 171.53 2.04 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.196 1.398 . . . . 0.0 110.621 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 116.238 -1.839 . . . . 0.0 113.15 -165.554 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.43 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.95 165.3 13.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.876 2.07 . . . . 0.0 106.866 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.83 89.76 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 166.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.84 -169.47 21.65 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 160.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 pt -74.46 -10.26 13.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -63.21 -28.93 70.38 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.613 1.965 . . . . 0.0 111.374 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -61.28 -28.98 69.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.742 0.817 . . . . 0.0 112.271 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -98.05 -2.22 40.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.275 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.03 86.87 0.55 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.343 0.974 . . . . 0.0 109.633 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.17 145.73 54.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -102.86 -16.0 16.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.125 0.42 . . . . 0.0 112.011 170.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.54 164.25 38.56 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.63 175.63 13.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.692 1.597 . . . . 0.0 108.067 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -131.53 125.44 32.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.48 156.19 48.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.81 29.7 12.38 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.314 -0.866 . . . . 0.0 112.937 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 53.85 22.77 3.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.1 2.16 . . . . 0.0 112.5 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.1 m -120.29 128.05 52.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.441 2.296 . . . . 0.0 105.775 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -84.09 150.8 25.32 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.069 0.948 . . . . 0.0 110.062 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -151.7 141.31 21.74 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 124.798 1.239 . . . . 0.0 110.211 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -124.4 167.18 14.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.42 1.488 . . . . 0.0 109.856 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.59 113.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.6 -4.51 32.72 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.092 -1.394 . . . . 0.0 113.458 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.18 -171.34 1.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.002 1.401 . . . . 0.0 107.968 166.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 149.48 50.43 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.172 -1.58 . . . . 0.0 109.382 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.6 158.14 43.22 Favored Pre-proline 0 N--CA 1.468 0.447 0 C-N-CA 124.15 0.98 . . . . 0.0 111.016 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.2 164.26 33.33 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.328 2.685 . . . . 0.0 111.619 165.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -16.11 44.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 112.703 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.2 mmt -53.64 -30.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.45 1.1 . . . . 0.0 111.884 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -102.94 -2.5 27.6 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.21 -23.59 24.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.097 0.862 . . . . 0.0 110.935 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.72 144.1 85.86 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 -4.62 9.88 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.554 3.503 . . . . 0.0 113.343 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.45 -16.85 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.25 2.22 . . . . 0.0 113.207 172.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -121.26 -1.84 9.66 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.59 1.086 . . . . 0.0 110.932 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.9 97.24 4.53 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.729 1.612 . . . . 0.0 112.502 -163.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -81.47 82.6 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 107.756 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.87 -30.92 69.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.647 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.98 36.38 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.436 1.894 . . . . 0.0 113.734 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -56.67 -34.47 67.38 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.398 -1.439 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.91 -39.35 93.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.584 1.554 . . . . 0.0 113.07 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -24.86 42.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.406 1.003 . . . . 0.0 110.647 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -80.05 -177.44 6.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.649 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.87 -19.66 40.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.467 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.93 144.67 76.4 Favored Pre-proline 0 CA--C 1.537 0.469 0 O-C-N 121.017 -1.052 . . . . 0.0 111.156 -161.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.95 164.48 27.13 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.75 2.967 . . . . 0.0 113.596 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.22 97.11 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.575 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.2 172.39 16.11 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.204 2.603 . . . . 0.0 110.608 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.48 167.73 19.8 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.851 -1.156 . . . . 0.0 109.294 168.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 34.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 115.397 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.9 33.17 0.06 OUTLIER Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.301 1.905 . . . . 0.0 110.303 173.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.0 p -144.24 166.12 25.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.121 0.961 . . . . 0.0 110.768 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -155.75 156.25 34.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.269 0.557 . . . . 0.0 111.315 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -81.32 143.93 31.86 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.347 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 p -138.67 179.52 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.306 1.842 . . . . 0.0 110.07 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -107.7 145.6 33.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.65 1.58 . . . . 0.0 107.822 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.9 147.21 29.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 166.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.81 -4.83 0.01 OUTLIER Glycine 0 CA--C 1.55 2.22 0 N-CA-C 117.589 1.796 . . . . 0.0 117.589 170.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.31 -10.75 19.77 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 121.144 2.472 . . . . 0.0 113.778 -167.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -103.0 173.13 6.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.548 2.739 . . . . 0.0 110.224 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -112.38 134.87 53.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.08 1.352 . . . . 0.0 109.261 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.72 154.06 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 119.69 1.132 . . . . 0.0 110.968 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.11 120.1 39.39 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.287 1.035 . . . . 0.0 109.031 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.3 pt -127.77 150.13 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.726 1.21 . . . . 0.0 109.483 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.13 140.69 39.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.032 0.833 . . . . 0.0 109.505 172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -14.73 61.78 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.407 1.083 . . . . 0.0 112.45 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -119.54 2.58 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.739 1.615 . . . . 0.0 111.1 -162.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -163.37 -45.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.982 0.913 . . . . 0.0 109.035 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.55 21.65 53.24 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.1 0.857 . . . . 0.0 112.497 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 130.33 43.78 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.22 95.78 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.792 1.637 . . . . 0.0 106.766 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 mt -80.09 -52.97 7.15 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.888 0.875 . . . . 0.0 109.574 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -144.59 160.5 41.05 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.779 0.832 . . . . 0.0 109.625 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.6 t -134.13 142.35 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -134.99 137.71 43.28 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 162.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -60.38 149.12 34.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.69 -15.12 32.27 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.948 1.737 . . . . 0.0 113.261 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.92 -30.29 61.41 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.393 1.597 . . . . 0.0 112.135 171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.81 -1.72 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.012 0.925 . . . . 0.0 111.745 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -60.05 -43.1 95.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.32 -1.487 . . . . 0.0 111.511 164.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -88.02 -17.64 30.74 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -64.59 160.98 18.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.915 1.286 . . . . 0.0 109.404 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.698 1.199 . . . . 0.0 107.836 -179.048 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.78 -176.7 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.075 1.35 . . . . 0.0 111.088 -154.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.38 56.79 7.39 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.332 1.053 . . . . 0.0 111.693 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.77 -172.59 49.02 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 159.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 pt -67.58 -11.18 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 124.831 1.252 . . . . 0.0 112.904 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.47 -34.61 69.2 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.931 1.692 . . . . 0.0 112.38 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -58.64 -28.97 66.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.541 0.737 . . . . 0.0 112.585 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -98.02 -2.51 40.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.834 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.93 87.13 1.31 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.279 0.945 . . . . 0.0 109.031 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.25 166.6 23.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -124.96 -25.11 3.93 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.265 0.626 . . . . 0.0 112.553 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 157.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.806 1.242 . . . . 0.0 107.933 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.5 177.04 11.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -131.24 129.29 41.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 163.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.79 149.27 46.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.98 34.15 24.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.199 1.0 . . . . 0.0 111.452 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 59.83 35.69 21.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.8 1.64 . . . . 0.0 112.01 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.5 m -136.98 121.05 17.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.832 1.653 . . . . 0.0 107.35 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -79.59 150.23 31.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.695 0.798 . . . . 0.0 109.017 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -150.05 159.36 44.47 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.41 1.484 . . . . 0.0 110.595 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -145.6 165.42 28.74 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.392 1.877 . . . . 0.0 108.781 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.93 120.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.38 3.9 84.0 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 117.454 -1.748 . . . . 0.0 113.559 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.21 178.41 2.34 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.017 1.908 . . . . 0.0 108.68 156.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.71 142.89 50.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.608 1.163 . . . . 0.0 109.073 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.32 163.77 35.38 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.171 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.98 154.22 63.0 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.458 2.772 . . . . 0.0 112.653 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.61 54.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.582 1.553 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -55.45 -22.6 21.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.588 1.155 . . . . 0.0 113.019 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 13.8 m-85 -113.9 -10.3 12.96 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.865 0.728 . . . . 0.0 112.906 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.23 -30.33 68.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.191 0.451 . . . . 0.0 109.961 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -65.49 144.11 98.86 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.543 0.737 . . . . 0.0 109.716 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.05 -4.85 9.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.246 3.297 . . . . 0.0 115.449 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -54.97 -33.96 62.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.898 1.279 . . . . 0.0 112.086 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -103.21 -8.56 20.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.964 0.802 . . . . 0.0 112.086 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.73 100.36 0.91 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.769 2.827 . . . . 0.0 111.952 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.93 85.58 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.764 1.226 . . . . 0.0 108.694 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -67.48 -10.86 55.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.356 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -95.44 89.51 5.45 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.72 1.208 . . . . 0.0 107.914 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -132.19 -25.71 1.97 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.924 -1.036 . . . . 0.0 113.557 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.21 -36.33 79.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.277 1.399 . . . . 0.0 111.613 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -82.82 8.52 12.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.624 0.77 . . . . 0.0 111.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -123.18 165.7 16.45 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.586 -1.322 . . . . 0.0 108.96 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.74 -22.63 56.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 -169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.58 156.41 17.13 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 125.211 1.404 . . . . 0.0 110.498 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.61 172.57 13.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.303 1.335 . . . . 0.0 110.774 168.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.5 165.51 2.16 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.491 164.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -67.97 171.46 12.36 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 120.97 1.113 . . . . 0.0 109.825 160.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' H ' HD21 ' A' ' 63' ' ' LEU . 3.3 m-20 -82.92 161.46 21.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 158.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.49 112.55 3.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 24.7 7.99 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.581 1.086 . . . . 0.0 111.907 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -149.42 169.02 21.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.889 1.845 . . . . 0.0 111.89 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -149.03 163.91 36.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.623 0.769 . . . . 0.0 110.354 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.95 141.95 28.29 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.279 0.631 . . . . 0.0 109.631 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -128.51 172.16 11.42 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -103.35 111.59 24.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.552 0.741 . . . . 0.0 110.343 173.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 ttm -129.89 118.0 21.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.823 1.649 . . . . 0.0 109.869 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 -11.27 4.08 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.922 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.07 -7.17 19.2 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.538 1.669 . . . . 0.0 112.319 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -109.85 172.94 6.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.657 1.583 . . . . 0.0 110.302 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -109.38 117.92 35.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 108.545 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.0 145.84 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD21 ' H ' ' A' ' 49' ' ' ASP . 66.9 tp -101.19 126.68 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.01 142.57 43.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.967 0.907 . . . . 0.0 110.239 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.44 131.26 44.99 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.423 0.689 . . . . 0.0 109.594 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.98 5.8 6.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.934 1.349 . . . . 0.0 113.503 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -127.7 1.22 6.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.895 2.478 . . . . 0.0 110.938 -171.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -166.87 -60.11 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.309 0.644 . . . . 0.0 109.36 -164.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 24.92 9.89 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 124.761 1.172 . . . . 0.0 113.931 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -60.48 129.11 39.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.548 2.174 . . . . 0.0 109.319 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 86.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 129.229 3.012 . . . . 0.0 106.067 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.4 mt -69.69 -44.63 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -145.64 161.31 40.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.457 0.703 . . . . 0.0 109.331 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.68 137.99 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -126.84 142.42 51.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 157.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 79' ' ' ILE . 10.3 t70 -59.49 151.14 24.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.72 -22.78 27.0 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.744 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -52.5 -29.6 25.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.048 1.424 . . . . 0.0 112.506 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 76' ' ' ASP . 14.8 tt -64.77 -9.09 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.025 0.93 . . . . 0.0 112.613 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.17 -50.79 44.44 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 120.424 -1.422 . . . . 0.0 110.546 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -80.15 -16.27 55.27 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.759 0.824 . . . . 0.0 111.921 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -55.36 124.9 18.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.736 2.414 . . . . 0.0 107.447 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 O-C-N 121.922 -0.486 . . . . 0.0 111.351 -162.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.08 63.77 1.47 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.377 1.871 . . . . 0.0 107.31 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.62 33.63 4.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.331 1.452 . . . . 0.0 109.951 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.67 -152.7 6.29 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt -54.41 -20.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.728 2.011 . . . . 0.0 114.506 -163.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -27.66 65.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.835 0.289 . . . . 0.0 111.756 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -61.59 -23.02 65.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.625 0.77 . . . . 0.0 112.674 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -102.44 -8.26 21.26 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.77 0.828 . . . . 0.0 110.905 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.11 92.13 4.37 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.22 162.84 27.05 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -112.66 -23.22 10.33 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.181 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -158.76 160.94 36.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.592 1.557 . . . . 0.0 109.032 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -157.18 -177.29 6.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.749 2.019 . . . . 0.0 108.808 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -135.93 114.94 12.24 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.76 152.42 45.4 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.274 1.6 p30 50.99 27.47 3.25 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 61.67 14.67 6.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.072 2.549 . . . . 0.0 112.732 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.9 m -98.23 124.29 42.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.527 2.331 . . . . 0.0 105.935 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.33 143.99 48.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -142.18 143.29 32.88 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 109.481 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -127.7 170.34 12.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.48 113.62 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.64 -2.08 42.28 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.431 -1.76 . . . . 0.0 114.386 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.36 -171.9 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.085 1.943 . . . . 0.0 108.684 164.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.08 143.46 51.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 120.533 -1.354 . . . . 0.0 108.803 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.91 162.96 71.9 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.597 -0.689 . . . . 0.0 110.297 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.41 161.9 42.98 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.484 2.789 . . . . 0.0 110.779 159.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.38 44.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.4 mmt -54.21 -20.09 6.3 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.198 1.799 . . . . 0.0 111.991 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -122.84 -8.77 8.37 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.063 0.945 . . . . 0.0 112.995 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.78 -18.08 56.82 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.901 0.88 . . . . 0.0 111.435 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 t -60.74 144.48 89.56 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.33 -4.35 14.79 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.195 3.263 . . . . 0.0 115.332 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -51.13 -30.85 17.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.724 2.01 . . . . 0.0 114.927 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.45 2.97 14.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.148 0.979 . . . . 0.0 110.975 -167.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -66.42 129.29 39.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.196 1.798 . . . . 0.0 110.858 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -106.82 90.84 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 108.268 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -22.93 63.0 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.686 -0.634 . . . . 0.0 111.285 163.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.12 30.67 0.58 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.808 1.243 . . . . 0.0 111.87 -166.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -75.35 -29.93 60.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.647 1.579 . . . . 0.0 115.167 -167.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -67.93 -38.16 82.54 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.864 1.666 . . . . 0.0 112.629 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -61.86 -11.24 11.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.978 0.911 . . . . 0.0 112.357 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.34 157.78 16.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -70.61 2.35 4.16 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.565 -0.709 . . . . 0.0 112.184 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.41 148.16 85.67 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 120.896 -1.127 . . . . 0.0 110.367 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.63 165.24 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.464 2.109 . . . . 0.0 111.798 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 149.63 89.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.834 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.37 171.15 14.55 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.298 2.665 . . . . 0.0 111.506 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.49 168.98 18.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.808 1.289 . . . . 0.0 109.398 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.55 38.88 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.219 2.608 . . . . 0.0 113.986 -167.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.97 37.71 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.239 1.876 . . . . 0.0 110.461 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.4 p -148.62 166.95 26.78 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.654 -0.91 . . . . 0.0 109.816 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -146.73 152.29 38.58 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.837 0.827 . . . . 0.0 111.054 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.47 144.81 46.1 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -133.62 162.65 31.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 109.868 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -105.23 65.87 0.74 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.944 0.898 . . . . 0.0 110.942 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 102.7 6.87 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.8 75.17 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.464 164.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.3 -5.6 33.77 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.118 1.459 . . . . 0.0 112.734 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -113.64 162.67 15.95 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.374 1.47 . . . . 0.0 107.325 -172.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 45.3 m-85 -109.77 111.23 22.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.04 132.48 69.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 tp -92.59 117.05 29.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.864 0.866 . . . . 0.0 108.697 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.4 pt -116.25 142.31 30.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.843 0.857 . . . . 0.0 109.499 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 143.03 51.4 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.58 9.74 5.69 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.683 0.793 . . . . 0.0 112.023 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 t -147.64 16.78 1.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.904 1.681 . . . . 0.0 110.525 -163.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -171.48 -45.37 0.02 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 126.536 1.934 . . . . 0.0 108.286 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 26.18 50.07 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.624 -1.098 . . . . 0.0 112.22 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.36 138.49 58.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -79.0 84.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.593 1.957 . . . . 0.0 106.176 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.12 -44.47 84.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.806 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -152.14 158.73 43.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.693 1.197 . . . . 0.0 108.894 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -135.52 143.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -135.87 145.72 46.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.084 1.353 . . . . 0.0 107.572 161.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.72 155.99 36.58 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.639 0.654 . . . . 0.0 111.86 172.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -58.08 -25.05 56.23 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 124.619 1.104 . . . . 0.0 114.132 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.38 -27.49 36.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.887 1.344 . . . . 0.0 113.116 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.9 -20.2 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.941 0.896 . . . . 0.0 112.504 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.7 -44.92 96.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.656 0.782 . . . . 0.0 109.725 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.15 -17.14 38.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.752 0.821 . . . . 0.0 111.478 -168.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -58.2 147.24 31.0 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 128.075 2.55 . . . . 0.0 109.552 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 . . . . . 0 C--O 1.248 1.022 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 172.124 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.77 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.78 -176.06 4.11 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.968 1.384 . . . . 0.0 109.614 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.97 3.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.673 1.989 . . . . 0.0 112.387 -167.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.16 -155.82 7.31 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.332 1.92 . . . . 0.0 109.703 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 pt -78.39 -10.97 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -34.1 72.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 111.746 -168.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -55.96 -33.85 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.486 1.115 . . . . 0.0 112.144 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.05 -4.71 56.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.648 -1.168 . . . . 0.0 110.784 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.81 90.98 0.81 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.731 1.605 . . . . 0.0 110.506 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.12 128.02 32.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.03 -16.57 37.79 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.37 0.986 . . . . 0.0 112.817 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.68 164.59 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -155.0 174.96 14.43 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 107.393 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -133.26 128.03 34.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' A' ' 57' ' ' MET . . . -145.83 137.03 24.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 44.59 62.42 2.05 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 110.003 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.263 1.7 p90 44.96 31.61 0.72 Allowed 'General case' 0 C--O 1.232 0.174 1 C-N-CA 132.004 4.122 . . . . 0.0 113.013 174.914 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 m -131.84 124.86 30.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -80.73 157.04 25.97 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -152.91 156.09 38.26 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.354 1.062 . . . . 0.0 110.26 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -140.2 167.67 21.61 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.929 1.692 . . . . 0.0 109.431 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.14 108.84 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.08 -7.02 21.52 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.326 -1.819 . . . . 0.0 114.162 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -174.8 1.49 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.771 1.786 . . . . 0.0 110.263 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.04 150.69 42.76 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.443 -1.411 . . . . 0.0 109.044 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.91 159.84 39.35 Favored Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 161.2 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.545 2.163 . . . . 0.0 111.557 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.58 -10.58 19.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.639 0.776 . . . . 0.0 112.748 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.88 -26.13 65.63 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.803 0.841 . . . . 0.0 111.549 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -107.83 -10.25 15.6 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.7 mt -75.9 -24.79 55.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.675 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -55.95 145.25 54.67 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.004 0.921 . . . . 0.0 109.943 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.87 -9.74 22.43 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 124.722 3.615 . . . . 0.0 112.17 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -56.04 -27.8 54.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.432 1.493 . . . . 0.0 113.504 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -117.02 2.52 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.806 0.842 . . . . 0.0 111.191 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -59.73 104.66 0.3 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 128.28 2.632 . . . . 0.0 111.301 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mm -77.03 79.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -39.65 73.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.931 169.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -88.82 66.06 7.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.311 1.044 . . . . 0.0 110.119 -174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -65.31 -50.25 66.37 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.047 -0.408 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -41.03 96.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.953 0.501 . . . . 0.0 111.985 -158.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.69 -25.8 60.8 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.527 1.131 . . . . 0.0 113.265 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.86 27.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.835 -1.165 . . . . 0.0 111.321 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m120 68.01 -3.67 1.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.988 2.115 . . . . 0.0 112.252 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -85.66 163.84 42.42 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.533 1.933 . . . . 0.0 111.847 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.46 175.23 11.54 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.446 2.764 . . . . 0.0 112.541 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 164.35 19.63 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 111.765 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -72.52 -169.66 0.5 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.047 2.498 . . . . 0.0 111.117 162.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.58 -172.34 2.48 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 158.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 104.05 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.803 169.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.28 -12.48 54.71 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.583 1.087 . . . . 0.0 114.587 169.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.2 p -73.41 168.52 19.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.822 1.311 . . . . 0.0 109.23 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -158.72 151.56 22.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.615 -0.678 . . . . 0.0 109.654 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -81.88 143.57 31.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -133.7 162.1 32.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.527 0.731 . . . . 0.0 110.644 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -96.32 96.95 9.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.989 1.316 . . . . 0.0 108.259 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -111.93 96.6 6.15 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.233 1.813 . . . . 0.0 106.848 -174.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.13 79.61 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.904 -1.498 . . . . 0.0 113.824 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.94 6.92 64.82 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.614 1.707 . . . . 0.0 112.373 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.31 147.14 31.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.403 1.602 . . . . 0.0 107.712 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 37.4 m-85 -96.94 114.29 25.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.08 131.92 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.45 112.76 24.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.02 143.57 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.193 0.997 . . . . 0.0 110.2 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.06 39.93 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -59.61 -18.57 42.42 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -115.85 12.35 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 126.295 1.838 . . . . 0.0 110.215 -161.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.94 -51.62 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.801 -1.187 . . . . 0.0 109.385 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.52 29.69 35.39 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 126.013 1.768 . . . . 0.0 112.594 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 138.32 58.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.379 1.09 . . . . 0.0 108.978 176.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.6 mt -79.7 84.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.66 -45.67 78.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.542 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -153.33 163.26 40.23 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.798 2.039 . . . . 0.0 107.633 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.7 t -137.13 151.53 27.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.21 157.97 42.96 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 156.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -63.63 156.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.392 0.677 . . . . 0.0 109.266 168.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -63.62 -22.36 65.9 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 124.764 1.173 . . . . 0.0 113.601 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.72 -17.39 34.37 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.62 1.21 . . . . 0.0 113.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.02 -26.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.973 0.909 . . . . 0.0 112.465 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -65.91 -12.04 51.68 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.675 -0.64 . . . . 0.0 111.544 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.43 18.44 12.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.57 -173.47 0.75 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 108.273 163.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.814 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.552 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.67 35.08 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 120.064 1.932 . . . . 0.0 108.664 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.03 -0.69 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.68 -142.55 12.35 Favored Glycine 0 N--CA 1.461 0.333 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 pt -93.64 -12.02 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.46 -32.38 68.69 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.984 0.811 . . . . 0.0 112.886 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -58.66 -27.25 64.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.803 0.841 . . . . 0.0 112.893 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -97.91 -1.65 42.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.956 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.18 90.22 5.48 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.199 1.363 . . . . 0.0 109.663 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.91 128.89 34.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -83.82 -17.87 39.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.264 0.484 . . . . 0.0 112.3 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.28 165.7 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.719 2.408 . . . . 0.0 107.236 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.11 179.61 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.715 1.206 . . . . 0.0 108.308 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -130.44 136.6 49.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.89 43.95 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 164.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.15 38.11 26.68 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.139 0.971 . . . . 0.0 111.666 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 60.02 14.31 4.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.443 1.897 . . . . 0.0 113.757 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.4 m -119.19 126.97 52.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.171 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -87.07 149.17 24.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -145.6 155.97 43.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.017 0.927 . . . . 0.0 110.798 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -139.61 164.0 31.07 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.405 1.482 . . . . 0.0 109.145 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.76 115.87 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 164.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.33 -0.09 55.81 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 117.676 -1.625 . . . . 0.0 114.811 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.89 -178.28 3.18 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.324 1.562 . . . . 0.0 109.851 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.39 152.25 41.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.952 1.701 . . . . 0.0 110.44 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.43 158.76 31.14 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 121.401 -0.812 . . . . 0.0 112.22 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 72.4 Cg_endo -68.62 158.0 59.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.799 2.333 . . . . 0.0 111.774 165.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.01 -14.43 62.89 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.501 1.12 . . . . 0.0 113.487 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 14.8 ptp -56.08 -22.7 29.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.894 0.878 . . . . 0.0 112.935 172.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.68 -10.63 14.07 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.4 -20.13 55.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.883 0.873 . . . . 0.0 111.299 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -64.03 152.5 87.43 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.246 1.418 . . . . 0.0 110.463 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.19 -7.77 16.58 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.127 2.551 . . . . 0.0 114.262 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.56 -18.97 55.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.13 0.972 . . . . 0.0 113.276 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -122.45 -5.36 8.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 112.496 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 106.9 1.51 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.7 1.6 . . . . 0.0 112.186 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 56' ' ' TYR . 8.4 mm -79.01 78.77 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 O-C-N 120.832 -1.167 . . . . 0.0 107.966 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -61.76 -28.75 69.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.008 -1.057 . . . . 0.0 112.664 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -93.2 65.32 3.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.804 1.242 . . . . 0.0 109.698 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -82.9 -44.36 15.47 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -30.81 69.08 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.724 0.693 . . . . 0.0 111.024 -170.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -78.8 17.24 0.74 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.377 1.471 . . . . 0.0 113.308 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HB2' HD12 ' A' ' 45' ' ' LEU . 4.4 mtt85 -129.56 22.89 5.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.286 1.403 . . . . 0.0 113.28 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 57.4 8.09 0.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.414 1.886 . . . . 0.0 114.035 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 43' ' ' ARG . 2.5 mt -90.59 165.25 23.5 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.689 -1.257 . . . . 0.0 110.956 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.18 170.14 20.64 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.617 3.545 . . . . 0.0 111.641 168.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.78 165.49 2.4 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 127.21 2.204 . . . . 0.0 112.292 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.54 -164.65 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.764 2.976 . . . . 0.0 111.235 160.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.66 -169.84 1.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 158.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.51 105.75 13.82 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.46 -1.4 . . . . 0.0 110.594 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.93 44.43 7.69 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 p -140.28 166.78 23.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -152.86 145.6 24.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.904 0.859 . . . . 0.0 110.512 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -72.84 147.48 45.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.82 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 p -139.4 170.28 16.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 128.746 2.818 . . . . 0.0 108.332 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' HD11 ' A' ' 37' ' ' ILE . 16.8 t80 -116.62 78.66 1.22 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.575 0.625 . . . . 0.0 112.18 -172.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 97.86 11.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.727 2.011 . . . . 0.0 109.611 -172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.86 11.4 63.03 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.354 -0.841 . . . . 0.0 114.623 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.8 -15.73 37.29 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.198 0.999 . . . . 0.0 112.054 -170.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -89.08 138.4 31.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.633 1.217 . . . . 0.0 108.303 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.7 112.47 18.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.93 125.22 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 tp -89.87 111.78 22.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.44 150.34 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 123.057 0.543 . . . . 0.0 110.211 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.65 139.29 43.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.511 0.724 . . . . 0.0 109.433 169.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.53 -17.41 64.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.422 0.629 . . . . 0.0 110.86 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 p -100.26 -5.19 27.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.163 2.185 . . . . 0.0 112.716 -161.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -174.79 -44.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 109.003 -157.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.42 28.4 61.75 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.362 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.32 132.47 53.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.814 1.307 . . . . 0.0 108.347 163.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.34 86.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 128.666 2.786 . . . . 0.0 105.512 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.97 -46.78 83.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -152.63 163.7 39.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.018 1.327 . . . . 0.0 109.653 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.63 145.15 26.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.06 157.79 45.91 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.806 1.643 . . . . 0.0 107.143 164.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.2 157.51 34.43 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -28.63 62.96 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.271 2.367 . . . . 0.0 113.142 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -62.96 -20.3 65.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.024 0.93 . . . . 0.0 112.514 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.45 -21.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.005 0.922 . . . . 0.0 111.889 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.53 -7.44 10.22 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 112.781 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -119.47 -0.97 10.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.005 1.322 . . . . 0.0 111.911 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -74.43 165.58 24.95 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.344 1.858 . . . . 0.0 109.488 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 129.328 3.051 . . . . 0.0 106.117 -178.038 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 CA-C-O 118.709 -1.05 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.52 28.15 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.284 2.634 . . . . 0.0 117.703 156.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.79 77.25 2.09 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.336 0.971 . . . . 0.0 110.373 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.93 -111.84 0.26 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 106.593 -2.603 . . . . 0.0 106.593 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 pt -121.3 -19.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.91 -22.64 64.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 118.065 0.393 . . . . 0.0 110.879 -169.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.71 -26.18 68.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.509 1.124 . . . . 0.0 113.015 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -99.5 0.34 42.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.72 1.208 . . . . 0.0 111.641 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.49 101.19 0.95 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.92 151.08 25.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -101.28 -12.56 18.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.527 0.731 . . . . 0.0 111.81 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -177.05 156.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -155.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -172.15 -179.1 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 109.232 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -125.95 135.32 51.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.06 137.82 46.53 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.71 34.38 23.73 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.337 1.065 . . . . 0.0 110.751 168.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 59.34 14.79 3.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.835 2.454 . . . . 0.0 114.376 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -103.08 134.54 46.34 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.489 1.516 . . . . 0.0 107.267 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -90.25 141.88 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.347 1.859 . . . . 0.0 109.161 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -146.45 155.62 42.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.047 0.385 . . . . 0.0 111.71 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -145.31 167.58 22.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.734 1.214 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.0 mm -58.86 117.31 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.17 -11.84 55.36 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.003 -1.443 . . . . 0.0 114.323 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.53 -178.44 4.1 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.79 1.795 . . . . 0.0 107.164 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.78 148.09 43.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 119.349 -2.094 . . . . 0.0 108.951 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.38 163.4 66.42 Favored Pre-proline 0 CA--C 1.538 0.5 0 O-C-N 121.581 -0.699 . . . . 0.0 110.396 170.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.14 160.91 39.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.286 2.657 . . . . 0.0 111.378 160.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -63.15 -23.5 67.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.571 1.148 . . . . 0.0 113.132 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.571 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 6.7 ptm -53.78 -20.93 6.34 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.823 1.249 . . . . 0.0 113.594 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 8.6 m-85 -117.55 -8.15 11.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.646 1.178 . . . . 0.0 112.557 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -79.03 -25.8 43.22 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.594 1.558 . . . . 0.0 110.873 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 t -62.35 144.79 94.88 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.69 -9.57 21.37 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.649 2.233 . . . . 0.0 114.463 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -55.55 -36.51 66.87 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.062 0.945 . . . . 0.0 110.968 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.78 -11.12 16.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.767 0.827 . . . . 0.0 111.052 -173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -61.07 111.04 1.54 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.944 1.698 . . . . 0.0 109.956 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.6 mt -87.99 90.63 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -73.43 -28.52 62.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.572 164.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.23 68.95 9.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.356 0.98 . . . . 0.0 109.137 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -69.92 -57.26 5.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 167.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -44.83 -47.76 11.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.44 1.496 . . . . 0.0 114.839 -159.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -63.31 -21.64 66.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -75.22 -165.34 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.26 2.62 31.78 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.845 -1.159 . . . . 0.0 111.431 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 79' ' ' ILE . 2.5 mm? -65.04 156.15 81.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 121.325 -0.86 . . . . 0.0 112.204 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.05 171.48 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.678 3.585 . . . . 0.0 111.061 161.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.02 158.36 26.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 112.484 173.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.99 158.92 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.356 2.037 . . . . 0.0 111.01 167.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.608 ' H ' HD21 ' A' ' 63' ' ' LEU . 31.8 m-20 -62.06 149.1 42.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.72 101.27 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.435 0.694 . . . . 0.0 110.504 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.49 12.98 10.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.621 -1.1 . . . . 0.0 113.378 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.7 p -132.4 176.08 8.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.136 1.468 . . . . 0.0 111.06 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -149.49 154.37 38.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.132 0.973 . . . . 0.0 110.474 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -72.77 156.05 39.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.971 0.509 . . . . 0.0 109.865 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -147.46 167.97 23.08 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.48 106.16 16.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.297 1.839 . . . . 0.0 108.342 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG2' HG22 ' A' ' 62' ' ' VAL . 86.7 mmm -81.56 -154.9 0.12 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.193 1.797 . . . . 0.0 109.693 175.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.03 58.51 0.55 Allowed Glycine 0 C--N 1.338 0.679 0 C-N-CA 129.607 3.48 . . . . 0.0 111.701 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.23 56.8 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 125.676 1.608 . . . . 0.0 113.992 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -130.96 158.66 39.65 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.073 1.436 . . . . 0.0 108.87 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -102.95 125.79 49.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 108.694 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 57' ' ' MET . 16.4 m -127.71 151.02 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.648 -0.657 . . . . 0.0 109.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.608 HD21 ' H ' ' A' ' 49' ' ' ASP . 63.7 tp -103.46 127.99 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.684 HD12 HD23 ' A' ' 31' ' ' LEU . 10.4 pt -131.67 131.91 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 125.429 1.492 . . . . 0.0 110.538 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.78 134.52 57.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -8.6 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.086 -1.009 . . . . 0.0 111.377 172.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 t -134.05 12.01 3.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.928 2.091 . . . . 0.0 109.494 -158.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -171.91 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 0.0 111.425 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.1 37.95 24.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.481 1.515 . . . . 0.0 113.01 -165.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -58.84 145.63 40.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 159.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.2 mt -81.78 91.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.8 mm? -61.31 -56.92 15.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.35 163.09 35.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.468 1.507 . . . . 0.0 110.395 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.1 t -137.18 136.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.326 1.851 . . . . 0.0 107.304 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.59 142.99 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.153 0.981 . . . . 0.0 108.357 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.41 146.19 54.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.59 -20.96 40.67 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.446 1.022 . . . . 0.0 112.798 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -49.65 -30.94 9.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.509 1.124 . . . . 0.0 112.42 171.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 tt -58.36 -25.49 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.72 1.208 . . . . 0.0 112.574 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.31 -35.28 76.92 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.565 0.62 . . . . 0.0 110.657 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.73 2.37 51.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.708 0.803 . . . . 0.0 113.048 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -84.15 -174.66 5.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.341 0.656 . . . . 0.0 110.116 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 C--O 1.248 0.987 0 C-N-CA 127.073 2.149 . . . . 0.0 109.207 -172.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.91 160.76 42.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.412 1.106 . . . . 0.0 108.96 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.09 24.98 1.78 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.118 0.967 . . . . 0.0 110.289 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.86 -170.01 21.67 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 125.51 1.529 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.4 pt -62.35 -18.71 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 124.318 1.047 . . . . 0.0 113.478 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -60.59 -24.83 65.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.101 1.76 . . . . 0.0 113.049 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.27 -34.86 77.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.289 0.636 . . . . 0.0 112.293 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -90.49 -3.84 57.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 117.833 -1.08 . . . . 0.0 111.099 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.39 0.78 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.432 1.014 . . . . 0.0 108.723 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.6 164.01 14.93 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -124.99 -20.06 5.04 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.46 1.504 . . . . 0.0 111.351 -172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -159.17 163.04 36.4 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.772 2.029 . . . . 0.0 107.505 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -163.71 175.56 10.43 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 110.148 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 m -127.74 112.68 15.06 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.47 158.48 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 25.39 12.94 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.264 0.938 . . . . 0.0 111.978 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 58.43 16.62 4.26 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.429 1.891 . . . . 0.0 113.133 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.7 m -117.8 125.9 51.43 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.661 1.984 . . . . 0.0 105.961 -171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -80.5 149.01 30.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -147.9 157.31 43.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.038 1.335 . . . . 0.0 109.495 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -138.68 167.67 21.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.318 1.447 . . . . 0.0 108.566 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.35 119.3 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.19 -13.35 40.44 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 117.782 -1.566 . . . . 0.0 114.014 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.86 -171.17 1.02 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 119.592 1.696 . . . . 0.0 107.879 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 142.56 50.49 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 118.379 -2.701 . . . . 0.0 109.981 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.36 156.56 73.63 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 121.547 -0.721 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.38 156.6 61.37 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.408 2.072 . . . . 0.0 110.564 165.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -61.22 -17.25 52.3 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.1 mmt -51.8 -27.44 12.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.533 1.533 . . . . 0.0 113.231 173.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -109.5 -7.31 15.18 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.8 mt -79.23 -23.75 43.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.584 1.154 . . . . 0.0 112.071 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -56.17 149.25 37.07 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.45 1.1 . . . . 0.0 110.262 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.77 -8.59 15.98 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.433 2.756 . . . . 0.0 113.18 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.02 -29.29 70.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.831 2.052 . . . . 0.0 111.861 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.38 1.22 9.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.671 1.188 . . . . 0.0 111.668 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 91.28 0.15 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.624 2.77 . . . . 0.0 108.915 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.78 112.61 5.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -88.55 -31.49 18.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 117.392 -1.29 . . . . 0.0 111.053 167.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.07 88.18 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.963 1.256 . . . . 0.0 110.655 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -104.15 -33.84 8.59 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.555 0.742 . . . . 0.0 111.972 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.76 -28.24 69.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.131 0.878 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -83.43 29.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.776 1.231 . . . . 0.0 110.754 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -141.49 169.14 18.16 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.862 2.465 . . . . 0.0 107.364 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -69.6 -13.91 62.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.737 1.215 . . . . 0.0 111.987 166.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.74 157.2 80.52 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.303 -0.873 . . . . 0.0 111.764 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -71.01 169.36 20.69 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.947 3.098 . . . . 0.0 111.253 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 149.72 77.14 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.72 166.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.96 169.54 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.108 2.539 . . . . 0.0 110.502 168.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -77.67 167.74 21.08 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.895 0.878 . . . . 0.0 108.666 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.03 42.24 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 114.426 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.65 56.12 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.4 p -159.91 171.78 18.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.305 0.642 . . . . 0.0 111.175 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -145.92 156.92 43.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.439 0.563 . . . . 0.0 110.95 167.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -80.94 153.17 27.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -136.53 168.81 18.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.397 1.079 . . . . 0.0 110.729 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -106.03 84.94 2.12 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.376 1.471 . . . . 0.0 107.646 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.3 mtp -94.85 102.06 13.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.131 0.972 . . . . 0.0 109.352 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.33 6.29 86.28 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.663 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.27 4.1 53.59 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.068 1.434 . . . . 0.0 112.007 -167.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -115.09 143.71 44.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 53.8 m-85 -93.88 113.38 25.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 74' ' ' VAL . 3.6 m -127.49 143.25 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -172.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 tp -102.6 122.9 45.32 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.1 pt -124.68 149.06 28.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 124.007 0.923 . . . . 0.0 109.872 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.65 136.75 41.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.08 -25.16 65.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.655 0.741 . . . . 0.0 112.388 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 t -123.12 27.13 7.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.152 1.781 . . . . 0.0 110.147 -161.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -173.96 -36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.783 1.633 . . . . 0.0 110.552 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.32 21.46 77.66 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.079 1.323 . . . . 0.0 113.894 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 136.18 57.85 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.543 1.137 . . . . 0.0 108.59 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.48 87.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.2 mt -70.67 -49.24 49.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.167 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -152.52 157.94 41.83 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 109.695 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 62' ' ' VAL . 52.0 t -140.67 130.17 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.626 1.97 . . . . 0.0 107.087 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -129.43 148.19 51.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.631 1.173 . . . . 0.0 108.73 168.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 79' ' ' ILE . 23.2 t70 -68.64 157.81 35.4 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.817 -0.552 . . . . 0.0 111.241 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -61.73 -27.2 67.92 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-O 118.454 -1.192 . . . . 0.0 113.975 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -55.88 -27.62 52.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.961 1.381 . . . . 0.0 112.738 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 76' ' ' ASP . 16.3 tt -55.67 -26.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.579 1.152 . . . . 0.0 112.324 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -62.79 -30.34 71.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.375 0.534 . . . . 0.0 111.24 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -99.17 4.38 46.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.03 0.932 . . . . 0.0 111.627 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -69.7 -178.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.273 1.829 . . . . 0.0 110.039 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 . . . . . 0 C--O 1.245 0.855 0 O-C-N 120.77 -1.206 . . . . 0.0 111.122 -166.862 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.324 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.63 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.825 2.05 . . . . 0.0 111.219 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.94 -6.08 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.581 1.553 . . . . 0.0 110.699 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.49 -168.53 44.38 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 164.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.79 -16.49 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 124.428 1.091 . . . . 0.0 112.968 -168.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.13 -22.99 67.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.011 0.924 . . . . 0.0 112.727 -170.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -60.4 -30.69 69.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.057 0.943 . . . . 0.0 112.693 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -95.52 -3.49 46.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.156 0.983 . . . . 0.0 110.688 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.88 82.24 7.6 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 109.365 -168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.96 151.27 46.74 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -16.24 15.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.071 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -156.66 157.62 35.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.067 1.347 . . . . 0.0 109.652 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -158.77 177.28 11.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.094 1.758 . . . . 0.0 109.286 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -126.13 128.75 47.81 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.08 44.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.45 38.04 4.96 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.948 1.356 . . . . 0.0 112.243 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 60.74 34.51 19.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.929 2.091 . . . . 0.0 112.953 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 m -142.33 131.85 23.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.594 1.557 . . . . 0.0 107.163 -174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.9 147.74 36.85 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.49 144.2 39.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.864 1.265 . . . . 0.0 108.48 175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.04 174.46 7.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.05 122.66 18.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.81 -1.54 55.41 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.342 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.93 -171.38 2.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.098 1.449 . . . . 0.0 108.678 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.29 127.31 25.9 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.325 -1.484 . . . . 0.0 110.894 -169.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.8 m -70.03 158.32 87.65 Favored Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 123.22 0.608 . . . . 0.0 111.492 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.52 159.96 51.1 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.187 1.925 . . . . 0.0 111.023 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.09 -15.89 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.325 0.65 . . . . 0.0 112.54 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -25.97 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 112.097 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -116.43 -9.49 11.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.72 1.208 . . . . 0.0 113.24 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.01 -18.41 37.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.525 0.73 . . . . 0.0 111.32 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 t -53.01 150.81 9.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.212 0.605 . . . . 0.0 109.408 166.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.96 -4.39 15.04 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.866 2.378 . . . . 0.0 113.842 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -57.3 -23.93 51.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 113.246 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -121.57 10.13 10.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.746 1.157 . . . . 0.0 113.199 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.23 106.39 0.61 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.686 2.394 . . . . 0.0 112.371 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.4 mm -73.91 79.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.312 1.045 . . . . 0.0 108.724 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.54 -32.44 73.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.353 -0.842 . . . . 0.0 110.8 166.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -76.65 34.34 0.14 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.843 1.257 . . . . 0.0 114.017 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -75.64 -32.83 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -65.04 -32.34 74.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.43 1.468 . . . . 0.0 110.547 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -85.61 27.24 0.86 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.686 0.794 . . . . 0.0 111.737 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -132.05 165.53 23.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 126.02 1.728 . . . . 0.0 107.614 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.515 HD21 ' HA ' ' A' ' 83' ' ' ARG . 2.1 m120 -73.81 -19.87 60.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.44 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.61 151.56 61.11 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.371 1.069 . . . . 0.0 110.331 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.43 164.47 32.55 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.693 1.596 . . . . 0.0 110.359 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.6 157.64 36.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.411 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.59 162.1 32.64 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.324 1.35 . . . . 0.0 110.083 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -70.74 167.54 18.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 162.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.65 61.25 1.79 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.928 1.291 . . . . 0.0 113.252 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.31 41.28 0.04 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.159 1.837 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 80.3 p -151.04 169.91 20.67 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.841 -0.799 . . . . 0.0 110.728 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -147.01 157.21 43.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.101 0.961 . . . . 0.0 110.184 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -98.56 137.3 37.42 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.283 0.633 . . . . 0.0 109.421 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -137.58 159.11 42.88 Favored 'General case' 0 C--O 1.236 0.395 0 O-C-N 121.642 -0.661 . . . . 0.0 110.015 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -99.92 61.27 1.11 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.83 0.824 . . . . 0.0 112.391 -167.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 102.89 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.985 2.114 . . . . 0.0 109.82 -164.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.33 14.12 59.19 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.335 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.29 -1.52 37.53 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.851 1.825 . . . . 0.0 112.965 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -114.84 161.47 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.74 1.77 . . . . 0.0 107.909 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.428 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 65.7 m-85 -105.05 113.84 27.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.16 135.08 63.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -92.27 110.88 22.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.655 1.182 . . . . 0.0 108.543 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.55 142.32 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.706 1.202 . . . . 0.0 108.683 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.77 143.7 54.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.82 -12.66 61.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -140.34 24.1 2.31 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.274 1.43 . . . . 0.0 109.176 -159.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -165.78 -44.42 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.469 1.508 . . . . 0.0 109.166 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.39 25.03 71.57 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.292 0.949 . . . . 0.0 113.306 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 133.39 55.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 167.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.73 88.69 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.049 2.139 . . . . 0.0 106.515 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.9 -45.95 66.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.287 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -152.17 160.9 43.3 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 109.673 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.2 141.72 40.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.172 1.789 . . . . 0.0 106.42 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -139.14 140.25 37.84 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.267 1.827 . . . . 0.0 106.378 165.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.98 155.84 35.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.431 1.014 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -51.49 -31.06 28.13 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.642 1.591 . . . . 0.0 112.789 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.56 -33.68 6.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.489 1.916 . . . . 0.0 112.551 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 tt -69.4 -12.09 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.534 1.134 . . . . 0.0 112.025 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -67.07 -34.93 78.72 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.845 -1.159 . . . . 0.0 111.182 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -91.32 -17.62 25.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.651 0.78 . . . . 0.0 111.329 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.11 141.64 55.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 128.27 2.628 . . . . 0.0 108.838 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HA ' HD21 ' A' ' 44' ' ' ASN . 12.2 mtt-85 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.1 141.16 56.26 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 155.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.31 49.8 0.83 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.235 1.414 . . . . 0.0 110.435 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.84 -168.87 23.38 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 pt -59.68 -16.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -165.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -53.53 -29.95 39.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.623 1.569 . . . . 0.0 112.651 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -64.2 -21.02 66.41 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -107.89 4.04 24.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.927 1.291 . . . . 0.0 110.766 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.63 94.51 1.01 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.12 163.64 24.36 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -121.79 -19.09 6.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.004 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.6 164.64 24.05 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.406 1.882 . . . . 0.0 107.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -168.59 -176.64 2.85 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.292 1.837 . . . . 0.0 109.084 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -135.67 133.45 38.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.106 0.962 . . . . 0.0 108.716 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.69 35.41 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.047 0.939 . . . . 0.0 109.409 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.2 39.81 20.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.924 1.29 . . . . 0.0 109.968 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.42 15.5 6.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.442 2.697 . . . . 0.0 114.855 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 m -114.21 131.82 56.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.419 1.488 . . . . 0.0 107.425 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.85 155.74 23.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.73 0.695 . . . . 0.0 109.373 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -149.26 153.66 37.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.408 1.483 . . . . 0.0 110.485 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -136.64 165.98 24.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.1 1.36 . . . . 0.0 107.365 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.7 mm -59.81 125.84 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 168.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.35 44.02 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.677 -1.624 . . . . 0.0 114.162 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.52 -175.89 0.91 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.213 1.506 . . . . 0.0 109.62 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 131.74 45.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 119.92 -1.737 . . . . 0.0 110.27 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' CG2' ' A' ' 64' ' ' ILE . 17.3 m -72.84 164.1 63.15 Favored Pre-proline 0 N--CA 1.467 0.397 0 C-N-CA 126.052 1.741 . . . . 0.0 111.984 -174.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 74.1 Cg_endo -74.09 158.5 45.52 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.497 2.798 . . . . 0.0 112.234 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.43 68.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.042 1.337 . . . . 0.0 111.797 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 19.6 ptt? -66.8 -33.44 75.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.358 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 25.5 m-85 -87.04 -4.3 59.15 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 118.261 -1.375 . . . . 0.0 114.146 -176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.37 -21.39 62.88 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.148 0.886 . . . . 0.0 110.95 168.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 p -69.62 148.7 96.89 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 121.899 -0.5 . . . . 0.0 111.035 -172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.5 -14.87 42.02 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.053 3.169 . . . . 0.0 111.809 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.48 -30.16 60.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.439 1.896 . . . . 0.0 112.563 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -112.62 -8.28 13.82 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.211 1.404 . . . . 0.0 111.833 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -80.77 118.22 22.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.808 1.643 . . . . 0.0 111.28 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.01 92.78 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.29 -21.09 63.89 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 111.63 169.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.57 40.12 0.29 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.621 1.168 . . . . 0.0 112.95 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -53.52 -41.45 66.38 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-O 117.603 -1.189 . . . . 0.0 112.279 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -61.71 -27.57 68.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.996 1.726 . . . . 0.0 114.68 -167.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -84.99 -14.86 46.13 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.461 1.482 . . . . 0.0 112.746 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 -83.74 172.11 12.54 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 166.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -109.78 8.15 24.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.325 -0.86 . . . . 0.0 111.491 -158.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.72 166.97 10.08 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 129.28 3.032 . . . . 0.0 112.613 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.07 175.5 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 121.387 1.391 . . . . 0.0 111.6 153.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 164.18 2.2 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.796 1.238 . . . . 0.0 111.238 166.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.63 167.93 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.278 1.319 . . . . 0.0 110.459 160.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -81.03 170.49 16.16 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.42 -0.8 . . . . 0.0 109.788 160.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.75 108.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.372 1.469 . . . . 0.0 110.909 167.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.64 29.78 51.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.764 174.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.6 p -130.77 171.36 13.21 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.475 1.138 . . . . 0.0 110.365 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -151.26 164.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.386 0.613 . . . . 0.0 111.445 172.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CD1' HD13 ' A' ' 63' ' ' LEU . 78.5 m95 -106.32 121.34 44.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.293 1.037 . . . . 0.0 110.129 -168.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.4 p -109.0 -179.97 4.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.303 1.441 . . . . 0.0 110.139 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -131.2 80.85 1.96 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.824 1.193 . . . . 0.0 111.323 -172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtp -99.18 105.5 17.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.593 1.557 . . . . 0.0 111.325 -168.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.09 15.31 62.73 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 118.711 -1.049 . . . . 0.0 113.787 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.58 8.6 59.49 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.105 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.75 127.91 54.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.228 1.514 . . . . 0.0 106.917 172.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 73.3 m-85 -85.29 121.2 27.68 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG12 HG13 ' A' ' 74' ' ' VAL . 13.3 m -127.3 145.46 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 118.847 0.748 . . . . 0.0 109.785 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' HD23 ' A' ' 72' ' ' LEU . 34.8 tp -103.53 126.67 50.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 26' ' ' VAL . 10.9 pt -131.09 135.33 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -172.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 138.89 57.87 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.412 -0.805 . . . . 0.0 109.012 170.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.94 -13.94 60.67 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.6 0.714 . . . . 0.0 110.726 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 p -109.04 -6.24 15.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.097 1.359 . . . . 0.0 111.011 -161.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.43 -37.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.701 1.201 . . . . 0.0 109.684 -160.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 26' ' ' VAL . . . 59.26 41.0 96.6 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 125.753 1.644 . . . . 0.0 111.888 -172.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' O ' HD22 ' A' ' 72' ' ' LEU . 9.6 tmtt? -65.69 133.99 52.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.13 93.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.517 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.4 mm? -65.26 -53.04 50.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -147.91 167.48 24.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 111.584 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 62' ' ' VAL . 68.7 t -142.55 141.18 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 127.448 2.299 . . . . 0.0 105.706 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -136.48 151.62 49.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.986 1.714 . . . . 0.0 108.019 167.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.59 153.32 40.26 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -62.88 -19.09 60.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 126.074 1.797 . . . . 0.0 113.0 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -57.02 -25.17 58.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.699 1.249 . . . . 0.0 111.405 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.27 -23.8 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.718 -0.613 . . . . 0.0 111.618 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -66.27 -13.05 59.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.856 1.207 . . . . 0.0 112.629 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -100.42 -4.94 27.95 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.417 -0.802 . . . . 0.0 110.251 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -77.53 69.89 3.84 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.419 2.287 . . . . 0.0 110.101 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.395 2.678 . . . . 0.0 117.144 158.044 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.443 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 152.71 19.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.711 0.805 . . . . 0.0 110.43 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.13 88.59 1.32 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.279 166.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.09 36.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 154.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.1 pt -68.51 -11.92 15.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 125.208 1.403 . . . . 0.0 113.268 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.84 -32.72 70.93 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 112.429 -168.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -56.13 -29.52 60.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.449 1.499 . . . . 0.0 113.618 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.99 -1.45 42.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.9 96.18 0.57 Allowed 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.748 1.158 . . . . 0.0 108.246 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt -82.62 140.38 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -84.57 -20.34 31.64 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 122.304 -0.247 . . . . 0.0 110.932 168.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -157.61 162.73 38.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.037 1.335 . . . . 0.0 108.927 -168.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.27 177.32 11.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.377 1.071 . . . . 0.0 108.651 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -126.92 132.52 50.86 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.64 153.91 46.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 27.01 15.76 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.379 0.991 . . . . 0.0 112.692 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 57.64 14.64 2.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.062 -172.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.2 m -111.52 137.2 49.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 128.271 2.628 . . . . 0.0 105.791 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.04 154.15 18.32 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -149.7 153.4 36.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.254 0.621 . . . . 0.0 109.953 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -143.28 169.06 18.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.648 0.779 . . . . 0.0 109.045 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.16 93.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.87 5.46 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-O 117.809 -1.551 . . . . 0.0 114.174 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.92 176.04 1.78 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.469 1.634 . . . . 0.0 108.384 166.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -134.71 138.5 44.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -82.19 157.81 67.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.2 158.01 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 110.653 166.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -19.74 43.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.39 1.076 . . . . 0.0 112.479 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtm -51.92 -35.94 47.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.062 1.345 . . . . 0.0 111.824 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -97.24 -7.44 32.26 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.93 -18.97 61.34 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.665 0.666 . . . . 0.0 110.158 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.4 p -55.29 158.08 5.79 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.03 1.332 . . . . 0.0 111.497 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.37 -12.24 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.981 2.454 . . . . 0.0 113.032 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.87 -21.85 66.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.554 1.141 . . . . 0.0 112.408 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -115.51 13.36 16.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.932 1.693 . . . . 0.0 111.243 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -89.48 82.38 6.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 126.864 2.066 . . . . 0.0 111.218 -162.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.5 71.29 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.491 1.516 . . . . 0.0 110.905 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -68.6 -23.09 64.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.197 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -74.1 94.36 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 170.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -125.4 -27.05 3.5 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 120.812 -1.18 . . . . 0.0 113.641 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -51.42 -44.1 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.721 0.691 . . . . 0.0 109.177 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.68 -24.2 8.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.825 2.45 . . . . 0.0 115.453 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -116.07 177.06 4.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.478 1.511 . . . . 0.0 108.32 -170.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -9.58 59.66 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.07 -0.394 . . . . 0.0 111.022 -172.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.22 144.94 98.35 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 123.364 0.666 . . . . 0.0 109.816 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.11 159.86 24.62 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.796 2.331 . . . . 0.0 108.959 166.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.42 147.42 68.59 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.841 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -63.62 158.15 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.427 1.418 . . . . 0.0 108.767 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -72.52 156.41 39.05 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.48 65.06 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.533 1.533 . . . . 0.0 112.362 -164.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 25.57 0.05 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 128.004 2.716 . . . . 0.0 110.94 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.0 p -143.84 167.49 22.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.163 1.481 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -146.55 152.35 38.81 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.024 0.53 . . . . 0.0 111.726 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -92.06 128.43 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -131.8 155.44 47.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.297 0.639 . . . . 0.0 111.035 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 11.5 t80 -91.11 119.76 31.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.465 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtt -141.57 110.43 6.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.558 1.072 . . . . 0.0 111.266 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 1.98 33.85 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.106 0.86 . . . . 0.0 113.499 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.461 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 113.99 -18.15 19.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.824 1.678 . . . . 0.0 111.833 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -82.97 162.83 21.35 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.707 1.203 . . . . 0.0 109.5 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 34.3 m-85 -109.87 118.11 35.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.478 1.511 . . . . 0.0 107.6 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 74' ' ' VAL . 3.1 m -131.72 131.45 62.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -89.0 111.02 21.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 pt -106.96 147.88 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.614 1.166 . . . . 0.0 108.09 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 141.75 52.15 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.3 -10.73 60.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.669 0.747 . . . . 0.0 112.543 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -124.05 -5.77 7.87 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.263 2.225 . . . . 0.0 111.299 -161.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -152.92 -32.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.36 1.464 . . . . 0.0 109.461 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.1 16.16 80.11 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 124.101 0.858 . . . . 0.0 113.138 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.5 OUTLIER -62.41 131.63 49.86 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.596 -0.943 . . . . 0.0 108.567 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.26 94.58 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.62 -52.56 14.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.867 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -150.15 162.53 40.26 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.116 1.366 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.566 HG13 HG12 ' A' ' 62' ' ' VAL . 86.9 t -139.58 136.45 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -133.89 143.52 48.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.37 1.068 . . . . 0.0 108.171 168.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.99 144.1 57.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -55.39 -22.78 32.01 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.337 1.446 . . . . 0.0 114.135 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.86 -20.46 57.27 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.182 1.491 . . . . 0.0 113.585 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 tt -60.27 -16.8 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 112.169 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.59 -49.38 69.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 120.862 -1.149 . . . . 0.0 110.056 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -82.52 -17.74 43.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.24 0.616 . . . . 0.0 111.707 -168.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.12 124.09 10.8 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 130.308 3.443 . . . . 0.0 108.747 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -179.016 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.45 -1.75 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.13 169.36 10.46 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.104 1.452 . . . . 0.0 108.201 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.16 12.93 1.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.03 -105.44 3.0 Favored Glycine 0 C--O 1.219 -0.791 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 79' ' ' ILE . 23.3 pt -117.93 -20.4 5.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.653 -0.91 . . . . 0.0 111.787 -174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.61 -15.58 63.57 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.88 0.472 . . . . 0.0 111.811 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.9 -21.95 66.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.297 1.439 . . . . 0.0 112.586 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.65 0.73 31.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.808 1.243 . . . . 0.0 111.722 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.599 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . . . -79.8 106.77 12.07 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.987 1.267 . . . . 0.0 109.574 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.93 HD13 HG12 ' A' ' 74' ' ' VAL . 2.9 mp -72.41 -162.12 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HE2' ' OE1' ' A' ' 12' ' ' GLU . 15.4 ptmt -134.92 -16.62 1.94 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 119.956 -1.715 . . . . 0.0 109.968 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.6 pt-20 -165.29 170.64 14.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -162.47 172.57 15.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.683 0.793 . . . . 0.0 109.501 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.11 141.3 45.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 159.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.25 142.74 32.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 160.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.64 31.14 12.08 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 170.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 70.15 13.72 7.72 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.451 2.701 . . . . 0.0 114.042 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.9 m -105.46 133.03 50.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 107.845 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.65 149.32 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.125 1.77 . . . . 0.0 110.25 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -157.12 146.9 20.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.887 0.875 . . . . 0.0 111.039 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -140.44 167.61 21.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.799 0.84 . . . . 0.0 110.475 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 mm -61.19 101.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.46 -10.97 9.77 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 117.577 -1.68 . . . . 0.0 116.16 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB2' HD12 ' A' ' 71' ' ' ILE . 14.8 m-20 -73.58 -174.76 1.8 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 121.005 2.403 . . . . 0.0 109.45 171.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.09 139.6 53.78 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.648 -1.282 . . . . 0.0 108.872 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.21 159.36 82.56 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 121.338 -0.851 . . . . 0.0 109.266 173.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.16 155.95 42.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.712 2.275 . . . . 0.0 111.137 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 31' ' ' LEU . . . -64.33 -11.48 32.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.15 -33.73 71.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 109.581 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -102.21 -8.3 21.43 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 28' ' ' ALA . 3.6 mm? -59.21 -27.06 65.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.2 -0.428 . . . . 0.0 109.98 167.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.3 p -64.42 144.45 98.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 117.837 0.29 . . . . 0.0 111.725 -168.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.39 -6.0 18.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.08 1.853 . . . . 0.0 111.871 -171.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.01 -38.36 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.095 2.158 . . . . 0.0 111.719 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -106.97 7.02 29.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.261 1.425 . . . . 0.0 111.702 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -90.92 107.84 19.46 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.296 1.839 . . . . 0.0 110.633 -171.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.0 mp -81.56 66.83 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.468 1.507 . . . . 0.0 110.211 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -54.23 -26.48 28.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.755 1.222 . . . . 0.0 112.133 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -72.84 90.34 1.43 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.834 1.654 . . . . 0.0 108.743 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -114.46 -28.84 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.379 1.445 . . . . 0.0 113.285 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.17 -38.84 77.43 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.773 1.229 . . . . 0.0 111.765 -168.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -119.28 44.7 2.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.807 1.243 . . . . 0.0 109.069 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -124.05 29.11 6.55 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.766 0.826 . . . . 0.0 112.4 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 m120 52.7 27.05 4.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.015 1.326 . . . . 0.0 111.853 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.9 mt -127.93 159.02 68.79 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 120.424 1.465 . . . . 0.0 110.448 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.32 173.47 13.78 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.025 2.483 . . . . 0.0 111.73 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.79 151.55 97.09 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.176 0.99 . . . . 0.0 110.947 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.31 164.89 34.27 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.559 3.506 . . . . 0.0 111.41 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.66 167.56 14.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.865 0.84 . . . . 0.0 109.186 163.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.65 51.82 0.28 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.586 2.355 . . . . 0.0 115.15 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.79 43.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 126.275 1.893 . . . . 0.0 109.156 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.2 p -154.73 168.38 27.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.469 1.135 . . . . 0.0 111.584 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -155.53 156.09 34.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.205 1.003 . . . . 0.0 109.962 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -80.57 141.31 35.19 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.277 1.031 . . . . 0.0 108.699 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.3 t -130.99 158.61 39.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.475 1.11 . . . . 0.0 108.692 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HB2' HD11 ' A' ' 37' ' ' ILE . 7.4 t80 -96.02 109.24 21.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.478 1.111 . . . . 0.0 108.592 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.87 112.86 13.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.943 1.297 . . . . 0.0 110.827 -170.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.57 -1.13 15.43 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.292 -175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.67 -12.52 25.26 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 120.066 1.933 . . . . 0.0 113.341 -164.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.76 163.01 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 118.642 1.221 . . . . 0.0 109.482 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -101.17 111.52 23.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.863 1.665 . . . . 0.0 108.376 172.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 74' ' ' VAL . 4.5 m -121.49 135.9 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.396 -0.815 . . . . 0.0 109.964 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 tp -89.11 113.3 24.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.563 1.545 . . . . 0.0 110.1 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.408 ' CD1' HD13 ' A' ' 31' ' ' LEU . 1.9 pp -119.28 142.28 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.598 1.159 . . . . 0.0 109.159 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 137.13 41.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.903 0.881 . . . . 0.0 109.408 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.06 1.85 4.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.944 0.898 . . . . 0.0 113.018 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 t -143.3 9.12 1.63 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.241 1.416 . . . . 0.0 110.775 -168.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -155.64 -42.65 0.08 Allowed 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.568 -1.332 . . . . 0.0 108.528 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 16.62 71.55 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.742 0.687 . . . . 0.0 111.461 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 139.72 58.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.35 1.075 . . . . 0.0 109.043 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 24' ' ' ASP . 71.4 mt -81.43 79.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.629 1.571 . . . . 0.0 107.523 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.54 -47.14 76.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.759 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -149.86 162.67 39.85 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.186 1.794 . . . . 0.0 108.878 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.93 HG12 HD13 ' A' ' 10' ' ' LEU . 45.0 t -140.62 136.93 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 9' ' ' ALA . 47.2 m-85 -137.27 144.83 42.9 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.994 1.718 . . . . 0.0 107.289 172.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 79' ' ' ILE . 52.1 t0 -70.57 159.42 34.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.83 0.741 . . . . 0.0 111.612 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.25 -28.71 72.69 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.04 0.829 . . . . 0.0 111.902 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.18 -21.51 33.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 112.455 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 5' ' ' ILE . 10.5 tt -61.88 -30.73 49.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.156 0.889 . . . . 0.0 111.469 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -66.57 -12.45 57.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 111.774 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.78 -8.01 20.14 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.488 1.115 . . . . 0.0 112.192 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -54.16 170.95 0.12 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.926 2.091 . . . . 0.0 110.046 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -173.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.026 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.69 32.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.397 2.679 . . . . 0.0 116.436 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.02 51.62 2.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.41 1.084 . . . . 0.0 111.724 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.81 10.18 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -53.56 -25.98 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -56.89 -19.51 18.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.139 2.176 . . . . 0.0 112.179 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.76 -33.93 77.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 0.0 112.576 170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -95.07 0.63 54.58 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.088 1.355 . . . . 0.0 111.81 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 87.4 1.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.927 0.891 . . . . 0.0 109.386 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.77 158.98 35.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -105.51 -13.3 15.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.112 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.82 160.76 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.717 1.607 . . . . 0.0 109.039 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -159.66 175.38 13.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.697 1.599 . . . . 0.0 108.869 168.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -117.38 143.67 45.74 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.07 153.77 34.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 166.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.07 24.13 13.36 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.165 0.893 . . . . 0.0 111.752 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 56.64 17.23 2.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.066 2.146 . . . . 0.0 113.54 -170.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -108.33 128.75 55.03 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.57 1.948 . . . . 0.0 106.787 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -82.55 149.27 27.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.596 1.559 . . . . 0.0 110.092 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -152.49 153.91 34.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.827 0.851 . . . . 0.0 111.052 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -139.62 165.17 27.97 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.422 1.089 . . . . 0.0 108.837 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.63 112.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.77 -9.81 34.71 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.288 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.44 -175.93 2.11 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 119.494 1.647 . . . . 0.0 107.142 167.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.09 161.33 21.17 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 119.046 -2.284 . . . . 0.0 108.243 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -90.81 163.11 31.27 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 123.707 0.803 . . . . 0.0 109.883 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.86 155.63 61.96 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.645 2.23 . . . . 0.0 110.97 158.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -62.44 -17.91 60.48 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.862 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.2 mmt -49.89 -22.17 1.41 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.907 2.083 . . . . 0.0 113.454 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -116.8 -10.16 11.1 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.374 0.988 . . . . 0.0 112.699 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.8 mt -72.56 -31.68 65.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.157 0.889 . . . . 0.0 110.945 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 t -50.94 144.67 13.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.071 1.348 . . . . 0.0 109.263 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.12 -11.32 31.79 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.011 2.474 . . . . 0.0 112.711 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.17 -18.85 11.27 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.615 1.566 . . . . 0.0 112.97 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -118.93 -1.44 11.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 112.358 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -70.37 99.51 1.59 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.724 1.61 . . . . 0.0 110.659 -168.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 mt -81.39 83.84 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -62.52 -23.32 66.9 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.709 -0.662 . . . . 0.0 111.477 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -83.67 104.89 14.15 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.539 1.063 . . . . 0.0 111.014 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.43 -25.92 2.6 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 117.652 -1.166 . . . . 0.0 114.112 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -33.92 73.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.959 1.254 . . . . 0.0 112.193 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.7 26.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.818 1.247 . . . . 0.0 111.327 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -141.32 163.76 32.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.571 1.149 . . . . 0.0 108.448 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -64.74 -28.54 69.65 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.752 0.821 . . . . 0.0 112.449 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.65 153.76 7.58 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 124.476 1.11 . . . . 0.0 112.255 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.19 177.43 8.87 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.904 2.403 . . . . 0.0 111.209 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.57 164.46 7.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.338 1.455 . . . . 0.0 111.429 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -67.52 178.2 3.4 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.619 2.212 . . . . 0.0 109.266 157.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -85.38 179.11 7.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 162.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.91 37.4 0.24 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.263 1.425 . . . . 0.0 114.72 -166.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.84 43.83 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.049 1.785 . . . . 0.0 109.757 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 3.3 p -147.05 172.41 13.79 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.58 -1.541 . . . . 0.0 109.604 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -145.56 149.33 34.38 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.774 0.321 . . . . 0.0 111.636 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.46 142.88 38.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -134.16 170.44 15.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.591 1.156 . . . . 0.0 109.94 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 25.8 t80 -106.55 104.22 13.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.418 1.087 . . . . 0.0 108.666 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.68 102.11 9.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.734 1.614 . . . . 0.0 109.149 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.98 3.14 50.63 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.992 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 111.23 -1.33 28.2 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.464 1.132 . . . . 0.0 113.04 -169.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -120.48 140.0 52.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.651 1.58 . . . . 0.0 107.673 -167.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.1 120.39 28.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.65 144.4 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.5 tp -102.11 125.18 48.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.2 pt -130.03 135.18 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.885 0.874 . . . . 0.0 111.942 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 52' ' ' SER . 0.0 OUTLIER -60.12 129.7 43.03 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.421 0.688 . . . . 0.0 111.348 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.94 15.73 0.84 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.743 1.217 . . . . 0.0 112.633 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -143.13 4.93 1.46 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.151 2.58 . . . . 0.0 111.642 -171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -168.69 -50.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.9 1.28 . . . . 0.0 108.876 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.43 41.7 29.63 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.439 1.971 . . . . 0.0 111.17 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -61.11 153.75 24.89 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 159.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.0 mt -87.61 89.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 -47.98 69.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 110.484 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -144.59 158.95 43.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.91 0.884 . . . . 0.0 110.679 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.87 130.89 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.988 2.115 . . . . 0.0 106.062 166.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -125.58 142.33 51.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 160.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -63.7 151.53 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.357 0.526 . . . . 0.0 110.039 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.84 -18.77 47.73 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.575 1.083 . . . . 0.0 113.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.37 -27.73 38.43 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.437 1.119 . . . . 0.0 111.907 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 tt -63.33 -20.57 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.558 1.143 . . . . 0.0 112.735 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.18 -50.68 72.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.362 0.983 . . . . 0.0 109.978 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -78.66 -15.51 58.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.878 1.671 . . . . 0.0 112.274 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -85.27 88.27 7.47 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -174.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 127.267 2.227 . . . . 0.0 112.575 178.613 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.04 168.5 15.23 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.89 1.676 . . . . 0.0 107.312 164.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.29 73.73 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.24 -105.58 0.23 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 pt -120.72 -17.27 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.15 -30.87 71.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.895 0.478 . . . . 0.0 111.449 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -64.0 -20.68 66.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.388 1.875 . . . . 0.0 112.802 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -105.34 2.2 28.62 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.202 1.401 . . . . 0.0 111.25 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.61 96.22 1.53 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.48 157.24 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -129.71 0.46 4.9 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.357 1.063 . . . . 0.0 111.528 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -173.04 161.01 4.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.929 2.891 . . . . 0.0 106.457 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -169.51 177.48 4.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.235 1.414 . . . . 0.0 109.329 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -132.52 140.58 48.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 165.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.8 41.87 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 165.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t0 54.14 27.02 7.16 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 61.24 29.06 18.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.52 1.928 . . . . 0.0 111.704 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 m -125.8 135.83 52.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -110.16 150.29 28.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 109.476 -171.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -148.67 146.37 28.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.565 -160.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -144.28 167.07 23.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.668 1.587 . . . . 0.0 108.266 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 mm -69.81 118.23 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.89 -11.0 57.46 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.866 -1.519 . . . . 0.0 113.71 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.14 -179.85 2.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.804 1.802 . . . . 0.0 107.363 166.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.58 157.31 31.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 119.306 -2.121 . . . . 0.0 107.617 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 64' ' ' ILE . 18.4 m -84.96 165.23 38.18 Favored Pre-proline 0 C--O 1.238 0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 111.444 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 73.3 Cg_endo -71.18 158.56 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.18 2.586 . . . . 0.0 111.42 163.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.8 67.52 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.02 0.928 . . . . 0.0 112.025 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 18.9 ptp -54.8 -20.44 8.58 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 126.104 1.762 . . . . 0.0 114.273 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.455 ' CE1' ' HG3' ' A' ' 29' ' ' MET . 10.8 m-85 -110.2 3.73 20.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.34 -23.0 35.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 111.508 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 t -66.65 145.53 98.95 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.197 0.999 . . . . 0.0 110.89 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.96 -6.71 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.531 3.487 . . . . 0.0 114.351 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -51.63 -42.44 62.02 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.44 1.096 . . . . 0.0 110.971 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.21 -12.15 19.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.521 0.728 . . . . 0.0 112.216 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -60.76 99.95 0.1 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.878 2.471 . . . . 0.0 112.211 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -78.18 79.31 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.123 1.769 . . . . 0.0 106.4 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -62.73 -29.24 70.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.6 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -76.05 76.59 2.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 111.639 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -98.54 -19.19 17.76 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.588 -0.695 . . . . 0.0 111.405 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -0.87 13.5 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.571 -1.331 . . . . 0.0 112.976 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.47 12.45 6.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.838 1.655 . . . . 0.0 111.775 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -120.86 173.58 7.14 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 120.842 -1.161 . . . . 0.0 107.953 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.03 -12.66 49.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.044 0.537 . . . . 0.0 112.079 -170.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.44 152.64 95.42 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.996 1.318 . . . . 0.0 109.904 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.46 167.14 19.52 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.245 2.63 . . . . 0.0 111.628 170.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.21 144.3 97.46 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.893 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.04 173.37 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.243 2.629 . . . . 0.0 110.847 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.66 175.64 9.99 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.005 0.922 . . . . 0.0 110.096 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.76 99.66 0.12 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.589 1.556 . . . . 0.0 111.422 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.3 49.36 20.84 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.169 -0.957 . . . . 0.0 111.058 -175.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -132.02 171.09 14.04 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 159.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.4 154.41 34.41 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.013 0.435 . . . . 0.0 111.113 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -75.62 143.51 42.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.523 175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -129.75 172.8 11.27 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.268 1.427 . . . . 0.0 109.02 168.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 114.47 28.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.42 ' CG ' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -89.41 -154.33 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.328 0.967 . . . . 0.0 110.016 175.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 57' ' ' MET . . . -46.55 7.63 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 1 C-N-CA 132.65 4.929 . . . . 0.0 117.862 170.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 57' ' ' MET . . . 138.37 -19.5 3.21 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 127.193 2.33 . . . . 0.0 110.883 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' OD1' HG13 ' A' ' 62' ' ' VAL . 15.5 p30 -92.5 162.9 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.346 1.458 . . . . 0.0 110.55 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.24 125.84 52.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.374 1.469 . . . . 0.0 107.496 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 60' ' ' ASN . 2.5 m -129.53 156.37 41.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 72' ' ' LEU . 64.0 tp -117.62 125.33 50.56 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.418 ' CG2' HG11 ' A' ' 26' ' ' VAL . 1.1 pt -130.72 136.55 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 124.397 1.079 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.61 135.45 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.744 0.818 . . . . 0.0 109.644 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.2 -6.25 8.94 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.818 -0.551 . . . . 0.0 112.221 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -135.85 12.68 3.4 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.673 1.589 . . . . 0.0 110.145 -158.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -170.95 -31.4 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 125.887 1.675 . . . . 0.0 109.822 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.43 35.65 21.83 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.271 1.415 . . . . 0.0 111.661 -165.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.469 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -64.86 152.61 42.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 170.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.7 mt -86.97 86.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.7 mm? -64.4 -51.76 61.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -149.8 161.88 41.38 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 109.364 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.13 142.35 40.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -132.49 152.14 51.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 161.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.49 160.8 28.41 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.877 -0.514 . . . . 0.0 111.02 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -22.19 71.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 124.451 1.024 . . . . 0.0 113.037 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -59.87 -18.57 45.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 112.296 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.33 -19.73 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 112.946 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -72.3 -35.06 68.56 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.512 1.051 . . . . 0.0 111.746 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -76.74 -16.42 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.775 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.669 ' CD2' ' H ' ' A' ' 83' ' ' ARG . 15.0 t60 -72.77 174.53 7.54 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.075 0.941 . . . . 0.0 110.378 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.669 ' H ' ' CD2' ' A' ' 82' ' ' HIS . 11.7 ptm180 . . . . . 0 C--O 1.246 0.916 0 C-N-CA 126.359 1.864 . . . . 0.0 110.518 -161.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.98 -162.97 0.16 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.137 0.975 . . . . 0.0 109.74 -152.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.57 0.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.165 2.186 . . . . 0.0 116.189 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.83 -160.37 32.92 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 164.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 pt -62.66 -20.25 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -165.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.92 -25.88 58.26 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.865 1.666 . . . . 0.0 113.166 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -65.75 -27.17 68.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.81 0.43 57.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.321 1.049 . . . . 0.0 110.507 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.56 90.96 2.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.851 1.26 . . . . 0.0 111.628 -167.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -80.8 129.37 34.49 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.402 1.081 . . . . 0.0 108.303 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -92.01 -15.95 27.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.095 0.862 . . . . 0.0 112.393 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.83 166.4 29.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.312 1.445 . . . . 0.0 107.625 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 44.4 p90 -156.72 176.8 12.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.047 0.939 . . . . 0.0 108.881 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -129.89 129.82 44.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 166.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.34 142.43 32.48 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 44.34 51.77 7.51 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.02 1.328 . . . . 0.0 109.961 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.299 2.6 p90 48.24 24.19 0.65 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.014 3.326 . . . . 0.0 114.601 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.6 m -115.48 138.0 51.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.669 1.988 . . . . 0.0 107.407 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -89.78 150.71 22.15 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.019 0.928 . . . . 0.0 109.33 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 87.8 m-85 -149.86 154.03 37.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.116 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -135.43 160.82 37.25 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.981 0.912 . . . . 0.0 108.644 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.27 113.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 -13.26 25.24 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.496 -1.724 . . . . 0.0 114.066 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.8 -172.38 1.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.078 1.939 . . . . 0.0 109.602 169.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.84 148.8 49.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.543 1.537 . . . . 0.0 108.966 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.67 154.55 45.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.681 -0.675 . . . . 0.0 110.234 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.28 165.63 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.929 2.419 . . . . 0.0 112.021 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.92 -8.93 32.99 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.884 0.874 . . . . 0.0 112.708 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -22.81 60.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.801 1.64 . . . . 0.0 110.838 170.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -110.66 -23.67 10.94 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.872 0.869 . . . . 0.0 113.153 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 64' ' ' ILE . 6.0 mt -76.97 -18.02 58.5 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.304 0.502 . . . . 0.0 111.456 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 t -54.06 147.98 23.45 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.346 1.858 . . . . 0.0 110.508 170.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.38 -11.37 31.2 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.71 -9.72 15.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.764 1.625 . . . . 0.0 113.761 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -132.12 0.19 3.78 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.527 1.058 . . . . 0.0 112.591 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.26 136.9 57.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.927 1.691 . . . . 0.0 110.645 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -118.71 88.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.696 1.599 . . . . 0.0 108.672 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.41 -14.23 62.79 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.702 -0.624 . . . . 0.0 111.839 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.16 43.12 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.053 1.341 . . . . 0.0 110.516 -162.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -70.6 -15.49 62.75 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.97 -25.58 67.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.397 0.999 . . . . 0.0 111.74 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.09 39.36 0.76 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 119.564 1.075 . . . . 0.0 111.712 -171.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 174.15 156.56 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 130.11 3.364 . . . . 0.0 106.684 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -81.82 0.75 37.98 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.526 -0.734 . . . . 0.0 111.621 -174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.22 151.87 16.97 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-N 119.261 0.937 . . . . 0.0 111.179 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.79 168.42 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.077 1.851 . . . . 0.0 110.481 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.52 158.18 11.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.282 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.9 162.51 37.5 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.734 1.623 . . . . 0.0 110.232 167.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -70.73 162.66 28.69 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 162.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 109.25 1.96 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.926 -1.109 . . . . 0.0 110.92 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.58 33.98 17.65 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.339 0.518 . . . . 0.0 111.895 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.3 p -130.69 171.12 13.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.018 0.927 . . . . 0.0 108.869 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -143.77 153.26 42.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -94.48 133.78 37.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.372 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -134.64 160.25 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.07 114.89 26.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.654 ' HG2' HG13 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -90.35 -152.89 0.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.972 1.309 . . . . 0.0 108.417 171.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.81 52.87 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 130.233 3.778 . . . . 0.0 115.3 166.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.97 3.49 89.13 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 117.818 0.809 . . . . 0.0 113.756 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' HB2' ' HE3' ' A' ' 57' ' ' MET . 10.3 m-80 -121.49 166.63 13.87 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.966 1.307 . . . . 0.0 107.566 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -108.6 120.65 43.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 57' ' ' MET . 30.4 m -112.07 155.63 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.4 tp -111.33 118.87 37.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.528 HD12 HD23 ' A' ' 31' ' ' LEU . 3.8 pt -116.9 145.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.366 1.867 . . . . 0.0 109.145 -174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.02 141.18 56.29 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 120.053 1.297 . . . . 0.0 107.69 166.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -73.18 -6.88 48.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.87 0.843 . . . . 0.0 112.368 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 t -136.07 23.24 3.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.434 1.894 . . . . 0.0 110.288 -163.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -172.92 -38.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.94 1.696 . . . . 0.0 109.2 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.63 25.97 68.65 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 125.14 1.352 . . . . 0.0 113.216 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.99 143.87 57.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.565 1.146 . . . . 0.0 108.972 174.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.97 91.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.991 1.716 . . . . 0.0 107.501 -169.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.5 mt -79.38 -48.3 14.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.631 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -146.27 163.03 36.76 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.467 1.507 . . . . 0.0 108.043 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 62' ' ' VAL . 42.0 t -140.58 142.83 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 166.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.72 148.96 51.48 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 161.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 79' ' ' ILE . 19.1 t70 -62.25 158.72 16.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.072 0.949 . . . . 0.0 112.44 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.3 -24.52 55.74 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 126.15 1.834 . . . . 0.0 115.083 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -63.84 -21.13 66.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 120.141 1.97 . . . . 0.0 112.694 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 76' ' ' ASP . 9.8 tt -67.48 0.67 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 121.271 -0.893 . . . . 0.0 111.564 172.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -66.29 -41.62 89.54 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.397 -1.439 . . . . 0.0 110.952 162.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -131.48 16.71 4.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.475 1.11 . . . . 0.0 112.848 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.5 133.44 29.94 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.894 2.077 . . . . 0.0 107.961 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.567 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.11 105.08 0.89 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.749 2.02 . . . . 0.0 107.058 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 44.02 49.58 7.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.555 1.942 . . . . 0.0 113.282 170.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.36 -95.59 1.82 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.18 -26.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.885 1.274 . . . . 0.0 110.539 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.74 -16.62 64.37 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.476 1.11 . . . . 0.0 112.798 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -57.94 -24.73 59.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.672 1.589 . . . . 0.0 112.457 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.98 -1.27 34.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.148 1.379 . . . . 0.0 111.98 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.77 104.07 10.1 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.862 0.755 . . . . 0.0 109.179 -172.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.14 125.57 29.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -65.84 -30.15 70.72 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.519 -1.363 . . . . 0.0 110.422 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -156.78 153.85 28.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.69 176.26 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.058 1.343 . . . . 0.0 108.554 171.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.3 m -126.74 139.07 53.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.45 151.11 37.69 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.33 35.18 13.19 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.875 0.87 . . . . 0.0 111.871 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 58.54 37.94 25.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.906 2.482 . . . . 0.0 112.691 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.0 m -138.12 133.19 33.08 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.998 1.719 . . . . 0.0 107.506 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.28 154.42 21.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.546 0.738 . . . . 0.0 109.688 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -147.5 154.28 40.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.079 1.752 . . . . 0.0 110.435 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -145.81 165.21 29.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.231 1.412 . . . . 0.0 109.364 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.0 mm -66.7 100.65 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.87 -1.92 19.69 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.042 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -79.51 -174.44 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.266 1.033 . . . . 0.0 108.679 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 164.81 20.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.712 1.605 . . . . 0.0 109.606 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.97 163.89 16.25 Favored Pre-proline 0 N--CA 1.47 0.534 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.11 155.54 47.29 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.756 1.637 . . . . 0.0 110.221 162.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.78 -16.39 57.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp -56.25 -18.19 9.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.018 1.727 . . . . 0.0 112.508 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 57' ' ' MET . 69.8 m-85 -116.35 -11.35 11.23 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.29 1.036 . . . . 0.0 113.268 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.5 -13.96 59.21 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-N 118.744 0.702 . . . . 0.0 110.61 171.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -64.88 145.04 99.05 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.163 -0.961 . . . . 0.0 108.44 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.1 -3.8 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.178 2.585 . . . . 0.0 114.209 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.02 -12.67 1.54 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.884 -1.135 . . . . 0.0 113.334 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -127.02 3.12 6.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.803 1.241 . . . . 0.0 112.042 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 116.84 5.71 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.429 2.691 . . . . 0.0 111.4 -170.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.76 122.14 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.813 1.645 . . . . 0.0 107.85 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -131.94 -5.14 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -71.82 34.57 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.445 1.93 . . . . 0.0 112.312 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.02 -29.25 70.15 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 120.737 -1.227 . . . . 0.0 110.916 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -56.88 -13.3 2.51 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.322 1.449 . . . . 0.0 113.712 172.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.15 1.77 7.89 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.722 1.609 . . . . 0.0 113.341 -173.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 -118.0 161.17 20.24 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.842 1.657 . . . . 0.0 109.493 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.01 58.63 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.151 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.61 155.41 73.55 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.013 1.325 . . . . 0.0 109.472 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.99 164.72 34.79 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.441 2.761 . . . . 0.0 113.095 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.29 84.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.045 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' CB ' HD11 ' A' ' 63' ' ' LEU . 38.2 Cg_endo -81.46 -59.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.594 0.891 . . . . 0.0 113.263 -166.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 176.61 -162.3 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 131.527 3.931 . . . . 0.0 105.681 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.08 2.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.178 2.191 . . . . 0.0 112.388 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.32 47.32 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 p -142.02 165.76 26.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.154 0.981 . . . . 0.0 110.883 168.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -137.49 157.49 46.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.889 0.476 . . . . 0.0 110.195 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -84.53 151.68 24.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.5 p -138.73 176.89 8.31 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.689 1.596 . . . . 0.0 109.119 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 59' ' ' GLY . 8.0 t80 -116.85 104.4 11.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.616 1.167 . . . . 0.0 108.661 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 30' ' ' TYR . 42.7 ttm -112.92 98.67 7.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.396 1.878 . . . . 0.0 108.176 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.31 11.22 64.1 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.444 1.02 . . . . 0.0 113.904 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' A' ' 56' ' ' TYR . . . 109.63 -12.42 32.8 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 118.973 1.386 . . . . 0.0 113.311 -172.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -94.51 120.17 34.33 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.468 2.307 . . . . 0.0 107.202 -171.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.485 ' CE2' ' HA2' ' A' ' 77' ' ' GLY . 30.7 m-85 -64.55 114.5 4.41 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.369 -0.832 . . . . 0.0 108.887 162.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG12 ' HB ' ' A' ' 74' ' ' VAL . 4.2 m -123.97 154.88 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 48' ' ' PRO . 27.0 tp -109.32 130.47 55.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.513 1.125 . . . . 0.0 109.864 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.6 pt -131.5 142.36 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.804 1.241 . . . . 0.0 110.061 -173.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 138.82 53.0 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 118.902 0.774 . . . . 0.0 109.772 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.51 -14.89 62.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.88 0.872 . . . . 0.0 112.113 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -128.59 1.37 5.55 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.115 1.766 . . . . 0.0 110.484 -167.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.16 -35.38 0.24 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.989 -1.069 . . . . 0.0 111.907 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.44 20.43 79.38 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.759 0.695 . . . . 0.0 113.228 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 132.99 55.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.26 92.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 127.568 2.347 . . . . 0.0 105.781 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.35 -54.07 16.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -151.16 170.69 18.83 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.743 0.817 . . . . 0.0 109.681 -170.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.2 p -143.23 140.78 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 1 C-N-CA 132.07 4.148 . . . . 0.0 105.113 171.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -142.79 112.37 6.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.412 -1.28 . . . . 0.0 108.262 160.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -49.19 146.73 3.44 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.904 1.229 . . . . 0.0 113.117 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.485 ' HA2' ' CE2' ' A' ' 61' ' ' TYR . . . -44.53 -26.15 0.98 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.732 -1.594 . . . . 0.0 116.175 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -49.67 -30.79 9.69 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.875 1.837 . . . . 0.0 112.686 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.06 -22.57 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.947 0.899 . . . . 0.0 112.379 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.16 -30.62 71.73 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 111.305 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -93.21 8.45 40.18 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.471 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -72.96 172.38 11.06 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.242 0.544 . . . . 0.0 110.594 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.325 0.65 . . . . 0.0 110.426 179.699 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.73 171.77 7.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.573 1.149 . . . . 0.0 110.696 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.71 52.44 0.82 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 109.884 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.47 -103.34 2.21 Favored Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 pt -141.48 -17.08 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.02 -20.43 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.437 0.562 . . . . 0.0 112.019 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -52.82 -26.51 14.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.007 2.123 . . . . 0.0 113.797 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -96.58 0.65 50.34 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.51 1.524 . . . . 0.0 112.31 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.65 118.43 22.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 120.406 1.457 . . . . 0.0 108.581 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.887 HD13 HG12 ' A' ' 74' ' ' VAL . 1.9 mp -83.4 -167.97 1.91 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 123.872 1.796 . . . . 0.0 106.753 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 -19.76 6.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.167 172.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -170.79 170.59 6.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -159.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -170.47 -178.38 2.68 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.862 1.665 . . . . 0.0 109.37 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -125.47 137.96 53.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 164.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.2 43.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 164.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.55 30.17 16.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.099 0.952 . . . . 0.0 112.06 176.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 58.35 25.22 12.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.672 1.189 . . . . 0.0 111.796 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 m -127.29 128.86 46.65 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 128.023 2.529 . . . . 0.0 106.768 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.88 152.96 29.35 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.831 0.853 . . . . 0.0 109.468 174.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -146.28 158.1 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.415 1.086 . . . . 0.0 110.024 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -139.73 164.44 29.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.135 1.774 . . . . 0.0 109.174 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.91 117.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 166.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 -5.78 56.1 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.169 -1.351 . . . . 0.0 113.892 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.55 -177.11 3.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.082 1.941 . . . . 0.0 107.484 165.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.11 157.09 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.257 -1.527 . . . . 0.0 108.524 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.16 162.45 34.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.906 0.775 . . . . 0.0 109.452 170.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.99 162.46 34.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.0 2.467 . . . . 0.0 111.633 163.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -17.08 24.92 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.581 1.153 . . . . 0.0 112.998 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.18 -21.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.057 1.343 . . . . 0.0 112.44 173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.95 -6.59 10.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.882 0.873 . . . . 0.0 112.774 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.81 -33.62 72.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.946 1.248 . . . . 0.0 109.873 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.2 t -49.35 144.3 8.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.644 1.578 . . . . 0.0 109.286 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.785 1.657 . . . . 0.0 113.015 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -54.69 -29.18 52.21 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -116.44 4.22 13.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.688 1.195 . . . . 0.0 111.204 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -80.85 118.07 22.04 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.446 2.299 . . . . 0.0 109.389 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.46 76.88 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -61.54 -30.44 70.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.366 -0.834 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.82 104.77 1.76 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -127.08 -15.03 5.38 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.813 -1.179 . . . . 0.0 113.795 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -30.72 32.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.047 1.294 . . . . 0.0 112.092 -177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -89.03 44.16 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.064 0.847 . . . . 0.0 108.805 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -146.7 -170.28 3.48 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.214 2.206 . . . . 0.0 106.503 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.85 -15.76 24.74 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.654 0.782 . . . . 0.0 111.607 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.96 150.77 96.22 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.05 169.35 20.75 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.609 1.54 . . . . 0.0 109.14 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.49 146.58 79.34 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.8 169.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.99 -167.43 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.518 3.479 . . . . 0.0 111.266 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.16 165.39 11.74 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 165.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.87 46.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.431 1.493 . . . . 0.0 113.026 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.59 23.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.957 2.218 . . . . 0.0 111.686 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 p -140.06 165.12 28.21 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.19 -1.183 . . . . 0.0 111.162 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -147.12 156.26 42.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.201 0.6 . . . . 0.0 111.203 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -77.97 134.41 37.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.945 0.898 . . . . 0.0 109.304 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -127.47 165.7 19.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.926 1.29 . . . . 0.0 109.429 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.11 105.65 15.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.249 1.419 . . . . 0.0 108.392 177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG2' HG22 ' A' ' 62' ' ' VAL . 97.4 mmm -78.53 -154.1 0.07 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.452 1.501 . . . . 0.0 108.934 174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.21 64.94 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 128.909 3.147 . . . . 0.0 111.895 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.61 14.67 79.54 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.448 -1.751 . . . . 0.0 114.569 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.23 159.05 43.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.846 1.823 . . . . 0.0 108.863 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.06 137.23 35.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 57' ' ' MET . 5.8 m -136.19 158.6 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 121.523 -0.736 . . . . 0.0 109.442 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.69 114.3 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.447 1.099 . . . . 0.0 109.066 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.47 144.99 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.102 0.961 . . . . 0.0 110.047 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 p -73.07 137.83 45.52 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -77.8 10.63 2.62 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.682 1.23 . . . . 0.0 113.26 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -139.44 7.68 2.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.749 2.02 . . . . 0.0 110.827 -167.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -167.14 -49.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.937 1.295 . . . . 0.0 109.059 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.45 19.55 17.98 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.174 1.369 . . . . 0.0 112.563 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 131.11 45.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.618 -0.931 . . . . 0.0 110.283 -173.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.76 91.95 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.507 1.523 . . . . 0.0 107.778 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.27 -42.66 25.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.418 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -149.15 155.28 40.43 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.183 0.993 . . . . 0.0 108.531 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.887 HG12 HD13 ' A' ' 10' ' ' LEU . 88.5 t -137.64 125.79 31.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -126.74 119.11 26.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 107.652 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.12 145.0 27.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.485 1.514 . . . . 0.0 111.702 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -7.26 40.02 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.196 -1.565 . . . . 0.0 114.521 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.3 -22.42 62.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.312 1.556 . . . . 0.0 111.049 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 -30.0 45.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-N 120.317 1.417 . . . . 0.0 111.126 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -53.05 -35.93 60.05 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.015 1.326 . . . . 0.0 111.316 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -87.22 20.79 2.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.802 0.841 . . . . 0.0 111.586 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -117.0 49.68 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.992 1.317 . . . . 0.0 111.805 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 115.815 -2.04 . . . . 0.0 108.828 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.9 36.28 1.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.863 2.065 . . . . 0.0 114.431 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.48 69.45 1.21 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.551 1.14 . . . . 0.0 110.839 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.62 -101.46 2.0 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 126.062 1.792 . . . . 0.0 109.924 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 pt -117.99 -21.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.82 -20.6 65.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.735 0.814 . . . . 0.0 111.029 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -65.15 -18.9 65.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.423 1.889 . . . . 0.0 113.969 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -102.69 2.95 36.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.329 1.052 . . . . 0.0 110.975 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 97.4 1.58 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.837 1.199 . . . . 0.0 109.141 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.8 143.31 46.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.0 -12.58 44.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.653 0.206 . . . . 0.0 110.713 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 177.87 164.93 0.67 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.165 2.186 . . . . 0.0 108.19 -164.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -168.56 -175.09 2.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.55 1.54 . . . . 0.0 109.589 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.93 141.88 47.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.83 152.95 38.51 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 162.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.83 30.19 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.289 1.043 . . . . 0.0 112.679 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 56.43 14.74 1.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.583 1.953 . . . . 0.0 113.122 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 m -100.12 117.22 33.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.729 2.012 . . . . 0.0 105.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.99 37.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.8 0.84 . . . . 0.0 109.81 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -148.1 154.01 39.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 110.956 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -146.65 161.86 39.66 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.577 1.551 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.91 122.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.65 7.95 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.014 -1.992 . . . . 0.0 113.867 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.06 -170.32 0.45 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 120.02 1.91 . . . . 0.0 109.871 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.02 160.72 32.82 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.676 1.99 . . . . 0.0 108.74 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 27' ' ' PRO . 20.7 m -107.71 163.74 16.31 Favored Pre-proline 0 N--CA 1.476 0.872 0 O-C-N 120.576 -1.327 . . . . 0.0 112.671 -174.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 41.8 Cg_endo -72.33 163.39 38.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.492 2.795 . . . . 0.0 114.198 169.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.79 66.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 112.23 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.62 -21.92 54.98 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 119.033 0.833 . . . . 0.0 111.044 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 27' ' ' PRO . 22.5 m-85 -109.32 11.09 25.43 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.58 -23.22 19.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.904 . . . . 0.0 111.952 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 t -69.44 147.81 97.0 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.598 0.759 . . . . 0.0 111.107 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.39 -4.62 9.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.609 3.539 . . . . 0.0 113.768 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.57 -22.83 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.16 1.784 . . . . 0.0 113.325 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -121.49 -6.12 9.26 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.636 1.175 . . . . 0.0 111.507 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.79 123.59 20.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.97 1.308 . . . . 0.0 111.047 -172.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -104.27 96.01 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.99 -37.41 87.03 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.567 -0.708 . . . . 0.0 110.36 173.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -89.02 109.06 19.95 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.191 0.996 . . . . 0.0 109.352 -167.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . 0.273 23.0 p-90 -112.83 -47.21 3.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 116.782 -1.58 . . . . 0.0 114.992 -170.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.71 -37.67 76.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.221 1.828 . . . . 0.0 111.11 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -55.7 -36.2 66.92 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.078 0.551 . . . . 0.0 111.932 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -88.97 24.14 2.17 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.095 -1.003 . . . . 0.0 111.397 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.31 6.32 5.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.292 2.637 . . . . 0.0 112.706 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.65 156.06 35.76 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 120.856 -1.152 . . . . 0.0 112.696 -159.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 166.82 25.9 Favored 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.581 4.187 . . . . 0.0 111.277 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.48 153.23 51.08 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.824 1.25 . . . . 0.0 110.478 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -65.46 170.37 11.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.159 1.906 . . . . 0.0 110.364 165.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.76 160.31 32.83 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 103.38 0.56 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.134 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.89 32.59 4.05 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.765 1.65 . . . . 0.0 111.057 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.8 p -150.58 173.6 13.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.613 -1.522 . . . . 0.0 110.239 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -156.09 158.81 38.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.722 0.772 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.97 144.1 37.05 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.801 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -131.93 172.26 12.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.09 1.356 . . . . 0.0 108.87 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.91 122.05 46.4 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.424 ' CG ' HG21 ' A' ' 62' ' ' VAL . 7.9 mmt -90.07 -162.71 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.119 1.367 . . . . 0.0 108.09 167.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.42 -12.02 5.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 127.32 2.39 . . . . 0.0 116.426 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.19 4.93 0.02 OUTLIER Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.888 1.709 . . . . 0.0 112.713 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -129.54 152.26 49.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 110.408 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.81 130.03 44.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.721 1.208 . . . . 0.0 108.602 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 57' ' ' MET . 1.6 m -135.61 155.75 36.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.43 115.81 24.22 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.662 1.585 . . . . 0.0 109.116 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.45 142.06 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.2 1.0 . . . . 0.0 109.396 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.05 143.62 50.66 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 122.753 0.421 . . . . 0.0 110.473 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -66.52 -18.38 65.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 t -120.25 -9.37 9.54 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.26 1.824 . . . . 0.0 110.83 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -144.92 -45.96 0.23 Allowed 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 124.38 1.072 . . . . 0.0 108.89 -165.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 22.4 66.62 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.663 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 131.61 51.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.539 1.17 . . . . 0.0 108.375 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.08 91.12 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 126.678 1.991 . . . . 0.0 105.881 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.36 -55.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.36 148.8 28.57 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.674 0.67 . . . . 0.0 109.568 -169.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -128.89 137.21 57.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -131.14 147.94 52.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.16 155.79 39.28 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.717 -0.615 . . . . 0.0 110.232 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.31 -11.55 59.41 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.796 1.188 . . . . 0.0 112.607 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.1 -32.96 56.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.763 1.625 . . . . 0.0 111.823 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -61.51 -23.33 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.422 0.555 . . . . 0.0 112.117 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -63.07 -30.32 71.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.562 -0.712 . . . . 0.0 111.65 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -77.46 -25.74 50.8 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.459 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -65.06 142.95 58.23 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.283 1.033 . . . . 0.0 109.05 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 . . . . . 0 C--O 1.251 1.15 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.185 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.7 54.13 0.47 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.271 1.428 . . . . 0.0 111.539 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 44.5 50.2 8.21 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 112.903 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.69 -99.73 2.21 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -132.71 -20.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 124.972 1.309 . . . . 0.0 111.671 -165.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.51 -27.86 62.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.426 1.09 . . . . 0.0 112.103 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -53.09 -34.46 56.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.033 1.333 . . . . 0.0 113.067 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.81 -6.82 58.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.886 0.874 . . . . 0.0 111.729 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 101.23 3.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.768 1.167 . . . . 0.0 109.13 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.79 129.15 37.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -64.35 -28.6 69.81 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 120.049 -1.657 . . . . 0.0 110.106 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.81 158.99 39.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.354 0.662 . . . . 0.0 110.145 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CD1' ' CE ' ' A' ' 57' ' ' MET . 54.9 p90 -160.04 -177.99 6.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.984 1.314 . . . . 0.0 110.877 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -133.88 139.21 46.05 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.922 1.289 . . . . 0.0 108.172 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.33 31.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.958 0.903 . . . . 0.0 109.778 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.54 41.25 4.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.951 1.7 . . . . 0.0 112.26 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 59.62 49.14 8.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.529 1.932 . . . . 0.0 111.066 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 m -152.73 144.77 23.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.882 1.673 . . . . 0.0 108.652 168.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.95 147.93 25.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.332 2.253 . . . . 0.0 110.01 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.03 160.25 41.68 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.914 1.686 . . . . 0.0 111.863 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -141.97 169.14 18.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.871 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm -58.85 121.87 7.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 5.87 70.32 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.866 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.66 -172.81 3.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.731 1.766 . . . . 0.0 108.976 160.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.47 139.99 53.24 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 109.001 175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.88 160.23 78.83 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -69.18 166.64 26.2 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.434 2.089 . . . . 0.0 110.261 161.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.0 -23.51 33.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.879 1.272 . . . . 0.0 112.141 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.8 mtp -55.88 -16.84 5.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.248 1.819 . . . . 0.0 113.694 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -118.92 -1.56 10.98 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -24.2 43.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.241 0.928 . . . . 0.0 110.372 171.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.38 154.22 23.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 127.17 2.188 . . . . 0.0 113.618 -174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -67.64 -5.43 14.22 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.434 4.089 . . . . 0.0 113.928 171.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -58.92 -63.89 1.14 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.605 1.162 . . . . 0.0 108.867 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -87.15 2.91 48.42 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.626 1.57 . . . . 0.0 112.709 -168.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -58.08 132.53 53.77 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.892 2.077 . . . . 0.0 110.314 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mm -119.06 80.04 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.529 1.131 . . . . 0.0 108.246 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -52.73 -29.05 24.85 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.017 -1.052 . . . . 0.0 112.099 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 0.45 17.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.705 1.202 . . . . 0.0 113.794 -165.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -59.66 -3.21 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -166.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -40.33 71.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 122.391 2.36 . . . . 0.0 112.908 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -137.54 55.86 1.78 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 110.337 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -137.48 34.88 2.48 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.607 1.163 . . . . 0.0 110.459 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.498 HD21 ' CA ' ' A' ' 83' ' ' ARG . 9.5 m120 75.32 -36.56 0.31 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 129.074 2.95 . . . . 0.0 113.714 172.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.83 149.99 61.66 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 126.212 1.805 . . . . 0.0 110.8 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.02 165.24 33.2 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.591 2.194 . . . . 0.0 111.78 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.76 97.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 165.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.47 172.76 12.71 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.563 2.176 . . . . 0.0 111.303 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 161.34 27.13 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 107.85 0.63 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.934 1.293 . . . . 0.0 110.569 175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.74 9.06 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.456 1.503 . . . . 0.0 112.414 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.5 p -146.63 166.38 26.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.816 1.308 . . . . 0.0 110.958 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -156.04 157.23 35.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.755 0.822 . . . . 0.0 111.259 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.06 130.73 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 p -124.84 154.94 40.23 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 105.8 11.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.603 ' CE ' HD22 ' A' ' 60' ' ' ASN . 8.2 ptm -77.4 -154.48 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.97 62.55 0.01 OUTLIER Glycine 0 C--N 1.334 0.451 1 C-N-CA 131.672 4.463 . . . . 0.0 112.89 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.64 6.75 88.91 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 126.309 1.909 . . . . 0.0 114.457 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.603 HD22 ' CE ' ' A' ' 57' ' ' MET . 14.3 m-80 -125.03 164.76 19.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.57 1.548 . . . . 0.0 106.828 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -95.74 131.71 41.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 74' ' ' VAL . 3.9 m -119.43 149.23 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 120.159 1.345 . . . . 0.0 109.238 170.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.38 119.3 32.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.66 146.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.852 1.261 . . . . 0.0 108.455 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.64 152.48 31.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.06 0.391 . . . . 0.0 111.515 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -34.81 78.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.442 165.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -86.97 -7.87 57.75 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.061 -1.024 . . . . 0.0 111.822 -171.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 70' ' ' LYS . 14.4 pt-20 -155.14 -35.55 0.09 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 172.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.5 49.58 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.813 -172.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -61.75 132.03 51.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.967 0.883 . . . . 0.0 108.95 176.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.88 82.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 129.174 2.989 . . . . 0.0 106.807 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.89 -50.08 58.36 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -145.27 168.09 21.28 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.898 1.279 . . . . 0.0 108.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 62' ' ' VAL . 1.1 p -133.94 149.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 1 C-N-CA 133.786 4.835 . . . . 0.0 105.222 167.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -140.05 130.63 25.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 151.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.34 146.43 9.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.662 0.664 . . . . 0.0 109.526 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.7 -26.82 11.2 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.519 -1.156 . . . . 0.0 113.206 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -54.74 -24.93 24.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.115 1.766 . . . . 0.0 112.161 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -55.98 -33.05 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.062 0.846 . . . . 0.0 110.996 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -61.43 -13.46 20.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.429 1.891 . . . . 0.0 112.433 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -108.16 -8.62 15.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.199 0.909 . . . . 0.0 112.977 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -81.0 34.7 0.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.395 1.878 . . . . 0.0 110.978 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.498 ' CA ' HD21 ' A' ' 44' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 C-N-CA 125.98 1.712 . . . . 0.0 111.641 -156.398 . . . . . . . . 2 2 . 1 stop_ save_